%PDF-1.2
%âãÏÓ
36 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
35 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
18 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
40 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
4 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
11 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
39 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
6 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
8 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
14 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
9 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
31 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
27 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
13 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
19 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
25 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
3 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
12 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
15 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
32 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
21 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
17 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
5 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
7 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
1 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
34 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
23 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
38 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
20 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
22 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
28 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
24 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
37 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
30 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
26 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
16 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
29 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
10 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
33 0 obj
<</Subtype/Form/Filter/FlateDecode/Type/XObject/Matrix [1 0 0 1 0 0]/FormType 1/Resources<</ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<</F1 2 0 R>>>>/BBox[0 0 612 792]/Length 321>>stream
xœ…‘AKÃ@„ïùsL!Ùì&¶iZj[¥ ThÄƒñ°M6v%Ù-›­¥ÿŞ]/ïğ`æ›yï¾’†2ÉQ¶EÌÀ@1.r’eÈó	a”}‚Ñbš¦yE!‹°ÒgÕiŞˆ­Ñ=Ö‡Y’hÕI%:¹7Ü\ÈYvâBjİ'–	£„Qš&U¸Û,7ÕÈÛÆŞ·
½¯[ä³ì–t6[lVñãúy3¾Ë%Ëí<§Ø_°³\µÚ4xQòK˜AÚK„WOÁö‡Œ§+Zá-Í3Iiš½ì„€=”Âô¸j°Ôª‘Vj5 
ÿ+`½,v²¸ş•U#ùïBÂœ:1@·8bíÜXYû7ÚPî~®–ÏÅÇNÖ|ß	,àÖõs	ûŞÇ{’µPƒ•ŸÅuºç¬Ëà<.À
endstream
endobj
42 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
43 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¤à’¯ÈÈ yJ%
endstream
endobj
44 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
45 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¡à’¯ÈÈ €È^
endstream
endobj
46 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
47 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ihªà’¯ÈÈ €™Y
endstream
endobj
48 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
49 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¨à’¯ÈÈ €V
endstream
endobj
50 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
51 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il à’¯ÈÈ €€V
endstream
endobj
52 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
53 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i©à’¯ÈÈ y‰,
endstream
endobj
54 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
55 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id©à’¯ÈÈ €Ç^
endstream
endobj
56 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
57 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘iªà’¯ÈÈ ye(
endstream
endobj
58 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
59 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ilªà’¯ÈÈ €­[
endstream
endobj
60 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
61 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih®à’¯ÈÈ €«[
endstream
endobj
62 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
63 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i à’¯ÈÈ y8#
endstream
endobj
64 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
65 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¡à’¯ÈÈ y€+
endstream
endobj
66 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
67 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¨à’¯ÈÈ €uU
endstream
endobj
68 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
69 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id à’¯ÈÈ €vU
endstream
endobj
70 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
71 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¨à’¯ÈÈ €‰W
endstream
endobj
72 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
73 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¦à’¯ÈÈ yn)
endstream
endobj
74 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
75 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘idªà’¯ÈÈ €£Z
endstream
endobj
76 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
77 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¡à’¯ÈÈ €¾]
endstream
endobj
78 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
79 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¦à’¯ÈÈ €¢Z
endstream
endobj
80 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
81 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¢à’¯ÈÈ €X
endstream
endobj
82 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
83 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¢à’¯ÈÈ y\'
endstream
endobj
84 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
85 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¬à’¯ÈÈ €‡W
endstream
endobj
86 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
87 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¨à’¯ÈÈ yA$
endstream
endobj
88 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
89 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id®à’¯ÈÈ €µ\
endstream
endobj
90 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
91 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¬à’¯ÈÈ €›Y
endstream
endobj
92 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
93 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i®à’¯ÈÈ yw*
endstream
endobj
94 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
95 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¢à’¯ÈÈ €¤Z
endstream
endobj
96 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
97 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¤à’¯ÈÈ €~V
endstream
endobj
98 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
99 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¬à’¯ÈÈ €‘X
endstream
endobj
100 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
101 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¦à’¯ÈÈ €¶\
endstream
endobj
102 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
103 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il¤à’¯ÈÈ €’X
endstream
endobj
104 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
105 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¢à’¯ÈÈ €šY
endstream
endobj
106 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
107 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¦à’¯ÈÈ €¬[
endstream
endobj
108 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
109 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘il®à’¯ÈÈ €¿]
endstream
endobj
110 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
111 0 obj
<</Filter/FlateDecode/Length 36>>stream
xœSä*ä*T0T0 B™œ« ‘i¬à’¯ÈÈ yS&
endstream
endobj
112 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
113 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih à’¯ÈÈ €lT
endstream
endobj
114 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
115 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘id¤à’¯ÈÈ €ˆW
endstream
endobj
116 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
117 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih¡à’¯ÈÈ €´\
endstream
endobj
118 0 obj
<</Filter/FlateDecode/Length 10>>stream
xœ+ä  î |
endstream
endobj
119 0 obj
<</Filter/FlateDecode/Length 37>>stream
xœSä*ä*T0T0 B™œ« ‘ih©à’¯ÈÈ €½]
endstream
endobj
132 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
133 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
121 0 obj
<</Length 10404>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(191)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.018 Tc
0.187 Tw
(controls are being enrolled from two study sites in)Tj
0 -1.2543 TD
0.045 Tc
0.188 Tw
(Ghana \(Accra and Kumasi\) and three in Nigeria)Tj
0 -1.2472 TD
0.009 Tc
0.053 Tw
(\(Enugu, Ibadan and Lagos\). Participants are invited to)Tj
0 -1.2543 TD
0.088 Tw
[(study clinics to obtain detailed epidemiologic, family)59(,)]TJ
0 -1.2472 TD
0.013 Tc
0.187 Tw
(and medical history information. Blood samples are)Tj
T*
0.006 Tc
0 Tw
(drawn to measure glucose, insulin, c-peptide, total cho-)Tj
0 -1.2543 TD
0.009 Tc
0.018 Tw
(lesterol, LDL, HDL, triglycerides, albumin, creatinine,)Tj
0 -1.2472 TD
0.152 Tw
(urea, uric acid, total calcium, and to detect autoanti-)Tj
0 -1.2543 TD
0.083 Tw
(bodies to glutamatic acid decarboxylase. High quality)Tj
0 -1.2472 TD
0.075 Tw
(DNA is isolated for genome analyses. Quality control)Tj
T*
0.094 Tw
(procedures for isolated DNA, including PCR amplifi-)Tj
0 -1.2543 TD
0.084 Tw
(cation with a core set of genomic markers, have been)Tj
0 -1.2472 TD
0.168 Tw
(implemented and routinely performed by the coordi-)Tj
T*
-0.001 Tw
[(nating center at Howard University)66(. )15(W)32(ith full informed)]TJ
0 -1.2543 TD
0.157 Tw
(consent, 162 individuals from 78 families have been)Tj
0 -1.2472 TD
0.144 Tw
(enrolled and examined since field activities began in)Tj
0 -1.2543 TD
0.008 Tc
0.049 Tw
[(June of 1997. )15(At the end of the third year \(September)29(,)]TJ
0 -1.2472 TD
0.002 Tc
0 Tw
[(2000\), the )52(AADM study will have enrolled 400 af)23(fected)]TJ
T*
0.008 Tc
0.076 Tw
[(sib-pairs and 200 spouse controls. )-56(This will provide a)]TJ
0 -1.2543 TD
0.009 Tc
0.024 Tw
(comprehensive epidemiologic and genetic resource for)Tj
0 -1.2472 TD
0.007 Tc
0.072 Tw
[(a powerful genome-wide search for )-56(W)]TJ
16.0016 0 TD
-0.014 Tc
(est )Tj
1.4102 0 TD
0.009 Tc
(African sus-)Tj
-17.4118 -1.2543 TD
0.008 Tc
0.051 Tw
[(ceptibility genes for type 2 diabetes. )-34(This presentation)]TJ
0 -1.2472 TD
0.009 Tc
0.154 Tw
(describes the design and results of the first phase of)Tj
T*
-0.032 Tw
[(the AADM )-46(study)66(.)]TJ
/T15 1 Tf
14 0 0 14 59.981 366.973 Tm
0 Tc
0 Tw
(3)Tj
/F5 1 Tf
8 0 0 8 59.981 349.002 Tm
0.009 Tc
(Glutathione S-transferases and susceptibility to)Tj
T*
0.01 Tc
0.001 Tw
[(peripheral arterial disease \(P)67(AD\) given exposur)24(e to)]TJ
0 -1.2543 TD
0.009 Tc
0 Tw
[(cigar)9(ette smoking: )16(The )52(ARIC Study)]TJ
/F14 1 Tf
0 -1.2472 TD
(R. Li,)Tj
4.8 0 0 4.8 78.973 322.583 Tm
0 Tc
(1)Tj
8 0 0 8 81.411 319.011 Tm
0.009 Tc
-0.046 Tw
[( A.R. )-53(Folsom,)]TJ
4.8 0 0 4.8 127.219 322.583 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 129.657 319.011 Tm
0.009 Tc
0.003 Tw
( R. Sharrett,)Tj
4.8 0 0 4.8 169.342 322.583 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 171.779 319.011 Tm
0.01 Tc
0.007 Tw
[( D. Couper)]TJ
4.8 0 0 4.8 208.063 322.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 210.501 319.011 Tm
(,)Tj
-18.815 -1.2543 TD
0.01 Tc
0.007 Tw
[(M. Bray)67(,)]TJ
4.8 0 0 4.8 88.838 312.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 91.276 308.976 Tm
0.009 Tc
0.008 Tw
[( H.A. )11(T)67(yroler)]TJ
4.8 0 0 4.8 135.269 312.605 Tm
0 Tc
0 Tw
(1)Tj
-15.685 -2.0787 TD
(1)Tj
8 0 0 8 62.476 298.998 Tm
0.01 Tc
0.008 Tw
[(Univ)74(. North Carolina, Chapel Hill, NC, USA; )]TJ
4.8 0 0 4.8 214.469 302.627 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 216.964 298.998 Tm
0.009 Tc
[(Univ)66(.)]TJ
-19.6228 -1.2472 TD
0.013 Tw
[(T)60(exas, Houston, USA; )]TJ
4.8 0 0 4.8 135.893 292.592 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 138.331 289.021 Tm
0.01 Tc
0.018 Tw
[(Univ)67(. Minnesota,)]TJ
-9.7937 -1.2543 TD
0.002 Tw
(Minneapolis, MN, USA; )Tj
4.8 0 0 4.8 142.866 282.614 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 145.304 278.986 Tm
0.011 Tc
0.006 Tw
(NIH/NHLBI, USA)Tj
-9.163 -1.8709 TD
0.026 Tc
0.186 Tw
[(Glutathione S-transferases M1 or )-174(T1 )-7(\(GSTM1/)]TJ
-1.5024 -1.2543 TD
0.009 Tc
0.023 Tw
[(GSTT1\) af)23(fect the body\222)52(s ability to detoxify or to acti-)]TJ
0 -1.2472 TD
0.114 Tw
(vate chemicals in cigarette smoke. Cigarette smoking)Tj
T*
0.1 Tw
[(increases the risk of P)]TJ
9.2976 0 TD
-0.02 Tc
0.205 Tw
[(AD. W)52(e)-29( )]TJ
3.7537 0 TD
0.009 Tc
0.1 Tw
(conducted a cross-sec-)Tj
-13.0513 -1.2543 TD
0.062 Tw
(tional study to evaluate a hypothesized interaction be-)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
[(tween the genetic polymorphisms, GSTM1 and )12(T1, and)]TJ
0 -1.2543 TD
-0.001 Tc
0.001 Tw
[(cigarette smoking on the risk of P)91(AD in the )57(ARIC study)63(.)]TJ
0 -1.2472 TD
0.009 Tc
0.135 Tw
[(A)51( stratified-random sample including 212 P)87(AD cases)]TJ
T*
0.029 Tw
(\(ankle-brachial index <0.9 in men or <0.85 in women\))Tj
0 -1.2543 TD
0.008 Tc
0.056 Tw
[(and 1,277 non-cases were selected from the )-6(ARIC co-)]TJ
0 -1.2472 TD
0.009 Tc
0.095 Tw
(hort of 12,041 middle-aged participants free of CHD,)Tj
0 -1.2543 TD
0.022 Tw
(transient ischemic attack and stroke at baseline \(1986\226)Tj
0 -1.2472 TD
0.149 Tw
[(89\). Smoking was more prevalent among P)87(AD cases)]TJ
T*
0.183 Tw
(than non-cases \(45% vs. 25%, current smoking, and)Tj
0 -1.2543 TD
0.064 Tw
[(58% vs. 29%, smoked 20+ pack-years \(pkyrs\)\). Over)9(-)]TJ
0 -1.2472 TD
0.01 Tc
0.063 Tw
[(all, the dif)24(ference in the proportions of GSTM1-0 and)]TJ
T*
0.009 Tc
0 Tw
(GSTT1-0 \(the homozygous deletion genotype\) was not)Tj
0 -1.2543 TD
0.014 Tc
0.187 Tw
(statistically significant between cases and non-cases)Tj
0 -1.2472 TD
0.008 Tc
0.081 Tw
[(\(44% vs. 41% and 28% vs. 18%\). )-70(There was no indi-)]TJ
25.5047 69.2504 TD
0.009 Tc
0.12 Tw
(cation that GSTM1 modified the association between)Tj
0 -1.2543 TD
0.03 Tc
0.124 Tw
[(smoking and P)101(AD. In contrast, GSTT1-1 \(the non-)]TJ
0 -1.2472 TD
0.029 Tc
0.1 Tw
(deletion genotype\) was associated with greater risk)Tj
0 -1.2543 TD
0.047 Tw
[(of P)93(AD given exposure to smoking after adjustment)]TJ
0 -1.2472 TD
0.026 Tc
0.14 Tw
[(for )7(other )7(risk )7(factors. )-112(The ORs \(95% CIs\) of P)90(A)-11(D)]TJ
T*
0.03 Tc
0.014 Tw
(were 3.6 \(1.4, 9.0\) for current smoking and 5.0 \(1.9,)Tj
0 -1.2543 TD
0.177 Tw
(13.0\) for 20+ pkyrs in individuals with GSTT1-1.)Tj
0 -1.2472 TD
0.027 Tc
0 Tw
[(Given GSTT1-0, the ORs were 0.8 \(0.2, 2.8\) for cur)20(-)]TJ
0 -1.2543 TD
0.106 Tw
[(rent smoking and 0.6 \(0.1, 2.1\) for 20+ pkyrs. )-80(The)]TJ
0 -1.2472 TD
0.029 Tc
0.09 Tw
(interaction was significant \(p<0.05\) on the additive)Tj
T*
0.085 Tw
(scale for current smoking, and on both the additive)Tj
0 -1.2543 TD
0.027 Tc
0 Tw
[(and multiplicative scales for 20+ pkyrs. )55(Among non-)]TJ
0 -1.2472 TD
0.019 Tc
[(smokers, GSTT1-1 was not associated with P)97(AD. )19(The)]TJ
T*
0.027 Tc
(results suggest that the GSTT1-1 polymorphism may)Tj
0 -1.2543 TD
0.029 Tc
0.041 Tw
[(be a susceptibility factor modifying the risk of P)100(A)-8(D)]TJ
0 -1.2472 TD
0.019 Tw
(associated with cigarette smoking.)Tj
/T15 1 Tf
14 0 0 14 264.019 447.024 Tm
0 Tc
0 Tw
(4)Tj
/F5 1 Tf
8 0 0 8 264.019 428.995 Tm
0.009 Tc
[(Likelihood )52(Alternatives to the )16(TDT)]TJ
/F14 1 Tf
T*
0.01 Tc
0.018 Tw
[(M.M.Iles, D.T)74(.Bishop)]TJ
0 -1.2543 TD
0.009 Tc
0.013 Tw
[(ICRF Genetic Epidemiology)59(, Leeds, UK)]TJ
1.4953 -1.8709 TD
0.002 Tc
-0.023 Tw
[(The TDT)16( )-22(\(Spielman )]TJ
/F16 1 Tf
8.348 0 TD
0.001 Tc
0 Tw
(et al.)Tj
/F14 1 Tf
2.0126 0 TD
[( 1993, )58(AJHG 52:506\226516\))]TJ
-11.8559 -1.2543 TD
0.009 Tc
0.121 Tw
[(tests for both association and linkage simultaneously)66(.)]TJ
0 -1.2472 TD
0.149 Tw
(Its main advantage is that it protects against popula-)Tj
T*
0.001 Tc
0 Tw
[(tion ef)22(fects by conditioning on parental genotype. How-)]TJ
0 -1.2543 TD
0.009 Tc
0.04 Tw
[(ever)44(, information from homozygous parents is wasted.)]TJ
0 -1.2472 TD
0.049 Tw
(Although homozygous parents provide no information)Tj
0 -1.2543 TD
0.033 Tw
(about linkage, they provide evidence of population as-)Tj
0 -1.2472 TD
0.01 Tc
(sociation.)Tj
1.4953 -1.2472 TD
0.009 Tc
0.1 Tw
[(V)107(arious tests are proposed using the same nuclear)]TJ
-1.4953 -1.2543 TD
0.006 Tc
0 Tw
[(family data as the )27(TDT)70(,)0( but including homozygous par)20(-)]TJ
0 -1.2472 TD
0.009 Tc
0.127 Tw
(ents. It is shown that extra power is gained by using)Tj
0 -1.2543 TD
0.006 Tc
0.141 Tw
[(all parents to detect deviation from Hardy )-122(W)71(einber)20(g)-9(.)]TJ
0 -1.2472 TD
0.007 Tc
0 Tw
(For instance, one maximum likelihood ratio test is con-)Tj
T*
0.009 Tc
0.115 Tw
(structed using all the data from nuclear families with)Tj
0 -1.2543 TD
0.146 Tw
[(af)23(fected of)16(fspring, making the assumption that trans-)]TJ
0 -1.2472 TD
0.016 Tc
0.187 Tw
(missions from parents are independent \(as does the)Tj
T*
0.01 Tc
0.01 Tw
(TDT\). Using this test, power can be increased by up to)Tj
0 -1.2543 TD
0.009 Tc
0.007 Tw
(10%, although results depend on modes of inheritance,)Tj
0 -1.2472 TD
0.028 Tw
(population frequencies, etc.)Tj
1.4953 -1.2543 TD
0.183 Tw
(It is shown that association at a marker leads to)Tj
-1.4953 -1.2472 TD
0.011 Tc
0.188 Tw
[(more heterozygous parents of af)18(fected children than)]TJ
T*
0.006 Tc
0.164 Tw
[(expected )8(under )8(Hardy )-140(W)78(einber)13(g)76(.)76( )-140(This is detected by)]TJ
0 -1.2543 TD
0.009 Tc
0.013 Tw
[(tests which uses all parents, but not the )9(T)-8(D)-8(T)80(. However)]TJ
0 -1.2472 TD
[(more heterozygotes means extra power for the )17(TDT)73(.)]TJ
1.4953 -1.2543 TD
0.038 Tc
0.187 Tw
(The main concern is that spurious association)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.137 Tw
(caused by either stratification or admixture may lead)Tj
T*
0.025 Tw
[(to an excess of false positive results. However)44(, any in-)]TJ
0 -1.2543 TD
0.111 Tw
[(crease in type 1 error caused by population ef)16(fects is)]TJ
0 -1.2472 TD
0.161 Tw
(minimal. In the test above, under realistic admixture)Tj
T*
0.128 Tw
(models, the type 1 error is increased from a nominal)Tj
0 -1.2543 TD
0.109 Tw
(value of 5% to no more than 8%, under stratification)Tj
0 -1.2472 TD
0.014 Tw
(the same test becomes conservative.)Tj
ET

endstream
endobj
142 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
143 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
141 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
135 0 obj
<</Length 10902>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(192)-2523(Abstracts)]TJ
/T16 1 Tf
14 0 0 14 50.981 633.997 Tm
0 Tc
0 Tw
(5)Tj
/F5 1 Tf
8 0 0 8 50.981 616.989 Tm
0.009 Tc
-0.001 Tw
[(A)44( r)16(egr)23(ession-based transmission/disequilibrium test)]TJ
0 -1.2472 TD
0 Tw
(for binary traits using logit link function)Tj
/F14 1 Tf
0 -1.2543 TD
0.008 Tc
0.001 Tw
[(V)121(.)-1( Geor)15(ge)]TJ
4.8 0 0 4.8 83.863 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 86.301 596.976 Tm
0.01 Tc
0.007 Tw
[(, H.K. )18(T)33(iwari)]TJ
4.8 0 0 4.8 129.898 600.605 Tm
0 Tc
0 Tw
(2)Tj
-16.4409 -2.0906 TD
(1)Tj
8 0 0 8 53.476 586.998 Tm
0.009 Tc
0.007 Tw
[(Medical College of )15(W)39(isconsin, Milwaukee, WI, USA;)]TJ
4.8 0 0 4.8 50.981 580.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 53.476 577.02 Tm
-0.011 Tc
0.009 Tw
[(Case )19(W)83(estern Reserve University)60(, Cleveland, OH, USA.)]TJ
1.1906 -1.7504 TD
0.009 Tc
0.093 Tw
(The transmission/disequilibrium test \(TDT\), origi-)Tj
-1.5024 -1.2543 TD
0.027 Tw
(nally proposed by Spielman, et al for binary traits, is a)Tj
0 -1.2472 TD
0.037 Tc
0.188 Tw
(powerful method for detecting linkage between a)Tj
0 -1.2543 TD
0.009 Tc
0.181 Tw
(marker locus and a disease locus in the presence of)Tj
0 -1.2472 TD
0.002 Tc
0.147 Tw
(allelic association. )Tj
8.1 0 TD
-0.039 Tc
0.328 Tw
[(The T)-52(D)-52(T)-32( )]TJ
4.3464 0 TD
0.009 Tc
0.147 Tw
(uses information on the)Tj
-12.4464 -1.2472 TD
0.011 Tc
0.187 Tw
[(parent-to-of)25(fspring transmission status of the associ-)]TJ
0 -1.2543 TD
0.009 Tc
0.096 Tw
(ated allele at the maker locus to assess linkage or as-)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
[(sociation in the presence of the other)60(. Recently)67(, Geor)10(ge,)]TJ
T*
0.009 Tc
0.054 Tw
[(et al proposed a regression-based )-35(TDT)16( for linkage be-)]TJ
0 -1.2543 TD
0.073 Tw
(tween a marker locus and a quantitative trait locus by)Tj
0 -1.2472 TD
0.171 Tw
(modeling the trait as the dependent variable and the)Tj
0 -1.2543 TD
0.014 Tw
(transmission status as one of the independent variables)Tj
0 -1.2472 TD
0.121 Tw
(along with other predictors and confounders in a lin-)Tj
T*
0.008 Tc
0.045 Tw
[(ear regression model. )-42(This test is very powerful, espe-)]TJ
0 -1.2543 TD
0.009 Tc
0.024 Tw
(cially when the marker locus is close to the trait locus.)Tj
0 -1.2472 TD
0.113 Tw
(In this presentation, we extend this idea to develop a)Tj
0 -1.2543 TD
0.143 Tw
(TDT for linkage between a binary trait locus and an)Tj
0 -1.2472 TD
0.103 Tw
(associated marker locus in nuclear families using lin-)Tj
T*
0.015 Tw
(ear mixed models with logit link function. The method)Tj
0 -1.2543 TD
0.025 Tc
0.188 Tw
(allows for flexible correlation structure among the)Tj
0 -1.2472 TD
0.009 Tc
0.068 Tw
[(members of the nuclear family)52(, and, allows us to esti-)]TJ
T*
0.146 Tw
[(mate the ef)16(fects of other relevant covariates simulta-)]TJ
0 -1.2543 TD
0.007 Tc
0.121 Tw
[(neously with the detection of linkage. )-107(W)72(e)-2( investigate)]TJ
0 -1.2472 TD
0.009 Tc
0.117 Tw
(the statistical power and validity of the test by simu-)Tj
0 -1.2543 TD
0.024 Tw
(lating markers at various recombination fractions from)Tj
0 -1.2472 TD
0.009 Tw
(the trait locus.)Tj
/T16 1 Tf
14 0 0 14 50.981 275.017 Tm
0 Tc
0 Tw
(6)Tj
/F5 1 Tf
8 0 0 8 50.981 258.009 Tm
0.009 Tc
[(Multipoint extension of the )9(WPC linkage method)]TJ
0 -1.2543 TD
0.002 Tw
[(for)16( large pedigr)16(ees with application to br)23(east)]TJ
0 -1.2472 TD
0.005 Tw
(cancer and alcoholism familial data.)Tj
/F14 1 Tf
T*
(A. Zinn-Justin)Tj
4.8 0 0 4.8 98.32 231.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 100.758 228.019 Tm
0.01 Tc
-0.046 Tw
[(,)6( A. )-52(Ziegler)]TJ
4.8 0 0 4.8 138.232 231.591 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 140.669 228.019 Tm
0.008 Tc
0.009 Tw
[(, L. )43(Abel)]TJ
4.8 0 0 4.8 169.526 231.591 Tm
0 Tc
0 Tw
(1)Tj
-24.6968 -2.0787 TD
(1)Tj
8 0 0 8 53.476 217.984 Tm
0.009 Tc
0.005 Tw
(INSERM U.436, Paris, France; )Tj
4.8 0 0 4.8 157.847 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 160.285 217.984 Tm
0.009 Tc
0.006 Tw
(Institute of Medical)Tj
-13.663 -1.2472 TD
0.026 Tw
[(Biometry & Epidemiology)59(, Philipps-University of)]TJ
T*
0.038 Tw
[(Marbur)9(g, Germany)52(.)]TJ
1.5024 -1.7504 TD
-0.011 Tc
0.135 Tw
(The non parametric \(model free\) method of linkage)Tj
-1.5024 -1.2543 TD
0.061 Tw
[(analysis )-54(WPC \(W)80(eighted Pairwise Correlation\) proposed)]TJ
0 -1.2472 TD
0.044 Tw
[(by Commenges [Genet Epidemiol 1994, 1)32(1:189\226200] al-)]TJ
0 -1.2543 TD
-0.01 Tc
0.138 Tw
(lows to analyze any kind of phenotype and to consider)Tj
0 -1.2472 TD
-0.011 Tc
0.086 Tw
[(all pairs of relatives in lar)10(ge pedigrees. )-8(W)61(e)-20( )]TJ
17.5674 0 TD
0.009 Tc
0.088 Tw
(recently ex-)Tj
-17.5674 -1.2472 TD
0.008 Tc
0.057 Tw
[(tended )6(the )-47(WPC method to introduce Identical by De-)]TJ
0 -1.2543 TD
0.045 Tc
0.187 Tw
(scent \(IBD\) information [Genet Epidemiol 1999,)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
[(17:35\22650]. Here, we propose a multipoint )16(WPC method)]TJ
T*
0.009 Tc
0.025 Tw
[(suitable for extended pedigrees with a lar)16(ge number of)]TJ
0 -1.2543 TD
0.072 Tw
(markers. For each pair of relative, the multipoint IBD)Tj
0 -1.2472 TD
0.01 Tc
0.053 Tw
(sharing is computed using the SOLAR package as de-)Tj
25.5047 69.2504 TD
-0.008 Tc
0.175 Tw
(scribed by )Tj
4.7835 0 TD
0.01 Tc
(Almasy and Blangero [Am J Hum Genet)Tj
-4.7835 -1.2543 TD
0.009 Tc
0 Tw
[(1998, 62:1)37(198\226121)37(1]. )59(A)51( valid )16(WPC test is obtained us-)]TJ
0 -1.2472 TD
0.108 Tw
(ing a new within-family Monte Carlo \(MC\) permuta-)Tj
0 -1.2543 TD
0.118 Tw
(tion procedure in which phenotypic resemblances are)Tj
0 -1.2472 TD
0.066 Tw
(permuted with IBD sharing for pairs of relatives from)Tj
T*
0.005 Tc
0 Tw
[(the same degree. )19(This procedure allows to compute fast)]TJ
0 -1.2543 TD
0.007 Tc
0.127 Tw
[(MC p-values and an empirical variance for the )-107(WPC)]TJ
0 -1.2472 TD
-0.01 Tc
(statistic. )Tj
3.7701 0 TD
0.009 Tc
0.181 Tw
(Application of the method to the 214 pedi-)Tj
-3.7701 -1.2543 TD
0.008 Tc
0 Tw
(grees from the Breast Cancer Linkage Consortium pro-)Tj
0 -1.2472 TD
0.007 Tc
0.187 Tw
(vided for the Genetic )Tj
9.7583 0 TD
-0.008 Tc
0.387 Tw
[(Analysis W)]TJ
4.9394 0 TD
0.016 Tc
0.187 Tw
[(orkshop \(GA)80(W\) 9)]TJ
-14.6976 -1.2472 TD
0.006 Tc
0.167 Tw
[(shows )7(that )7(multipoint )-140(WPC statistic values were not)]TJ
0 -1.2543 TD
0.003 Tc
0 Tw
(far from lod score values obtained by the classical para-)Tj
0 -1.2472 TD
0 Tc
0.162 Tw
[(metric linkage method. )-156(The multipoint )]TJ
16.8378 0 TD
0.009 Tc
0.163 Tw
(WPC method)Tj
-16.8378 -1.2472 TD
0.125 Tw
(was also used to analyze the familial COGA data on)Tj
0 -1.2543 TD
0.086 Tw
[(alcoholism released for GA)80(W1)37(1, and allowed a better)]TJ
0 -1.2472 TD
0.02 Tw
(specification of the linkage results previously obtained)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
[(within the chromosome 4 region [Zinn-Justin and )55(Abel,)]TJ
0 -1.2472 TD
0.009 Tc
0.015 Tw
(Genet Epidemiol, in press].)Tj
/T16 1 Tf
14 0 0 14 255.019 433.02 Tm
0 Tc
0 Tw
(7)Tj
/F5 1 Tf
8 0 0 8 255.019 416.976 Tm
0.01 Tc
0.006 Tw
[(Evaluation of average lod scor)17(e and estimated size)]TJ
T*
0.009 Tc
0.004 Tw
(of modeled effects in a variance components)Tj
T*
0.012 Tc
[(appr)26(oach)]TJ
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
-0.011 Tw
[(Y)51(i)8(n)8( Y)100(ao )-24(Shugart)]TJ
4.8 0 0 4.8 309.047 390.614 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 311.485 386.986 Tm
0.009 Tc
0.013 Tw
[(, Jef)16(f O\222Connell)]TJ
4.8 0 0 4.8 364.55 390.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 366.987 386.986 Tm
0.009 Tc
-0.032 Tw
[(,)11( Alexander )-35(W)32(ilson)]TJ
4.8 0 0 4.8 430.087 390.614 Tm
0 Tc
0 Tw
(3)Tj
-36.4724 -2.0906 TD
(1)Tj
8 0 0 8 257.457 377.008 Tm
0.008 Tc
0.019 Tw
[(Johns Hopkins University)65(, Baltimore, )]TJ
4.8 0 0 4.8 383.428 380.58 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 385.866 377.008 Tm
0.009 Tc
0.025 Tw
(University of)Tj
-16.3559 -1.2543 TD
0.008 Tc
0.01 Tw
[(Pittsbur)15(gh, Pittsbur)15(gh, )]TJ
4.8 0 0 4.8 330.364 370.602 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 332.802 366.973 Tm
0.01 Tc
0.013 Tw
(NIH/NHGRI, Baltimore, USA)Tj
-8.2276 -1.6228 TD
0.007 Tc
0 Tw
(The variance components approach implemented in)Tj
-1.4953 -1.2472 TD
0.01 Tc
(the Beta version of GENEHUNTER 2 \(GH2\) was used)Tj
0 -1.2543 TD
0.009 Tc
0.031 Tw
(to determine average lod scores \(ALS\) and to estimate)Tj
0 -1.2472 TD
0.049 Tw
(the size of single locus \(SL\) and polygenic \(PG\) com-)Tj
T*
0.047 Tw
[(ponents for four dif)23(ferent genetic models. Each gener)9(-)]TJ
0 -1.2543 TD
0.119 Tw
(ating model contained 100 families of sibship size 5.)Tj
0 -1.2472 TD
0.068 Tw
(For each model, 2000 replicates were simulated using)Tj
0 -1.2543 TD
0.089 Tw
[(G.A.S.P)115(. \(W)30(ilson et al 1997\). In model 1, 30% of the)]TJ
0 -1.2472 TD
0.01 Tc
0.014 Tw
(variance was due to a major locus and 70% was due to)Tj
T*
0.009 Tc
0.054 Tw
(random environment. In models 2\2264, 30% of the vari-)Tj
0 -1.2543 TD
0.11 Tw
(ance was attributed to a major locus, 40% to random)Tj
0 -1.2472 TD
0.105 Tw
(environment, and 30% to other factors. More specifi-)Tj
T*
0.042 Tw
[(cally)66(, model 2 contained an unlinked second major lo-)]TJ
0 -1.2543 TD
0.055 Tw
(cus, model 3 had a polygenic component and model 4)Tj
0 -1.2472 TD
0.188 Tw
(had a common environmental component. )Tj
18.574 0 TD
-0.045 Tc
0.374 Tw
[(The A)-64(L)-64(S)]TJ
-18.574 -1.2543 TD
0.01 Tc
0.168 Tw
(generated under model 1 was 1.4, compared to 1.74)Tj
0 -1.2472 TD
0.007 Tc
0.088 Tw
(and 1.72 for model 2 and 3. )Tj
12.1748 0 TD
-0.022 Tc
(The )Tj
1.8709 0 TD
0.009 Tc
(ALS nearly doubled)Tj
-14.0457 -1.2472 TD
0.007 Tw
(\(2.57\) when a common sibship environment was simu-)Tj
0 -1.2543 TD
0.117 Tw
(lated in model 4. In model 1\2263, GH2 underestimated)Tj
0 -1.2472 TD
0.047 Tw
(the variance attributed to the SL component, while in-)Tj
0 -1.2543 TD
0.125 Tw
(flating the variance attributed to the PG component .)Tj
0 -1.2472 TD
0.086 Tw
[(In model 4, however)44(, the environmental variance was)]TJ
T*
0.01 Tc
0.062 Tw
[(also underestimated \(1)45(1%\) while the PG variance was)]TJ
0 -1.2543 TD
0.184 Tw
[(severely overestimated \(64%\). )-171(The )-7(variance )-7(compo-)]TJ
0 -1.2472 TD
0.009 Tc
0.064 Tw
(nents approach in GH2 appears to underestimate vari-)Tj
T*
0.179 Tw
(ance attributed to a SL component and overestimate)Tj
0 -1.2543 TD
0.005 Tw
(variance attributed to a PG component in all four mod-)Tj
0 -1.2472 TD
0.011 Tw
(els regardless the source of variation.)Tj
ET

endstream
endobj
154 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
155 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
153 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
152 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
145 0 obj
<</Length 11049>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(193)]TJ
/T17 1 Tf
14 0 0 14 59.981 633.997 Tm
0 Tc
0 Tw
(8)Tj
/F5 1 Tf
8 0 0 8 59.981 616.989 Tm
0.009 Tc
0.003 Tw
(Bias and efficiency in family-matched gene)Tj
0 -1.2472 TD
[(association studies: Conditional, pr)9(ospective,)]TJ
0 -1.2543 TD
0 Tw
[(r)14(etr)23(ospective, and joint likelihoods)]TJ
/F14 1 Tf
0 -1.2472 TD
0.004 Tw
[(P)34( Kraft, DC )9(Thomas)]TJ
T*
0.012 Tw
[(University of Southern California, Los )44(Angeles, CA,)]TJ
0 -1.2543 TD
0.011 Tc
(USA.)Tj
1.5024 -1.7504 TD
0.028 Tc
0 Tw
[(W)79(e)0( revisit the standard conditional likelihood for)]TJ
-1.5024 -1.2472 TD
0.032 Tc
0.187 Tw
(stratum-matched case-control studies and consider)Tj
0 -1.2543 TD
0.029 Tc
0.107 Tw
(three alternatives that may be more appropriate for)Tj
0 -1.2472 TD
0.156 Tw
(family-matched gene association studies: First, the)Tj
T*
0.083 Tw
(ascertainment-corrected prospective likelihood, that)Tj
0 -1.2543 TD
0.134 Tw
(is, Pr\(D|G,A\); second, the retrospective likelihood,)Tj
0 -1.2472 TD
0.003 Tw
(Pr\(G|D\); and third, the ascertainment-corrected joint)Tj
T*
0.019 Tc
-0.001 Tw
[(likelihood, Pr\(D,G|A\). )18(W)77(e)1( show that these likeli)]TJ
20.1189 0 TD
-0.002 Tc
(hoods)Tj
-20.1189 -1.1906 TD
0.009 Tc
0.005 Tw
(provide unbiased estimators of genetic relative risk pa-)Tj
T*
0.098 Tw
(rameters, as well as population allele frequencies and)Tj
0 -1.1835 TD
-0.002 Tc
0.159 Tw
(baseline risks. )Tj
6.3638 0 TD
0.009 Tc
(The parameter estimates based on the)Tj
-6.3638 -1.1906 TD
0.003 Tc
0 Tw
(retrospective likelihood remain unbiased even when the)Tj
0 -1.1835 TD
0.009 Tc
0.143 Tw
(ascertainment scheme cannot be modeled, as long as)Tj
0 -1.1905 TD
0.009 Tw
(ascertainment only depends on families\222 phenotypes.)Tj
1.5024 -1.1835 TD
-0.011 Tc
0.188 Tw
(Despite the need to estimate additional parameters,)Tj
-1.5024 -1.1906 TD
0.168 Tw
(the prospective, retrospective, and joint likelihoods can)Tj
T*
-0.017 Tc
0 Tw
[(lead to considerable gains in ef)18(ficiency relative to the stan-)]TJ
0 -1.1835 TD
-0.013 Tc
0.1 Tw
[(dard conditional likelihood. )-84(This is true if baseline risks)]TJ
0 -1.1906 TD
-0.019 Tc
0 Tw
(and allele frequencies can be assumed to be homogeneous.)Tj
1.5024 -1.1835 TD
0.009 Tc
0.089 Tw
[(In the presence of heterogeneity)66(, however)37(, the pa-)]TJ
-1.5024 -1.1905 TD
0.111 Tw
(rameter estimates assuming homogeneity can be seri-)Tj
0 -1.1835 TD
0.007 Tc
0 Tw
[(ously biased. )14(W)79(e)0( discuss the extent of this problem and)]TJ
0 -1.1905 TD
0.009 Tc
0.155 Tw
(present a mixed models approach for providing con-)Tj
T*
0.023 Tw
(sistent parameter estimates when baseline risks and al-)Tj
0 -1.1835 TD
0.006 Tc
0.15 Tw
[(lele frequencies are heterogeneous. )-142(W)78(e)-4( also compare)]TJ
0 -1.1906 TD
0.009 Tc
0.144 Tw
[(the ef)16(ficiency of the mixed-model prospective, retro-)]TJ
0 -1.1835 TD
0 Tw
[(spective, and joint likelihoods to the ef)16(ficiency of stan-)]TJ
0 -1.1905 TD
0.038 Tw
(dard conditional likelihood.)Tj
/T17 1 Tf
14 0 0 14 59.981 255.005 Tm
0 Tc
0 Tw
(9)Tj
/F5 1 Tf
8 0 0 8 59.981 237.997 Tm
0.009 Tc
0.001 Tw
[(Effects of Stratification in the )52(Analysis of )59(Affected)]TJ
0 -1.2472 TD
0 Tw
(Sib-Pair Data.)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.006 Tw
[(Suzanne M. Leal and Jur)10(g Ott)]TJ
0 -1.2472 TD
0.009 Tc
0.009 Tw
(Laboratory of Statistical Genetics, The Rockefeller)Tj
T*
0.01 Tc
0.011 Tw
[(University)60(, New )32(Y)101(ork, NY)]TJ
1.5024 -1.7504 TD
-0.011 Tc
0.068 Tw
[(The benefits and costs of stratifying af)24(fected sib-pair)]TJ
-1.5024 -1.2543 TD
0.176 Tw
(\(ASP\) data are examined in three situations where. 1.\))Tj
0 -1.2472 TD
0.04 Tw
[(There is no dif)17(ference in identity-by-descent \(IBD\) allele)]TJ
0 -1.2543 TD
0.054 Tw
[(sharing between stratified and unstratified )-12(ASP)45( data sets.)]TJ
0 -1.2472 TD
-0.054 Tc
(2.\) )Tj
1.4032 0 TD
-0.011 Tc
0.126 Tw
(There is an increase in IBD allele sharing in one of)Tj
-1.4032 -1.2472 TD
0.039 Tw
[(the stratified groups. 3.\) )-26(The data is stratified based upon)]TJ
0 -1.2543 TD
0.113 Tw
(IBD allele sharing status at one locus, and the stratified)Tj
0 -1.2472 TD
0.009 Tw
(ASPs are then analyzed for linkage at a second locus.)Tj
1.5024 -1.2472 TD
0.01 Tc
0.184 Tw
[(Where there is no dif)17(ference in IBD sharing be-)]TJ
-1.5024 -1.2543 TD
0.009 Tc
0.173 Tw
(tween strata, a penalty is always paid for stratifying)Tj
0 -1.2472 TD
-0.011 Tc
0.185 Tw
(the data. )Tj
4.0819 0 TD
0.009 Tc
(The loss of power to detect linkage in the)Tj
21.4228 69.2504 TD
-0.002 Tc
0.167 Tw
[(stratified A)-13(S)-13(P)33( )]TJ
6.1358 0 TD
0.009 Tc
0.108 Tw
(data sets is due to multiple testing and)Tj
-6.1358 -1.2543 TD
0.011 Tw
(the smaller sample size within individual strata.)Tj
1.4953 -1.2472 TD
-0.011 Tc
0.098 Tw
[(In the case where etiologic heterogeneity \(i.e. sever)17(-)]TJ
-1.4953 -1.2543 TD
0.046 Tw
(ity of phenotype, age of onset\) represents genetic hetero-)Tj
0 -1.2472 TD
0.085 Tw
[(geneity)60(, the power to detect linkage can be increased by)]TJ
T*
0.032 Tw
[(stratifying )23(A)-6(S)-6(P)38( data. )-19(This benefit is obtained where there)]TJ
0 -1.2543 TD
0.008 Tw
[(is suf)24(ficient IBD allele sharing and sample sizes.)]TJ
1.4953 -1.2472 TD
0.009 Tc
0.111 Tw
(Once linkage has been established for a given lo-)Tj
-1.4953 -1.2543 TD
0.182 Tw
(cus, data can be stratified based upon IBD status at)Tj
0 -1.2472 TD
0.066 Tw
(this locus, and tested at a second locus for linkage. In)Tj
T*
0.075 Tw
(the case where the relative risk is in the vicinity of 1,)Tj
0 -1.2543 TD
0.113 Tw
(the power to detect linkage at the second locus is al-)Tj
0 -1.2472 TD
0.006 Tc
0.176 Tw
[(ways greater for the unstratified )-124(ASP)41( )-6(data )-6(set. )-6(Even)]TJ
T*
-0.001 Tw
[(for values of the relative risk which suf)19(ficiently diver)19(ge)]TJ
0 -1.2543 TD
0.002 Tc
0 Tw
[(from 1, with adequate sample sizes and IBD allele shar)16(-)]TJ
0 -1.2472 TD
0.008 Tc
0.009 Tw
[(ing, the benefits of stratifying )44(ASP)29( data are minimal.)]TJ
1.4953 -1.2543 TD
0.03 Tc
0.188 Tw
(Although stratification can be advantageous, it)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.079 Tw
(should be carried out with caution in order to avoid a)Tj
T*
0.013 Tw
(potential loss in power to detect linkage.)Tj
/T17 1 Tf
14 0 0 14 264.019 419.981 Tm
-0.021 Tc
(10)Tj
/F5 1 Tf
8 0 0 8 264.019 402.973 Tm
0.009 Tc
0.004 Tw
[(Detection of a dominant major)16( gene pr)23(edisposing)]TJ
T*
0.002 Tw
[(to HTL)94(V)79(-I infection in a Noir)30(-Marr)16(on population)]TJ
T*
0.01 Tc
-0.001 Tw
[(of Fr)17(ench Giuana.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.006 Tw
(S. Plancoulaine)Tj
4.8 0 0 4.8 314.929 376.611 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 321.109 372.983 Tm
0.008 Tc
-0.044 Tw
[(, A. )-52(Gessain)]TJ
4.8 0 0 4.8 360.794 376.611 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 363.231 372.983 Tm
0.009 Tc
0.006 Tw
[(, R.P)108(. Buigues,)]TJ
-12.4016 -1.1835 TD
-0.003 Tw
[(P)111(.)12( T)67(ortevoye)]TJ
4.8 0 0 4.8 304.668 367.087 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 307.162 363.515 Tm
0.009 Tc
0.009 Tw
(, M. Joubert)Tj
4.8 0 0 4.8 346.847 367.087 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 349.285 363.515 Tm
0.009 Tc
0.01 Tw
(, I. Jeanne)Tj
4.8 0 0 4.8 382.734 367.087 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 385.172 363.515 Tm
0.007 Tc
-0.033 Tw
[(,)6( A. )-35(T)65(alarmin)]TJ
4.8 0 0 4.8 428.315 367.087 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 430.753 363.515 Tm
(,)Tj
-20.8417 -1.1906 TD
0.009 Tc
0.003 Tw
[(G. de )16(Th\351)]TJ
4.8 0 0 4.8 296.39 357.619 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 298.828 353.991 Tm
0.009 Tc
0.006 Tw
[(, L. )44(Abel)]TJ
4.8 0 0 4.8 327.628 357.619 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 330.066 353.991 Tm
(.)Tj
4.8 0 0 4.8 264.019 348.094 Tm
(1)Tj
8 0 0 8 266.457 344.523 Tm
0.01 Tc
0.002 Tw
(INSERM U 436, Paris, France\240; )Tj
4.8 0 0 4.8 372.869 348.094 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 375.364 344.523 Tm
0.009 Tc
0.006 Tw
(Institut Pasteur de)Tj
-13.9181 -1.1905 TD
(Paris, France\240; )Tj
4.8 0 0 4.8 313.285 338.627 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 315.723 334.998 Tm
0.009 Tc
0.01 Tw
(Institut Pasteur de Guyane, Cayenne,)Tj
-6.463 -1.1906 TD
0.009 Tw
(Guyane fran\347aise; )Tj
4.8 0 0 4.8 325.474 329.102 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 327.968 325.474 Tm
0.009 Tc
0.013 Tw
(Centre de Sant\351, Maripasoula,)Tj
-7.9937 -1.1835 TD
0.01 Tc
0.025 Tw
(Guyane fran\347aise.)Tj
1.4953 -1.6866 TD
0.034 Tc
0.188 Tw
[(T)64(o)0( investigate whether familial aggregation of)]TJ
-1.4953 -1.1905 TD
0.009 Tc
0.187 Tw
[(HTL)94(V)93(-I seropositivity could be explained in part by)]TJ
0 -1.1835 TD
0.037 Tw
[(genetic factors, we conducted a lar)23(ge genetic epidemi-)]TJ
0 -1.1906 TD
0.033 Tc
0.187 Tw
(ology survey in an endemic population of French)Tj
0 -1.1835 TD
0.009 Tc
0.022 Tw
[(Guiana. )30(All families of two Noir)16(-Marron villages were)]TJ
0 -1.1906 TD
0.05 Tw
(included representing 94 pedigrees with 1567 subjects)Tj
T*
0.168 Tw
(\(730 females, 837 males\)\240of whom 151 \(9.6%\) were)Tj
0 -1.1835 TD
0.007 Tc
0 Tw
[(H)-6(T)-6(L)99(V)91(-I positive. )14(The familial segregation analysis was)]TJ
0 -1.1906 TD
0.009 Tc
0.175 Tw
(performed with regressive logistic models which are)Tj
0 -1.1835 TD
0.186 Tw
(testing for the presence of a major gene taking into)Tj
0 -1.1906 TD
0.027 Tw
[(account simultaneously covariates influencing HTL)94(V)93(-)2(I)]TJ
0 -1.1835 TD
0.184 Tw
(infection \(e.g. age and gender\) and other sources of)Tj
0 -1.1905 TD
0.163 Tw
(familial dependencies \(e.g. due to virus transmission)Tj
T*
0.077 Tw
(routes\). Results show the presence of a dominant ma-)Tj
0 -1.1835 TD
0.089 Tw
[(jor gene predisposing to HTL)94(V)93(-I infection in addition)]TJ
0 -1.1906 TD
0 Tw
[(to the expected familial correlations \(mother)16(-of)16(fspring,)]TJ
0 -1.1835 TD
0.168 Tw
(spouse-spouse\) due to the transmission routes of the)Tj
0 -1.1905 TD
0.008 Tc
0 Tw
[(virus. )15(The Mendelian transmission hypothesis was bor)22(-)]TJ
0 -1.1835 TD
0.007 Tc
0.086 Tw
(derline rejected \(p=0.03\) when using a )Tj
/F17 1 Tf
16.5756 0 TD
0 Tc
0 Tw
(c)Tj
/F14 1 Tf
4.8 0 0 4.8 401.159 135.099 Tm
(2)Tj
8 0 0 8 403.597 131.528 Tm
0.009 Tc
0.087 Tw
[( distribution)]TJ
-17.4472 -1.1906 TD
0.044 Tw
[(with 3 dfs. However)44(, simulation studies show that, for)]TJ
T*
0.01 Tc
0.187 Tw
(this latter test, the use of an asymptotic distribution)Tj
0 -1.1835 TD
-0.011 Tc
0.119 Tw
(was inappropriate and the empirical p value was >0.05,)Tj
0 -1.1906 TD
0.07 Tw
[(indicating that HTL)95(V)87(-I familial data are compatible with)]TJ
0 -1.1835 TD
-0.006 Tc
0.188 Tw
(the segregation of a dominant major gene. Under this)Tj
ET

endstream
endobj
165 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
164 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
163 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
157 0 obj
<</Length 10742>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(194)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.035 Tw
(dominant model, about 2% of the population is predicted)Tj
0 -1.2543 TD
-0.01 Tc
0.043 Tw
[(to be highly predisposed to HTL)96(V)88(-I infection, and serop-)]TJ
0 -1.2472 TD
-0.011 Tc
0.006 Tw
(ositive children <10 years are genetic cases whereas most)Tj
0 -1.2543 TD
0.158 Tw
[(H)-6(T)-6(L)95(V)87(-I seropositive adults are sporadic cases. Linkage)]TJ
0 -1.2472 TD
0.042 Tw
(and association studies with genetic markers are ongoing)Tj
T*
0.013 Tw
(to confirm and identify these genetic factors.)Tj
/T18 1 Tf
14 0 0 14 50.981 549.978 Tm
-0.021 Tc
(11)Tj
/F5 1 Tf
8 0 0 8 50.981 532.97 Tm
0.009 Tc
0 Tw
[(Multilocus linkage tests based on affected r)16(elative)]TJ
T*
0.007 Tc
(pairs)Tj
/F14 1 Tf
T*
0.01 Tc
0.007 Tw
[(Heather J. Cordell, Geof)10(frey C. )16(W)75(edig, Kevin B.)]TJ
0 -1.2543 TD
0.012 Tw
(Jacobs, Robert C. Elston)Tj
0 -1.2472 TD
0.009 Tc
0.018 Tw
(Department of Epidemiology and Biostatistics, Case)Tj
T*
0.011 Tw
[(W)74(estern Reserve University)66(, Cleveland, Ohio, USA)]TJ
1.5024 -1.7504 TD
0.162 Tw
(For complex diseases, methods that take into ac-)Tj
-1.5024 -1.2543 TD
0.006 Tw
[(count joint ef)16(fects at several interacting loci are of par)16(-)]TJ
0 -1.2472 TD
0.05 Tw
[(ticular interest. Conditioning on ef)9(fects of disease loci)]TJ
0 -1.2543 TD
0.061 Tw
(at known locations can lead to increased power to de-)Tj
0 -1.2472 TD
0.107 Tw
[(tect ef)16(fects at other loci. Moreover)37(, use of multilocus)]TJ
T*
0.004 Tc
0 Tw
(models allows modeling of etiological mechanisms that)Tj
0 -1.2543 TD
0.017 Tc
0.188 Tw
(may be involved in the disease. Here we present a)Tj
0 -1.2472 TD
0.009 Tc
0.099 Tw
(method for simultaneously analyzing joint genetic ef-)Tj
T*
0.109 Tw
[(fects at several linked or unlinked loci using af)16(fected)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
[(relative pairs. )12(W)84(e)0( express the relative risk, )]TJ
/F17 1 Tf
17.4331 0 TD
0 Tc
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 194.924 377.802 Tm
(R)Tj
8 0 0 8 198.156 378.992 Tm
0.004 Tc
(, to a rela-)Tj
-18.3968 -1.2472 TD
0.009 Tc
0.077 Tw
[(tive of an af)16(fected individual, in terms of the additive)]TJ
0 -1.2543 TD
0.01 Tc
0.187 Tw
(and epistatic components of variance at an arbitrary)Tj
0 -1.2472 TD
0.009 Tc
0.01 Tw
(number of disease loci, and show how this can be used)Tj
T*
0.051 Tw
(to fit a likelihood model to the multilocus identity-by-)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
[(descent sharing among pairs of af)15(fected relatives in ex-)]TJ
0 -1.2472 TD
0 Tc
0.183 Tw
[(tended pedigrees. )-185(W)79(e)0( implement the method )]TJ
19.5236 0 TD
-0.011 Tc
0.188 Tw
(using a)Tj
-19.5236 -1.2543 TD
0.085 Tw
(stepwise strategy in which, given evidence of linkage to)Tj
0 -1.2472 TD
-0.017 Tc
0.053 Tw
(disease at )Tj
/F16 1 Tf
4.0961 0 TD
0 Tc
0 Tw
(m)Tj
/F14 1 Tf
0.7157 0 TD
-0.011 Tc
0.055 Tw
(-1 locations on the genome, we calculate the)Tj
-4.8118 -1.2472 TD
-0.014 Tc
0 Tw
(conditional likelihood curve across the genome for an )Tj
/F16 1 Tf
21.0331 0 TD
0 Tc
(m)Tj
/F14 1 Tf
0.7158 0 TD
-0.02 Tc
(th)Tj
-21.7488 -1.2543 TD
-0.011 Tc
0.103 Tw
(disease locus, using multipoint methods similar to those)Tj
0 -1.2472 TD
0 Tw
(implemented in MAPMAKER/SIBS. In analysis of simu-)Tj
T*
0.117 Tw
(lated data, our method shows increased power to detect)Tj
0 -1.2543 TD
0 Tw
[(non-multiplicative ef)9(fects compared to single-locus meth-)]TJ
0 -1.2472 TD
-0.052 Tc
0.361 Tw
[(ods. W)42(e)-41( )]TJ
3.6812 0 TD
-0.011 Tc
0.167 Tw
(apply the method to real data from a genome)Tj
-3.6812 -1.2543 TD
0.153 Tw
(screen for type 1 diabetes, and find increased evidence)Tj
0 -1.2472 TD
0.051 Tw
[(for disease loci on chromosomes 6, 8, 1)24(1, 15, 16 and 18,)]TJ
T*
0.017 Tw
(when multilocus models are used.)Tj
/T18 1 Tf
14 0 0 14 50.981 170.986 Tm
-0.021 Tc
(12)Tj
/F5 1 Tf
8 0 0 8 50.981 153.978 Tm
0.009 Tc
0.009 Tw
(Demography of Genotypes: The Italian)Tj
T*
0.008 Tc
0 Tw
(Centenarians Study)Tj
/F14 1 Tf
T*
0.009 Tc
[(Y)93(ashin)]TJ
4.8 0 0 4.8 73.375 137.594 Tm
0 Tc
(1)Tj
8 0 0 8 75.813 134.022 Tm
0.009 Tc
0.007 Tw
[( )53(A.I., De Benedictis)]TJ
4.8 0 0 4.8 140.613 137.594 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 143.05 134.022 Tm
0.009 Tc
0.007 Tw
[( G., V)107(aupel1 J,W)94(.,)]TJ
-11.5087 -1.2543 TD
0.01 Tc
(Andreev)Tj
4.8 0 0 4.8 79.101 127.616 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 81.539 123.987 Tm
0.01 Tc
0.009 Tw
[( K.F)88(., )13(T)68(a)4(n)]TJ
4.8 0 0 4.8 113.797 127.616 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 116.235 123.987 Tm
0.01 Tc
0.006 Tw
[( Q, Iachine)]TJ
4.8 0 0 4.8 152.575 127.616 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 155.013 123.987 Tm
0.01 Tc
0.006 Tw
[( I.A., Bonafe)]TJ
4.8 0 0 4.8 197.702 127.616 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 200.14 123.987 Tm
0.009 Tc
0.006 Tw
[( M.,)]TJ
-18.6449 -1.2472 TD
[(V)100(alensin)]TJ
4.8 0 0 4.8 79.158 117.581 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 81.595 114.01 Tm
0.009 Tc
0.007 Tw
[( S., Carotenuto)]TJ
4.8 0 0 4.8 130.862 117.581 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 133.299 114.01 Tm
0.01 Tc
0.008 Tw
[( L., C. Franceschi)]TJ
4.8 0 0 4.8 191.806 117.581 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 194.244 114.01 Tm
(.)Tj
4.8 0 0 4.8 50.981 107.603 Tm
(1)Tj
8 0 0 8 53.476 104.032 Tm
0.009 Tc
0.01 Tw
(Max Planck Inst. for Dem. Res., Rostock, Germany;)Tj
4.8 0 0 4.8 50.981 97.625 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 53.476 93.997 Tm
0.009 Tc
0.008 Tw
[(Dept. of Cell Biol., Univ)66(. of Calabria, Rende, Italy;)]TJ
4.8 0 0 4.8 50.981 87.591 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 53.476 84.019 Tm
0.01 Tc
0.009 Tw
[(Dept. of Stat. and Dem., Odense Univ)60(., Denmark;)]TJ
4.8 0 0 4.8 255.019 641.594 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 257.457 638.022 Tm
0.009 Tc
0.009 Tw
[(Dep. of Biomed. Sci., Univ)59(. of Modena, Italy; )]TJ
4.8 0 0 4.8 410.414 641.594 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 412.852 638.022 Tm
0.01 Tc
(Dept.)Tj
-19.7291 -1.2543 TD
0.009 Tc
0.005 Tw
[(of Syst. Sci., Univ)66(. of Calabria, Italy)59(.)]TJ
1.4953 -1.7504 TD
-0.009 Tc
0.187 Tw
(In population studies of aging, the data on genetic)Tj
-1.4953 -1.2472 TD
-0.011 Tc
0.042 Tw
[(markers are often collected for individuals from dif)17(ferent)]TJ
0 -1.2543 TD
-0.019 Tc
0.001 Tw
[(age groups. )25(W)82(e)0( show that the traditional methods of analy-)]TJ
0 -1.2472 TD
-0.013 Tc
0.118 Tw
[(sis of such data may lead to erroneous conclusions. )-105(W)81(e)]TJ
T*
-0.011 Tc
0.075 Tw
(show how such factors as changes in the initial frequen-)Tj
0 -1.2543 TD
0.096 Tw
(cies of candidate genes in subsequent cohorts or secular)Tj
0 -1.2472 TD
0.042 Tw
(trends in cohort mortality may influence the results of an)Tj
0 -1.2543 TD
0 Tw
[(analysis. )16(The unexpected results observed in genetic stud-)]TJ
0 -1.2472 TD
0.063 Tw
[(ies of centenarians are reviewed. )-55(The new approaches to)]TJ
T*
-0.01 Tc
0.187 Tw
(the analysis of cross-sectional data on genetic markers)Tj
0 -1.2543 TD
0 Tw
[(are developed. )25(These approaches allow us to combine ge-)]TJ
0 -1.2472 TD
-0.011 Tc
0.16 Tw
(netic data with demographic information about popula-)Tj
T*
0.005 Tc
0.188 Tw
[(tion under study)69(.)189( )-179(The parametric and semiparametric)]TJ
0 -1.2543 TD
-0.011 Tc
0.051 Tw
(methods of analysis which may control for observed and)Tj
0 -1.2472 TD
0.011 Tw
[(unobserved heterogeneity are discussed. )10(The methods are)]TJ
0 -1.2543 TD
0.072 Tw
(tested on simulated data and then applied to the analysis)Tj
0 -1.2472 TD
0.012 Tw
(of data on genetic markers obtained in the study of cente-)Tj
T*
0.081 Tw
[(narians in Italy)60(.)81( )-61(The relative risks and initial frequencies)]TJ
0 -1.2543 TD
0.018 Tw
(of candidate genes from six loci \(5 nuclear loci and mito-)Tj
0 -1.2472 TD
-0.014 Tc
0.148 Tw
[(chondrial DNA\) are estimated. )-135(The interaction of these)]TJ
0 -1.2543 TD
-0.011 Tc
0.126 Tw
[(genes with covariates describing the ef)17(fects of area and)]TJ
0 -1.2472 TD
-0.013 Tc
0.144 Tw
[(sex )10(are )10(tested. )-117(The results of statistical analysis of data)]TJ
T*
-0.011 Tc
0.013 Tw
(and directions of further research are discussed.)Tj
/T18 1 Tf
14 0 0 14 255.019 355.011 Tm
-0.021 Tc
(13)Tj
/F5 1 Tf
8 0 0 8 255.019 338.003 Tm
0.009 Tc
0 Tw
(Adding further power to the Haseman and Elston)Tj
T*
0.008 Tc
(Method for detecting linkage)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.003 Tw
(S. Shete, K. Jacobs, R. Elston)Tj
0 -1.2472 TD
0.009 Tc
0.022 Tw
(Department of Epidemiology and Biostatistics)Tj
0 -1.2543 TD
0.01 Tw
[(Case )9(W)74(estern Reserve University)59(, Cleveland, OH.)]TJ
1.4953 -1.7504 TD
-0.011 Tc
0.109 Tw
(Abstract: Haseman and Elston \(H-E\) proposed a ro-)Tj
-1.4953 -1.2472 TD
0.02 Tw
(bust test to detect linkage between a quantitative trait and)Tj
T*
-0.013 Tc
0 Tw
[(a genetic marker)58(. In their method the squared sib-pair trait)]TJ
0 -1.2543 TD
-0.011 Tc
0.06 Tw
[(dif)17(ference is regressed on the estimated proportion of al-)]TJ
0 -1.2472 TD
-0.014 Tc
0.179 Tw
[(leles shared identical by descent by the sib pairs. )-171(This)]TJ
T*
-0.011 Tc
0.077 Tw
(method has recently been improved by changing the de-)Tj
0 -1.2543 TD
0.029 Tw
[(pendent variable from the squared dif)17(ference to the mean)]TJ
0 -1.2472 TD
0.187 Tw
(corrected product of the sib-pair trait values, a signifi-)Tj
0 -1.2543 TD
-0.016 Tc
0 Tw
(cantly positive regression indicating linkage. Here we pro-)Tj
0 -1.2472 TD
-0.011 Tc
0.059 Tw
(pose a further improvement of the H-E method in which)Tj
T*
0.009 Tw
(generalized least squares estimators of the regressions are)Tj
0 -1.2543 TD
0.171 Tw
[(obtained separately for the squared sib-pair trait dif)17(fer)17(-)]TJ
0 -1.2472 TD
0.036 Tw
[(ences and the squared sib-pair mean corrected sums. )-19(The)]TJ
0 -1.2543 TD
0.136 Tw
(test for linkage is then based on a weighted average of)Tj
0 -1.2472 TD
0.035 Tw
[(these two estimators, the weights being inversely propor)24(-)]TJ
T*
0.117 Tw
(tional to the residual variances obtained from these two)Tj
0 -1.2543 TD
0.091 Tw
[(dif)17(ferent regressions. Control over the type I error prob-)]TJ
0 -1.2472 TD
0.03 Tw
(abilities and the increased power is investigated by simu-)Tj
T*
0.012 Tw
[(lation. )45(A)52( similar strategy of weighing estimators based on)]TJ
0 -1.2543 TD
0.162 Tw
(the residual variances is suggested for multivariate and)Tj
0 -1.2472 TD
0.018 Tw
(binary traits.)Tj
ET

endstream
endobj
176 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
175 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
173 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
174 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
167 0 obj
<</Length 10089>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(195)]TJ
/T19 1 Tf
14 0 0 14 59.981 633.997 Tm
-0.021 Tc
(14)Tj
/F5 1 Tf
8 0 0 8 59.981 616.989 Tm
0.009 Tc
0.003 Tw
[(A)51( general conditional logistic r)23(egr)9(ession model for)]TJ
0 -1.2472 TD
0.001 Tw
[(affected-r)16(elative-pair)23( linkage studies.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.009 Tw
(Jane M. Olson)Tj
0 -1.2472 TD
0.009 Tc
0.022 Tw
(Department of Epidemiology and Biostatistics,)Tj
T*
0.012 Tw
[(MetroHealth Campus, Case W)88(estern Reserve)]TJ
0 -1.2543 TD
0.01 Tc
0.025 Tw
[(University)67(, Cleveland, Ohio)]TJ
1.5024 -1.7504 TD
0.009 Tc
0.1 Tw
(Model-free lod-score methods are often employed)Tj
-1.5024 -1.2472 TD
0.005 Tc
0 Tw
(to detect linkage between marker loci and common dis-)Tj
0 -1.2543 TD
0.008 Tc
0.087 Tw
[(eases, using samples of af)8(fected sib pairs \(ASPs\). )-35(Al-)]TJ
0 -1.2472 TD
0.005 Tc
0 Tw
(though extensions of the basic one-disease-locus model)Tj
T*
0.01 Tc
0.187 Tw
(have been proposed that allow separate inclusion of)Tj
0 -1.2543 TD
0.009 Tc
0.173 Tw
(additional disease loci, covariates, other types of af-)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
(fected relative pairs \(ARPs\) or discordant pairs, a com-)Tj
T*
0.009 Tc
0.098 Tw
(mon framework that can handle simultaneously all of)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
(these features has been lacking. I propose a conditional)Tj
0 -1.2472 TD
0.009 Tc
0.105 Tw
(logistic parameterization that generalizes easily to in-)Tj
0 -1.2543 TD
0.012 Tw
[(clude all of these features. The Risch single-locus )43(ASP)]TJ
0 -1.2472 TD
0.032 Tw
(model is reparameterized in terms of the logarithms of)Tj
T*
0.008 Tc
0.05 Tw
[(the of)15(fspring and monozygotic twin relative risks )]TJ
/F17 1 Tf
20.7567 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 230.57 431.773 Tm
(o)Tj
8 0 0 8 233.008 433.02 Tm
0.058 Tc
( =)Tj
-21.6283 -1.2543 TD
0 Tc
(e)Tj
/F17 1 Tf
4.8 0 0 4.8 63.666 426.614 Tm
(b)Tj
/F14 1 Tf
0.5551 0 TD
(1)Tj
8 0 0 8 68.825 422.986 Tm
-0.172 Tc
(, )Tj
/F17 1 Tf
0.6874 0 TD
0 Tc
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 78.86 421.795 Tm
(m)Tj
8 0 0 8 82.658 422.986 Tm
0.007 Tc
0.181 Tw
[( = e)]TJ
/F17 1 Tf
4.8 0 0 4.8 97.909 426.614 Tm
0 Tc
0 Tw
(b)Tj
/F14 1 Tf
0.5551 0 TD
(2)Tj
8 0 0 8 103.068 422.986 Tm
0.009 Tc
0.18 Tw
[( and written in a form that is generally)]TJ
-5.3858 -1.2472 TD
-0.001 Tw
[(applicable to all types of )58(ARPs, provided one can com-)]TJ
0 -1.2543 TD
0.003 Tc
0.187 Tw
(pute the )Tj
4.0039 0 TD
0.026 Tc
[(ARP\222)47(s marker allele-sharing probabilities.)]TJ
-4.0039 -1.2472 TD
0.009 Tc
0.163 Tw
(Multilocus models are parameterized in terms of the)Tj
T*
0.008 Tc
0 Tw
(logarithms of joint-allele-sharing-specific relative risks)Tj
0 -1.2543 TD
0.009 Tc
0.085 Tw
(and are easily written in general, multiplicative, addi-)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
(tive, and mixed forms. Discordant pairs can be included)Tj
T*
0.009 Tc
0.026 Tw
[(with the addition of a single parameter)59(. Covariates can)]TJ
0 -1.2543 TD
0.073 Tw
(be included in both the single- and multilocus models)Tj
0 -1.2472 TD
0.111 Tw
(under the assumption that the covariate acts multipli-)Tj
0 -1.2543 TD
0.025 Tw
(catively on the relative risks, i.e., additively on the log)Tj
0 -1.2472 TD
0.003 Tw
(relative risks. Examples are given to demonstrate these)Tj
T*
0.011 Tc
(extensions.)Tj
/T19 1 Tf
14 0 0 14 59.981 264.983 Tm
-0.021 Tc
(15)Tj
/F5 1 Tf
8 0 0 8 59.981 247.975 Tm
0.009 Tc
0.006 Tw
[(T)67(rimmed-haplotype analysis for)23( fine-scale mapping)]TJ
T*
0.013 Tw
(of complex traits)Tj
/F14 1 Tf
T*
0.01 Tc
0.006 Tw
(MacLean CJ and Martin RB)Tj
0 -1.2543 TD
0.009 Tc
0.014 Tw
[(V)51(i)11(r)16(ginia Institute for Psychiatric and Behavioral)]TJ
0 -1.2472 TD
0.008 Tc
0.026 Tw
[(Genetics, )-12(V)57(i)10(r)8(ginia Commonwealth University)65(,)]TJ
T*
0.01 Tc
0.002 Tw
[(Richmond, V)123(A, )-13(USA)]TJ
1.5024 -1.7504 TD
0.014 Tc
0.188 Tw
[(W)37(ith the advent of myriad tightly linked micro-)]TJ
-1.5024 -1.2543 TD
-0.001 Tc
0 Tw
(satellite markers, we have an opportunity to extend link-)Tj
0 -1.2472 TD
0.022 Tc
0.188 Tw
(age disequilibrium analysis from single markers to)Tj
0 -1.2543 TD
0.009 Tc
0.154 Tw
(multiple marker haplotypes that have greater statisti-)Tj
0 -1.2472 TD
0.023 Tw
(cal power to disclose the presence of a disease suscep-)Tj
T*
0.05 Tw
(tibility locus. Since any particular haplotype may well)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
(be rare, related haplotypes are also needed as evidence.)Tj
0 -1.2472 TD
0.018 Tc
0.187 Tw
[(T)34(rimmed-haplotype analysis encompasses the entire)]TJ
T*
0.001 Tc
0 Tw
(cluster of partly related, partly unrelated haplotypes that)Tj
0 -1.2543 TD
0.009 Tc
0.1 Tw
(would result from historical recombination and muta-)Tj
0 -1.2472 TD
0.018 Tw
(tion in markers surrounding an ancestral disease locus.)Tj
25.5047 69.2504 TD
0.016 Tc
0.187 Tw
(The probability of preservation of each category of)Tj
0 -1.2543 TD
0.01 Tc
0.188 Tw
[(trimmed haplotypes is a function of its inter)24(-marker)]TJ
0 -1.2472 TD
0.009 Tc
0.089 Tw
(distances and of time, whereas the probability of ran-)Tj
0 -1.2543 TD
0.177 Tw
(dom similarity in absence of a disease susceptibility)Tj
0 -1.2472 TD
0.023 Tw
(locus is a product of haplotype frequencies. Therefore,)Tj
T*
0.033 Tw
(a statistical test for the existence of a disease suscepti-)Tj
0 -1.2543 TD
0.001 Tc
0 Tw
(bility locus is based on trimmed-haplotype category fre-)Tj
0 -1.2472 TD
0.009 Tc
0.056 Tw
[(quencies. Rather than standard parent-of)16(fspring triads,)]TJ
0 -1.2543 TD
0.016 Tc
0.188 Tw
(trimmed-haplotype analysis exploits multiplex pedi-)Tj
0 -1.2472 TD
0.009 Tc
0 Tw
(grees by considering the pattern of haplotype transmis-)Tj
T*
0.159 Tw
[(sion and af)16(fection status in the pedigree as a whole.)]TJ
0 -1.2543 TD
0.111 Tw
[(T)39(rimmed-haplotype analysis has been incorporated in)]TJ
0 -1.2472 TD
0.038 Tw
(a software package called HAL, that is available to all)Tj
T*
0.019 Tw
(investigators on the internet.)Tj
/T19 1 Tf
14 0 0 14 264.019 472.989 Tm
-0.021 Tc
(16)Tj
/F5 1 Tf
8 0 0 8 264.019 457.002 Tm
0.009 Tc
0.004 Tw
[(The Impact of Racial )58(Admixtur)23(e on )9(T)74(raditional)]TJ
T*
-0.045 Tw
(Linkage Analysis)Tj
/F14 1 Tf
0 -1.2543 TD
0.006 Tw
(J.S. Barnholtz)Tj
4.8 0 0 4.8 310.167 440.617 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 316.346 436.989 Tm
0.009 Tc
0.011 Tw
[(, M. de )36(Andrade)]TJ
4.8 0 0 4.8 369.581 440.617 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 372.019 436.989 Tm
0.01 Tc
0.012 Tw
(, R. Chakraborty)Tj
4.8 0 0 4.8 426.841 440.617 Tm
0 Tc
0 Tw
(2)Tj
-33.9213 -2.0906 TD
(1)Tj
8 0 0 8 266.343 427.011 Tm
-0.01 Tc
0.015 Tw
[(M)7(D)7( )46(Anderson Cancer Center)33(, Dept. of Epidemiology)61(,)]TJ
-0.2906 -1.2543 TD
-0.012 Tc
-0.007 Tw
(Houston, TX; )Tj
4.8 0 0 4.8 308.92 420.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 311.301 416.976 Tm
-0.011 Tc
0.011 Tw
[(UT)17( School of Public Health, Houston, TX)]TJ
-4.415 -1.6228 TD
0.009 Tc
0.177 Tw
(Racially admixed families are routinely excluded)Tj
-1.4953 -1.2472 TD
0.096 Tw
(from traditional \(LOD score\) linkage analysis or ana-)Tj
0 -1.2543 TD
-0.001 Tc
0.001 Tw
[(lyzed as racially homogeneous using the proband\222)56(s race.)]TJ
0 -1.2472 TD
0.009 Tc
0.11 Tw
[(Through simulation, we investigated the ef)16(fect of ad-)]TJ
T*
0.081 Tw
(mixture on the LOD score of two racial groups under)Tj
0 -1.2543 TD
0.05 Tw
(various conditions.)Tj
1.4953 -1.2472 TD
0.003 Tc
0 Tw
[(Four)17(-generation racially homogeneous and admixed)]TJ
-1.4953 -1.2543 TD
0.031 Tc
0.188 Tw
(families were simulated with 27 markers and two)Tj
0 -1.2472 TD
0.009 Tc
0.056 Tw
(linked, bi-allelic disease loci. One locus was linked to)Tj
T*
0.004 Tc
0 Tw
(a marker with correct allele frequencies for both groups)Tj
0 -1.2543 TD
0.009 Tc
0.103 Tw
(and the other was linked to a marker with correct in-)Tj
0 -1.2472 TD
0.007 Tc
0.124 Tw
[(formation for only one group. )-100(T)58(wo dif)21(ferent types of)]TJ
0 -1.2543 TD
0.009 Tc
0.065 Tw
(admixture were tested: admixture within a family unit)Tj
0 -1.2472 TD
0.096 Tw
(and a mixture of homogeneous families within a data)Tj
T*
-0.004 Tc
(set. )Tj
1.6866 0 TD
0.009 Tc
0.05 Tw
(The mixing was done at the founder level in three)Tj
-1.6866 -1.2543 TD
0.028 Tw
[(dif)23(ferent proportions: 30/70, 50/50 and 70/30.)]TJ
1.4953 -1.2472 TD
0.01 Tc
0.025 Tw
[(W)75(e)0( observed that the LOD scores under both mod-)]TJ
-1.4953 -1.2472 TD
0.008 Tc
0 Tw
(els of admixture were closest to the homogeneous fam-)Tj
0 -1.2543 TD
(ily scores of the racial group having the highest mixing)Tj
0 -1.2472 TD
0.01 Tc
0.015 Tw
(proportion. In the 50/50 case, the LOD scores were in-)Tj
0 -1.2543 TD
0.009 Tc
0.18 Tw
(between the homogeneous scores. Random sampling)Tj
0 -1.2472 TD
0.161 Tw
(of families or ascertainment of families with disease)Tj
T*
0.049 Tw
[(af)23(fection status did not af)23(fect this observation, nor did)]TJ
0 -1.2543 TD
0.183 Tw
(the mode of inheritance \(dominant/recessive\) or dis-)Tj
0 -1.2472 TD
0.016 Tw
(ease/marker allele frequencies.)Tj
1.4953 -1.2543 TD
0.159 Tw
(LOD scores in admixed family data were further)Tj
-1.4953 -1.2472 TD
0.177 Tw
[(af)23(fected due to departures from Hardy-W)73(einber)16(g ex-)]TJ
T*
0.013 Tc
0.188 Tw
(pectations of genotypic frequencies and presence of)Tj
0 -1.2543 TD
0.01 Tc
(linkage disequilibrium in admixed populations. Sub-)Tj
0 -1.2472 TD
0.009 Tc
0.118 Tw
(routines performing these tasks with relaxed assump-)Tj
T*
0.022 Tc
0.188 Tw
(tions are being implemented in current LOD score)Tj
0 -1.2543 TD
0.046 Tc
0.187 Tw
(analysis programs. \(Research supported by NCI-)Tj
0 -1.2472 TD
0.01 Tc
0.05 Tw
(R25CA57730-07 and NIH-GM41399.\))Tj
ET

endstream
endobj
187 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
185 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
186 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
184 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
178 0 obj
<</Length 9837>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(196)-2523(Abstracts)]TJ
/T20 1 Tf
14 0 0 14 50.981 633.997 Tm
-0.021 Tc
(17)Tj
/F5 1 Tf
8 0 0 8 50.981 618.009 Tm
0.01 Tc
0 Tw
[(Power)17( Comparisons Between the TDT)24( and )9(T)75(w)-8(o)]TJ
0 -1.2543 TD
0.009 Tc
-0.011 Tw
[(Likelihood-Based T)88(ests )-15(for)16( )-16(Complex )-7(T)74(raits)]TJ
/F14 1 Tf
0 -1.2472 TD
0 Tw
(Slager SL)Tj
4.8 0 0 4.8 83.466 601.568 Tm
0 Tc
(1)Tj
8 0 0 8 85.904 597.997 Tm
0.009 Tc
0.006 Tw
(, Huang J)Tj
4.8 0 0 4.8 117.142 601.568 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 119.58 597.997 Tm
0.007 Tc
-0.001 Tw
[(, V)56(ieland VJ)]TJ
4.8 0 0 4.8 160.058 601.568 Tm
0.013 Tc
(1,3)Tj
8 0 0 8 166.181 597.997 Tm
0 Tc
0 Tw
(.)Tj
4.8 0 0 4.8 50.981 591.59 Tm
(1)Tj
8 0 0 8 53.476 588.019 Tm
0.009 Tc
0.015 Tw
(Department of Preventive Medicine, Division of)Tj
-0.3118 -1.2543 TD
0.008 Tc
(Biostatistics, )Tj
4.8 0 0 4.8 95.202 581.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 97.639 577.984 Tm
0.008 Tc
0.01 Tw
[(Department of Statistics and )44(Actuarial)]TJ
-5.8323 -1.2472 TD
0.009 Tc
0.009 Tw
(Science, and )Tj
4.8 0 0 4.8 94.635 571.578 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 97.073 568.006 Tm
0.009 Tc
0.013 Tw
[(Department of Psychiatry)66(, College of)]TJ
-5.7614 -1.2543 TD
0.011 Tw
[(Medicine, University of Iowa, Iowa City)52(.)]TJ
1.5024 -1.8071 TD
-0.002 Tc
0 Tw
[(Currently)69(, linkage tests are used for genomic screens)]TJ
-1.5024 -1.3181 TD
0.009 Tc
0.069 Tw
(and association tests are used for fine mapping. How-)Tj
0 -1.311 TD
0.135 Tw
[(ever)37(, advancements in molecular technology)59(, promis-)]TJ
T*
0.006 Tc
0 Tw
(ing maps on the order of a million markers using single)Tj
T*
[(nucleotide polymorphisms, could change this. )19(W)77(e)-1( com-)]TJ
T*
0.007 Tc
0.101 Tw
[(pare the statistical power of the )-93(T)-6(D)-6(T)21( with two likeli-)]TJ
0 -1.3181 TD
0.009 Tc
0.029 Tw
(hood-based linkage tests, the classical LOD score, and)Tj
0 -1.311 TD
0.116 Tw
(a modified LOD score in which a linkage disequilib-)Tj
T*
0.006 Tc
0 Tw
(rium \(LD\) parameter is incorporated into the likelihood)Tj
T*
0.003 Tc
[(\(LD-LOD\). )10(W)90(e)0( hypothesize that the LD-LOD will have)]TJ
T*
0.001 Tc
(the greatest power of the three tests when LD is present,)Tj
0 -1.3181 TD
0.007 Tc
0.079 Tw
[(since )9(the )-69(T)-6(D)-6(T)14( is a score test based on a pseudolikeli-)]TJ
0 -1.311 TD
0.009 Tc
0.022 Tw
(hood rather than the correct likelihood when multiplex)Tj
T*
0.033 Tw
(families are ascertained, and the LOD score has previ-)Tj
T*
0.01 Tc
0.173 Tw
(ously been shown to be underestimated when LD is)Tj
T*
0.007 Tc
0 Tw
[(present \(Cler)14(get-Darpoux, 1982\). )21(W)79(e)1( test this claim us-)]TJ
0 -1.3181 TD
0.009 Tc
0.008 Tw
[(ing a simulation study in which we generate )36(ASP)37( pedi-)]TJ
0 -1.311 TD
0.017 Tc
0.187 Tw
(grees under a range of genetic models, varying the)Tj
T*
0.009 Tc
0.077 Tw
(genotypic relative risk \(GRR\) from 6 to 16. Since the)Tj
T*
0.103 Tw
(likelihood-based tests require that a genetic model be)Tj
T*
0.151 Tw
(specified, we compare the tests under two scenarios,)Tj
0 -1.3181 TD
0.121 Tw
(\(i\) we assume the true genetic model in the analysis,)Tj
0 -1.311 TD
0.003 Tc
0 Tw
(and \(ii\) we compare the tests when the LD-LOD \(LOD\))Tj
T*
0.009 Tc
0.127 Tw
(is maximized over two wrong genetic models. Based)Tj
T*
0.083 Tw
(on the generating models we considered, we find that)Tj
T*
0.008 Tc
0 Tw
[(the LD-LOD tends to have greater power than the )15(TDT)]TJ
0 -1.3181 TD
0.009 Tc
0.081 Tw
(even when the genetic model is mis-specified and the)Tj
0 -1.311 TD
0.007 Tc
0.103 Tw
[(results corrected for multiple tests. )-85(The most extreme)]TJ
T*
0.009 Tc
0.168 Tw
[(dif)16(ference occurs under the multiplicative and domi-)]TJ
T*
0.1 Tw
[(nant models, for which the dif)16(ference in power could)]TJ
T*
0.024 Tw
(be as high as 40% at maximum LD. Only for the addi-)Tj
0 -1.3181 TD
0.006 Tc
0.155 Tw
[(tive model we find the )-162(T)-7(D)-7(T)13( )-8(to )-8(have )-8(slightly )-8(greater)]TJ
0 -1.311 TD
0.01 Tc
0.18 Tw
(power than the LD-LOD \(7% dif)Tj
14.3575 0 TD
-0.01 Tc
(ference\). )Tj
4.0323 0 TD
0.012 Tc
(The LOD)Tj
-18.3898 -1.311 TD
0.009 Tc
0.023 Tw
(score provides the lowest power in the presence of LD)Tj
T*
0.01 Tc
0.01 Tw
(for the range of GRR considered here.)Tj
/T20 1 Tf
14 0 0 14 50.981 150.52 Tm
-0.021 Tc
(18)Tj
/F5 1 Tf
8 0 0 8 50.981 134.532 Tm
0.009 Tc
0.003 Tw
(High-density Genome Scans with Quantitative)Tj
0 -1.2543 TD
0.006 Tw
[(T)67(raits \226 Resolving critical issues)]TJ
/F14 1 Tf
0 -1.2472 TD
0 Tw
(S. Nath)Tj
4.8 0 0 4.8 75.586 118.091 Tm
0 Tc
(1)Tj
8 0 0 8 78.024 114.52 Tm
0.01 Tc
0.006 Tw
(, J. Gardner)Tj
4.8 0 0 4.8 116.348 118.091 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 118.786 114.52 Tm
0.008 Tc
-0.044 Tw
[(, )-7(A. A)78(viv)]TJ
4.8 0 0 4.8 147.926 118.091 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 150.364 114.52 Tm
0.01 Tc
0.007 Tw
(, N. Schork)Tj
4.8 0 0 4.8 187.781 118.091 Tm
0 Tc
0 Tw
(1)Tj
-28.5 -2.0787 TD
(1)Tj
8 0 0 8 53.476 104.485 Tm
0.009 Tc
0.018 Tw
(Department of Epidemiology and Biostatistics, Case)Tj
-0.3118 -1.2472 TD
0.01 Tw
[(W)74(estern Reserve University)59(, Cleveland, OH, )]TJ
4.8 0 0 4.8 199.743 98.079 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 202.181 94.507 Tm
0.013 Tc
(New)Tj
-18.9 -1.2472 TD
0.009 Tc
0.01 Tw
[(Jersey School of Medicine and Dentistry)59(, Newark, NJ)]TJ
27 69.1866 TD
0.07 Tw
(Linkage analyses for complex traits are beset by a)Tj
-1.4953 -1.2543 TD
0.145 Tw
(number of problems, including 1\) accommodation of)Tj
0 -1.311 TD
0.029 Tc
0.126 Tw
(covariates in the analyses, 2\) possibility of hetero-)Tj
T*
0.004 Tw
[(geneity)64(, 3\) correct and appropriate modeling of mul-)]TJ
T*
0.066 Tc
0.193 Tw
[(tiple genetic ef)23(fects, and 4\) assessment of the)]TJ
0 -1.3181 TD
0.027 Tc
0.082 Tw
[(statistical significance of linkage results. )-65(W)85(e)-2( inves-)]TJ
0 -1.311 TD
0.029 Tc
0.16 Tw
(tigated each of these problems in the context of a)Tj
T*
0.033 Tw
(variance component analysis of quantitative cellular)Tj
T*
0.019 Tw
(phenotypes using a highly dense map of 7745 mark-)Tj
0 -1.3181 TD
0.009 Tc
0.057 Tw
(ers. Our aim was to identify loci for genes controlling)Tj
0 -1.311 TD
0.02 Tw
(two cellular phenotypes associated with store-operated)Tj
T*
0.133 Tw
[(calcium entry while considering some )]TJ
16.4926 0 TD
0.029 Tc
0.134 Tw
(theoretical is-)Tj
-16.4926 -1.311 TD
0.021 Tc
0 Tw
(sues in linkage analyses. Stable phenotypes were col-)Tj
T*
0.057 Tc
0.188 Tw
(lected for five densely mapped CEPH families.)Tj
0 -1.3181 TD
0.029 Tc
0.117 Tw
(Evidence for linkage was obtained at several chro-)Tj
0 -1.311 TD
0.11 Tw
(mosomal regions. Our results suggest that variance)Tj
T*
0.019 Tc
0 Tw
(component linkage analysis of densely mapped mark-)Tj
T*
0.029 Tc
0.035 Tw
(ers can reveal chromosomal regions likely to harbor)Tj
T*
0.019 Tc
0 Tw
(loci influencing complex traits but care must be taken)Tj
0 -1.3181 TD
0.029 Tc
0.016 Tw
(when conducting linkage-based genome scans to ac-)Tj
0 -1.311 TD
0.036 Tw
[(commodate covariate, heterogeneity)57(, multiple locus,)]TJ
T*
0.015 Tw
(and statistical significance.)Tj
/T20 1 Tf
14 0 0 14 255.019 377.008 Tm
-0.021 Tc
(19)Tj
/F5 1 Tf
8 0 0 8 255.019 360 Tm
0.009 Tc
0.006 Tw
[(Haplotyping in pedigr)16(ees via a genetic algorithm)]TJ
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.009 Tw
[(Pradip )9(T)68(apadar)45(, Saurabh Ghosh, Partha P)102(.)1( Majumder)]TJ
0 -1.2543 TD
0.009 Tc
0.011 Tw
(Indian Statistical Institute, Calcutta, India.)Tj
1.4953 -1.8142 TD
0.109 Tw
(Genome-wide scanning for localization of disease)Tj
-1.4953 -1.311 TD
0.148 Tw
[(genes has become very popular)66(.)146( )-97(Analyses of data on)]TJ
T*
0.149 Tw
(families generated by genome-wide scans necessitate)Tj
T*
0.007 Tc
0 Tw
(the reconstruction of haplotypes for identifying, among)Tj
T*
0.009 Tc
0.019 Tw
(others, the smallest genomic region containing the dis-)Tj
0 -1.3181 TD
0.059 Tw
(ease gene and also genotyping errors. Several system-)Tj
0 -1.311 TD
0.044 Tc
0.188 Tw
(atic methods for haplotype reconstruction, either)Tj
T*
0.009 Tc
0.029 Tw
(likelihood-based or rule-based, are currently available.)Tj
T*
0.077 Tw
[(W)81(e)0( propose a rule-based method for haplotype recon-)]TJ
T*
0.025 Tc
0.187 Tw
(struction in pedigrees using a \223genetic algorithm\224,)Tj
0 -1.3181 TD
0.009 Tc
0.16 Tw
(which a member of the class of computational algo-)Tj
0 -1.311 TD
0.119 Tw
(rithms that use certain principles of biological evolu-)Tj
T*
0.013 Tc
0.187 Tw
(tion to find optimal solutions to complex problems.)Tj
T*
0.044 Tc
0.188 Tw
(Compared to the currently-available methods for)Tj
T*
0.009 Tc
0 Tw
(haplotyping, the proposed method uses much fewer as-)Tj
0 -1.3181 TD
0.033 Tc
0.188 Tw
[(sumptions and is much less data-demanding. )-179(The)]TJ
0 -1.311 TD
0.009 Tc
0.016 Tw
(optimality criterion used in the proposed method is the)Tj
T*
0.004 Tc
0 Tw
(minimum number of recombinations over possible hap-)Tj
T*
0.009 Tc
0.02 Tw
(lotype configurations of members of a pedigree. Using)Tj
T*
(simulations, we show that the proposed method results)Tj
0 -1.3181 TD
0.034 Tc
0.188 Tw
[(in virtually error)20(-free determination of multilocus)]TJ
0 -1.311 TD
0.009 Tc
0.179 Tw
(haplotypes in extremely short computational time. It)Tj
T*
0.002 Tc
0 Tw
(also provides multiple optimal haplotype configurations)Tj
T*
0.009 Tc
0.011 Tw
(of a pedigree, if such multiple optima exist.)Tj
ET

endstream
endobj
198 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
199 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
197 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
189 0 obj
<</Length 11857>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(197)]TJ
/T21 1 Tf
14 0 0 14 59.981 633.997 Tm
-0.021 Tc
(20)Tj
/F5 1 Tf
8 0 0 8 59.981 616.989 Tm
0.009 Tc
0.001 Tw
[(Evidence for)23( further)16( Br)23(east Cancer)23( susceptibility)]TJ
0 -1.2472 TD
0.01 Tc
0 Tw
[(genes in addition to BRCA1 and BRCA2: the )53(ABC)]TJ
0 -1.2543 TD
0.008 Tc
[(study)51(.)]TJ
/F14 1 Tf
0 -1.2472 TD
0.009 Tc
-0.038 Tw
(A.C. Antoniou)Tj
4.8 0 0 4.8 108 590.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 110.438 586.998 Tm
0.01 Tc
0.009 Tw
[(, P)109(.D. Pharoah)]TJ
4.8 0 0 4.8 157.266 590.57 Tm
0.013 Tc
(2,3)Tj
8 0 0 8 163.389 586.998 Tm
0.011 Tc
(, N.E. Day)Tj
4.8 0 0 4.8 198.368 590.57 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 200.863 586.998 Tm
(,)Tj
-17.6102 -1.2472 TD
0.009 Tc
(B.J.Ponder)Tj
4.8 0 0 4.8 95.924 580.592 Tm
0 Tc
(2)Tj
8 0 0 8 98.362 577.02 Tm
0.01 Tc
0.009 Tw
[(, D.F)81(. Easton)]TJ
4.8 0 0 4.8 140.882 580.592 Tm
0 Tc
0 Tw
(1)Tj
-16.8543 -2.0787 TD
(1)Tj
8 0 0 8 62.476 566.986 Tm
0.009 Tc
0.012 Tw
(CRC Genetic Epidemiology Unit, IPH, )Tj
4.8 0 0 4.8 193.039 570.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 195.477 566.986 Tm
0.011 Tc
0.012 Tw
(CRC Human)Tj
-16.937 -1.2472 TD
0.009 Tc
0.01 Tw
(Cancer Genetics Research Group, )Tj
4.8 0 0 4.8 173.197 560.579 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 175.635 557.008 Tm
0.01 Tc
0.012 Tw
(Dept of)Tj
-14.4567 -1.2543 TD
0.009 Tc
0.02 Tw
(Community Medicine, University of Cambridge, UK.)Tj
1.5024 -1.7504 TD
0.014 Tc
0.188 Tw
[(W)86(e)0( used data from a population based series of)]TJ
-1.5024 -1.2472 TD
0.009 Tc
0.111 Tw
(breast cancer cases to investigate genetic models that)Tj
T*
0.015 Tw
(can best explain familial breast cancer outside BRCA1)Tj
0 -1.2543 TD
0.003 Tc
0 Tw
(and BRCA2 families, and evaluate the evidence for risk)Tj
0 -1.2472 TD
0.007 Tc
0.105 Tw
[(modifiers in BRCA1/2 carriers. )-92(The dataset consisted)]TJ
T*
0.009 Tc
0.093 Tw
(of 1484 cases diagnosed with breast cancer under the)Tj
0 -1.2543 TD
0.01 Tc
0.017 Tw
(age 55 between 1991 and 1996 in the region served by)Tj
0 -1.2472 TD
-0.016 Tc
(the )Tj
1.5307 0 TD
0.009 Tc
0.079 Tw
[(Anglian cancer registry)59(. BRCA1 and BRCA2 mu-)]TJ
-1.5307 -1.2543 TD
0.008 Tc
0.077 Tw
[(tations were detected in 21 cases. )-71(The genetic models)]TJ
0 -1.2472 TD
0.009 Tc
0.041 Tw
(were constructed using information on the first-degree)Tj
T*
0.007 Tc
-0.001 Tw
[(relatives with the computer program MENDEL. )20(W)79(e)1( es-)]TJ
0 -1.2543 TD
0.01 Tc
0.089 Tw
[(timated the ef)24(fects of BRCA1, BRCA2, a third hypo-)]TJ
0 -1.2472 TD
0.013 Tc
0.187 Tw
(thetical gene \223BRCA3\224 and a polygenic ef)Tj
18.6803 0 TD
-0.025 Tc
0.39 Tw
[(fect. T)-38(h)-38(e)]TJ
-18.6803 -1.2543 TD
0.008 Tc
0.044 Tw
(cancer incidence rate for an individual )Tj
/F16 1 Tf
16.2425 0 TD
0 Tc
0 Tw
(i)Tj
/F14 1 Tf
0.2835 0 TD
0.009 Tc
0.044 Tw
[( was modelled)]TJ
-16.526 -1.2472 TD
-0.08 Tc
(as )Tj
/F19 1 Tf
1.2898 0 TD
0 Tc
0 Tw
(l)Tj
/F16 1 Tf
4.8 0 0 4.8 74.778 391.805 Tm
(i)Tj
8 0 0 8 76.195 392.995 Tm
-0.036 Tc
(\(t\)= )Tj
/F19 1 Tf
2.0906 0 TD
0 Tc
(l)Tj
/F16 1 Tf
4.8 0 0 4.8 97.398 391.805 Tm
(0)Tj
8 0 0 8 99.836 392.995 Tm
0.009 Tc
(\(t\)exp\(G)Tj
4.8 0 0 4.8 127.559 391.805 Tm
0 Tc
(i)Tj
8 0 0 8 128.92 392.995 Tm
0.011 Tc
(+P)Tj
4.8 0 0 4.8 139.408 391.805 Tm
0 Tc
(i)Tj
8 0 0 8 140.825 392.995 Tm
-0.082 Tc
(\), )Tj
/F14 1 Tf
1.0417 0 TD
-0.025 Tc
(where )Tj
/F19 1 Tf
2.9268 0 TD
0 Tc
(l)Tj
/F16 1 Tf
4.8 0 0 4.8 177.109 391.805 Tm
(0)Tj
8 0 0 8 179.546 392.995 Tm
-0.054 Tc
(\(t\) )Tj
/F14 1 Tf
1.4031 0 TD
0.009 Tc
0.357 Tw
[(i)91(s)91( the )176(baseline)]TJ
-16.3488 -1.2472 TD
0.004 Tc
0.075 Tw
(incidence rate, )Tj
/F16 1 Tf
6.385 0 TD
0 Tc
0 Tw
(G)Tj
4.8 0 0 4.8 116.957 381.827 Tm
(i)Tj
/F14 1 Tf
8 0 0 8 118.375 383.017 Tm
0.01 Tc
0.075 Tw
[( depends on the major genotype and)]TJ
/F16 1 Tf
-7.2992 -1.2543 TD
0 Tc
0 Tw
(P)Tj
4.8 0 0 4.8 65.027 371.792 Tm
(i)Tj
/F14 1 Tf
8 0 0 8 66.387 372.983 Tm
0.007 Tc
0.107 Tw
[( on the polygenotype of the individual. )-100(The Hyper)7(-)]TJ
-0.8008 -1.2472 TD
0.009 Tc
0.078 Tw
(geometric Polygenic Model)Tj
4.8 0 0 4.8 151.937 366.576 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 154.375 363.005 Tm
0.009 Tc
0.08 Tw
[( was used to approximate)]TJ
-11.7992 -1.2472 TD
0.006 Tc
0.191 Tw
[(polygenic )8(inheritance. )-168(The models were assessed by)]TJ
0 -1.2543 TD
0.009 Tc
0.098 Tw
(likelihood comparisons and by comparison of the ob-)Tj
0 -1.2472 TD
0.002 Tw
[(served number of mutations and af)16(fected relatives with)]TJ
0 -1.2543 TD
0.028 Tc
0.192 Tw
[(the )9(predicted )9(numbers. )-180(The best fitting model for)]TJ
0 -1.2472 TD
0.009 Tc
0.173 Tw
(BRCA3 was a recessive model with a disease allele)Tj
T*
0.01 Tc
0.086 Tw
(frequency 24% and penetrance 42% by age 70. How-)Tj
0 -1.2543 TD
0.008 Tc
0.043 Tw
[(ever a polygenic model also fitted well. )-34(The estimated)]TJ
0 -1.2472 TD
0.01 Tc
0.044 Tw
(population frequencies for BRCA1 and BRCA2 muta-)Tj
0 -1.2543 TD
0.187 Tw
[(tions were 0.024% and 0.041% respectively)60(.)187( )-175(The fit)]TJ
0 -1.2472 TD
0.114 Tw
(was improved when the penetrance of BRCA1/2 was)Tj
T*
0.009 Tc
0.124 Tw
(assumed to be lower than the Breast Cancer Linkage)Tj
0 -1.2543 TD
0.008 Tc
0.038 Tw
[(Consortium estimates. )-20(W)80(e)-1( are currently combining the)]TJ
0 -1.2472 TD
0.009 Tc
0.054 Tw
(results from this population series with those obtained)Tj
T*
0 Tc
0 Tw
(from mutation testing in multiple case families to evalu-)Tj
0 -1.2543 TD
0.009 Tc
0.007 Tw
[(ate the ef)16(fect of risk modifiers.)]TJ
4.8 0 0 4.8 72 206.589 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 74.438 203.017 Tm
0.01 Tc
0.039 Tw
(Lange \(1997\), Genetics 147:1423\2261430)Tj
/T21 1 Tf
14 0 0 14 59.981 164.523 Tm
-0.021 Tc
(21)Tj
/F5 1 Tf
8 0 0 8 59.981 147.515 Tm
0.008 Tc
0 Tw
(An extended transmission/disequilibrium test)Tj
T*
0.009 Tc
(\(TDT\) for two multi-allele marker loci)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.011 Tw
[(M. Knapp, )53(A. Hahn)]TJ
/F20 1 Tf
0 -1.1976 TD
0.009 Tc
0.006 Tw
[(Institute for Medical S)9(tatistics, University of Bonn,)]TJ
0 -1.2047 TD
0.011 Tc
(Germany)Tj
/F14 1 Tf
1.5024 -1.7504 TD
0.009 Tc
0.131 Tw
(The transmission/disequilibrium test \(TDT\) as in-)Tj
-1.5024 -1.2472 TD
0.003 Tc
0 Tw
(troduced by Spielman et al. \(Am J Hum Genet 52: 502\226)Tj
25.5047 69.215 TD
0.009 Tc
0.009 Tw
(516, 1993\) is a test for linkage between a complex dis-)Tj
0 -1.2543 TD
0.013 Tw
[(ease and a diallelic marker)59(.)12( The original )9(T)-8(D)-8(T)23( has been)]TJ
0 -1.2472 TD
0.175 Tw
(extended by a number of authors in several aspects.)Tj
0 -1.2543 TD
0.006 Tw
[(Surprisingly)73(, there currently is no practicable approach)]TJ
0 -1.2472 TD
0.154 Tw
(available which allows for simultaneous inclusion of)Tj
T*
0.008 Tc
0.07 Tw
[(more than one marker locus in the )-50(TDT)72(.)76( )-64(W)31(ilson \(Ann)]TJ
0 -1.2543 TD
0.01 Tc
0.044 Tw
(Hum Genet 61: 151\226161, 1997\) described a two-locus)Tj
0 -1.2472 TD
0.001 Tc
0.188 Tw
[(extension of the )-176(T)-19(D)-19(T)65(,)-12( )]TJ
10.0319 0 TD
0.013 Tc
0.187 Tw
(but she assumed that marker)Tj
-10.0319 -1.2543 TD
0.011 Tc
(haplotypes can be observed in parents and children.)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
[(Usually)57(, however)35(, the data will consist of marker geno-)]TJ
T*
0.009 Tc
0.01 Tw
(types at both loci, and the reconstruction of haplotypes)Tj
0 -1.2543 TD
0.151 Tw
(will not be possible in some families, even if one is)Tj
0 -1.2472 TD
0.024 Tw
(willing to assume that both marker loci are completely)Tj
T*
-0.002 Tc
(linked. )Tj
3.3661 0 TD
0.025 Tc
0.187 Tw
(The beta-release of the new version of the)Tj
-3.3661 -1.2543 TD
0.01 Tc
0.091 Tw
(GENEHUNTER program contains a two-, three-, and)Tj
0 -1.2472 TD
0.009 Tc
0.005 Tw
[(four)23(-locus extension of the )16(TDT)73(, but this program sim-)]TJ
0 -1.2543 TD
0.055 Tw
(ply discards families for which phase is ambiguous. It)Tj
0 -1.2472 TD
0.125 Tw
(can be shown that this approach may give biased re-)Tj
T*
0.008 Tw
(sults due to an inflation of the type I error rate.)Tj
1.4953 -1.2543 TD
(Here we propose a two-locus extension of the TDT)Tj
-1.4953 -1.2472 TD
0.063 Tw
(which is based on the conditional likelihood approach)Tj
0 -1.2543 TD
0 Tw
(similar to the one considered by Sham and Curtis \(Ann)Tj
0 -1.2472 TD
0.185 Tw
(Hum Genet 59: 323\226336, 1995\) for a single marker)Tj
T*
0.146 Tw
(locus. It will be assumed that the sample consists of)Tj
0 -1.2543 TD
0.029 Tw
(simplex families and that all individuals in all families)Tj
0 -1.2472 TD
0.006 Tc
-0.001 Tw
[(have been typed at both marker loci. Finally)70(, the imple-)]TJ
0 -1.2543 TD
0.008 Tc
0.079 Tw
[(mentation of this two-locus )-63(TDT)15( \(2L-TDT\) by means)]TJ
0 -1.2472 TD
0.01 Tc
0.032 Tw
[(of SAS-IML)38( software \(SAS Institute, Cary)60(, NC, 1995\))]TJ
T*
0.009 Tc
0.019 Tw
(is described.)Tj
/T21 1 Tf
14 0 0 14 264.019 306.992 Tm
-0.021 Tc
(22)Tj
/F5 1 Tf
8 0 0 8 264.019 289.021 Tm
-0.011 Tc
0.011 Tw
[(Localization of pr)24(ostate cancer)17( aggr)24(essiveness genes)]TJ
/F14 1 Tf
0 -1.2543 TD
0.006 Tc
0 Tw
[(JS W)43(itte)]TJ
4.8 0 0 4.8 291.515 282.614 Tm
0 Tc
(1)Tj
8 0 0 8 293.953 278.986 Tm
0.01 Tc
0.007 Tw
(, KAB Goddard)Tj
4.8 0 0 4.8 346.053 282.614 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 348.491 278.986 Tm
0.01 Tc
0.006 Tw
(, RC Elston)Tj
4.8 0 0 4.8 386.589 282.614 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 389.027 278.986 Tm
0.008 Tc
-0.002 Tw
[(, W)17( )-9(Catalona)]TJ
4.8 0 0 4.8 431.716 282.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 434.211 278.986 Tm
(,)Tj
-21.274 -1.2472 TD
0.009 Tc
0.009 Tw
(and the Prostate Cancer Genetics Study)Tj
4.8 0 0 4.8 264.019 262.602 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 266.457 259.03 Tm
0.01 Tc
0.008 Tw
[(Case )9(W)82(estern Reserve Univ)67(., Cleveland, OH;)]TJ
4.8 0 0 4.8 264.019 252.624 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 266.457 248.995 Tm
0.01 Tc
0.008 Tw
[(W)82(ashington Univ)60(., St. Louis, MO, USA)]TJ
1.1905 -1.8709 TD
0.009 Tc
0.044 Tw
(A measure of prostate cancer aggressiveness is the)Tj
-1.4953 -1.2543 TD
0.009 Tw
[(Gleason score, which may be a strong predictor of sur)16(-)]TJ
0 -1.2472 TD
0.042 Tw
(vival. Localizing genes that predispose men to present)Tj
0 -1.2543 TD
0.023 Tc
0.188 Tw
(with higher Gleason scores\227and who may require)Tj
0 -1.2472 TD
0.009 Tc
0.119 Tw
(more active screening and treatment\227is a significant)Tj
T*
0.01 Tc
0.1 Tw
[(research priority)67(.)101( )-83(Therefore, we conducted a genome-)]TJ
0 -1.2543 TD
0.001 Tc
0 Tw
(wide scan among 441 Caucasian men with prostate can-)Tj
0 -1.2472 TD
0.007 Tc
0.075 Tw
[(cer \(i.e., the equivalent of 282 sib-pairs\). )-57(W)72(e)-2( evaluate)]TJ
0 -1.2543 TD
0.009 Tc
0.171 Tw
(the evidence for linkage with Gleason score using a)Tj
0 -1.2472 TD
0.01 Tc
0.188 Tw
[(new)60(, more powerful, version of the Haseman-Elston)]TJ
T*
0.005 Tc
0.182 Tw
(\(HE\) statistical method \(Elston et al., 1999; )Tj
/F16 1 Tf
19.3252 0 TD
0.01 Tc
(Genetic)Tj
-19.3252 -1.2543 TD
0.007 Tc
(Epi)Tj
/F14 1 Tf
1.4173 0 TD
0.074 Tw
[(: )6(in )6(press\). )-55(The modified HE method is essentially)]TJ
-1.4173 -1.2472 TD
0.02 Tc
0.188 Tw
(linear regression where the dependent variable, the)Tj
T*
0.009 Tc
0.042 Tw
(mean-corrected cross product, is regressed on the esti-)Tj
0 -1.2543 TD
0.002 Tc
0 Tw
(mated proportion of marker alleles shared among broth-)Tj
0 -1.2472 TD
0.009 Tc
0.037 Tw
(ers identical-by-descent.)Tj
ET

endstream
endobj
210 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
208 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
209 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
207 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
201 0 obj
<</Length 10254>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(198)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 63 638.022 Tm
0.012 Tc
0.187 Tw
(Our multipoint analyses indicated that there was)Tj
-1.5024 -1.2543 TD
0.009 Tc
0.087 Tw
(suggestive evidence for linkage \(p < 0.01\) in five ge-)Tj
0 -1.2472 TD
0.011 Tc
0.188 Tw
(nomic regions on chromosomes: 5, 7 \(two regions\),)Tj
0 -1.2543 TD
0.009 Tc
0.019 Tw
(10, and 19. There is broad support for linkage in many)Tj
0 -1.2472 TD
0.017 Tw
[(of these regions. )-13(W)88(e)0( are presently adding more closely)]TJ
T*
0.055 Tw
(spaced markers around the peaks in each region to try)Tj
0 -1.2543 TD
0.068 Tw
(and determine whether the peaks remain, and if so, to)Tj
0 -1.2472 TD
0.008 Tc
0.031 Tw
[(further refine the regions. )-21(W)87(e)-1( will present results from)]TJ
0 -1.2543 TD
0.009 Tc
0.131 Tw
(this analysis, and discuss our next step in attempting)Tj
0 -1.2472 TD
0.013 Tw
(to localize gene\(s\) for prostate cancer aggressiveness.)Tj
/T22 1 Tf
14 0 0 14 50.981 513.014 Tm
-0.021 Tc
(23)Tj
/F5 1 Tf
8 0 0 8 50.981 496.97 Tm
0.008 Tc
0 Tw
[(Linkage disequilibrium and allele fr)22(equency)]TJ
T*
0.01 Tc
[(distributions in 1)53(14 SNPs acr)17(oss the genome in five)]TJ
T*
0.009 Tc
(populations)Tj
/F14 1 Tf
0 -1.2543 TD
0.011 Tc
(KAB Goddard)Tj
4.8 0 0 4.8 98.83 470.608 Tm
0 Tc
(1)Tj
8 0 0 8 101.325 466.979 Tm
0.009 Tc
0.003 Tw
(, JM Hall)Tj
4.8 0 0 4.8 131.995 470.608 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 134.433 466.979 Tm
0.007 Tc
0.006 Tw
[(, JS W)37(itte)]TJ
4.8 0 0 4.8 166.181 470.608 Tm
0 Tc
0 Tw
(1)Tj
-24 -2.0906 TD
(1)Tj
8 0 0 8 53.476 457.002 Tm
0.009 Tc
0.007 Tw
[(Case )10(W)81(estern Reserve Univ)66(., Cleveland, OH, USA,)]TJ
4.8 0 0 4.8 50.981 450.595 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 53.476 447.024 Tm
0.01 Tc
(PPGx, Inc, La Jolla, CA, USA)Tj
1.1906 -1.6299 TD
-0.007 Tc
0.188 Tw
(Single nucleotide polymorphisms \(SNPs\) are com-)Tj
-1.5024 -1.2472 TD
-0.011 Tc
0.098 Tw
(monly observed in the genome, and may be less expen-)Tj
0 -1.2543 TD
-0.016 Tc
0 Tw
[(sive to genotype compared to conventional markers. )12(Thus,)]TJ
0 -1.2472 TD
-0.015 Tc
(some researchers suggest using SNPs for both linkage and)Tj
T*
-0.011 Tc
0.076 Tw
[(association mapping studies of complex traits. However)39(,)]TJ
0 -1.2543 TD
0.064 Tw
(little is known about the distribution of SNP characteris-)Tj
0 -1.2472 TD
0.03 Tw
(tics that are important in mapping studies\227such as allele)Tj
T*
0.019 Tc
0.187 Tw
[(frequencies and inter)12(-marker linkage disequilibrium)]TJ
0 -1.2543 TD
-0.006 Tc
0.188 Tw
[(\(LD\)\227particularly in the context of population dif)15(fer)15(-)]TJ
0 -1.2472 TD
-0.033 Tc
(ences. )Tj
2.7638 0 TD
-0.01 Tc
0.131 Tw
[(Therefore, we evaluated 1)33(14 SNPs distributed in)]TJ
-2.7638 -1.2543 TD
0.002 Tw
(33 genes on 16 chromosomes. Genes were selected based)Tj
0 -1.2472 TD
-0.016 Tc
0 Tw
[(on having potential pharmacogenomic ef)19(fects. )27(The sample)]TJ
T*
-0.013 Tc
0.045 Tw
[(included 727 individuals from African )8(American, Cauca-)]TJ
0 -1.2543 TD
0.188 Tw
[(sian, Chinese, Hispanic, and Japanese populations. )-175(W)74(e)]TJ
0 -1.2472 TD
-0.011 Tc
0.033 Tw
(used the EM algorithm to estimate haplotype frequencies)Tj
0 -1.2543 TD
-0.01 Tc
0.056 Tw
(for SNPs within a gene, and we considered several mea-)Tj
0 -1.2472 TD
0.006 Tw
(sures of LD.)Tj
1.5024 -1.2472 TD
-0.011 Tc
0.045 Tw
[(Both alleles were observed in 105 SNPs for the )17(Afri-)]TJ
-1.5024 -1.2543 TD
-0.021 Tc
(can )Tj
1.5803 0 TD
-0.01 Tc
0.032 Tw
(Americans compared to only 68 and 70 SNPs for the)Tj
-1.5803 -1.2472 TD
-0.011 Tc
0.041 Tw
[(Japanese and Chinese respectively)60(. Comparing allele fre-)]TJ
T*
0.161 Tw
(quencies among populations, the Japanese and Chinese)Tj
0 -1.2543 TD
0.094 Tw
(had the highest correlation \(R=.99\), the Hispanics had a)Tj
0 -1.2472 TD
0.076 Tw
(high correlation \(R>.87\) with all others, and the remain-)Tj
0 -1.2543 TD
-0.013 Tc
0.186 Tw
[(ing pairs of populations had R<.83. )-177(The correlation in)]TJ
0 -1.2472 TD
-0.018 Tc
0 Tw
(LD among populations appeared to distinguish two groups)Tj
T*
-0.01 Tc
0.128 Tw
(\(Japanese and Chinese vs. the others\), where R>.87 for)Tj
0 -1.2543 TD
-0.011 Tc
0.016 Tw
(populations within groups, and R<.65 for populations be-)Tj
0 -1.2472 TD
-0.01 Tc
0.117 Tw
(tween groups. In most cases, pairwise LD was detected)Tj
0 -1.2543 TD
-0.011 Tc
(\(p-value)Tj
/F17 1 Tf
3.2457 0 TD
0 Tc
0 Tw
(\243)Tj
/F14 1 Tf
0.5386 0 TD
-0.011 Tc
0.028 Tw
(05\) if the common allele frequency was <.95 in)Tj
-3.7843 -1.2472 TD
-0.01 Tc
0.018 Tw
(both SNPs. Exceptions included 22/74 and 15/78 pairs of)Tj
T*
-0.011 Tc
0.12 Tw
[(SNPs for the Chinese and Japanese, respectively)53(.)120( )-96(These)]TJ
0 -1.2543 TD
0.171 Tw
(results suggest that one must carefully select SNPs for)Tj
0 -1.2472 TD
-0.01 Tc
0.188 Tw
(use in a genome screen using LD or linkage mapping)Tj
T*
-0.012 Tc
0.055 Tw
[(methods. Also, the inter)9(-marker LD we observed may il-)]TJ
0 -1.2543 TD
0.15 Tw
[(lustrate the distribution of marker)17(-trait LD for complex)]TJ
0 -1.2472 TD
-0.01 Tc
(diseases.)Tj
/T22 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.021 Tc
(24)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.009 Tc
0.001 Tw
(Detecting allelic association in nuclear families.)Tj
/F14 1 Tf
T*
0.014 Tw
[(K.D. Siegmund, )9(W)88(.J. Gauderman, D.C. )9(Thomas.)]TJ
0 -1.2543 TD
0.011 Tw
[(University of Southern California, Los )44(Angeles, USA)]TJ
0 -1.2472 TD
0 Tc
0 Tw
(.)Tj
1.4953 -1.7504 TD
0.009 Tc
0.127 Tw
[(W)74(e)0( present methods for testing allelic association)]TJ
-1.4953 -1.2472 TD
0.059 Tw
(in the presence of linkage from sibships with multiple)Tj
0 -1.2543 TD
0.008 Tc
0.072 Tw
[(cases and/or controls. )-56(W)80(e)-1( describe how recent \221allele-)]TJ
0 -1.2472 TD
0.009 Tc
0.161 Tw
(counting\222 methods can be applied using a likelihood)Tj
0 -1.2543 TD
0.011 Tc
0.187 Tw
(that conditions on the phase and identity-by-descent)Tj
0 -1.2472 TD
0.009 Tc
0.138 Tw
(\(ibd\) structure of the sibling genotypes, an extension)Tj
T*
0.004 Tc
0 Tw
(of the conditional likelihood approach proposed by Self)Tj
0 -1.2543 TD
0.009 Tc
0.05 Tw
(et al. \(1991\). Under an additional assumption of equal)Tj
0 -1.2472 TD
0.188 Tw
(male and female recombination fractions, the condi-)Tj
T*
0.094 Tw
(tioning statement can be relaxed to condition only on)Tj
0 -1.2543 TD
-0.011 Tc
0.007 Tw
(the number of alleles shared identical by descent between)Tj
0 -1.2472 TD
0.126 Tw
[(sib pairs. In a simulation study)60(, we compare score tests)]TJ
0 -1.2543 TD
-0.018 Tc
0 Tw
(from likelihoods that condition on \(1\) parental mating type)Tj
0 -1.2472 TD
-0.011 Tc
0.103 Tw
[(only)60(, \(2\) parental mating type and ibd structure, and \(3\))]TJ
T*
-0.014 Tc
0.131 Tw
[(parental mating type, ibd structure, and phase. )-120(W)80(e)-4( con-)]TJ
0 -1.2543 TD
-0.011 Tc
0.101 Tw
(sider a single diallelic susceptibility gene with a disease)Tj
0 -1.2472 TD
0.054 Tw
(gene freqeuncy of 5% and population attributable risk of)Tj
0 -1.2543 TD
0.109 Tw
(20%, and a linked marker with four alleles; the popula-)Tj
0 -1.2472 TD
0.077 Tw
(tion frequency of disease is 10%. Under tight linkage \()Tj
/F17 1 Tf
21.9756 0 TD
0 Tc
0 Tw
(q)Tj
/F14 1 Tf
-21.9756 -1.2472 TD
-0.011 Tc
0.053 Tw
(= 0\), the test size from a likelihood conditioning only on)Tj
0 -1.2543 TD
0.052 Tw
[(parental mating type is high. For af)17(fected sib triplets, the)]TJ
0 -1.2472 TD
0.055 Tw
(false-positive rate under the multiplicative gene model is)Tj
T*
0.058 Tw
(twice the nominal value at the 5% significance level and)Tj
0 -1.2543 TD
0.032 Tw
(4-times the rate at the 0.1% level. Score tests from likeli-)Tj
0 -1.2472 TD
0.16 Tw
(hoods that condition on \(2\) or \(3\) achieve the nominal)Tj
0 -1.2543 TD
0.108 Tw
(level, however tests from the latter appear conservative.)Tj
0 -1.2472 TD
0.073 Tw
[(W)83(e)0( estimate power when the disease allele is in positive)]TJ
T*
-0.007 Tc
0.187 Tw
(disequilibrium with one marker allele \()Tj
/F17 1 Tf
16.285 0 TD
0 Tc
0 Tw
(d)Tj
/F14 1 Tf
4.8 0 0 4.8 389.211 301.776 Tm
(1)Tj
8 0 0 8 391.535 303.024 Tm
-0.007 Tc
0.188 Tw
[(\))92(.)92( )-127(At 50% of)]TJ
-17.0646 -1.2543 TD
-0.012 Tc
(max\()Tj
/F17 1 Tf
2.0126 0 TD
0 Tc
0 Tw
(d)Tj
/F14 1 Tf
4.8 0 0 4.8 274.975 291.798 Tm
(1)Tj
8 0 0 8 277.299 292.989 Tm
-0.011 Tc
0.058 Tw
[(\), the power for a sample of 100 af)17(fected sib trip-)]TJ
-2.785 -1.2472 TD
0.095 Tw
(lets is 81% when conditioning on ibd compared to 74%)Tj
0 -1.2543 TD
0.065 Tw
(when conditioning on ibd and phase \()Tj
/F17 1 Tf
15.0591 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6236 0 TD
-0.011 Tc
0.066 Tw
[( = 0.05\). In sum-)]TJ
-15.6827 -1.2472 TD
0.132 Tw
[(mary)60(, this likelihood approach provides a flexible alter)17(-)]TJ
T*
0.168 Tw
(native to the \221allele-counting\222 methods proposed in the)Tj
0 -1.2543 TD
0.154 Tw
(literature; it will be useful for the fine-mapping of dis-)Tj
0 -1.2472 TD
0.038 Tw
(ease genes in sibships of arbitrary size, when linkage has)Tj
T*
0.022 Tw
(already been established.)Tj
/T22 1 Tf
14 0 0 14 255.019 184.989 Tm
-0.021 Tc
(25)Tj
/F5 1 Tf
8 0 0 8 255.019 167.981 Tm
0.009 Tc
0.001 Tw
[(The use of conditional logistic r)16(egr)16(ession and)]TJ
T*
0.011 Tw
[(family-based contr)16(ols to investigate association of a)]TJ
T*
0 Tw
(candidate autoimmune gene with rheumatoid)Tj
0 -1.2543 TD
(arthritis)Tj
/F14 1 Tf
0 -1.2472 TD
0.009 Tw
[(J H Barrett, S John, )43(A)51( Myerscough, J W)81(orthington)]TJ
0 -1.2543 TD
0.018 Tw
[(ARC Epidemiology Unit, University of Manchester)37(,)]TJ
0 -1.2472 TD
0.01 Tc
0.014 Tw
[(Manchester)38(, UK)]TJ
1.4953 -1.7504 TD
0.009 Tc
0.153 Tw
(Rheumatoid arthritis \(RA\) is an autoimmune dis-)Tj
-1.4953 -1.2472 TD
-0.02 Tc
(ease. )Tj
2.4591 0 TD
0.018 Tc
0.187 Tw
(Apart from an association with HLA, little is)Tj
ET

endstream
endobj
220 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
219 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
218 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
212 0 obj
<</Length 11072>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(199)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.008 Tc
0.068 Tw
[(known of the genetic basis of the disease. )-56(W)73(e)-1( investi-)]TJ
0 -1.2543 TD
0.009 Tc
0.141 Tw
(gated association of D6S446, a microsatellite marker)Tj
0 -1.2472 TD
0.011 Tc
0.188 Tw
(previously shown to be linked to other autoimmune)Tj
0 -1.2543 TD
0.009 Tc
0.174 Tw
(diseases, with RA, using family-based controls from)Tj
0 -1.2472 TD
0.014 Tw
[(dif)16(ferent types of family unit.)]TJ
1.5024 -1.2472 TD
-0.011 Tc
0 Tw
(A conditional logistic regression framework was used)Tj
-1.5024 -1.2543 TD
0.111 Tw
(to combine data on RA patients and either their parents)Tj
0 -1.2472 TD
-0.018 Tc
0 Tw
[(or unaf)17(fected and af)17(fected siblings \(Schaid and Rowland)]TJ
4.8 0 0 4.8 233.178 571.578 Tm
0 Tc
(1)Tj
8 0 0 8 235.559 568.006 Tm
-0.03 Tc
(\).)Tj
-21.9472 -1.2543 TD
-0.011 Tc
0.008 Tw
(Once evidence for association with a particular allele was)Tj
0 -1.2472 TD
0.063 Tw
[(established, possible dif)24(ferences in association according)]TJ
T*
-0.01 Tc
0.184 Tw
(to HLA genotype, age at disease onset and sex of the)Tj
0 -1.2543 TD
-0.011 Tc
0.114 Tw
(case were investigated by including interaction terms in)Tj
0 -1.2472 TD
-0.024 Tc
0.136 Tw
(the model. )Tj
4.5709 0 TD
-0.011 Tc
(After excluding uninformative families, data)Tj
-4.5709 -1.2472 TD
-0.013 Tc
0 Tw
[(consisted of 80 parent-af)15(fected-child trios, 32 parent-child)]TJ
0 -1.2543 TD
-0.011 Tc
0.062 Tw
(duos and 32 sibships, consisting of between 3 and 8 sib-)Tj
0 -1.2472 TD
0.011 Tw
[(lings \(with at least one af)10(fected and one unaf)24(fected\).)]TJ
1.5024 -1.2543 TD
0.009 Tc
0.037 Tw
(There was overall evidence of association between)Tj
-1.5024 -1.2472 TD
0.011 Tc
0.13 Tw
[(D6S446 and RA)54( )11(\()12(p)12( )11(=)12( )]TJ
9.4921 0 TD
0.006 Tc
0.134 Tw
[(0.002\). )-111(The strongest evidence)]TJ
-9.4921 -1.2472 TD
0.009 Tc
0.145 Tw
(was for preferential transmission of allele 4, with an)Tj
0 -1.2543 TD
0.163 Tw
(estimated odds ratio for RA of 2.7 \(95% confidence)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
[(interval 1.4, 5.3\) for subjects with the allele. )15(There was)]TJ
0 -1.2543 TD
0.009 Tc
0.025 Tw
(no evidence of interaction of this allele with HLA, sex)Tj
0 -1.2472 TD
0.008 Tw
(or age at disease onset.)Tj
1.5024 -1.2472 TD
0.002 Tc
0 Tw
(The results provide evidence of association between)Tj
-1.5024 -1.2543 TD
0.01 Tc
0.102 Tw
(D6S446, a candidate autoimmune locus, and RA in a)Tj
0 -1.2472 TD
0.009 Tc
0.04 Tw
(family-based design, ruling out a result due to popula-)Tj
0 -1.2543 TD
0.006 Tc
0.165 Tw
[(tion )8(stratification. )-147(The conditional logistic regression)]TJ
0 -1.2472 TD
0.009 Tc
0.13 Tw
(framework provides a flexible method for combining)Tj
T*
0.034 Tw
[(data from dif)9(ferent types of families and incorporating)]TJ
0 -1.2543 TD
0.015 Tw
(information on other factors of interest.)Tj
4.8 0 0 4.8 72 341.575 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 74.438 338.003 Tm
0.006 Tc
0.154 Tw
[(Schaid DJ and Rowland C. )-110(Am. )-6(J. )-6(Hum. )-6(Genet.)]TJ
-1.8071 -1.2472 TD
0.01 Tc
0.094 Tw
(63:1492\2261506, 1998)Tj
/T23 1 Tf
14 0 0 14 59.981 292.989 Tm
-0.021 Tc
(26)Tj
/F5 1 Tf
8 0 0 8 59.981 277.002 Tm
0.009 Tc
0.003 Tw
(Random effect models for combination of)Tj
T*
0 Tw
(association and sib-pair analysis applied to)Tj
0 -1.2543 TD
0.019 Tw
(osteoarthritis \(OA\))Tj
/F14 1 Tf
0 -1.2472 TD
-0.01 Tc
0.012 Tw
(J.J. Houwing-Duistermatt)Tj
4.8 0 0 4.8 140.485 250.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 142.866 247.011 Tm
-0.01 Tc
0.012 Tw
(, C. Bijkerk)Tj
4.8 0 0 4.8 179.376 250.583 Tm
-0.011 Tc
(1,2)Tj
8 0 0 8 185.272 247.011 Tm
0.016 Tw
(, I. Meulenbelt)Tj
4.8 0 0 4.8 231.307 250.583 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 233.631 247.011 Tm
(,)Tj
-21.7063 -1.2543 TD
-0.011 Tc
0.007 Tw
(Th. Stijnen)Tj
4.8 0 0 4.8 94.62 240.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 97.002 236.976 Tm
-0.009 Tc
0.008 Tw
[(, P)111(.E. Slagboom)]TJ
4.8 0 0 4.8 146.778 240.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 149.159 236.976 Tm
-0.01 Tc
0.01 Tw
(, C.M. van Duijn)Tj
4.8 0 0 4.8 202.28 240.605 Tm
0 Tc
0 Tw
(1)Tj
-29.6457 -2.0787 TD
(1)Tj
8 0 0 8 62.476 226.998 Tm
0.009 Tc
0.016 Tw
(Dept. of Epidemiology & Biostatistics, Erasmus)Tj
-0.3118 -1.2472 TD
0.008 Tc
0.013 Tw
(University Rotterdam; )Tj
4.8 0 0 4.8 135.553 220.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 137.991 217.021 Tm
0.009 Tc
0.017 Tw
(TNO, Institute of Prevention)Tj
-9.7512 -1.2543 TD
0.01 Tc
0.018 Tw
[(and Health, Gaubius Laboratory)60(, Leiden, Netherlands.)]TJ
1.5024 -1.6228 TD
0.009 Tc
0.014 Tw
[(Aim: Investigating the ef)16(fect of Col2A1 on various)]TJ
-1.5024 -1.2472 TD
0.06 Tw
(OA outcomes in a population based cohort \(749\) with)Tj
0 -1.2543 TD
0.058 Tw
(additional information on siblings \(230\) in a subset of)Tj
0 -1.2472 TD
0.004 Tc
-0.001 Tw
[(this cohort \(120\). )10(The observed outcomes are knee, hip,)]TJ
0 -1.2543 TD
0 Tw
(spine OA \(binary\) and generalized and hand OA \(quan-)Tj
0 -1.2472 TD
0.009 Tc
0.038 Tw
(titative\). Evidence exists that several genes play a role)Tj
T*
0.001 Tc
0 Tw
[(in OA)51( [1]. In the population cohort the ef)22(fect of Col2A1)]TJ
0 -1.2543 TD
0.01 Tc
0.012 Tw
[(on OA)53( for women was significant. However)38(, a sib-pair)]TJ
0 -1.2472 TD
0.009 Tc
0.187 Tw
(analysis did not confirm this result, necessitating an)Tj
T*
0.019 Tw
(analysis that combines both types of information.)Tj
1.5024 -1.2543 TD
0.141 Tw
[(W)81(e)-1( propose random ef)16(fect models with logit link)]TJ
-1.5024 -1.2472 TD
0.086 Tw
(for the binary outcomes and with identity link for the)Tj
25.5047 69.2504 TD
0.018 Tc
0.188 Tw
(quantitative outcomes. Col2A1 is incorporated as a)Tj
0 -1.2543 TD
0.009 Tc
0.057 Tw
(fixed ef)Tj
3.189 0 TD
-0.003 Tc
0.109 Tw
[(fect. T)55(w)-12(o)-12( )]TJ
4.1987 0 TD
0.009 Tc
0.056 Tw
(causes of correlation within sibships)Tj
-7.3877 -1.2472 TD
0.046 Tw
(are modelled namely due to 1\) sharing unlinked genes)Tj
0 -1.2543 TD
0.008 Tc
0.044 Tw
[(and 2\) sharing genes located near Col2A1. )-27(T)59(esting the)]TJ
0 -1.2472 TD
0.009 Tc
0.071 Tw
(null hypothesis of no correlation versus a certain type)Tj
T*
0.073 Tw
(of correlation is straightforward [2]. For the logit link)Tj
0 -1.2543 TD
0.118 Tw
(and correlation 2, modelling, assuming normal distri-)Tj
0 -1.2472 TD
0.013 Tw
[(butions for the random ef)16(fects is complex [2].)]TJ
1.4953 -1.2543 TD
0.127 Tw
(Our hypothesis is that if Col2A1 has a causal ef-)Tj
-1.4953 -1.2472 TD
0.041 Tw
(fect the model with correlation 1 will give the best fit,)Tj
T*
0.011 Tc
0.188 Tw
(while if Col2A1 is in linkage disequilibrium with a)Tj
0 -1.2543 TD
0.009 Tc
0.015 Tw
[(causal gene model 2 will give the best fit. )51(At the meet-)]TJ
0 -1.2472 TD
0.01 Tw
(ing the results will be presented.)Tj
1.4953 -1.2472 TD
0.007 Tw
[([1] Bijkerk C et al. )8(T)67(o)0( appear in )44(Arthritis Rheum)]TJ
0 -1.2543 TD
0.139 Tw
([2] Houwing-Duistermaat JJ et al. \(1998\) Stat. in)Tj
-1.4953 -1.2472 TD
0.01 Tc
0.062 Tw
(Med. 2939\2262954)Tj
/T23 1 Tf
14 0 0 14 264.019 452.976 Tm
-0.021 Tc
(27)Tj
/F5 1 Tf
8 0 0 8 264.019 436.989 Tm
0.01 Tc
0.003 Tw
[(HLA)60( and mate selection in North Car)17(olina)]TJ
T*
0.009 Tc
(populations)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
[(L.B. Pollak Jr)67(.)]TJ
4.8 0 0 4.8 311.187 420.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 313.625 416.976 Tm
0.01 Tc
0.006 Tw
(, E.G. Reisner)Tj
4.8 0 0 4.8 359.943 420.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 362.381 416.976 Tm
0.01 Tc
0.007 Tw
(, D.D. Kostyu)Tj
4.8 0 0 4.8 408.246 420.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 410.683 416.976 Tm
(,)Tj
-18.3331 -1.2472 TD
0.011 Tc
0.012 Tw
[(D.V)139(. Dawson)]TJ
4.8 0 0 4.8 307.786 410.627 Tm
0 Tc
0 Tw
(1)Tj
-9.1181 -2.0906 TD
(1)Tj
8 0 0 8 266.457 397.02 Tm
0.01 Tc
0.008 Tw
[(Case )9(W)82(estern Reserve Univ)67(., Cleveland, OH;)]TJ
4.8 0 0 4.8 264.019 390.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 266.457 386.986 Tm
0.011 Tc
0.014 Tw
[(Duke Univ)68(., Durham NC)]TJ
1.1905 -1.6228 TD
0.01 Tc
0.012 Tw
(HLA-A and HLA-B phenotypes collected from pa-)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.125 Tw
(ternity litigation cases \(1980\2261997\) were analyzed to)Tj
0 -1.2543 TD
0.017 Tw
(see if the degree of antigen sharing between mates dif-)Tj
0 -1.2472 TD
0.143 Tw
(fered from the degree of sharing expected in the ab-)Tj
0 -1.2543 TD
0.006 Tc
0.185 Tw
[(sence of selective factors. )-174(Those )-7(pairs )-7(with )-7(putative)]TJ
0 -1.2472 TD
0.01 Tc
0.129 Tw
(fathers whose HLA phenotype or blood type was in-)Tj
T*
0.02 Tc
0.188 Tw
(compatible with paternity were not included in the)Tj
0 -1.2543 TD
-0.009 Tc
(analysis. )Tj
3.9472 0 TD
0.006 Tc
0.157 Tw
[(The remaining data consist of 287 )-108(African-)]TJ
-3.9472 -1.2472 TD
0.001 Tc
0 Tw
(American pairs and 326 Caucasian pairs. Race was self-)Tj
0 -1.311 TD
0.007 Tc
0.107 Tw
[(reported. Data for Caucasians and )-43(African-Americans)]TJ
0 -1.3181 TD
0.009 Tc
0.042 Tw
(were permuted within race so that all possible pairs of)Tj
0 -1.311 TD
0.162 Tw
(mates were created, resulting in 326 samples of 326)Tj
T*
0.064 Tw
(pairs each and 287 samples of 287 pairs each, respec-)Tj
T*
0.011 Tc
0.186 Tw
[(tively)68(.)188( )-175(The average number of shared HLA)61( antigens)]TJ
T*
0.007 Tc
0.127 Tw
[(was calculated for each permuted sample. )-121(These val-)]TJ
0 -1.3181 TD
0.009 Tc
0.037 Tw
(ues were used to construct empiric distributions of an-)Tj
0 -1.311 TD
0.013 Tc
0.188 Tw
(tigen sharing corresponding to the hypothesis of no)Tj
T*
0.009 Tc
0.07 Tw
(mate selection, to which the observed data were com-)Tj
T*
0.01 Tc
0.083 Tw
(pared. Of 287 generated samples, only 8 \(2.78%\) had)Tj
T*
0.006 Tc
0.187 Tw
[(equal or greater sharing at the )-129(A)41( locus than )-5(did the)]TJ
0 -1.3181 TD
0 Tc
(observed data for )Tj
7.8874 0 TD
0.011 Tc
(African-Americans. Only 7 of the)Tj
-7.8874 -1.311 TD
0.009 Tc
0.121 Tw
[(permuted samples \(2.44%\) had equal or greater shar)16(-)]TJ
T*
0.006 Tc
0.146 Tw
[(ing )7(at )7(the )7(B )7(locus. )-119(When the numbers of matches at)]TJ
T*
0.008 Tc
0 Tw
(the two loci were combined, no other sample had equal)Tj
T*
0.009 Tc
0.07 Tw
(or greater HLA sharing than the observed data. In the)Tj
0 -1.3181 TD
0.037 Tc
0.187 Tw
(Caucasian data, only 7 of 326 generated samples)Tj
0 -1.311 TD
0.009 Tc
0.142 Tw
(\(2.15%\) had equal or decreased sharing compared to)Tj
T*
0.005 Tc
0.11 Tw
[(the observed data for the )-45(A)47( )]TJ
11.8986 0 TD
-0.006 Tc
0.223 Tw
[(locus. T)]TJ
3.3447 0 TD
0.009 Tc
0.111 Tw
(wenty-five of the)Tj
-15.2433 -1.311 TD
0.02 Tw
(samples \(7.67%\) had equal or greater sharing than that)Tj
ET

endstream
endobj
233 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
232 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
231 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
230 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
229 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
222 0 obj
<</Length 12529>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(200)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.009 Tc
0.162 Tw
(seen in the sample for the B locus. Findings for the)Tj
0 -1.2543 TD
0.007 Tc
0.125 Tw
[(two groups were thus quite disparate. )-114(While findings)]TJ
0 -1.2472 TD
0.023 Tc
0.187 Tw
(for HLA-A in Caucasians parallel previous studies)Tj
0 -1.2543 TD
0.01 Tc
0.188 Tw
(which suggested that mate choice might lead to de-)Tj
0 -1.2472 TD
0.009 Tc
0.011 Tw
[(creased HLA)52( sharing, the reverse was true for )37(African-)]TJ
T*
0.007 Tc
0 Tw
[(Americans. )14(This finding, combined with other negative)]TJ
0 -1.2543 TD
0.009 Tc
0.063 Tw
(reports, suggests that negative assortative mating with)Tj
0 -1.2472 TD
0 Tw
(respect to HLA is not universal.)Tj
/T24 1 Tf
14 0 0 14 50.981 527.017 Tm
-0.021 Tc
(28)Tj
/F5 1 Tf
8 0 0 8 50.981 508.989 Tm
0.009 Tc
(Ramifications of HLA class I polymorphism and)Tj
T*
(population genetics for vaccine development.)Tj
/F14 1 Tf
0 -1.2543 TD
0.011 Tc
0.006 Tw
[(D.V)131(. Dawson)]TJ
4.8 0 0 4.8 94.748 492.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 97.413 488.976 Tm
0.009 Tc
0.007 Tw
(, M. Ozgur)Tj
4.8 0 0 4.8 133.413 492.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 135.85 488.976 Tm
0.01 Tc
0.006 Tw
(, M. Ghanayem)Tj
4.8 0 0 4.8 186.761 492.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 189.199 488.976 Tm
0.009 Tc
0.006 Tw
(, K. Sari)Tj
4.8 0 0 4.8 216.638 492.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 219.132 488.976 Tm
(,)Tj
-21.0189 -1.2472 TD
0.011 Tc
0.018 Tw
(D.D. Kostyu)Tj
4.8 0 0 4.8 92.764 482.57 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 95.202 478.998 Tm
(.)Tj
4.8 0 0 4.8 50.981 472.592 Tm
(1)Tj
8 0 0 8 53.476 469.02 Tm
0.01 Tc
0.008 Tw
[(Case )9(W)82(estern Reserve Univ)67(., Cleveland, OH;)]TJ
4.8 0 0 4.8 50.981 462.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 53.476 458.986 Tm
0.011 Tc
0.009 Tw
[(Duke Univ)68(., Durham, NC; USA.)]TJ
1.1906 -1.8709 TD
0.021 Tc
0 Tw
(The remarkable level of polymorphism associated)Tj
-1.5024 -1.2543 TD
0.029 Tc
0.08 Tw
(with the class I loci of the HLA \(human major his-)Tj
0 -1.2472 TD
0.019 Tc
0 Tw
(tocompatibility\) complex is well known, with the less)Tj
0 -1.2543 TD
0.026 Tc
(than complete molecular typing to date yielding over)Tj
0 -1.2472 TD
0.03 Tc
0.09 Tw
[(300 HLA-A, -B and -C alleles. Further)37(, these HLA)]TJ
T*
0.029 Tc
0.139 Tw
(alleles are not randomly distributed across popula-)Tj
0 -1.2543 TD
0.054 Tc
0.188 Tw
[(tions, but show considerable ethnic dif)19(ferences.)]TJ
0 -1.2472 TD
0.029 Tc
0 Tw
(These factors may pose a serious concern for the de-)Tj
T*
0.127 Tw
(sign of peptide vaccines due to HLA restriction of)Tj
0 -1.2543 TD
0.124 Tw
(antigen recognition: It is quite possible that a vac-)Tj
0 -1.2472 TD
0.103 Tw
[(cine ef)15(fective in one population may be inef)15(fective)]TJ
0 -1.2543 TD
0.019 Tc
0 Tw
[(in another)40(, due to dif)12(fering distributions of HLA)54( class)]TJ
0 -1.2472 TD
0.027 Tc
0.101 Tw
[(I )10(alleles. )-84(The types of vaccines potentially af)13(fected)]TJ
T*
0.029 Tc
0.166 Tw
(include those for prevention of infectious diseases)Tj
0 -1.2543 TD
0.041 Tw
(and for immunotherapy of tumors. In order to begin)Tj
0 -1.2472 TD
0.174 Tw
(to assess the potential problems in vaccine design)Tj
0 -1.2543 TD
0.03 Tc
0.059 Tw
(due to HLA class I polymorphism, we have applied)Tj
0 -1.2472 TD
0.029 Tc
0.063 Tw
(an algorithm to predict levels of favorable response)Tj
T*
0.188 Tw
(in 15 populations embracing a spectrum of ethnic)Tj
0 -1.2543 TD
0.038 Tc
(and racial groups, based upon population genetic)Tj
0 -1.2472 TD
0.029 Tc
0.063 Tw
(models and known allele and haplotype frequencies)Tj
T*
0.028 Tc
0.032 Tw
[(for class I HLA)49( loci. )14(Approaches developed provide)]TJ
0 -1.2543 TD
0.029 Tc
0.176 Tw
[(for the identification of alleles that should be tar)8(-)]TJ
0 -1.2472 TD
0.133 Tw
(geted when designing vaccines, and permit predic-)Tj
0 -1.2543 TD
0.064 Tw
(tion of responder status in any given population for)Tj
0 -1.2472 TD
0.021 Tc
0 Tw
[(vaccines with known HLA)56( restricted epitope\(s\). )14(They)]TJ
T*
0.029 Tc
0.048 Tw
(may also facilitate analysis of a protein sequence in)Tj
0 -1.2543 TD
0.027 Tw
(order to identify potential epitopes for use in immu-)Tj
0 -1.2472 TD
0.028 Tc
0 Tw
[(notherapeutic vaccines. Further)28(, results from peptide)]TJ
0 -1.2543 TD
0.029 Tc
0.07 Tw
(binding studies suggest that, in some cases, peptide)Tj
0 -1.2472 TD
0.037 Tw
[(binding dif)8(fers among DNA-defined subtypes of se-)]TJ
T*
0.117 Tw
(rologically defined HLA antigens; this is shown to)Tj
0 -1.2543 TD
0.028 Tc
0 Tw
(have potentially significant impact on the proportion)Tj
0 -1.2472 TD
0.023 Tc
[(of persons theoretically capable of responding to cer)9(-)]TJ
T*
0.025 Tc
[(tain vaccines. )18(These findings therefore may have im-)]TJ
0 -1.2543 TD
0.02 Tc
(plications for the design of both vaccines and vaccine)Tj
0 -1.2472 TD
0.028 Tc
(trials.)Tj
/T24 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.021 Tc
(29)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.008 Tc
[(The r)22(elationship between the sibling r)22(ecurr)8(ence)]TJ
T*
0.009 Tc
0.003 Tw
[(risk-ratio and genotype r)23(elative risk)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.009 Tw
[(B. R)45(ybicki)]TJ
4.8 0 0 4.8 290.225 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 292.663 596.976 Tm
0.01 Tc
0.012 Tw
[( and R.C. Elston)]TJ
4.8 0 0 4.8 346.918 600.605 Tm
0 Tc
0 Tw
(2)Tj
-19.1457 -2.0906 TD
(1)Tj
8 0 0 8 257.457 586.998 Tm
0.009 Tc
0.008 Tw
(Henry Ford Health System, Detroit, MI;)Tj
4.8 0 0 4.8 255.019 580.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 257.457 577.02 Tm
0.009 Tc
0.01 Tw
[(Case W)81(estern Reserve University)59(, Cleveland, OH.)]TJ
1.1906 -1.7504 TD
0.008 Tc
0.039 Tw
(The recurrence risk-ratio of disease in sibs, )Tj
/F17 1 Tf
18.1913 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 416.991 561.77 Tm
(S)Tj
8 0 0 8 419.712 563.017 Tm
0.009 Tc
0.044 Tw
(, has)Tj
-20.5866 -1.2543 TD
0.06 Tw
(become a standard parameter used to estimate the sta-)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
[(tistical power of af)24(fected-sib-pair linkage studies. How-)]TJ
0 -1.2543 TD
0.01 Tc
[(ever)38(,)182( )]TJ
/F17 1 Tf
2.4165 0 TD
0 Tc
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 278.83 531.779 Tm
(S)Tj
8 0 0 8 281.551 532.97 Tm
0.009 Tc
0.182 Tw
[( serves only as a surrogate for the genotype)]TJ
-3.3165 -1.2472 TD
0.002 Tc
0.096 Tw
(relative risk, )Tj
/F17 1 Tf
5.5701 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
0.009 Tc
0.098 Tw
(, the parameter that directly determines)Tj
-5.9953 -1.2472 TD
0.144 Tw
(the statistical power to detect a specific disease loci.)Tj
0 -1.2543 TD
0.014 Tw
[(W)81(e)0( demonstrate that based on the definition of the two)]TJ
0 -1.2472 TD
-0.006 Tc
(parameters, )Tj
/F17 1 Tf
5.1449 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 300.713 491.811 Tm
(S)Tj
8 0 0 8 303.378 493.002 Tm
0.009 Tc
0.161 Tw
[( varies significantly more with respect)]TJ
-6.0449 -1.2472 TD
0.007 Tc
(to )Tj
/F17 1 Tf
1.0488 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
0.006 Tc
( and the disease allele frequency for two-locus mul-)Tj
-1.474 -1.2543 TD
0.028 Tc
0.187 Tw
(tiplicative interaction models compared with other)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
(two-locus and single gene models. Furthermore, for any)Tj
0 -1.2543 TD
0.009 Tc
0.102 Tw
(given disease allele frequency and inheritance model,)Tj
/F17 1 Tf
0 -1.2472 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 259.498 441.808 Tm
(S)Tj
8 0 0 8 262.219 442.998 Tm
0.008 Tc
0.02 Tw
[( has an upper limit as )]TJ
/F17 1 Tf
9.1063 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
0.009 Tc
0.02 Tw
[( increases. Under most inher)16(-)]TJ
-10.4315 -1.2472 TD
0.095 Tw
(itance models we tested, for a disease allele with fre-)Tj
0 -1.2543 TD
0.01 Tc
0.033 Tw
[(quency of 20% or greater)31(,)41( )]TJ
/F17 1 Tf
11.0409 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 347.825 421.795 Tm
(S)Tj
8 0 0 8 350.547 422.986 Tm
0.01 Tc
0.034 Tw
[( cannot exceed 10. Under)]TJ
-11.9409 -1.2472 TD
0.023 Tc
0.187 Tw
(dominant inheritance, if one or more susceptibility)Tj
0 -1.2543 TD
0.009 Tc
0.098 Tw
(genotypes are known, restricting sibships to those as-)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
(certained by a proband with the high risk genotype will)Tj
T*
0.004 Tc
0.091 Tw
(inflate the estimate of )Tj
/F17 1 Tf
9.5102 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 335.58 381.827 Tm
(S)Tj
8 0 0 8 338.301 383.017 Tm
0.009 Tc
0.092 Tw
[( and can serve as an indirect)]TJ
-10.4102 -1.2543 TD
0.15 Tw
(way of testing if the putative susceptibility genotype)Tj
0 -1.2472 TD
0.006 Tc
0.153 Tw
[(increases )7(disease )7(risk. )-126(While disease genes with val-)]TJ
T*
-0.002 Tc
0.062 Tw
(ues of )Tj
/F17 1 Tf
2.8559 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
0.009 Tc
0.064 Tw
[( less than 4 cannot be mapped under most ge-)]TJ
-3.2811 -1.2543 TD
-0.002 Tc
0.128 Tw
(netic models, )Tj
/F17 1 Tf
5.9598 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 307.176 341.802 Tm
(S)Tj
8 0 0 8 309.898 342.992 Tm
0.01 Tc
0.129 Tw
[( in the range of 2 to 3 portend good)]TJ
-6.8598 -1.2472 TD
0.009 Tc
0.118 Tw
(success in gene mapping under a wide variety of ge-)Tj
0 -1.2543 TD
0.026 Tw
(netic models. Investigators need to be cognizant of the)Tj
0 -1.2472 TD
0.005 Tc
0.096 Tw
[(basic dif)12(ferences between )]TJ
/F17 1 Tf
11.0906 0 TD
0 Tc
0 Tw
(l)Tj
/F14 1 Tf
4.8 0 0 4.8 348.279 311.811 Tm
(S)Tj
8 0 0 8 350.943 313.002 Tm
-0.015 Tc
0.097 Tw
[( and )]TJ
/F17 1 Tf
2.1898 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
0.009 Tc
0.099 Tw
[( in the planning of)]TJ
-14.6055 -1.2472 TD
0.025 Tw
[(af)23(fected-sib-pair linkage studies.)]TJ
/T24 1 Tf
14 0 0 14 255.019 264.983 Tm
-0.021 Tc
(30)Tj
/F5 1 Tf
8 0 0 8 255.019 247.975 Tm
0.009 Tc
0 Tw
[(The genetics of r)16(egional fat distribution phenotypes)]TJ
T*
(in the population-based National Heart, Lung, and)Tj
T*
0.004 Tw
(Blood Institute Family Heart Study \(NHLBI-FHS\).)Tj
/F14 1 Tf
0 -1.2543 TD
0 Tw
(M. Feitosa)Tj
4.8 0 0 4.8 289.942 221.613 Tm
0 Tc
(1)Tj
8 0 0 8 292.38 217.984 Tm
0.009 Tc
0.003 Tw
(, I. Borecki)Tj
4.8 0 0 4.8 329.343 221.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 331.781 217.984 Tm
0.009 Tc
0.003 Tw
(, S. Hunt)Tj
4.8 0 0 4.8 360.978 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 363.472 217.984 Tm
0.009 Tc
0.007 Tw
[(, D. )52(Arnett)]TJ
4.8 0 0 4.8 398.225 221.613 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 400.663 217.984 Tm
(,)Tj
-18.2055 -1.2472 TD
0.009 Tc
[(P)111(.)0( Schreiner)]TJ
4.8 0 0 4.8 294.08 211.578 Tm
0 Tc
(3)Tj
8 0 0 8 296.575 208.006 Tm
0.011 Tc
0.003 Tw
(, D.C. Rao)Tj
4.8 0 0 4.8 331.441 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 333.879 208.006 Tm
0.009 Tc
0.007 Tw
(, M. Province)Tj
4.8 0 0 4.8 378.553 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 380.991 208.006 Tm
(.)Tj
4.8 0 0 4.8 255.019 201.6 Tm
(1)Tj
8 0 0 8 257.457 198.028 Tm
0.009 Tc
0.011 Tw
[(W)81(ashington Univ)59(., St. Louis, MO, )]TJ
4.8 0 0 4.8 371.75 201.6 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 374.187 198.028 Tm
0.011 Tc
0.012 Tw
[(Univ)68(. Utah,)]TJ
-14.8961 -1.2543 TD
0.01 Tc
0.009 Tw
[(Salt Lake City)67(, UT)60(;)16( )]TJ
4.8 0 0 4.8 321.009 191.622 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 323.447 187.994 Tm
0.009 Tc
0.013 Tw
[(Univ)66(. Minnesota, Minneapolis,)]TJ
-8.5535 -1.2472 TD
0.011 Tc
0 Tw
(MN \226 USA.)Tj
1.4953 -1.7504 TD
0.003 Tc
(Intra-abdominal fat is associated with increased risk)Tj
-1.4953 -1.2543 TD
0.011 Tc
0.188 Tw
[(of cardiovascular disease \(CVD\). )-173(W)76(aist to hip ratio)]TJ
0 -1.2472 TD
0.009 Tc
0.155 Tw
(\(WHR\) and subscapular to triceps skinfold thickness)Tj
T*
0.092 Tw
(ratio \(STR\) are measures of relative central fat distri-)Tj
0 -1.2543 TD
0.01 Tc
0.016 Tw
(bution; they have been shown to be predictors of CVD)Tj
0 -1.2472 TD
0.009 Tc
0.069 Tw
[(morbidity and mortality)59(, but the genetics are less well)]TJ
T*
-0.017 Tc
(known. )Tj
3.4937 0 TD
0.009 Tc
0.185 Tw
[(The inheritance patterns of )-171(WHR )-9(and )-9(STR,)]TJ
-3.4937 -1.2543 TD
0.081 Tw
(both before and after adjustment for body mass index)Tj
0 -1.2472 TD
0.063 Tw
(\(BMI\), were investigated in the random sample of the)Tj
ET

endstream
endobj
243 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
242 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
241 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
235 0 obj
<</Length 9789>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(201)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.017 Tc
0.187 Tw
(NHLBI-FHS, a multicenter population-based family)Tj
0 -1.2543 TD
0.009 Tc
0.063 Tw
(study \(N=2,716 subjects\). Segregation analysis results)Tj
0 -1.2472 TD
-0.001 Tc
0 Tw
[(for age adjusted )13(WHR suggested an additive major gene)]TJ
0 -1.2543 TD
0.009 Tc
0.012 Tw
(that accounts for 35% of the phenotypic variance, with)Tj
0 -1.2472 TD
0.044 Tw
(approximately 30% of the sample homozygous for the)Tj
T*
0.008 Tw
[(\223high\224 genotype. )9(The results for age and BMI adjusted)]TJ
0 -1.2543 TD
0.122 Tw
(WHR were also compatible with a major gene, how-)Tj
0 -1.2472 TD
0.056 Tw
(ever the multifactorial model provided the most parsi-)Tj
0 -1.2543 TD
0.021 Tc
0.186 Tw
[(monious fit to the data. It is unclear if )-179(WHR )-6(was)]TJ
0 -1.2472 TD
0.01 Tc
0.038 Tw
(picking up a BMI gene. On the other hand, there is no)Tj
T*
0.009 Tc
0.016 Tw
(evidence that the familial resemblance for STR pheno-)Tj
0 -1.2543 TD
0.069 Tw
(type is influenced by a Mendelian gene, whether con-)Tj
0 -1.2472 TD
0.036 Tw
[(trolling for BMI or not. )-13(Therefore, while both of these)]TJ
T*
0.061 Tw
(obesity measurements are potent predictors of chronic)Tj
0 -1.2543 TD
-0.006 Tc
(diseases, )Tj
3.9827 0 TD
0.009 Tc
0.13 Tw
(WHR also may be informative for studying)Tj
-3.9827 -1.2472 TD
0.106 Tw
[(the genetics of obesity)59(, especially as a cardiovascular)]TJ
0 -1.2543 TD
0.012 Tw
[(risk factor)52(.)]TJ
/T25 1 Tf
14 0 0 14 59.981 442.998 Tm
-0.021 Tc
(31)Tj
/F5 1 Tf
8 0 0 8 59.981 427.011 Tm
0.01 Tc
0.001 Tw
[(On a Randomization Pr)17(ocedur)17(e in Linkage)]TJ
T*
0.009 Tc
(Analysis)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.007 Tw
(H. Zhao)Tj
4.8 0 0 4.8 86.854 410.627 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 92.976 406.998 Tm
0.01 Tc
0.009 Tw
(, K.R. Merikangas)Tj
4.8 0 0 4.8 153.354 410.627 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 155.792 406.998 Tm
0.011 Tc
0.009 Tw
(, K.K. Kidd)Tj
4.8 0 0 4.8 194.457 410.627 Tm
0 Tc
0 Tw
(2)Tj
-28.0157 -2.0906 TD
(1)Tj
8 0 0 8 62.476 397.02 Tm
0.009 Tc
0.018 Tw
(Department of Epidemiology and Public Health, and)Tj
4.8 0 0 4.8 59.981 390.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 62.476 386.986 Tm
0.009 Tc
0.012 Tw
[(Department of Genetics, )38(Y)100(ale University School of)]TJ
-0.3118 -1.2472 TD
0.01 Tc
0.01 Tw
(Medicine, New Haven, CT 06520)Tj
1.5024 -1.6228 TD
0.009 Tc
0.165 Tw
[(Although much theoretical work has been under)9(-)]TJ
-1.5024 -1.2543 TD
0.019 Tw
(taken to derive thresholds for statistical significance in)Tj
0 -1.2472 TD
0.009 Tw
(genetic linkage studies, real data are often complicated)Tj
0 -1.2543 TD
0.084 Tw
(by many factors, such as missing individuals or unin-)Tj
0 -1.2472 TD
0.166 Tw
(formative markers, which make the validity of these)Tj
T*
0.148 Tw
(theoretical results questionable. In a typical genome-)Tj
0 -1.2543 TD
0 Tw
(wide scan, many markers on the same chromosome are)Tj
0 -1.2472 TD
0.078 Tw
(typed. Because of the dependence among these mark-)Tj
0 -1.2543 TD
0.055 Tw
(ers and the uncertainties in inferring the allele sharing)Tj
0 -1.2472 TD
0.053 Tw
[(status at a given position along the genome, the deter)9(-)]TJ
T*
0.07 Tw
(mination of statistical significance levels based on as-)Tj
0 -1.2543 TD
0.061 Tw
(ymptotic results for these statistical procedures is also)Tj
0 -1.2472 TD
0.028 Tc
0.187 Tw
(problematic. Many simulation-based methods have)Tj
T*
0.011 Tc
(been proposed in the literature to determine empiri-)Tj
0 -1.2543 TD
0.004 Tc
0 Tw
(cally the statistical significance of the observed test sta-)Tj
0 -1.2472 TD
0.006 Tc
[(tistics. However)34(, these methods are either not generally)]TJ
0 -1.2543 TD
0.009 Tc
0.067 Tw
(applicable to complex pedigree structures, or too time)Tj
0 -1.2472 TD
0.071 Tw
(consuming. In this presentation, we propose a general)Tj
T*
0 Tw
[(and computationally ef)16(ficient randomization procedure)]TJ
0 -1.2543 TD
0.008 Tc
0.058 Tw
[(that is applicable to arbitrary pedigree structures. )-35(This)]TJ
0 -1.2472 TD
0.001 Tc
0 Tw
(randomization procedure can be combined with any sta-)Tj
0 -1.2543 TD
0.009 Tc
0.054 Tw
(tistical test to assess the statistical significance for ge-)Tj
0 -1.2472 TD
0.026 Tc
0.188 Tw
(netic linkage between a locus and a qualitative or)Tj
T*
0.009 Tc
0.157 Tw
(quantitative trait. Furthermore, the genome-wide sig-)Tj
0 -1.2543 TD
0.172 Tw
(nificance level can be appropriately controlled when)Tj
0 -1.2472 TD
0.015 Tc
0.188 Tw
(many linked markers are studied in a genome-wide)Tj
T*
0.009 Tc
0.127 Tw
(scan. Simulated data and a diabetes data set are ana-)Tj
0 -1.2543 TD
0.002 Tw
(lyzed to demonstrate the usefulness of this novel simu-)Tj
0 -1.2472 TD
0.037 Tw
(lation method.)Tj
/T25 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.021 Tc
(32)Tj
/F5 1 Tf
8 0 0 8 264.019 616.989 Tm
0.009 Tc
0 Tw
(Association tests with marker haplotypes.)Tj
/F14 1 Tf
T*
0.007 Tw
(D. Clayton)Tj
4.8 0 0 4.8 299.962 610.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 302.4 607.011 Tm
0.01 Tc
0.007 Tw
[( & H. B. Jones)]TJ
4.8 0 0 4.8 350.816 610.583 Tm
0.013 Tc
(1,2)Tj
-18.0827 -2.0787 TD
0 Tc
0 Tw
(1)Tj
8 0 0 8 266.457 596.976 Tm
0.009 Tc
0.017 Tw
[(Cambridge Univ)66(., Cambridge, UK; )]TJ
4.8 0 0 4.8 383.868 600.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 386.305 596.976 Tm
0.009 Tc
0.019 Tw
[(Stanford Univ)66(.,)]TJ
-15.2858 -1.2472 TD
0.01 Tc
0.003 Tw
(Stanford, CA, USA.)Tj
1.4953 -1.7504 TD
-0.011 Tc
0.149 Tw
[(W)40(ith the increasing availability of single nucleotide)]TJ
-1.4953 -1.2472 TD
0.146 Tw
[(polymorphism\222)60(s \(SNPs\), methods for determining asso-)]TJ
0 -1.2543 TD
0.023 Tw
(ciation between haplotypes composed of several adjacent)Tj
0 -1.2472 TD
0.048 Tw
[(markers are needed. )-20(The transmission/disequilibrium test)]TJ
0 -1.2543 TD
0.061 Tw
[(\(TDT\) can be extended to multiple markers by consider)24(-)]TJ
0 -1.2472 TD
-0.014 Tc
0.139 Tw
[(ing the transmission of all distinct haplotypes. )-120(This has)]TJ
T*
-0.011 Tc
0 Tw
(the disadvantage of ignoring any \223similarity\224 between the)Tj
0 -1.2543 TD
-0.02 Tc
(haplotypes that are derived from a common ancestral chro-)Tj
0 -1.2472 TD
-0.011 Tc
0.147 Tw
[(mosome. Furthermore, there may be a lar)10(ge number of)]TJ
T*
0.128 Tw
[(haplotypes leading to relatively low statistical power)60(.)121( )-60(A)]TJ
0 -1.2543 TD
0.076 Tw
(method that takes account of the similarity between sus-)Tj
0 -1.2472 TD
0.037 Tw
[(ceptibility haplotypes is described. )-19(This is based on tech-)]TJ
0 -1.2543 TD
-0.015 Tc
0 Tw
(niques developed in spatial statistics and tests for a greater)Tj
0 -1.2472 TD
-0.01 Tc
0.187 Tw
[(similarity between haplotypes that are transmitted than)]TJ
T*
-0.011 Tc
0.029 Tw
[(between those that are not transmitted to the af)24(fected of)10(f-)]TJ
0 -1.2543 TD
0.07 Tw
(spring. Similarity is measured as the size of the contigu-)Tj
0 -1.2472 TD
0.027 Tw
(ous section of the chromosome that is identical measured)Tj
0 -1.2543 TD
0.044 Tw
(from a focal point. Such similarity will arise when muta-)Tj
0 -1.2472 TD
0.058 Tw
(tion and recombination occur on the ancestral predispos-)Tj
T*
0.004 Tc
0.188 Tw
[(ing haplotype leading to several dif)18(ferent but related)]TJ
0 -1.2543 TD
-0.011 Tc
0.095 Tw
(haplotypes, each conferring susceptibility to the disease.)Tj
0 -1.2472 TD
-0.013 Tc
0 Tw
(Application of this method to data from auto-immune dis-)Tj
T*
-0.011 Tc
0.054 Tw
(eases show that it can detect associations that are missed)Tj
0 -1.2543 TD
0.021 Tw
(by single marker methods.)Tj
/T25 1 Tf
14 0 0 14 264.019 305.008 Tm
-0.021 Tc
(33)Tj
/F5 1 Tf
8 0 0 8 264.019 288 Tm
0.009 Tc
0 Tw
(Selecting contingency table in population-based)Tj
0 -1.2472 TD
0.005 Tw
[(association study: )59(Allele fr)16(equency or)23( positivity?)]TJ
/F14 1 Tf
0 -1.2543 TD
0.019 Tw
[(Jun Ohashi and Katsushi T)67(okunaga)]TJ
0 -1.2472 TD
0.014 Tw
(Department of Human Genetics, Graduate School of)Tj
0 -1.2543 TD
0.008 Tc
0.022 Tw
[(Medicine, University of T)66(okyo, Hongo, )-6(T)66(okyo 1)36(13,)]TJ
0 -1.2472 TD
0.012 Tc
(Japan.)Tj
1.4953 -1.7504 TD
-0.009 Tc
0.187 Tw
[(In population-based association studies, the signifi-)]TJ
-1.4953 -1.2472 TD
-0.01 Tc
0.072 Tw
(cance of the association between a candidate gene and a)Tj
0 -1.2543 TD
-0.011 Tc
0.107 Tw
(disease is usually examined by a simple chi-square test.)Tj
0 -1.2472 TD
0.052 Tw
(Such studies require a 2 by 2 contingency table made up)Tj
T*
0.077 Tw
[(of either allele frequencies or positivities in af)24(fected and)]TJ
0 -1.2543 TD
0.183 Tw
(control groups. In order to investigate the influence of)Tj
0 -1.2472 TD
0.098 Tw
(each 2 by 2 table on the power of the chi-square test, P)Tj
0 -1.2543 TD
0.019 Tw
(values were calculated for two penetrance models \(multi-)Tj
0 -1.2472 TD
0 Tw
[(plicative and additive\). )23(When the value of penetrance was)]TJ
T*
-0.018 Tc
[(small and not markedly dif)17(ferent among genotypes, a lar)25(ge)]TJ
0 -1.2543 TD
[(dif)17(ference in the power of the chi-square test was observed)]TJ
0 -1.2472 TD
-0.011 Tc
0.042 Tw
(between the two tables. In a multiplicative model, the al-)Tj
T*
0.147 Tw
(lele frequency table was superior to the positivity table)Tj
0 -1.2543 TD
0.006 Tc
0.188 Tw
(for detecting significance. In contrast, in an additive)Tj
0 -1.2472 TD
-0.011 Tc
0.051 Tw
(model, the positivity table was most suitable. Selecting a)Tj
ET

endstream
endobj
253 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
254 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
251 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
252 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
245 0 obj
<</Length 10013>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(202)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.082 Tw
(contingency table was especially important for detecting)Tj
0 -1.2543 TD
0.009 Tw
(true association, when the required significance level was)Tj
0 -1.2472 TD
0.057 Tw
(corrected to avoid a problem of multiple hypothesis test-)Tj
0 -1.2543 TD
-0.04 Tc
(ing. )Tj
1.8283 0 TD
-0.011 Tc
0.12 Tw
(The chi-square test, therefore, should be performed)Tj
-1.8283 -1.2472 TD
0.095 Tw
(for both tables to identify a susceptible gene with a low)Tj
T*
-0.009 Tc
0.188 Tw
[(penetrance, even when no significant dif)19(ference is ob-)]TJ
0 -1.2543 TD
-0.011 Tc
0.013 Tw
(served in one table.)Tj
/T26 1 Tf
14 0 0 14 50.981 536.995 Tm
-0.021 Tc
(34)Tj
/F5 1 Tf
8 0 0 8 50.981 519.987 Tm
0.009 Tc
0.014 Tw
[(Homozygosity mapping and heter)16(ogeneity: a)]TJ
0 -1.2472 TD
(challenge.)Tj
/F14 1 Tf
0 -1.2543 TD
0.022 Tw
[(Emmanuelle G\351nin and Fran\347oise Cler)16(get-Darpoux)]TJ
0 -1.2472 TD
0.01 Tc
0.015 Tw
[(INSERM U155, Genetic Epidemiology)53(, France)]TJ
1.5024 -1.7504 TD
0.009 Tc
0.153 Tw
[(T)60(o)0( find genes involved in recessive diseases, ho-)]TJ
-1.5024 -1.2472 TD
0.006 Tc
0 Tw
[(mozygosity mapping has proven its power)49(. )20(The method)]TJ
0 -1.2543 TD
0.009 Tc
0.186 Tw
[(focuses on inbred af)16(fected individuals and looks for)]TJ
0 -1.2472 TD
0.001 Tc
0 Tw
(regions of the genome where they are homozygous with)Tj
T*
0.009 Tc
0.033 Tw
(the idea that the gene involved will be found in one of)Tj
0 -1.2543 TD
0.025 Tw
(these regions.)Tj
1.5024 -1.2472 TD
-0.006 Tc
0.187 Tw
[(For many recessive diseases however)37(, the mutated)]TJ
-1.5024 -1.2543 TD
-0.011 Tc
0.053 Tw
[(gene may dif)10(fer from one family to another)53(.)53( )-39(This hetero-)]TJ
0 -1.2472 TD
-0.009 Tc
0.188 Tw
(geneity considerably reduces the power of the method)Tj
T*
-0.011 Tc
0.162 Tw
(and in most situations, it becomes impossible to detect)Tj
0 -1.2543 TD
0.057 Tw
(any of the genes involved using samples of unrelated in-)Tj
0 -1.2472 TD
0.079 Tw
[(bred af)10(fected individuals. For instance, with a sample of)]TJ
0 -1.2543 TD
0.118 Tw
[(20 first cousin progeny)60(, the probability to detect a gene)]TJ
0 -1.2472 TD
0.179 Tw
(responsible for half the disease cases is only 25% and)Tj
T*
0.011 Tw
(falls below 6% for a gene involved in 40% of cases.)Tj
1.5024 -1.2543 TD
0.009 Tc
0.122 Tw
[(T)60(o)0( reduce the level of heterogeneity)66(, one strategy)]TJ
-1.5024 -1.2472 TD
0.008 Tc
0.035 Tw
[(consists in using lar)15(ge inbred families. )-13(W)73(e)-1( have inves-)]TJ
T*
0.009 Tc
0.051 Tw
(tigated this possibility and determined the information)Tj
0 -1.2543 TD
0 Tc
0 Tw
[(provided by related inbred af)14(fected individuals and their)]TJ
0 -1.2472 TD
0.001 Tc
-0.001 Tw
[(unaf)15(fected sibling in dif)8(ferent situations. Based on these)]TJ
0 -1.2543 TD
0.009 Tc
0.141 Tw
(computations, guidelines regarding which individuals)Tj
0 -1.2472 TD
0.019 Tw
(to type and what markers to use for the genome screen)Tj
T*
0.01 Tc
0.031 Tw
(are proposed.)Tj
/T26 1 Tf
14 0 0 14 50.981 214.98 Tm
-0.021 Tc
(35)Tj
/F5 1 Tf
8 0 0 8 50.981 198.028 Tm
0.009 Tc
0 Tw
[(Setting the pr)23(evalence constraint in linkage)]TJ
0 -1.2543 TD
0.012 Tw
(analysis of multifactorial diseases.)Tj
/F14 1 Tf
0 -1.2472 TD
-0.011 Tc
0.007 Tw
[(P)113(.)-1( Mar)17(garitte-Jeannin)]TJ
4.8 0 0 4.8 117.482 181.587 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 119.806 178.016 Tm
-0.01 Tc
0.009 Tw
(, M.C. Babron)Tj
4.8 0 0 4.8 164.934 181.587 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 167.258 178.016 Tm
-0.01 Tc
0.006 Tw
(, H. Quesneville)Tj
4.8 0 0 4.8 217.999 181.587 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 220.38 178.016 Tm
-0.01 Tc
0.013 Tw
[(, F)82(.)]TJ
-21.1748 -1.2543 TD
-0.009 Tc
[(Cler)12(get-Darpoux)]TJ
4.8 0 0 4.8 104.046 171.61 Tm
0 Tc
0 Tw
(1)Tj
-11.0551 -2.0787 TD
(1)Tj
8 0 0 8 53.476 158.003 Tm
0.009 Tc
0.01 Tw
(INSERM U155; )Tj
4.8 0 0 4.8 108.921 161.632 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 111.359 158.003 Tm
0.009 Tc
0.012 Tw
(Institut Jacques Monod; Paris,)Tj
-7.5472 -1.2472 TD
0.01 Tc
(France)Tj
1.5024 -1.7504 TD
0.012 Tc
0.187 Tw
(For multifactorial diseases, \223model free\224 linkage)Tj
-1.5024 -1.2543 TD
0.009 Tc
0.102 Tw
(analyses are frequently applied to detect linkage with)Tj
0 -1.2472 TD
0.028 Tw
[(a set of markers. It is often ar)23(gued that it may be more)]TJ
T*
0.017 Tc
0.187 Tw
(powerful to employ the classical lod score analysis)Tj
0 -1.2543 TD
0.009 Tc
0.181 Tw
(\(Morton, 1955\) while maximizing on the underlying)Tj
0 -1.2472 TD
0.073 Tw
[(unknown genetic model. Because of the lar)16(ge number)]TJ
25.5047 69.2504 TD
0.012 Tw
(of parameters to be varied, the disease prevalence con-)Tj
0 -1.2543 TD
0.039 Tw
(straint is often set to limit the space of models consid-)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
[(ered. However)37(, this constraint is not valid if the familial)]TJ
0 -1.2543 TD
0.009 Tc
0.053 Tw
(correlation for the disease is not explained by a single)Tj
0 -1.2472 TD
0.093 Tw
(susceptibility locus, which is likely to be the case for)Tj
T*
0.025 Tw
(multifactorial diseases.)Tj
1.4953 -1.2543 TD
0.084 Tw
(The question addressed in this study is the impact)Tj
-1.4953 -1.2472 TD
0.077 Tw
(of setting this constraint on linkage conclusion in dif-)Tj
0 -1.2543 TD
0.006 Tc
0.159 Tw
[(ferent )9(situations. )-154(Family data is simulated under dif-)]TJ
0 -1.2472 TD
0.007 Tc
0.187 Tw
[(ferent disease models and marker maps. )-135(Among the)]TJ
T*
0.009 Tc
0.026 Tw
(possible models, we consider a\) two susceptibility loci)Tj
0 -1.2543 TD
0.093 Tw
(with and without interaction; and b\) a possible famil-)Tj
0 -1.2472 TD
0.078 Tw
(ial environment interacting with a disease susceptibil-)Tj
T*
0.002 Tc
0 Tw
[(ity locus. Lastly)66(, the impact of the prevalence constraint)]TJ
0 -1.2543 TD
0.011 Tc
0.188 Tw
[(will be evaluated on the GA)82(W1)32(1 simulated datasets)]TJ
0 -1.2472 TD
0.009 Tc
0.147 Tw
[(\(Greenber)23(g, 1999\), in which several familial correla-)]TJ
0 -1.2543 TD
0.02 Tw
[(tion factors \(genes and environment\) interplay)59(.)]TJ
/T26 1 Tf
14 0 0 14 255.019 436.989 Tm
-0.021 Tc
(36)Tj
/F5 1 Tf
8 0 0 8 255.019 419.017 Tm
0.009 Tc
-0.001 Tw
[(Repr)23(oductive factors and genetic pr)16(edisposition for)]TJ
T*
0.01 Tc
0 Tw
[(br)24(east cancer: main ef)10(fects and gene-envionment)]TJ
0 -1.2472 TD
0.009 Tc
0.004 Tw
[(interactions. Results fr)23(om a case-contr)23(ol study)52(.)]TJ
/F14 1 Tf
T*
0.01 Tc
0.012 Tw
(Jenny Chang-Claude)Tj
4.8 0 0 4.8 323.391 392.598 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 325.828 389.027 Tm
0.009 Tc
0.015 Tw
(, Silke Schmidt)Tj
4.8 0 0 4.8 376.285 392.598 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 378.78 389.027 Tm
0.009 Tc
0.019 Tw
(, Heiko Becher)Tj
4.8 0 0 4.8 428.329 392.598 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 430.824 389.027 Tm
(.)Tj
4.8 0 0 4.8 255.019 382.62 Tm
(1)Tj
8 0 0 8 257.457 378.992 Tm
0.01 Tc
0.012 Tw
[(German Cancer Research Center)38(, Heidelber)17(g)-5(,)]TJ
4.8 0 0 4.8 255.019 372.586 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 257.457 369.014 Tm
0.009 Tc
0.022 Tw
[(University of Heidelber)16(g)]TJ
1.1906 -1.878 TD
-0.011 Tc
0.067 Tw
(A case-control study to quantify reproductive factors)Tj
-1.4953 -1.2472 TD
0.007 Tc
0.188 Tw
(\(number of full-term pregnancies, induced abortions,)Tj
0 -1.2543 TD
-0.011 Tc
0.075 Tw
(breast-feeding\) and genetic predisposition on breast can-)Tj
0 -1.2472 TD
0.014 Tw
[(cer risk including gene-environment interactions was car)24(-)]TJ
T*
0.079 Tw
(ried out in two geographical areas in Germany with 706)Tj
0 -1.2543 TD
0.075 Tw
(incident, histologically verified breast cancer cases diag-)Tj
0 -1.2472 TD
-0.01 Tc
0.061 Tw
(nosed between 1992 and 1995, 1391 population controls)Tj
0 -1.2543 TD
-0.011 Tc
0.141 Tw
(and 252 sister controls. Data was collected with a self-)Tj
0 -1.2472 TD
0.101 Tw
[(administered questionnaire. Main ef)17(fects were estimated)]TJ
0 -1.1835 TD
0.051 Tw
(with multiple logistic regression. For estimation of gene-)Tj
0 -1.1906 TD
0 Tw
[(environment interaction we used dif)16(ferent approaches: \(1\))]TJ
T*
0.033 Tw
(inclusion of a variable for familial predisposition into the)Tj
0 -1.1835 TD
-0.021 Tc
0 Tw
(logistic model \(number of first degree relatives with breast/)Tj
0 -1.1906 TD
-0.011 Tc
0.138 Tw
[(ovarian cancer)32(, or family risk score, or a modified ver)17(-)]TJ
0 -1.1835 TD
0.085 Tw
(sion of the gene carrier probability estimated from a ge-)Tj
0 -1.1906 TD
0 Tw
(netic model using the complete pedigree information\), \(2\))Tj
0 -1.1835 TD
0.112 Tw
(analysis based on the case-only-design and \(3\) mixture-)Tj
0 -1.1905 TD
-0.001 Tc
0.188 Tw
(likelihood-model, in which the estimated gene carrier)Tj
T*
-0.011 Tc
0.019 Tw
(probabilities were used.)Tj
1.4953 -1.1835 TD
0.005 Tc
0 Tw
(In the multiple logistic model comparing cases with)Tj
-1.4953 -1.1906 TD
0.009 Tc
0.054 Tw
(population controls we found a highly significant pro-)Tj
0 -1.1835 TD
0.111 Tw
[(tective ef)16(fect for duration of breastfeeding \(p < 0.01\))]TJ
0 -1.1905 TD
0.173 Tw
(and number of births \(p < 0.05\). Increased risk was)Tj
0 -1.1835 TD
0.067 Tw
(found for abortions \(p < 0.05\) and genetic predisposi-)Tj
0 -1.1906 TD
0.007 Tc
0.099 Tw
[(tion \(p < 0.001\). )-85(The comparison with the sister con-)]TJ
T*
-0.006 Tc
0.188 Tw
(trol group yielded similar results. Some indication for)Tj
0 -1.1835 TD
-0.011 Tc
0.051 Tw
(positive interaction between predisposition and abortions)Tj
0 -1.1906 TD
0.048 Tw
[(was found. )9(A)51( detailed comparison of the results from the)]TJ
0 -1.1835 TD
0.014 Tw
[(dif)17(ferent methods of analysis will be presented.)]TJ
ET

endstream
endobj
265 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
263 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
264 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
262 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
256 0 obj
<</Length 11143>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(203)]TJ
/F14 1 Tf
8 0 0 8 72 638.022 Tm
0.009 Tc
0 Tw
(For interpretation it must be taken into account that)Tj
-1.5024 -1.2543 TD
0.055 Tw
(assessment of genetic predispositon is based on surro-)Tj
0 -1.2472 TD
0.153 Tw
(gate variables rather than direct assessment of muta-)Tj
0 -1.2543 TD
0.036 Tc
0.188 Tw
(tions in the susceptibility genes such as BRCA1/)Tj
0 -1.2472 TD
0.009 Tc
0.01 Tw
(BRCA2 which limits the power of the analysis.)Tj
/T27 1 Tf
14 0 0 14 59.981 560.013 Tm
-0.021 Tc
(37)Tj
/F5 1 Tf
8 0 0 8 59.981 543.005 Tm
0.009 Tc
0.003 Tw
(Family ascertainment using a population-based)Tj
0 -1.2543 TD
0.015 Tw
[(r)14(egistry of myocardial infar)16(ction)]TJ
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.006 Tw
(S. Engel)Tj
4.8 0 0 4.8 87.817 526.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 90.255 522.992 Tm
0.009 Tc
0.013 Tw
(, H. Bickeb\366ller)Tj
4.8 0 0 4.8 142.809 526.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 145.247 522.992 Tm
0.01 Tc
0.012 Tw
[(, C. Hengstenber)24(g)]TJ
4.8 0 0 4.8 204.378 526.62 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 206.872 522.992 Tm
(,)Tj
-18.3614 -1.2472 TD
0.009 Tc
(S. Holmer)Tj
4.8 0 0 4.8 93.543 516.586 Tm
0 Tc
(2)Tj
8 0 0 8 95.981 513.014 Tm
0.01 Tc
0.006 Tw
(, H. L\366wel)Tj
4.8 0 0 4.8 131.131 516.586 Tm
0 Tc
0 Tw
(1)Tj
-14.8228 -2.0787 TD
(1)Tj
8 0 0 8 62.476 502.979 Tm
0.009 Tc
0.02 Tw
[(GSF-Institute of Epidemiology)66(, Neuherber)9(g, Bavaria,)]TJ
-0.3118 -1.2472 TD
0.007 Tc
(Germany )Tj
4.8 0 0 4.8 92.523 496.573 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 95.017 493.002 Tm
0.01 Tc
0.021 Tw
[(Univ)74(. of Regensbur)10(g, Regensbur)17(g, Bavaria,)]TJ
-4.3795 -1.2472 TD
0.012 Tc
[(Germany)55(.)]TJ
1.5024 -1.7504 TD
-0.013 Tc
0 Tw
(Myocardial infarction \(MI\) is a late onset disease with)Tj
-1.5024 -1.2543 TD
-0.011 Tc
0.118 Tw
[(a high case fatality)53(.)118( )-96(This study reports experiences with)]TJ
0 -1.2472 TD
0.132 Tw
[(the ascertainment of MI af)10(fected families when starting)]TJ
0 -1.2543 TD
0.029 Tw
(from a population-based registry which is an optimal set-)Tj
0 -1.2472 TD
0.021 Tw
(ting, monitoring 310,000 subjects aged 25 to 59 years for)Tj
T*
-0.015 Tc
0.081 Tw
[(1)31(1)0( years \(1985\22695\). )]TJ
/F5 1 Tf
8.2772 0 TD
-0.01 Tc
(Methods)Tj
/F14 1 Tf
3.6496 0 TD
-0.011 Tc
0.083 Tw
(: 1381 MI survivors under)Tj
-11.9268 -1.2543 TD
0.033 Tw
(age 60 were asked for participation in a family study and)Tj
0 -1.2472 TD
0.074 Tw
(for information on vital status and history of MI of their)Tj
0 -1.1905 TD
0.008 Tw
(first degree relatives. Index probands \(IPs\) and living sib-)Tj
0 -1.1835 TD
0.171 Tw
(lings were invited for a standardized interview and of-)Tj
0 -1.1906 TD
-0.014 Tc
0.129 Tw
(fered an extensive cardiovascular examination. )Tj
/F5 1 Tf
19.1905 0 TD
-0.011 Tc
(Results)Tj
/F14 1 Tf
3.0331 0 TD
0 Tc
0 Tw
(:)Tj
-22.2236 -1.1835 TD
-0.011 Tc
0.135 Tw
(In 1996, 371 IPs were lost to follow-up, mainly due to)Tj
0 -1.1906 TD
0.121 Tw
(death \(266 IPs\). Of the remaining 1007 IPs, 504 \(50%\))Tj
0 -1.1835 TD
0.062 Tw
(had to be excluded for unavailable family members. Out)Tj
0 -1.1906 TD
0.15 Tw
(of the 503 eligible IPs, 293 \(21% of the MI survivors\))Tj
T*
0.113 Tw
(were examined with at least 1 sibling \(536 sibs\). 31 af-)Tj
0 -1.1835 TD
0.128 Tw
[(fected sib-pairs were ascertained. Over 90% of the par)17(-)]TJ
0 -1.1906 TD
0.072 Tw
(ents were deceased. Using baseline characteristics of the)Tj
0 -1.1835 TD
0.113 Tw
[(registry)60(, loss to follow-up was associated with recurrent)]TJ
0 -1.1906 TD
-0.016 Tc
0 Tw
(MI, diabetes, cigarette smoking, application of thromboly-)Tj
0 -1.1835 TD
-0.011 Tc
0.118 Tw
[(sis at the acute event and type of dischar)10(ge medication.)]TJ
0 -1.1906 TD
0.158 Tw
(Exclusion from the study was associated with cigarette)Tj
T*
-0.015 Tc
0.188 Tw
(smoking and negative parental history of MI. )Tj
/F5 1 Tf
19.1693 0 TD
-0.01 Tc
(Conclu-)Tj
-19.1693 -1.1835 TD
-0.012 Tc
(sion)Tj
/F14 1 Tf
1.6866 0 TD
0.023 Tw
[(:)30( )-11(The sample ascertained from the registry appears to)]TJ
-1.6866 -1.1906 TD
0.013 Tw
(be suited for discordant sib pair analyses. It is selected by)Tj
0 -1.1835 TD
0.089 Tw
(survival, but apparently also by positive parental history)Tj
0 -1.1906 TD
0.046 Tw
[(of )9(MI. )-32(This latter overrepresentation counteracts the sug-)]TJ
0 -1.1835 TD
-0.013 Tc
0 Tw
(gested elevated hereditary proportion in early fatal events.)Tj
/T27 1 Tf
14 0 0 14 59.981 170.986 Tm
-0.021 Tc
(38)Tj
/F5 1 Tf
8 0 0 8 59.981 153.978 Tm
-0.011 Tc
(Incorporating Genetic Marker Information into the)Tj
0 -1.2472 TD
-0.01 Tc
0.001 Tw
[(Analysis of T)76(win Survival Data: )67(A)53( Simulation Study)]TJ
/F14 1 Tf
T*
0.009 Tc
0.006 Tw
(I.A. Iachine)Tj
4.8 0 0 4.8 98.929 137.594 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 101.424 134.022 Tm
0.009 Tc
0.01 Tw
(, K. Christensen)Tj
4.8 0 0 4.8 154.375 137.594 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 156.813 134.022 Tm
0.009 Tc
-0.042 Tw
[(,)8( A.I. )-21(Y)93(ashin)]TJ
4.8 0 0 4.8 197.518 137.594 Tm
0 Tc
0 Tw
(3)Tj
-28.6535 -2.0787 TD
(1)Tj
8 0 0 8 62.476 123.987 Tm
0.009 Tc
0.016 Tw
[(Department of Statistics and Demography)59(, Odense)]TJ
-0.3118 -1.2472 TD
0.014 Tw
[(University)59(, Odense, Denmark; )]TJ
4.8 0 0 4.8 161.802 117.581 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 164.239 114.01 Tm
0.009 Tc
0.015 Tw
(Institute of Public)Tj
-13.0323 -1.2472 TD
[(Health, Odense University)59(, Odense, Denmark; )]TJ
4.8 0 0 4.8 214.526 107.603 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 217.02 104.032 Tm
0.008 Tc
(Max)Tj
-19.6299 -1.2543 TD
0.009 Tc
0.017 Tw
(Planck Institute for Demographic Research, Rostock,)Tj
0 -1.2472 TD
0.013 Tw
[(Germany and Duke University)59(, Durham, NC, USA.)]TJ
27 69.2504 TD
0.061 Tw
[(T)32(raditional methods of linkage analysis of sib-pair)]TJ
-1.4953 -1.2543 TD
0.134 Tw
(data for quantitative traits are not well suited for the)Tj
0 -1.2472 TD
0.017 Tw
[(analysis of survival data. In particular)37(, analysis of cen-)]TJ
0 -1.2543 TD
-0.001 Tc
0 Tw
(sored and truncated survival times requires a completely)Tj
0 -1.2472 TD
0.007 Tc
0.107 Tw
[(parametric )7(model. )-83(T)65(o)-2( address the censoring and trun-)]TJ
T*
0.018 Tc
0.188 Tw
(cation problem, semiparametric frailty models have)Tj
0 -1.2543 TD
0.009 Tc
0.014 Tw
(been developed and successfully applied in the genetic)Tj
0 -1.2472 TD
0.008 Tc
0.082 Tw
[(analysis of survival data on Danish )-64(T)66(wins without in-)]TJ
0 -1.2543 TD
0.009 Tc
0.169 Tw
(formation on genetic markers. In this paper we sug-)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
(gest a method for analysis of sib-pair survival data with)Tj
T*
0.022 Tc
0.187 Tw
(genetic marker information that combines both ap-)Tj
0 -1.2543 TD
-0.002 Tc
0.192 Tw
[(proaches. W)70(e)-11( )]TJ
5.9126 0 TD
0.009 Tc
0.098 Tw
(develop a bivariate frailty model where)Tj
-5.9126 -1.2472 TD
0.09 Tw
(individual frailty is treated as a quantitative trait with)Tj
T*
0.005 Tc
0 Tw
(an underlying genetic locus that may be in genetic link-)Tj
0 -1.2543 TD
0.009 Tc
0.102 Tw
(age with one or more genetic markers, with the loca-)Tj
0 -1.2472 TD
0.012 Tc
0.186 Tw
[(tion of the frailty gene to be estimated. )-174(The model)]TJ
0 -1.2543 TD
0.009 Tc
0.055 Tw
(includes additional frailty components associated with)Tj
0 -1.2472 TD
0.01 Tc
0.141 Tw
[(ef)24(fects of polygenes, shared and non-shared environ-)]TJ
T*
-0.024 Tc
0.344 Tw
[(ment. W)55(e)-33( )]TJ
4.4406 0 TD
0.009 Tc
0.164 Tw
(suggest a semiparametric maximum likeli-)Tj
-4.4406 -1.2543 TD
0.064 Tw
(hood estimation procedure and study the properties of)Tj
0 -1.2472 TD
0.153 Tw
(the new model using simulated survival data on MZ)Tj
0 -1.2543 TD
0.048 Tw
[(and DZ twins. In particular)44(, we investigate the sample)]TJ
0 -1.2472 TD
0.023 Tw
[(size required for detecting linkage under dif)16(ferent cen-)]TJ
T*
0.065 Tw
(soring mechanisms and consider the situation where a)Tj
0 -1.2543 TD
0.067 Tw
(genetic marker is a mortality risk factor in addition to)Tj
0 -1.2472 TD
0.014 Tw
(being linked to the frailty gene.)Tj
/T27 1 Tf
14 0 0 14 264.019 353.027 Tm
-0.021 Tc
(39)Tj
/F5 1 Tf
8 0 0 8 264.019 336.983 Tm
0.009 Tc
0.008 Tw
[(Comparison of )16(T)67(ype I err)16(or)16( rates of Haseman-)]TJ
T*
0 Tw
(Elston sib-pair linkage method in various)Tj
T*
0.006 Tw
(quantitative trait models.)Tj
/F14 1 Tf
0 -1.2543 TD
0.004 Tw
(D. M. Mandal)Tj
4.8 0 0 4.8 310.28 310.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 312.718 306.992 Tm
0.008 Tc
-0.039 Tw
[(, A. )-46(F)86(.)2( )-35(W)38(ilson)]TJ
4.8 0 0 4.8 357.676 310.62 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 360.17 306.992 Tm
0.009 Tc
0.007 Tw
[(, J. E. Bailey-W)37(ilson)]TJ
4.8 0 0 4.8 428.258 310.62 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 430.696 306.992 Tm
(.)Tj
4.8 0 0 4.8 264.019 300.586 Tm
(1)Tj
8 0 0 8 266.457 297.014 Tm
0.009 Tc
0.009 Tw
[(Louisiana State University Medical Center)37(, New)]TJ
-0.3047 -1.2543 TD
(Orleans, USA; )Tj
4.8 0 0 4.8 314.362 290.608 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 316.8 286.98 Tm
0.01 Tc
0.012 Tw
(National Human Genome Research)Tj
-6.5976 -1.2472 TD
0.009 Tc
0.009 Tw
(Institute, Baltimore, USA.)Tj
1.4953 -1.6228 TD
0.165 Tw
(It is well known that Haseman-Elston \(H-E\) sib-)Tj
-1.4953 -1.2543 TD
0.109 Tw
(pair linkage method does not assume that the genetic)Tj
0 -1.2472 TD
0.137 Tw
(model underlying the trait phenotype is known with-)Tj
T*
0.06 Tw
(out error although this assumption is made for marker)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
[(loci. However)38(, misspecification of allele frequencies)]TJ
0 -1.2472 TD
0.009 Tc
0.05 Tw
(at the marker locus decreases power when some or all)Tj
0 -1.2543 TD
0.004 Tc
-0.001 Tw
[(parental genotypes are unknown. In this study)61(, the )17(T)62(ype)]TJ
0 -1.2472 TD
0.009 Tc
0.163 Tw
(I error rates of the H-E sib-pair methods were com-)Tj
T*
0.035 Tw
[(pared for dif)16(ferent types of traits when some or all pa-)]TJ
0 -1.2543 TD
0.107 Tw
(rental data were missing and allele frequencies at the)Tj
0 -1.2472 TD
0.012 Tw
(marker loci were misspecified.)Tj
1.4953 -1.2543 TD
0.018 Tc
0.187 Tw
(Data were generated for a quantitative trait and)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.069 Tw
[(marker loci in nuclear families using G.A.S.P)122(. \(V3.3\).)]TJ
T*
0.01 Tc
0.188 Tw
(Three types of traits were simulated: two due to an)Tj
0 -1.2543 TD
0.009 Tc
0.174 Tw
(unlinked additive major locus with two equifrequent)Tj
0 -1.2472 TD
-0.011 Tc
0.124 Tw
[(alleles with a random environmental ef)24(fect \(50%, 90%\))]TJ
T*
-0.013 Tc
0 Tw
(and one that was completely environmentally determined.)Tj
0 -1.2543 TD
-0.011 Tc
0.177 Tw
(The simulated data were analyzed using \(i\) one of the)Tj
0 -1.2472 TD
-0.01 Tc
0.187 Tw
[(parent\222)61(s marker data, and \(ii\) no parental marker data,)]TJ
ET

endstream
endobj
275 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
276 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
274 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
273 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
267 0 obj
<</Length 12715>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(204)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.026 Tw
(with both correct and incorrect marker allele frequencies.)Tj
0 -1.2543 TD
-0.004 Tc
0.187 Tw
[(When the trait was completely environmentally deter)17(-)]TJ
0 -1.2472 TD
-0.023 Tc
0.115 Tw
[(mined, the )-116(T)]TJ
5.1024 0 TD
-0.011 Tc
0.116 Tw
(ype I error rate of the H-E sib-pair linkage)Tj
-5.1024 -1.2543 TD
0.131 Tw
(analysis was robust to misspecification of marker allele)Tj
0 -1.2472 TD
0.138 Tw
(frequencies even if the allele frequencies were severely)Tj
T*
0.187 Tw
[(misspecified \(i.e., \2610.8 of true frequencies\). )-168(Thus, this)]TJ
0 -1.2543 TD
0.153 Tw
(method appeared to be remarkably robust to even very)Tj
0 -1.2472 TD
0.014 Tw
[(lar)17(ge misspecifications of allele frequencies.)]TJ
/T28 1 Tf
14 0 0 14 50.981 530.022 Tm
-0.021 Tc
(40)Tj
/F5 1 Tf
8 0 0 8 50.981 513.014 Tm
0.009 Tc
-0.001 Tw
[(T)88(esting for)16( )52(Allelic )58(Associations in Structur)23(ed)]TJ
0 -1.2543 TD
(Populations)Tj
/F14 1 Tf
0 -1.2472 TD
0.022 Tw
(N. Chapman, E. Thompson)Tj
T*
0.009 Tw
[(University of )9(W)74(ashington, Seattle, )9(W)110(A, USA.)]TJ
1.5024 -1.7504 TD
0.001 Tc
0 Tw
(Understanding disequilibria within and between loci)Tj
-1.5024 -1.2543 TD
0.009 Tc
0.004 Tw
(is important for disease mapping from population data.)Tj
0 -1.2472 TD
0.089 Tw
(In genetic isolates, the population structure has a ma-)Tj
0 -1.2543 TD
0.107 Tw
(jor impact on allelic associations both within and be-)Tj
0 -1.2472 TD
0.006 Tc
0.188 Tw
[(tween loci. )-192(W)71(e)-17( )]TJ
7.0854 0 TD
0.023 Tc
0.187 Tw
(study disequilibria using the North)Tj
-7.0854 -1.2472 TD
0.01 Tc
0.188 Tw
(American Hutterites as an example isolate, focusing)Tj
0 -1.2543 TD
0.009 Tc
0.009 Tw
(first on a single locus.)Tj
1.5024 -1.2472 TD
0.012 Tw
(Disequilibrium at a single locus is described by the)Tj
-1.5024 -1.2472 TD
0.17 Tw
(departure of observed heterozygote proportions from)Tj
0 -1.2543 TD
0.022 Tc
0.185 Tw
[(those expected under Hardy )-186(W)80(einber)15(g )-6(Equilibrium)]TJ
0 -1.2472 TD
0.004 Tc
0 Tw
[(\(HWE\). )11(The observed deficiency or excess of heterozy-)]TJ
0 -1.2543 TD
0.009 Tc
0.1 Tw
(gotes depends on the extent to which mates are more)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
[(or less closely related than a randomly chosen pair)50(. Ex-)]TJ
T*
0.009 Tc
0.047 Tw
(cess homozygosity is of particular interest to epidemi-)Tj
0 -1.2543 TD
0.011 Tw
(ologists, since it can result in higher prevalence of rare)Tj
0 -1.2472 TD
0.007 Tc
0.11 Tw
[(recessive )6(disorders. )-90(T)65(esting for HWE is done using a)]TJ
/F17 1 Tf
0 -1.2543 TD
0 Tc
0 Tw
(c)Tj
/F14 1 Tf
0.5669 0 TD
0.009 Tc
0.083 Tw
(2 statistic, to compare the observed genotype counts)Tj
-0.5669 -1.2472 TD
0.008 Tc
0.047 Tw
[(with HW)15( expectations. )-35(The distribution of the statistic)]TJ
T*
0.009 Tc
0.063 Tw
(under the null hypothesis depends on having indepen-)Tj
0 -1.2543 TD
0.051 Tw
(dently sampled genotypes, which is not the case if the)Tj
0 -1.2472 TD
0.034 Tw
(sample consists of groups of siblings. In this situation,)Tj
T*
0.047 Tw
(the type I error of the test can be grossly inflated over)Tj
0 -1.2543 TD
0.019 Tw
(the nominal significance level.)Tj
1.5024 -1.2472 TD
0.009 Tw
(The Hutterite population is divided into three sepa-)Tj
-1.5024 -1.2543 TD
0.13 Tw
(rate sub-populations \(which are called leut\), and into)Tj
0 -1.2472 TD
0.02 Tw
[(colonies within leut. W)81(e)0( test for departures from HWE)]TJ
T*
0.007 Tc
0 Tw
(within leut, where the genotype data consist of samples)Tj
0 -1.2543 TD
0.009 Tc
0.139 Tw
(of groups of siblings, and the sibships are also more)Tj
0 -1.2472 TD
0.007 Tc
0.095 Tw
[(distantly related. )-78(W)79(e)-2( use simulation to find the distri-)]TJ
0 -1.2543 TD
0.009 Tc
0.058 Tw
(bution of the test statistic under the null hypothesis of)Tj
0 -1.2472 TD
0.021 Tw
(random mating within leut.)Tj
/T28 1 Tf
14 0 0 14 50.981 131.017 Tm
-0.021 Tc
(41)Tj
/F5 1 Tf
8 0 0 8 50.981 114.01 Tm
0.009 Tc
0 Tw
[(Mapping disease genes using haplotype shar)23(ed)]TJ
T*
0.008 Tc
(lengths)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.008 Tw
[(D. Qian, D.C. )10(Thomas)]TJ
0 -1.2472 TD
[(Univ)67(. of Southern California, Los )52(Angeles, CA, USA.)]TJ
27 69.2504 TD
0.009 Tc
0.017 Tw
[(W)74(e)0( describe an approach to mapping disease genes)]TJ
-1.4953 -1.2543 TD
0.087 Tw
(based on the sharing of haplotypes between unrelated)Tj
0 -1.2472 TD
0.005 Tc
0.188 Tw
[(parents in a set of nuclear families. )-136(A)47( disease score)]TJ
/F16 1 Tf
0 -1.2543 TD
0 Tc
0 Tw
(d)Tj
4.8 0 0 4.8 259.101 606.784 Tm
(i)Tj
8 0 0 8 260.518 607.975 Tm
0.008 Tc
(\(x\))Tj
/F14 1 Tf
1.1339 0 TD
0.005 Tc
0.106 Tw
[( at a candidate location )]TJ
/F16 1 Tf
10.2331 0 TD
-0.099 Tc
(x )Tj
/F14 1 Tf
0.822 0 TD
0.009 Tc
(is assigned to each pa-)Tj
-12.8764 -1.2472 TD
0.001 Tc
0.128 Tw
(rental haplotype )Tj
/F16 1 Tf
7.1291 0 TD
-0.128 Tc
(i )Tj
/F14 1 Tf
0.6732 0 TD
0.009 Tc
0.131 Tw
(based on the numbers of transmis-)Tj
-7.8024 -1.2472 TD
0.008 Tc
0.036 Tw
[(sions to af)15(fected and unaf)22(fected of)8(fspring. )-13(The lengths)]TJ
/F16 1 Tf
0 -1.2543 TD
0 Tc
0 Tw
(L)Tj
4.8 0 0 4.8 259.554 576.794 Tm
0.023 Tc
(ij)Tj
8 0 0 8 262.332 577.984 Tm
0.008 Tc
(\(x\))Tj
/F14 1 Tf
1.1409 0 TD
0.009 Tc
0.008 Tw
[( of the segments surrounding )]TJ
/F16 1 Tf
12.1677 0 TD
0.001 Tc
(x )Tj
/F14 1 Tf
0.7157 0 TD
0.009 Tc
0.011 Tw
(that are shared be-)Tj
-14.9386 -1.2472 TD
0.003 Tc
0.153 Tw
(tween all possible pairs )Tj
/F16 1 Tf
10.4457 0 TD
-0.153 Tc
(i )Tj
/F14 1 Tf
0.7016 0 TD
-0.043 Tc
(and )Tj
/F16 1 Tf
1.885 0 TD
-0.146 Tc
(j )Tj
/F14 1 Tf
0.6945 0 TD
0.009 Tc
0.156 Tw
(of unrelated parental)Tj
-13.7268 -1.2543 TD
0.004 Tc
0.113 Tw
[(haplotypes are computed. )-103(The summary statistic )]TJ
/F17 1 Tf
20.6646 0 TD
0 Tc
0 Tw
(L)Tj
/F14 1 Tf
0.7016 0 TD
(\()Tj
/F16 1 Tf
0.3472 0 TD
(x)Tj
/F14 1 Tf
0.4535 0 TD
(\))Tj
-22.1669 -1.2472 TD
-0.061 Tc
(= )Tj
/F17 1 Tf
0.9 0 TD
0 Tc
(S)Tj
/F14 1 Tf
4.8 0 0 4.8 267.038 546.803 Tm
0.01 Tc
({i)Tj
/F17 1 Tf
0.7795 0 TD
0 Tc
(\271)Tj
/F14 1 Tf
0.5669 0 TD
0.01 Tc
(j})Tj
8 0 0 8 277.243 547.994 Tm
0 Tc
( )Tj
/F16 1 Tf
0.3402 0 TD
(d)Tj
4.8 0 0 4.8 284.046 546.803 Tm
(i)Tj
/F14 1 Tf
8 0 0 8 285.463 547.994 Tm
(\()Tj
/F16 1 Tf
0.3402 0 TD
(x)Tj
/F14 1 Tf
0.4606 0 TD
-0.07 Tc
(\) )Tj
/F16 1 Tf
0.6732 0 TD
0 Tc
(d)Tj
4.8 0 0 4.8 301.337 546.803 Tm
(j)Tj
/F14 1 Tf
8 0 0 8 302.754 547.994 Tm
(\()Tj
/F16 1 Tf
0.3402 0 TD
(x)Tj
/F14 1 Tf
0.4606 0 TD
-0.07 Tc
(\) )Tj
/F16 1 Tf
0.6732 0 TD
0 Tc
(L)Tj
4.8 0 0 4.8 319.082 546.803 Tm
0.023 Tc
(ij)Tj
/F14 1 Tf
8 0 0 8 321.917 547.994 Tm
0 Tc
(\()Tj
/F16 1 Tf
0.3402 0 TD
(x)Tj
/F14 1 Tf
0.4606 0 TD
0.009 Tc
0.074 Tw
(\) is compared with a null distri-)Tj
-9.163 -1.2472 TD
0.025 Tc
0.188 Tw
(bution obtained by randomizing the disease scores)Tj
0 -1.2543 TD
-0.011 Tc
0.077 Tw
(against the lengths. In 4 out of 10 simulations of an iso-)Tj
0 -1.2472 TD
0.105 Tw
(lated population with age of 100 generations on a chro-)Tj
T*
-0.003 Tc
0.187 Tw
(mosomal segment of length 100 cM with 99 diallelic)Tj
0 -1.2543 TD
-0.014 Tc
0 Tw
(markers, the strongest peak occurred flanking the true dis-)Tj
0 -1.2472 TD
-0.011 Tc
0.16 Tw
(ease location, and in 4 others, the second highest peak)Tj
0 -1.2543 TD
0.173 Tw
(occurred there. Strong signals at flanking disease loca-)Tj
0 -1.2472 TD
0.181 Tw
(tions are observed in populations with more than 80%)Tj
T*
-0.013 Tc
0 Tw
(disease haplotypes sharing only 1 or 2 same ancestral mu-)Tj
0 -1.2543 TD
-0.012 Tc
0.04 Tw
[(tations. )-18(T)68(o)-1( estimate the location x0 of the disease gene, a)]TJ
0 -1.2472 TD
0.036 Tw
(generalized estimating equations approach is proposed to)Tj
0 -1.2543 TD
-0.013 Tc
0 Tw
(regress haplotype-pair scores )Tj
/F16 1 Tf
11.5299 0 TD
0 Tc
(D)Tj
4.8 0 0 4.8 352.928 426.784 Tm
-0.001 Tc
(ij)Tj
/F14 1 Tf
8 0 0 8 355.479 427.975 Tm
-0.012 Tc
( = \()Tj
/F16 1 Tf
1.3535 0 TD
0 Tc
(d)Tj
4.8 0 0 4.8 370.162 426.784 Tm
(i)Tj
/F14 1 Tf
8 0 0 8 371.466 427.975 Tm
(\226)Tj
/F17 1 Tf
0.489 0 TD
(m)Tj
/F14 1 Tf
0.5598 0 TD
-0.014 Tc
(\)\()Tj
/F16 1 Tf
0.6378 0 TD
0 Tc
(d)Tj
4.8 0 0 4.8 388.871 426.784 Tm
(j)Tj
/F14 1 Tf
8 0 0 8 390.118 427.975 Tm
(\226)Tj
/F17 1 Tf
0.489 0 TD
(m)Tj
/F14 1 Tf
0.5598 0 TD
-0.013 Tc
(\) on a mean)Tj
-17.9362 -1.2472 TD
-0.014 Tc
0.07 Tw
(function of the form )Tj
/F17 1 Tf
8.3764 0 TD
0 Tc
0 Tw
(S)Tj
/F16 1 Tf
0.5811 0 TD
(x)Tj
/F14 1 Tf
0.4323 0 TD
( )Tj
/F16 1 Tf
0.3047 0 TD
(L)Tj
4.8 0 0 4.8 336.94 416.806 Tm
-0.001 Tc
(ij)Tj
/F14 1 Tf
8 0 0 8 339.548 417.997 Tm
0 Tc
(\()Tj
/F16 1 Tf
0.3189 0 TD
(x)Tj
/F14 1 Tf
0.4323 0 TD
-0.01 Tc
0.069 Tw
(\) exp[\226)Tj
/F17 1 Tf
2.8559 0 TD
0 Tc
0 Tw
(b)Tj
/F14 1 Tf
0.5386 0 TD
(\()Tj
/F16 1 Tf
0.3189 0 TD
(x)Tj
/F14 1 Tf
0.4323 0 TD
(-)Tj
/F16 1 Tf
0.3189 0 TD
(x)Tj
/F14 1 Tf
4.8 0 0 4.8 384.676 416.806 Tm
(0)Tj
8 0 0 8 387.057 417.997 Tm
(\))Tj
4.8 0 0 4.8 389.608 421.625 Tm
(2)Tj
8 0 0 8 391.932 417.997 Tm
-0.01 Tc
0.082 Tw
[(])35(.)35( A)53( )11(weighted)]TJ
-17.1142 -1.2472 TD
-0.006 Tc
0.187 Tw
(variance estimator using the shared length of the four)Tj
0 -1.2543 TD
-0.011 Tc
0.041 Tw
(members in each pair of paired haplotypes is constructed)Tj
0 -1.2472 TD
-0.015 Tc
0 Tw
(in a similar way to that proposed by Lumley and Heagerty)Tj
0 -1.2543 TD
-0.012 Tc
0.042 Tw
[(\(1999\). )-18(The performance of these estimating equations is)]TJ
0 -1.2472 TD
0.05 Tw
(under investigation.)Tj
/T28 1 Tf
14 0 0 14 255.019 327.005 Tm
-0.021 Tc
(42)Tj
/F5 1 Tf
8 0 0 8 255.019 308.976 Tm
0.009 Tc
0.005 Tw
[(A)51( two-locus model for)23( nonsyndr)16(omic congenital)]TJ
T*
0 Tw
(dysplasia of the hip)Tj
/F14 1 Tf
T*
(C. Scapoli)Tj
4.8 0 0 4.8 289.091 292.592 Tm
0 Tc
(1)Tj
8 0 0 8 291.529 289.021 Tm
0.009 Tc
0.003 Tw
(, G. Bertolani)Tj
4.8 0 0 4.8 336.203 292.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 338.641 289.021 Tm
0.008 Tc
0.004 Tw
[(, G. )44(Atti)]TJ
4.8 0 0 4.8 365.173 292.592 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 367.611 289.021 Tm
0.008 Tc
-0.009 Tw
[(, V)121(.)-1( )-16(Sollazzo)]TJ
4.8 0 0 4.8 408.827 292.592 Tm
0 Tc
0 Tw
(2)Tj
-32.0433 -2.0787 TD
(1)Tj
8 0 0 8 257.457 278.986 Tm
0.008 Tc
0.01 Tw
(Biology Dep., )Tj
4.8 0 0 4.8 305.816 282.614 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 308.254 278.986 Tm
0.009 Tc
0.013 Tw
[(Paediatric Div)66(.)8(,)8( )]TJ
4.8 0 0 4.8 361.205 282.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 363.643 278.986 Tm
0.009 Tc
0.013 Tw
(Biomed. Science and)Tj
-13.578 -1.2472 TD
0.011 Tw
[(advanced therapies - Ferrara University)66(, Italy)]TJ
1.4953 -1.8779 TD
-0.011 Tc
0.1 Tw
(Congenital dysplasia of the hip \(CDH\) is one of the)Tj
-1.4953 -1.2472 TD
0.063 Tw
(most common skeletal congenital anomalies. For Cauca-)Tj
T*
-0.01 Tc
0.031 Tw
(sian populations an incidence of CDH of 1 per 1,000 can)Tj
0 -1.2543 TD
-0.011 Tc
0.064 Tw
[(be assumed. In Italy)60(, the incidence is about 10 per 1,000)]TJ
0 -1.2472 TD
0.056 Tw
[(and in Ferrara is still higher)39(, equal to 18.4 per 1,000 live)]TJ
0 -1.2543 TD
0.106 Tw
(births. Several examples of familial transmission of iso-)Tj
0 -1.2472 TD
-0.01 Tc
0.079 Tw
[(lated CDH are well known; however)40(, the cause of CDH)]TJ
T*
-0.011 Tc
0.052 Tw
[(is not yet completely clear)32(, even if the importance of ge-)]TJ
0 -1.2543 TD
0.016 Tw
(netic and environmental factors is evident.)Tj
1.4953 -1.2472 TD
0.009 Tc
0.116 Tw
[(Among all patients treated at the Ferrara\222)44(s Center)]TJ
-1.4953 -1.2543 TD
0.01 Tc
0.043 Tw
(for the study of CDH in the period 1991\22696, a sample)Tj
0 -1.2472 TD
0.017 Tc
0.188 Tw
(of 171 patients with positive familial recurrence of)Tj
T*
0.007 Tc
0.107 Tw
[(nonsyndromic CDH was collected. )-92(The 171 available)]TJ
0 -1.2543 TD
0.011 Tc
0.187 Tw
(pedigrees were partitioned into 507 nuclear families)Tj
0 -1.2472 TD
0.009 Tc
0.186 Tw
(and complex segregation analysis was performed by)Tj
T*
0.052 Tw
(applying the mixed model of inheritance, expanded as)Tj
0 -1.2543 TD
0.119 Tw
(the unified model, implemented in the computer pro-)Tj
0 -1.2472 TD
0.01 Tc
0.005 Tw
(grams POINTER and COMDS.)Tj
ET

endstream
endobj
285 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
286 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
284 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
278 0 obj
<</Length 10347>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(205)]TJ
/F14 1 Tf
8 0 0 8 72 638.022 Tm
0.01 Tc
0.028 Tw
(Using POINTER, the hypotheses of sporadic, mul-)Tj
-1.5024 -1.2543 TD
0.007 Tc
0 Tw
(tifactorial and polygenic transmission of nonsyndromic)Tj
0 -1.2472 TD
0.128 Tw
[(CDH )6(were )6(rejected. )-62(Among the models postulating a)]TJ
0 -1.2543 TD
0.009 Tc
0.012 Tw
(major locus only the recessive was accepted.)Tj
1.5024 -1.2472 TD
0.007 Tc
0 Tw
(Since the evaluation of CDH severity was made ac-)Tj
-1.5024 -1.2472 TD
0.009 Tc
0.037 Tw
[(cording to Graf)-62(\222)59(s)0( echographic classification, assuming)]TJ
0 -1.2543 TD
0.009 Tw
[(4 pathological levels with increasing gravity)52(, we tested)]TJ
0 -1.2472 TD
0.031 Tc
0.187 Tw
(the two-locus model including this information in)Tj
0 -1.2543 TD
0.009 Tc
0.073 Tw
(COMDS analysis. Under this model, a significant im-)Tj
0 -1.2472 TD
0.029 Tc
0.188 Tw
(provement of the general likelihood was observed)Tj
T*
0 Tc
0 Tw
(\()Tj
/F17 1 Tf
0.3402 0 TD
(c)Tj
/F14 1 Tf
0.5528 0 TD
(\262)Tj
4.8 0 0 4.8 69.562 536.768 Tm
0.002 Tc
([4])Tj
8 0 0 8 75.175 538.016 Tm
-0.001 Tc
(=26.2, P<0.001\), supporting the presence of at least)Tj
-1.8992 -1.2543 TD
0.006 Tc
0.129 Tw
[(a )8(second )8(locus. )-69(Amongst the various two-locus mod-)]TJ
0 -1.2472 TD
0.01 Tc
0.188 Tw
(els, the one assuming recessive transmission for the)Tj
T*
0.009 Tc
0.088 Tw
(major gene \(frequency of the deleterious allele = 0.2\))Tj
0 -1.2543 TD
0.05 Tw
(showed the best likelihood. For the modifier locus, all)Tj
0 -1.2472 TD
0.01 Tc
0.129 Tw
[(mendelian genetic hypotheses were accepted on LR)60(T)]TJ
0 -1.2543 TD
0.009 Tc
0.188 Tw
[(basis; however)30(, since the recessive-recessive two-lo-)]TJ
0 -1.2472 TD
0.087 Tw
(cus model was the most parsimonious, we considered)Tj
T*
0.011 Tw
(it the most appropriate for our data.)Tj
/T29 1 Tf
14 0 0 14 59.981 422.986 Tm
-0.021 Tc
(43)Tj
/F5 1 Tf
8 0 0 8 59.981 406.998 Tm
0.009 Tc
0 Tw
(Significance and power estimates of genome scans)Tj
T*
0.004 Tw
[(in r)16(elation to follow up strategies.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.01 Tw
(S. Loesgen, H. Bickeb\366ller)Tj
0 -1.2472 TD
0.009 Tc
0.017 Tw
[(Institute of Epidemiology)52(, GSF-National Research)]TJ
0 -1.2543 TD
0.01 Tc
0.018 Tw
[(Center for Environment and Health, Neuherber)24(g,)]TJ
0 -1.2472 TD
0.013 Tc
(Germany)Tj
1.5024 -1.6228 TD
-0.016 Tc
0 Tw
[(Simulation studies are widely used to evaluate the per)12(-)]TJ
-1.5024 -1.2543 TD
-0.011 Tc
0.124 Tw
(formance of statistical methods for identifying suscepti-)Tj
0 -1.2472 TD
0.001 Tc
0.188 Tw
(bility genes, including whole genome simulations for)Tj
T*
-0.016 Tc
0 Tw
(multipoint methods. Here, the classification into \221true\222 and)Tj
0 -1.2543 TD
-0.011 Tc
0.152 Tw
(\221false\222 regions is a special problem hardly discussed in)Tj
0 -1.2472 TD
0.01 Tw
(the literature where the variety of used definitions is vast.)Tj
1.5024 -1.2543 TD
0.01 Tc
0.187 Tw
(A fast and flexible genome scan simulation pro-)Tj
-1.5024 -1.2472 TD
0.009 Tc
0 Tw
(gram GESIMS is presented. Results are given for 1000)Tj
T*
0.03 Tw
[(sets of 2x200 af)9(fected sib pair families generated for a)]TJ
0 -1.2543 TD
0.118 Tw
(multiplicative disease model with a genotype relative)Tj
0 -1.2472 TD
0.008 Tc
0.034 Tw
[(risk of 4. )-14(V)106(arious classification schemes are applied to)]TJ
T*
0.009 Tc
0.152 Tw
(a 10cM screen on the first 200 families. Power esti-)Tj
0 -1.2543 TD
0.006 Tc
0 Tw
(mates to a screening level of p=0.01 vary between 77%)Tj
0 -1.2472 TD
0.009 Tc
0.109 Tw
(and 90% if only the marker next to the disease locus)Tj
0 -1.2543 TD
0.006 Tc
0.139 Tw
[(or the whole chromosome is counted. )-122(The dif)13(ference)]TJ
0 -1.2472 TD
0.008 Tc
0 Tw
(in power estimates which take subsequent finemapping)Tj
T*
0.009 Tc
0.118 Tw
(into account is less than 2% if a 1cM mapping in an)Tj
0 -1.2543 TD
0.01 Tc
0.046 Tw
[(area of 20cM or 60cM around peaks is planned, while)]TJ
0 -1.2472 TD
0.009 Tc
0.091 Tw
(the mean number of typed markers increases from 42)Tj
0 -1.2543 TD
0.177 Tw
(to 78.5 and 2.2 to 5.2 on the linked respectively an)Tj
0 -1.2472 TD
0.005 Tc
-0.001 Tw
[(unlinked chromosome \(of length 150cM\). )18(W)35(ith the sec-)]TJ
T*
0.009 Tc
0.157 Tw
[(ond set of families the results of dif)16(ferent fine map-)]TJ
0 -1.2543 TD
0.015 Tw
(ping strategies are evaluated.)Tj
1.5024 -1.2472 TD
0.069 Tw
(For realistic power estimates not only the nominal)Tj
-1.5024 -1.2472 TD
0.073 Tw
(p-value but the width of the region one is prepared to)Tj
0 -1.2543 TD
0.008 Tc
0.066 Tw
[(follow up has to be considered. )-56(The dif)15(ferences in es-)]TJ
0 -1.2472 TD
0.009 Tc
0.163 Tw
(timates obtained by the various definitions underline)Tj
25.5047 69.2504 TD
0.01 Tc
0.187 Tw
(the need to set a standard, which must adapt to the)Tj
0 -1.2543 TD
0.009 Tc
0.015 Tw
(change in cost of marker typing.)Tj
/T29 1 Tf
14 0 0 14 264.019 590.003 Tm
-0.021 Tc
(44)Tj
/F5 1 Tf
8 0 0 8 264.019 572.995 Tm
0.008 Tc
0 Tw
(HLA associations with subtypes of juvenile)Tj
0 -1.2472 TD
0.009 Tc
0.002 Tw
(idiopathic arthritis based on a latent class analysis)Tj
0 -1.2543 TD
0.025 Tw
(of symptoms)Tj
/F14 1 Tf
0 -1.2472 TD
0.006 Tw
(Barrett JH)Tj
4.8 0 0 4.8 297.921 546.576 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 300.359 543.005 Tm
0.01 Tc
-0.008 Tw
[(,)9( Thomas )-17(E)]TJ
4.8 0 0 4.8 337.776 546.576 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 340.271 543.005 Tm
0.009 Tc
-0.007 Tw
[(,)8( Thomson W)]TJ
4.8 0 0 4.8 384.718 546.576 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 387.212 543.005 Tm
0.01 Tc
0.013 Tw
(, Donn R)Tj
4.8 0 0 4.8 417.203 546.576 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 419.641 543.005 Tm
(,)Tj
-19.4528 -1.2543 TD
0.008 Tc
0.013 Tw
[(W)80(oo P)]TJ
4.8 0 0 4.8 285.846 536.598 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 288.283 532.97 Tm
0.009 Tc
0.011 Tw
(, Southwood TR)Tj
4.8 0 0 4.8 342.142 536.598 Tm
0 Tc
0 Tw
(3)Tj
-16.2756 -2.0787 TD
(1)Tj
8 0 0 8 266.457 522.992 Tm
0.009 Tc
0.018 Tw
[(ARC Epidemiology Unit, University of Manchester)37(,)]TJ
4.8 0 0 4.8 264.019 516.586 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 266.457 513.014 Tm
0.009 Tc
0.025 Tw
[(Department of Molecular Rheumatology)73(, University)]TJ
-0.3047 -1.2543 TD
0.008 Tc
0.028 Tw
(College London, )Tj
4.8 0 0 4.8 321.505 506.608 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 323.943 502.979 Tm
0.009 Tc
0.028 Tw
[(Department of Rheumatology)59(,)]TJ
-7.4906 -1.2472 TD
(University of Birmingham)Tj
1.4953 -1.7504 TD
0.014 Tc
0.188 Tw
(Juvenile idiopathic arthritis \(JIA\) is a childhood)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.085 Tw
(rheumatic condition with known HLA associations. It)Tj
0 -1.2543 TD
0.122 Tw
(encompasses a spectrum of diseases that vary widely)Tj
0 -1.2472 TD
0.09 Tw
(in onset characteristics, clinical course and associated)Tj
0 -1.2543 TD
0.055 Tw
(manifestations. Existing widely used systems for clas-)Tj
0 -1.2472 TD
0.075 Tw
[(sifying JIA)52( into subtypes are based on clinicians\222)73( per)9(-)]TJ
T*
0.043 Tc
0.188 Tw
(ceptions of disease patterns, and may not define)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
[(biologically homogeneous subgroups. )19(W)77(e)0( have used la-)]TJ
0 -1.2472 TD
0.008 Tc
(tent class analysis \(LCA\) to identify underlying classes)Tj
T*
0.009 Tc
0.153 Tw
(which best explain the relationships between clinical)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
(variables and investigated HLA associations with these)Tj
0 -1.2472 TD
0.009 Tc
0.075 Tw
(subgroups. Clinical data were obtained from 572 sub-)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
(jects in the British Paediatric Rheumatology Group Na-)Tj
0 -1.2472 TD
0.007 Tc
0.112 Tw
[(tional Repository for JIA. )-93(The analysis was based on)]TJ
T*
-0.011 Tc
0.078 Tw
(the age at onset of arthritis \(< 5 years, 5\2269 years, 10\22616)Tj
0 -1.2543 TD
0.089 Tw
(years\), and 9 other key clinical variables, each of which)Tj
0 -1.2472 TD
0.077 Tw
[(was recorded as present or absent. )-56(The most appropriate)]TJ
0 -1.2543 TD
0.029 Tw
(solution statistically was based on 7 latent classes, 4 with)Tj
0 -1.2472 TD
-0.01 Tc
0.188 Tw
(approximately 20% of the patients each and 3 smaller)Tj
T*
-0.011 Tc
0.041 Tw
(classes. Of the JIA patients 461 \(81%\) could be assigned)Tj
0 -1.2543 TD
-0.02 Tc
0 Tw
[(to a particular class with probability greater than 0.7. )23(There)]TJ
0 -1.2472 TD
-0.011 Tc
0.054 Tw
(was some correspondence between the latent classes and)Tj
T*
-0.02 Tc
0 Tw
(currently identified subgroups, but these were by no means)Tj
0 -1.2543 TD
-0.009 Tc
0.187 Tw
[(coincident. Marked dif)26(ferences in HLA)48( phenotype fre-)]TJ
0 -1.2472 TD
-0.011 Tc
0.115 Tw
[(quencies were observed in the dif)24(ferent classes. For ex-)]TJ
0 -1.2543 TD
-0.017 Tc
0 Tw
(ample DRB1*08, which shows an overall association with)Tj
0 -1.2472 TD
-0.011 Tc
0.024 Tw
(JIA, was found to be associated with four of the JIA sub-)Tj
T*
0.049 Tw
[(groups, but not the other three. )-26(This analysis provides an)]TJ
0 -1.2543 TD
-0.014 Tc
0 Tw
(alternative way of identifying homogeneous groups of pa-)Tj
0 -1.2472 TD
-0.011 Tc
0.033 Tw
(tients. Further work examining other genetic associations)Tj
0 -1.2543 TD
0.017 Tw
(and prognosis in the latent class subgroups)Tj
/T29 1 Tf
14 0 0 14 264.019 140.995 Tm
-0.021 Tc
(45)Tj
/F5 1 Tf
8 0 0 8 264.019 123.987 Tm
0.009 Tc
0.001 Tw
(Design and analysis options for the estimation of)Tj
0 -1.2472 TD
0.01 Tw
[(gene-envir)16(onment interaction fr)16(om epidemiological)]TJ
T*
-0.001 Tw
[(case-contr)23(ol studies)]TJ
/F14 1 Tf
0 -1.2543 TD
0.008 Tc
0.013 Tw
(Silke Schmidt)Tj
4.8 0 0 4.8 310.167 97.625 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 312.605 93.997 Tm
0.009 Tc
0.016 Tw
(, Heiko Becher)Tj
4.8 0 0 4.8 362.154 97.625 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 364.592 93.997 Tm
0.009 Tc
0.019 Tw
(, Jenny Chang-Claude)Tj
4.8 0 0 4.8 437.329 97.625 Tm
0 Tc
0 Tw
(3)Tj
-36.1063 -2.0905 TD
(1)Tj
8 0 0 8 266.457 84.019 Tm
0.009 Tc
0.013 Tw
[(Duke University Medical Center)37(, Durham, NC;)]TJ
ET

endstream
endobj
296 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
295 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
294 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
288 0 obj
<</Length 11292>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(206)-2523(Abstracts)]TJ
/F14 1 Tf
4.8 0 0 4.8 50.981 641.594 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 53.476 638.022 Tm
0.009 Tc
0.02 Tw
[(University of Heidelber)16(g, Heidelber)16(g, Germany;)]TJ
4.8 0 0 4.8 50.981 631.616 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 53.476 627.987 Tm
0.01 Tc
0.012 Tw
[(German Cancer Research Center)38(, Heidelber)24(g)-5(,)]TJ
-0.3118 -1.2472 TD
0.012 Tc
[(Germany)55(.)]TJ
1.5024 -1.7504 TD
0.019 Tc
0.188 Tw
(The assessment of gene-environment interaction)Tj
-1.5024 -1.2543 TD
0.009 Tc
0.139 Tw
[(with data from lar)9(ge epidemiologic studies continues)]TJ
0 -1.2472 TD
0.015 Tc
0.187 Tw
[(to of)8(fer methodological challenges, especially when)]TJ
T*
0.009 Tc
0.054 Tw
(rare and highly penetrant susceptibility genes are con-)Tj
0 -1.2543 TD
-0.007 Tc
(cerned. )Tj
3.3449 0 TD
0.009 Tc
0.118 Tw
(When measured genotypes of study probands)Tj
-3.3449 -1.2472 TD
0.037 Tw
(are available, it is of interest to compare the following)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
[(design options with simulated case-control data: a pair)14(-)]TJ
0 -1.2472 TD
0.004 Tc
[(matched case-control study)54(, either using a pair)18(-matched)]TJ
T*
0.009 Tc
0.135 Tw
(or an age-stratified analysis; an unmatched case-con-)Tj
0 -1.2543 TD
0.036 Tw
[(trol study)59(, either including age in the model or using a)]TJ
0 -1.2472 TD
0.001 Tw
[(post-hoc age stratification; a pair)16(-matched case-control)]TJ
T*
0.008 Tc
0 Tw
(study using sibling rather than population controls; and)Tj
0 -1.2543 TD
0.009 Tc
0.11 Tw
(a case-only analysis discarding the controls, allowing)Tj
0 -1.2472 TD
0.066 Tw
(for better precision of the interaction estimate, but as-)Tj
0 -1.2543 TD
0.105 Tw
[(suming a dif)23(ferent scale of measurement than a case-)]TJ
0 -1.2472 TD
0.031 Tw
(control analysis.)Tj
1.5024 -1.2472 TD
0.168 Tw
[(In lar)16(ge case-control studies, it is often cost-pro-)]TJ
-1.5024 -1.2543 TD
0.021 Tc
0.188 Tw
(hibitive to obtain measured genotypes on all study)Tj
0 -1.2472 TD
0.009 Tc
(probands. Some approaches for assessing gene-envi-)Tj
0 -1.2543 TD
0.012 Tc
0.187 Tw
(ronment interaction with surrogate genetic measures)Tj
0 -1.2472 TD
0.188 Tw
(based on family history information from cases and)Tj
T*
0.023 Tc
0.187 Tw
(controls may then be compared on simulated data.)Tj
0 -1.2543 TD
0.009 Tc
0.088 Tw
(These methods are also illustrated on a German case-)Tj
0 -1.2472 TD
0.019 Tw
[(control study of premenopausal breast cancer)44(.)]TJ
/T30 1 Tf
14 0 0 14 50.981 334.998 Tm
-0.021 Tc
(46)Tj
/F5 1 Tf
8 0 0 8 50.981 317.991 Tm
0.009 Tc
0.004 Tw
(Extending family based tests of association: using)Tj
T*
0 Tw
(unaffected sibs, covariates, and testing for gene-)Tj
0 -1.2543 TD
0.01 Tc
(gene interaction.)Tj
/F14 1 Tf
0 -1.2472 TD
(KL Lunetta)Tj
4.8 0 0 4.8 88.909 291.628 Tm
0 Tc
(1)Tj
8 0 0 8 91.347 288 Tm
0.01 Tc
(, S Faraone)Tj
4.8 0 0 4.8 128.48 291.628 Tm
0 Tc
(2)Tj
8 0 0 8 130.918 288 Tm
0.009 Tc
(, J Biederman)Tj
4.8 0 0 4.8 176.102 291.628 Tm
0 Tc
(2)Tj
8 0 0 8 178.484 288 Tm
(,)Tj
-15.9378 -1.2472 TD
0.009 Tc
0.006 Tw
(D Rabinowitz)Tj
4.8 0 0 4.8 96.676 281.594 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 99.113 278.022 Tm
0.01 Tc
0.009 Tw
(, NM Laird)Tj
4.8 0 0 4.8 136.247 281.594 Tm
0 Tc
0 Tw
(1)Tj
-17.7638 -2.0787 TD
(1)Tj
8 0 0 8 53.476 267.987 Tm
0.009 Tc
0.011 Tw
(Harvard School of Public Health and )Tj
4.8 0 0 4.8 177.18 271.616 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 179.617 267.987 Tm
0.009 Tc
(Medical)Tj
-16.0795 -1.2472 TD
0.012 Tw
(School, Boston, MA; )Tj
4.8 0 0 4.8 122.868 261.581 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 125.306 258.009 Tm
0.009 Tc
0.014 Tw
[(Columbia Univ)59(., New )23(Y)100(ork,)]TJ
-9.2905 -1.2543 TD
0.01 Tc
0.001 Tw
[(NY)123(. USA)]TJ
1.5024 -1.7433 TD
0.021 Tc
0.188 Tw
[(W)86(e)0( extend the methodology of Self \(1991\) and)]TJ
-1.5024 -1.2543 TD
0.009 Tc
0.06 Tw
(Schaid \(1996\) to incorporate arbitrary phenotypes and)Tj
0 -1.2472 TD
0.006 Tc
0.145 Tw
[(covariates into general score tests of association. )-128(W)71(e)]TJ
0 -1.2543 TD
0.009 Tc
0.143 Tw
(first use standard models of association for a pheno-)Tj
0 -1.2472 TD
-0.024 Tc
0.255 Tw
(type Y )Tj
3.1898 0 TD
0.009 Tc
0.125 Tw
(and any number of predictors, which may in-)Tj
-3.1898 -1.2472 TD
0.019 Tc
0.187 Tw
(clude indicators for gene alleles and environmental)Tj
0 -1.2543 TD
0.008 Tc
0.054 Tw
[(factors. )-34(W)80(e)-1( then construct the score by assuming like-)]TJ
0 -1.2472 TD
0.006 Tc
0.093 Tw
[(lihoods for the distribution of )-66(Y)126(,)2( given genotype. )-80(The)]TJ
0 -1.2543 TD
0.009 Tc
0.104 Tw
(distribution of the score is computed as a function of)Tj
0 -1.2472 TD
0.059 Tw
[(of)16(fspring genotypes conditional on parental genotypes)]TJ
T*
0.08 Tw
[(and trait values for of)16(fspring and parents \(Rabinowitz)]TJ
0 -1.2543 TD
0.169 Tw
(& Laird 1999\). Our approach provides a natural ex-)Tj
0 -1.2472 TD
0.008 Tc
0.053 Tw
[(tension of the )-41(T)-5(D)-5(T)15( \(Spielman et al. 1993\) to any phe-)]TJ
T*
0.01 Tc
0.188 Tw
(notype and multiple genes or environmental factors,)Tj
0 -1.2543 TD
0.009 Tc
0.024 Tw
(and allows the examination of gene-gene and gene-en-)Tj
0 -1.2472 TD
0.05 Tw
(vironment interaction.)Tj
27 69.2504 TD
0.006 Tc
0.143 Tw
[(When )10(the )10(trait )-104(Y)26( varies among subjects, or when)]TJ
-1.4953 -1.2543 TD
0.009 Tc
0.006 Tw
(there are covariates in the model, the score statistic de-)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
(pends on one or more nuisance parameters. Often these)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(parameters do not depend on genotype, and popula-)Tj
0 -1.2472 TD
0.009 Tc
0 Tw
(tion estimates may be available. Sometimes the param-)Tj
T*
0.007 Tc
0.121 Tw
[(eters may be estimated from the data. )-107(W)79(e)-3( suggest an)]TJ
0 -1.2543 TD
0.091 Tw
(alternative approach in which we optimize the )Tj
/F17 1 Tf
19.8071 0 TD
0 Tc
0 Tw
(c)Tj
/F14 1 Tf
4.8 0 0 4.8 418.011 581.613 Tm
(2)Tj
8 0 0 8 420.449 577.984 Tm
0.008 Tc
0.094 Tw
[( sta-)]TJ
-20.6787 -1.2472 TD
0.009 Tc
0.05 Tw
[(tistic over a nuisance parameter)37(, and then apply a cor)16(-)]TJ
0 -1.2543 TD
0.016 Tw
(rection to the p-value suggested by Davies \(1977\).)Tj
1.4953 -1.2472 TD
0.025 Tc
0.187 Tw
[(W)76(e)0( illustrate our methods with a sample of 43)]TJ
-1.4953 -1.2472 TD
-0.002 Tc
0 Tw
(nuclear families having )Tj
/F17 1 Tf
9.5953 0 TD
0 Tc
(\263)Tj
/F14 1 Tf
0.5598 0 TD
-0.002 Tc
0.001 Tw
[(1 member with )63(Attention Defi-)]TJ
-10.1551 -1.2543 TD
0.01 Tc
0.123 Tw
[(cit Hyperactivity Disorder \(ADHD\), with 44 af)17(fected)]TJ
0 -1.2472 TD
0.143 Tw
(and 34 unaf)Tj
5.0953 0 TD
0.004 Tc
0.148 Tw
[(fected )10(children. )-132(W)76(e)-5( examine associations)]TJ
-5.0953 -1.2472 TD
0.009 Tc
0.024 Tw
[(and interactions between )30(ADHD or a related measured)]TJ
0 -1.2543 TD
0.091 Tw
(phenotype and the dopamine D4 and dopamine trans-)Tj
0 -1.2472 TD
0.033 Tw
[(porter genes, using sex and parental af)23(fection status as)]TJ
0 -1.2543 TD
0.182 Tw
(covariates. For tests without covariates, we compare)Tj
0 -1.2472 TD
0.137 Tw
(results using population and sample estimates of one)Tj
T*
0.007 Tc
0.062 Tw
(nuisance parameter and the optimized )Tj
/F17 1 Tf
16.0512 0 TD
0 Tc
0 Tw
(c)Tj
/F14 1 Tf
4.8 0 0 4.8 387.964 461.594 Tm
(2)Tj
8 0 0 8 390.402 458.022 Tm
0.008 Tc
0.063 Tw
[( statistic with)]TJ
-16.9228 -1.2543 TD
0.009 Tc
0.025 Tw
(Davies \(1977\) correction.)Tj
/T30 1 Tf
14 0 0 14 255.019 406.998 Tm
-0.021 Tc
(47)Tj
/F5 1 Tf
8 0 0 8 255.019 389.027 Tm
0.009 Tc
0 Tw
[(T)88(esting Gene-envir)16(onment Interaction Using)]TJ
T*
0.008 Tc
(Affected Sibpairs)Tj
/F14 1 Tf
0 -1.2472 TD
0.011 Tc
(FZ Sun)Tj
4.8 0 0 4.8 279.284 372.586 Tm
0 Tc
(1)Tj
8 0 0 8 281.778 369.014 Tm
0.01 Tc
-0.011 Tw
[(,)6( WD )-17(Flanders)]TJ
4.8 0 0 4.8 329.627 372.586 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 332.065 369.014 Tm
0.009 Tc
0.004 Tw
[(, QH )31(Y)100(ang)]TJ
4.8 0 0 4.8 366.647 372.586 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 369.085 369.014 Tm
0.011 Tc
0.006 Tw
[(, HY)39( Zhao)]TJ
4.8 0 0 4.8 403.668 372.586 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 406.106 369.014 Tm
(,)Tj
-18.8858 -1.2543 TD
0.01 Tc
0.025 Tw
(MJ Khoury)Tj
4.8 0 0 4.8 292.55 362.608 Tm
0 Tc
0 Tw
(2)Tj
-7.8189 -2.0905 TD
(1)Tj
8 0 0 8 257.457 349.002 Tm
0.01 Tc
0.005 Tw
[(Emory Univ)67(., )45(Atlanta, GA, USA; )]TJ
4.8 0 0 4.8 368.291 352.573 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 370.729 349.002 Tm
0.01 Tc
-0.039 Tw
[(CDC, Atlanta, )-46(GA,)]TJ
-14.4638 -1.2472 TD
0.009 Tc
(USA; )Tj
4.8 0 0 4.8 275.655 342.595 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 278.093 339.024 Tm
0.01 Tc
0.002 Tw
[(Y)94(ale Univ)67(., New Haven, CT)67(, USA)]TJ
-1.389 -1.878 TD
0.009 Tc
[(T)60(esting for gene-environment interactions is an im-)]TJ
-1.4953 -1.2472 TD
-0.001 Tc
0.001 Tw
[(portant problem in genetic epidemilogy)56(. Several designs)]TJ
0 -1.2543 TD
0.009 Tc
0.069 Tw
(are available to test for gene-environment interactions)Tj
0 -1.2472 TD
0 Tc
0 Tw
(such as case-control studies, case-only studies, and fam-)Tj
0 -1.2543 TD
0.009 Tc
0.142 Tw
[(ily based case-control studies. Families with af)16(fected)]TJ
0 -1.2472 TD
0.005 Tc
0 Tw
(sibpairs are routinely collected to find the genetic bases)Tj
T*
0.009 Tc
0.111 Tw
(of complex diseases. Here we compare several meth-)Tj
0 -1.2543 TD
0.09 Tw
(ods for detecting gene-environment interactions using)Tj
0 -1.2472 TD
-0.002 Tc
0.188 Tw
[(a)-12(f)5(fected sibpairs. )-186(W)70(e)-12( )]TJ
9.3844 0 TD
0.01 Tc
(considered the following tests:)Tj
-9.3844 -1.2472 TD
0.009 Tc
0.057 Tw
[(\(1\) comparing the fraction of af)23(fected sibpairs sharing)]TJ
0 -1.2543 TD
0.143 Tw
(0 alleles identity by decent \(IBD\) when the environ-)Tj
0 -1.2472 TD
0.079 Tw
(ment is present with the fraction of sibpairs sharing 0)Tj
0 -1.2543 TD
0.074 Tw
(alleles IBD when the environment is absent; \(2\) com-)Tj
0 -1.2472 TD
0.107 Tw
(paring the average allele sharing IBD when the envi-)Tj
T*
0.023 Tw
(ronment is present with the average allele sharing IBD)Tj
0 -1.2543 TD
-0.011 Tc
0.101 Tw
(when the environment is absent; \(3\) regress the average)Tj
0 -1.2472 TD
0.138 Tw
(allele sharing probability with respect to the number of)Tj
0 -1.2543 TD
0.034 Tw
[(sibs having the environment. )-12(W)82(e)-1( compare the tests under)]TJ
0 -1.2472 TD
0.089 Tw
(two models. In the first model, the environment is inde-)Tj
T*
-0.014 Tc
0.171 Tw
[(pendently distributed among individuals. )-156(W)80(e)-3( show that)]TJ
0 -1.2543 TD
-0.011 Tc
0.104 Tw
(generally the third test is the most powerful. In the sec-)Tj
0 -1.2472 TD
0.063 Tw
[(ond model, the environment is the same within a family)67(.)]TJ
T*
0.094 Tw
[(W)83(e)0( show that the third and the second tests have essen-)]TJ
0 -1.2543 TD
0.147 Tw
(tially the same power and are generally more powerful)Tj
0 -1.2472 TD
0.156 Tw
(than the first test. Even for the most powerful test, the)Tj
ET

endstream
endobj
308 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
309 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
307 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
306 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
305 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
304 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
298 0 obj
<</Length 9568>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(207)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
-0.011 Tc
0.062 Tw
(sample size needed to have a reasonable power to detect)Tj
0 -1.2543 TD
0.141 Tw
[(the gene-environment interaction is usually too lar)24(ge to)]TJ
0 -1.2472 TD
0.04 Tw
(be realistic. Alternative methods should be used to detect)Tj
0 -1.2543 TD
0.069 Tw
(gene-environment interactions.)Tj
/T31 1 Tf
14 0 0 14 59.981 566.986 Tm
-0.021 Tc
(48)Tj
/F5 1 Tf
8 0 0 8 59.981 549.978 Tm
0.01 Tc
0.001 Tw
[(A)52( Note on the Relative Powers of )10(TDT)74(, S-TDT)24( and)]TJ
0 -1.2472 TD
0.013 Tc
(1-TDT)Tj
/F14 1 Tf
T*
0.009 Tc
0.013 Tw
[(Dai W)81(ang and Fengzhu Sun)]TJ
0 -1.2543 TD
0.01 Tc
0.009 Tw
[(Emory University)53(,)16( )38(Atlanta, GA, USA)]TJ
1.5024 -1.7504 TD
0.021 Tc
0.188 Tw
(The transmission/disequilibrium test \(TDT\) is a)Tj
-1.5024 -1.2472 TD
0.009 Tc
0.16 Tw
(widely used method to detect the linkage disequilib-)Tj
0 -1.2543 TD
0.093 Tw
(rium between a candidate locus \(a marker\) and a dis-)Tj
0 -1.2472 TD
0.007 Tc
0.095 Tw
[(ease )8(locus. )-69(T)-10(D)-10(T)21( is a family-based design and has the)]TJ
T*
0.009 Tc
0.04 Tw
(advantage that it is a valid test when population strati-)Tj
0 -1.2543 TD
0.003 Tc
-0.001 Tw
[(fication exists. Standard )9(TDT)17( requires the marker geno-)]TJ
0 -1.2472 TD
0.02 Tc
0.188 Tw
[(types of af)6(fected individuals and their parents. For)]TJ
T*
0.009 Tc
0.037 Tw
[(diseases with late age of onset, it is dif)9(ficult or impos-)]TJ
0 -1.2543 TD
0.01 Tc
0.188 Tw
(sible to obtain the marker genotypes of the parents.)Tj
0 -1.2472 TD
0.009 Tc
0.028 Tw
(When both parents\222 marker genotypes are unavailable,)Tj
0 -1.2543 TD
0.043 Tw
[(Ewens and Spielman extended the standard )-27(TDT)16( to S-)]TJ
0 -1.2472 TD
0.02 Tw
[(TDT)16( for use in sibships with at least one af)23(fected indi-)]TJ
T*
0.007 Tc
0.116 Tw
[(vidual and one unaf)21(fected )6(individual. )-97(When only one)]TJ
0 -1.2543 TD
0.009 Tc
0.163 Tw
[(parent\222)52(s genotype is available, Sun et al. proposed a)]TJ
0 -1.2472 TD
0.094 Tw
[(test, the 1-TDT)66(, for use with marker genotypes of af-)]TJ
0 -1.2543 TD
0.057 Tw
(fected individuals and only one available parent. Here)Tj
0 -1.2472 TD
0.007 Tc
0.145 Tw
[(we study the relative powers of )-128(T)-10(D)-10(T)78(, )-5(S-TDT)21( and 1-)]TJ
T*
0.009 Tc
0.042 Tw
[(TDT)73(.)48( )-33(W)81(e)0( show that the sample size needed for 1-TDT)]TJ
0 -1.2543 TD
0.115 Tw
(is roughly the same as the sample size needed for S-)Tj
0 -1.2472 TD
0.064 Tw
(TDT with two sibs and is about twice the sample size)Tj
T*
0.008 Tc
0.056 Tw
[(needed for standard )-42(T)-5(D)-5(T)72(.)61( )-49(W)80(e)-1( are currently comparing)]TJ
0 -1.2543 TD
0.01 Tc
0.031 Tw
(the powers of S-TDT and 1-TDT with the correspond-)Tj
0 -1.2472 TD
0.009 Tc
0.135 Tw
(ing statistics for DNA pooling data studied by Risch)Tj
0 -1.2543 TD
0.005 Tc
0.034 Tw
[(and T)56(eng.)]TJ
/T31 1 Tf
14 0 0 14 59.981 234.992 Tm
-0.021 Tc
(49)Tj
/F5 1 Tf
8 0 0 8 59.981 217.984 Tm
0.009 Tc
0 Tw
[(T)67(r)21(ee-based Methods for)23( Mapping Genes in)]TJ
0 -1.2472 TD
0.01 Tc
0.018 Tw
(Complex Diseases)Tj
/F14 1 Tf
T*
(Heping Zhang)Tj
4.8 0 0 4.8 107.093 201.6 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 109.531 198.028 Tm
0.011 Tc
0.022 Tw
[( and Geor)18(ge Bonney)]TJ
4.8 0 0 4.8 177.392 201.6 Tm
0 Tc
0 Tw
(2)Tj
-24.4606 -2.0787 TD
(1)Tj
8 0 0 8 62.476 187.994 Tm
0.009 Tc
0.016 Tw
[(Department of Epidemiology and Public Health, )31(Y)93(ale)]TJ
-0.3118 -1.2472 TD
0.01 Tc
0.01 Tw
(University School of Medicine, New Have, CT 06520,)Tj
0 -1.2543 TD
0.005 Tc
(and )Tj
4.8 0 0 4.8 73.928 171.61 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 76.422 167.981 Tm
0.01 Tc
0.013 Tw
(National Human Genome Center at Howard)Tj
-2.0551 -1.2472 TD
0.009 Tc
[(University)59(, 2216 sixth Street, N.W)101(., W)81(ashington, DC)]TJ
T*
0.016 Tc
(20059)Tj
1.5024 -1.7504 TD
0.009 Tc
0 Tw
[(W)81(e)0( propose the use of tree-based methods for map-)]TJ
-1.5024 -1.2543 TD
0.001 Tc
-0.001 Tw
[(ping genetic markers for complex diseases. )21(These meth-)]TJ
0 -1.2472 TD
0.009 Tc
0.078 Tw
(ods are known for their capability to incorporate high)Tj
T*
0.079 Tw
(dimensional data and have great potential in selecting)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
(candidate genes among many markers for complex dis-)Tj
0 -1.2472 TD
0.018 Tc
0.188 Tw
(eases, particularly in the presence of epistasis. Our)Tj
25.5047 69.2504 TD
0.013 Tc
0.187 Tw
(methods combine the tree-based model described in)Tj
0 -1.2543 TD
0.009 Tc
0.17 Tw
(Zhang \(1998\) with the regressive models of Bonney)Tj
0 -1.2472 TD
0.065 Tw
(\(1986\) by generalizing the goodness of node split and)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
(the tree cost-complexity measure. Both simulations and)Tj
0 -1.2472 TD
0.009 Tc
0.078 Tw
(real applications will be used to test the usefulness of)Tj
T*
0.031 Tw
(these methods.)Tj
/T31 1 Tf
14 0 0 14 264.019 546.973 Tm
-0.021 Tc
(50)Tj
/F5 1 Tf
8 0 0 8 264.019 530.022 Tm
0.009 Tc
0.004 Tw
[(Meta-analysis for)23( interpr)16(eting r)16(esults fr)16(om)]TJ
0 -1.2543 TD
0.003 Tw
(multiple genome scans)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.008 Tw
[(J.A. Badner)45(, E.S. Gershon)]TJ
0 -1.2543 TD
0.011 Tw
(University of Chicago, Chicago, IL, USA)Tj
1.4953 -1.7504 TD
0.009 Tc
0.018 Tw
(Lander and Kruglyak gave guidelines for interpret-)Tj
-1.4953 -1.2472 TD
0.01 Tc
0.188 Tw
(ing linkage results based on estimating how often a)Tj
T*
0.005 Tc
0 Tw
(particular threshold for significance would be exceeded)Tj
0 -1.2543 TD
0.009 Tc
0.164 Tw
(by chance in a single genome scan. Criteria for sig-)Tj
0 -1.2472 TD
0.171 Tw
(nificant linkage was recommended to be a threshold)Tj
T*
0.001 Tc
0 Tw
(that would be exceeded 0.05 times by chance in a single)Tj
0 -1.2543 TD
0.007 Tc
0.109 Tw
[(genome )9(scan. )-89(These criteria do not always enable in-)]TJ
0 -1.2472 TD
0.009 Tc
0.051 Tw
(terpretation of the results of multiple genome scans of)Tj
0 -1.2543 TD
0.011 Tc
0.188 Tw
(a genetic trait. In some cases, there may be several)Tj
0 -1.2472 TD
0.009 Tc
0.058 Tw
(scans that show significant results within the same re-)Tj
T*
0.023 Tw
(gion but none of the individual results would meet cri-)Tj
0 -1.2543 TD
0.004 Tc
0 Tw
(teria for significant linkage. In other cases, two or more)Tj
0 -1.2472 TD
0.009 Tc
0.085 Tw
(studies exceed criteria for significant linkage but sev-)Tj
0 -1.2543 TD
0.184 Tw
(eral other studies do not show nominally significant)Tj
0 -1.2472 TD
0.006 Tc
0.152 Tw
[(results with the same region. )-146(This )-6(may )-6(occur )-6(due )-6(to)]TJ
T*
0.01 Tc
0.187 Tw
[(low power to detect genes of small ef)17(fect using the)]TJ
0 -1.2543 TD
0.009 Tc
0.182 Tw
[(criteria recommended by Lander and Kruglyak. One)]TJ
0 -1.2472 TD
0.152 Tw
(possibility is to combine the results of these studies.)Tj
T*
0.008 Tc
0.064 Tw
[(However)43(, this is dif)22(ficult to do in many instances. )-43(W)73(e)]TJ
0 -1.2543 TD
0.009 Tc
0.106 Tw
(propose a type of meta-analysis which involves com-)Tj
0 -1.2472 TD
0.005 Tc
0.176 Tw
[(bining p values across the studies. )-158(W)77(e)-4( make recom-)]TJ
0 -1.2543 TD
0.009 Tc
0.114 Tw
(mendations for criteria of linkage using this analysis.)Tj
0 -1.2472 TD
0.13 Tw
(Comparisons of the power of this meta-analysis with)Tj
T*
0.008 Tc
0.081 Tw
[(Lander and Kruglyak criteria are presented. )-63(W)87(e)-2( apply)]TJ
0 -1.2543 TD
0.009 Tc
(this method of meta-analysis to the evidence for link-)Tj
0 -1.2472 TD
0.011 Tw
(age of IDDM susceptibility loci.)Tj
/T31 1 Tf
14 0 0 14 264.019 195.024 Tm
-0.021 Tc
(51)Tj
/F5 1 Tf
8 0 0 8 264.019 178.016 Tm
0.01 Tc
0.009 Tw
[(Segr)24(egation analysis of cancer)31( in families of glioma)]TJ
0 -1.2543 TD
0.008 Tc
(patients.)Tj
/F14 1 Tf
0 -1.2472 TD
0.009 Tc
0.004 Tw
[(M de )49(Andrade)]TJ
4.8 0 0 4.8 310.79 161.632 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 313.228 158.003 Tm
0.009 Tc
0.007 Tw
(, J S Barnholtz)Tj
4.8 0 0 4.8 361.644 161.632 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 367.767 158.003 Tm
0.008 Tc
[(, C I )44(Amos)]TJ
4.8 0 0 4.8 403.37 161.632 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 405.864 158.003 Tm
(,)Tj
-17.7307 -1.2472 TD
0.01 Tc
-0.054 Tw
[(P)35( Adatto)]TJ
4.8 0 0 4.8 292.139 151.597 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 294.576 148.025 Tm
0.01 Tc
0.006 Tw
(, C Spencer)Tj
4.8 0 0 4.8 332.674 151.597 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 335.168 148.025 Tm
0.01 Tc
0.009 Tw
(, M Bondy)Tj
4.8 0 0 4.8 370.431 151.597 Tm
0 Tc
0 Tw
(1)Tj
-22.1693 -2.0787 TD
(1)Tj
8 0 0 8 266.457 137.991 Tm
0.009 Tc
0.014 Tw
[(Department of Epidemiology)66(, UT)16( M D )29(Anderson)]TJ
-0.3047 -1.2472 TD
0.01 Tw
[(Cancer Center)37(, Houston, )10(T)67(exas; )]TJ
4.8 0 0 4.8 370.148 131.584 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 372.586 128.013 Tm
0.01 Tc
0.01 Tw
[(UT)17( School of Public)]TJ
-13.5709 -1.2543 TD
0.008 Tc
0.019 Tw
[(Health, Houston, )-6(T)73(exas)]TJ
1.4953 -1.7433 TD
0.009 Tc
0.029 Tw
(The probands were patients diagnosed with glioma)Tj
-1.4953 -1.2543 TD
0.002 Tc
0 Tw
(between June 1992 and June 1995 registered at the Uni-)Tj
0 -1.2472 TD
-0.008 Tc
0.165 Tw
[(versity of )-164(T)50(exas M. D. )]TJ
10.2047 0 TD
0.01 Tc
0.164 Tw
[(Anderson Cancer Center)53(.)172( )-111(All)]TJ
ET

endstream
endobj
320 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
318 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
319 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
317 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
311 0 obj
<</Length 9744>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(208)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.01 Tc
0.043 Tw
(probands were younger than 65 years at diagnosis and)Tj
0 -1.2543 TD
0.008 Tc
0.07 Tw
[(resided in the United States or Canada. )-56(W)80(e)-2( used a se-)]TJ
0 -1.2472 TD
0.009 Tc
0.173 Tw
(quential sampling scheme where second-degree rela-)Tj
0 -1.2543 TD
0.106 Tw
(tives were included only if a first-degree relative had)Tj
0 -1.2472 TD
0.092 Tw
[(cancer)52(.)98( )-83(The study included 5088 relatives \(3810 first-)]TJ
T*
0.008 Tc
0.075 Tw
[(degree and 1278 second-degree\) of 639 probands. )-56(W)73(e)]TJ
0 -1.2543 TD
0.009 Tc
0.186 Tw
[(performed segregation analyses using P)87(A)-10(P)37( \(Pedigree)]TJ
0 -1.2472 TD
0.175 Tw
(Analysis Package\). Gliomas are a rare type of brain)Tj
0 -1.2543 TD
0.15 Tw
(cancer \(~1\2262% of all cancers are gliomas\), therefore)Tj
0 -1.2472 TD
0.071 Tw
(analyses were divided in three categories: 1\) using all)Tj
T*
0.091 Tw
(639 families; 2\) using families with at least one first-)Tj
0 -1.2543 TD
0.168 Tw
(degree relative with cancer; 3\) using families whose)Tj
0 -1.2472 TD
0.023 Tw
(probands have p53 information \(brain cancer is part of)Tj
T*
0.114 Tw
(the Li-Fraumeni syndrome\). In all analyses, we dem-)Tj
0 -1.2543 TD
0.096 Tw
(onstrated that a multifactorial model was favored and)Tj
0 -1.2472 TD
0.154 Tw
(a model postulating a purely environmental cause of)Tj
0 -1.2543 TD
0.007 Tw
(cancer was rejected.)Tj
/T32 1 Tf
14 0 0 14 50.981 442.998 Tm
-0.021 Tc
(52)Tj
/F5 1 Tf
8 0 0 8 50.981 427.011 Tm
0.009 Tc
[(Familial )52(Aggr)9(egation and Patterns of inheritance of)]TJ
T*
0.003 Tw
[(Resting Metabolic Rates in )44(African-American)]TJ
0 -1.2472 TD
0.01 Tc
(Families.)Tj
/F14 1 Tf
T*
0.009 Tw
[(Luke )46(A*, Rotimi C, Guo X, Zhu X, Cooper R.)]TJ
0 -1.2543 TD
0.009 Tc
0.019 Tw
[(Loyola University Medical Center)30(, Maywood,)]TJ
0 -1.2472 TD
0.01 Tc
(Illinois,USA)Tj
1.5024 -1.6228 TD
0.012 Tc
0.188 Tw
(Epidemiologic studies have consistently reported)Tj
-1.5024 -1.2543 TD
-0.016 Tc
0.083 Tw
[(higher rate of obesity among )-35(African )]TJ
15.0307 0 TD
-0.011 Tc
0.08 Tw
(Americans relative)Tj
-15.0307 -1.2472 TD
0.096 Tw
[(to their white counterparts. )-76(The reason for the increased)]TJ
0 -1.2543 TD
0.042 Tw
(rate is complex and poorly understood. Although lacking)Tj
0 -1.2472 TD
0.072 Tw
(consistent data, several investigators have suggested that)Tj
T*
0.109 Tw
(the variation observed in resting metabolic rate \(RMR -)Tj
0 -1.2543 TD
0.088 Tw
[(which can represent up to 70% of total daily ener)17(gy ex-)]TJ
0 -1.2472 TD
0.072 Tw
(penditure\) may explain in part the increased rate of obe-)Tj
0 -1.2543 TD
-0.019 Tc
0 Tw
[(sity observed in this ethnic group. )16(This study was designed)]TJ
0 -1.2472 TD
-0.011 Tc
0.044 Tw
(to address the issue of heritability of RMR in a cohort of)Tj
T*
0.07 Tw
(African-American families enrolled and examined in the)Tj
0 -1.2543 TD
-0.014 Tc
0.171 Tw
[(Chicago area. RMR was measured using Delta )-164(T)37(rac II)]TJ
0 -1.2472 TD
-0.011 Tc
0.036 Tw
[(metabolic cart \(SensorMedics, )18(Anaheim, CA\) on a popu-)]TJ
T*
-0.021 Tc
0 Tw
(lation sample of 639 persons from159 families. Body com-)Tj
0 -1.2543 TD
-0.011 Tc
0.034 Tw
(position was measured by bioelectric impedance analysis)Tj
0 -1.2472 TD
-0.01 Tc
0.117 Tw
[(\(BIA; RJL, Inc., Clinton T)]TJ
10.8 0 TD
0.009 Tc
[(ownship, MI\). Familial cor)16(-)]TJ
-10.8 -1.2543 TD
(relation was estimated for adjusted \(age, sex and fat-)Tj
0 -1.2472 TD
0.181 Tw
(free mass FFM, fat mass FM\) and unadjusted RMR)Tj
T*
0.002 Tc
0 Tw
(using the FCOR sub-routine available in S.A.G.E. Heri-)Tj
0 -1.2543 TD
0.008 Tc
(tability \(h)Tj
4.8 0 0 4.8 83.126 177.619 Tm
0 Tc
(2)Tj
8 0 0 8 85.564 173.991 Tm
0.009 Tc
(\) estimates for adjusted-RMR were 30% and)Tj
-4.3228 -1.2472 TD
0.108 Tw
[(52% for unadjusted-RMR. FFM was the most impor)9(-)]TJ
0 -1.2543 TD
0.033 Tw
(tant determinant of RMR accounting for about 63% of)Tj
0 -1.2472 TD
0.006 Tc
0.147 Tw
[(observed )8(variance. )-132(The heritability estimate for FFM)]TJ
T*
0.008 Tc
0.067 Tw
[(was )8(49%. )-54(The presence of a moderate spouse correla-)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
[(tion \(0.15 vs 0.1)33(1\) respectively for RMR and FFM sug-)]TJ
0 -1.2472 TD
0.009 Tc
0.103 Tw
(gests the importance of shared environmental factors.)Tj
T*
0.005 Tc
0 Tw
[(In summary)55(, the findings of this study suggest the com-)]TJ
0 -1.2543 TD
0.009 Tc
0.154 Tw
(bined influence of genetic and environmental factors)Tj
0 -1.2472 TD
0.018 Tw
(in the determination of measured RMR phenotype.)Tj
/T32 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.021 Tc
(53)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.009 Tc
0.008 Tw
[(Segr)23(egation analysis of late onset )52(Alzheimer)-12(\222)37(s)]TJ
T*
0 Tw
(disease: evidence for a major gene)Tj
/F14 1 Tf
0 -1.2543 TD
(E.Drigalenko)Tj
4.8 0 0 4.8 298.786 600.605 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 304.965 596.976 Tm
0.01 Tc
0.012 Tw
(, S.E. Poduslo)Tj
4.8 0 0 4.8 351.34 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 353.778 596.976 Tm
0.01 Tc
0.012 Tw
(, R.C. Elston)Tj
4.8 0 0 4.8 396.128 600.605 Tm
0 Tc
0 Tw
(2)Tj
-29.3976 -2.0906 TD
(1)Tj
8 0 0 8 257.457 586.998 Tm
0.009 Tc
0.009 Tw
[(T)67(exas )9(T)67(ech University Health Sciences Center)30(,)]TJ
-0.3047 -1.2472 TD
0.007 Tc
0.005 Tw
(Lubbock, TX; )Tj
4.8 0 0 4.8 303.435 580.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 305.929 577.02 Tm
0.009 Tc
0.013 Tw
[(Case )10(W)74(estern Reserve University)59(,)]TJ
-6.3638 -1.2543 TD
0.01 Tc
0.019 Tw
(Cleveland, OH)Tj
1.4953 -1.7504 TD
-0.013 Tc
0 Tw
[(Alzheimer)-48(\222)58(s)0( disease was considered as a dichotomous)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.098 Tw
(trait determined by a diallelic locus with \(geno\)type-,)Tj
0 -1.2543 TD
0.001 Tc
-0.001 Tw
[(age-, and sex-dependent penetrances. )21(The subjects com-)]TJ
0 -1.2472 TD
0.009 Tc
0.18 Tw
(prise 171 Caucasian families, each ascertained via a)Tj
T*
-0.004 Tc
0.099 Tw
[(patient in )-94(T)54(exas. )-51(A)45( )]TJ
8.2288 0 TD
0.009 Tc
0.097 Tw
(total of 3615 family members, in-)Tj
-8.2288 -1.2543 TD
0.027 Tw
[(cluding 308 af)23(fected, having age of onset not less than)]TJ
0 -1.2472 TD
0.072 Tw
[(65 years, were analyzed. )-20(Age of onset was known for)]TJ
T*
0.162 Tw
(each patient, and age at examination was known for)Tj
0 -1.2543 TD
0.016 Tw
[(each unaf)23(fected relative.)]TJ
1.4953 -1.2472 TD
0.123 Tw
(Segregation analysis was performed under the lo-)Tj
-1.4953 -1.2543 TD
0.025 Tc
0.188 Tw
(gistic regressive model using the program REGTL)Tj
0 -1.2472 TD
0.01 Tc
0.148 Tw
(\(S.A.G.E. 1998\). Model I \(Elston et al 1978\), which)Tj
T*
0.009 Tc
0.102 Tw
(assumed type-dependent age of onset distribution, re-)Tj
0 -1.2543 TD
0 Tw
(sulted in the penetrance of heterozygotes being smaller)Tj
0 -1.2472 TD
0.006 Tc
0.157 Tw
[(than those of both homozygotes in all samples. )-136(This)]TJ
0 -1.2543 TD
0.009 Tc
0.027 Tw
(model was rejected in favor of Model II, which allows)Tj
0 -1.2472 TD
0.011 Tw
[(for type- \(and sex-\) dependent susceptibilities. )23(The hy-)]TJ
T*
0.051 Tw
(pothesis of \223No major gene\224 was rejected in all cases.)Tj
0 -1.2543 TD
0.011 Tc
0.188 Tw
[(Hardy-W)82(einber)11(g disequilibrium, familial ef)11(fects, age)]TJ
0 -1.2472 TD
0.006 Tc
0 Tw
(transformation, and sex-dependence of age of onset pa-)Tj
T*
0.009 Tc
0.014 Tw
(rameters were tested and found to be non-significant.)Tj
1.4953 -1.2543 TD
0.166 Tw
(Families in which the mean age of onset for pa-)Tj
-1.4953 -1.2472 TD
0.119 Tw
(tients was between 65 and 74 years \(the last was the)Tj
0 -1.2543 TD
-0.001 Tc
0 Tw
(median of the family means\) were found to have a Men-)Tj
0 -1.2472 TD
0.009 Tc
0.181 Tw
(delian recessive inheritance with an allele frequency)Tj
T*
0.045 Tc
0.187 Tw
(of 20%. Dominant inheritance was rejected with)Tj
0 -1.2543 TD
0.009 Tc
0.098 Tw
(P=0.012. For families with the mean age of onset for)Tj
0 -1.2472 TD
0.01 Tc
0.187 Tw
(patients over or equal to 75 years dominant inherit-)Tj
0 -1.2543 TD
0.009 Tc
0.086 Tw
(ance was preferable; but recessive type of inheritance)Tj
0 -1.2472 TD
0.01 Tc
0.172 Tw
(was not rejected. Hence, using age 75 as a dividing)Tj
T*
0.009 Tc
(point between early and late onset yielded more ge-)Tj
0 -1.2543 TD
0.038 Tw
(netically homogeneous samples.)Tj
1.4953 -1.2472 TD
0.018 Tw
[(Supported by funds from T)67(exas and grants P41RR-)]TJ
-1.4953 -1.2472 TD
0.01 Tc
0.038 Tw
(03655, GM28356, and F05TW05285.)Tj
/T32 1 Tf
14 0 0 14 255.019 184.989 Tm
-0.021 Tc
(54)Tj
/F5 1 Tf
8 0 0 8 255.019 167.981 Tm
0.009 Tc
0.003 Tw
[(Least Squar)16(es Estimation of )15(V)86(ariance Components)]TJ
T*
0.004 Tw
[(for)23( Genetic Linkage )44(Analysis)]TJ
/F14 1 Tf
T*
0.016 Tw
[(Christopher I. )44(Amos and Xiangjun Gu)]TJ
0 -1.2543 TD
-0.011 Tc
0.008 Tw
[(UT)17( M D )39(Anderson Cancer Center)32(, Houston, )10(T)61(exas, USA)]TJ
1.4953 -1.7504 TD
0.009 Tc
0.058 Tw
[(V)100(ariance components methods provide an ef)23(ficient)]TJ
-1.4953 -1.2472 TD
0.066 Tw
(method to detect genetic linkage for quantitative data.)Tj
T*
0.05 Tw
[(A)72(vailable procedures for variance components estima-)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
(tion either require multivariate normal assumptions and)Tj
0 -1.2472 TD
0.029 Tc
0.187 Tw
(use iterative maximum likelihood methods, or use)Tj
ET

endstream
endobj
329 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
330 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
328 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
322 0 obj
<</Length 11342>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(209)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
-0.021 Tc
0 Tw
(computationally intensive generalized estimation equations)Tj
0 -1.2543 TD
-0.011 Tc
0.017 Tw
(methods. Here, we develop a rapid and simple estimation)Tj
0 -1.2472 TD
0.078 Tw
(procedure using a least squares approach. Using this ap-)Tj
0 -1.2543 TD
0.073 Tw
(proach, we provide closed-form noniterative expressions)Tj
0 -1.2472 TD
0.121 Tw
(for the variance components estimates. Using simulated)Tj
T*
0 Tw
(data, we have compared least squares and maximum like-)Tj
0 -1.2543 TD
-0.015 Tc
(lihood estimation approaches for normal and skewed data.)Tj
0 -1.2472 TD
-0.011 Tc
0.064 Tw
(For normally distributed data, the least squares approach)Tj
0 -1.2543 TD
0.175 Tw
(provided estimates of the variance components at least)Tj
0 -1.2472 TD
0.092 Tw
(80 times faster than the maximum likelihood procedure.)Tj
T*
0.101 Tw
(For data generated with a chi-squared residual, the least)Tj
0 -1.2543 TD
0.043 Tw
(squares procedure was between 100 and 900 times faster)Tj
0 -1.2472 TD
-0.017 Tc
0 Tw
[(than the maximum likelihood procedure. )11(The least squares)]TJ
T*
-0.011 Tc
0.033 Tw
(methods yielded unbiased estimates of the variance com-)Tj
0 -1.2543 TD
-0.02 Tc
0.001 Tw
[(ponents, but with the ef)15(ficiency \(relative to maximum like-)]TJ
0 -1.2472 TD
-0.009 Tc
0.187 Tw
[(lihood\) ranging from 40\2261)26(12% with lower ef)19(ficiencies)]TJ
0 -1.2543 TD
0.023 Tc
[(for the normal data and higher ef)16(ficiencies for the)]TJ
0 -1.2472 TD
-0.011 Tc
0.044 Tw
(nonnormal data.)Tj
/T33 1 Tf
14 0 0 14 59.981 427.011 Tm
-0.021 Tc
(55)Tj
/F5 1 Tf
8 0 0 8 59.981 408.983 Tm
0.009 Tc
0 Tw
[(The Influence of Envir)16(onment on Heritability of)]TJ
T*
0.01 Tc
0.001 Tw
[(ACE and )52(Angiotensinogen: )52(A)59( Comparison of US)]TJ
T*
0.009 Tc
0 Tw
(Blacks and Nigerians)Tj
/F14 1 Tf
0 -1.2543 TD
0.011 Tc
0.006 Tw
(X. Guo)Tj
4.8 0 0 4.8 84.132 382.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 86.57 378.992 Tm
0.01 Tc
0.007 Tw
(, R. Cooper)Tj
4.8 0 0 4.8 124.498 382.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 126.935 378.992 Tm
0.009 Tc
0.006 Tw
(, C. Rotimi)Tj
4.8 0 0 4.8 163.446 382.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 165.883 378.992 Tm
0.01 Tc
-0.046 Tw
[(,)6( A. )-53(Luke)]TJ
4.8 0 0 4.8 196.498 382.62 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 198.935 378.992 Tm
0.008 Tc
0.008 Tw
[(, R. W)87(ard)]TJ
4.8 0 0 4.8 230.116 382.62 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 232.554 378.992 Tm
(,)Tj
-21.5717 -1.2472 TD
0.008 Tc
-0.031 Tw
(A. Adeyemo)Tj
4.8 0 0 4.8 101.367 372.586 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 103.805 369.014 Tm
0.009 Tc
0.013 Tw
(, S. Danilov)Tj
4.8 0 0 4.8 143.15 372.586 Tm
0 Tc
0 Tw
(4)Tj
-17.3268 -2.0787 TD
(1)Tj
8 0 0 8 62.476 358.98 Tm
0.009 Tc
0.019 Tw
(Loyola University Chicago, IL; )Tj
4.8 0 0 4.8 168.321 362.608 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 170.759 358.98 Tm
0.009 Tc
0.019 Tw
[(Oxford University)59(,)]TJ
-13.8472 -1.2472 TD
0.005 Tc
(UK; )Tj
4.8 0 0 4.8 76.195 352.573 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 78.633 349.002 Tm
0.009 Tc
0.012 Tw
(University of Ibadan, Nigeria; )Tj
4.8 0 0 4.8 179.773 352.573 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 182.268 349.002 Tm
0.009 Tc
0.013 Tw
(University of)Tj
-15.2858 -1.2472 TD
0.016 Tw
(Illinois, Chicago, IL.)Tj
1.5024 -1.878 TD
0.001 Tc
0 Tw
(Both angiotensinogen \(AGT\) and angiotensin-I con-)Tj
-1.5024 -1.2472 TD
0.01 Tc
0.18 Tw
(verting enzyme \(ACE\) have been shown to be heri-)Tj
0 -1.2543 TD
0.009 Tc
0.168 Tw
(table traits and genetic markers have been identified)Tj
0 -1.2472 TD
0.045 Tw
(that are associated with variation in their blood levels.)Tj
0 -1.2543 TD
0.115 Tw
[(The extent to which the environmental context deter)9(-)]TJ
0 -1.2472 TD
0.003 Tc
0 Tw
[(mines heritability has not been examined, however)53(. )17(The)]TJ
T*
0.009 Tc
0.137 Tw
(African diaspora provides an opportunity to compare)Tj
0 -1.2543 TD
-0.002 Tc
0 Tw
(the expression of these traits in genetically related popu-)Tj
0 -1.2472 TD
0.008 Tc
0.032 Tw
[(lations that live under widely contrasting lifestyles. )23(A)-8(s)]TJ
T*
0.009 Tc
0.054 Tw
(part of an on-going study on the genetics of hyperten-)Tj
0 -1.2543 TD
0.028 Tw
(sion we examined nuclear families that included 2,093)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
[(Nigerians and 1,993 )50(African )50(Americans. Body mass in-)]TJ
0 -1.2543 TD
0.009 Tc
0.009 Tw
(dex \(BMI; weight[kg]/height[m])Tj
4.8 0 0 4.8 166.734 207.609 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 169.172 203.981 Tm
0.01 Tc
0.01 Tw
(\) was 21 kg/m)Tj
4.8 0 0 4.8 216 207.609 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 218.438 203.981 Tm
0.009 Tc
0.013 Tw
[( in Ni-)]TJ
-19.8071 -1.2472 TD
0.087 Tw
(geria kg/m)Tj
4.8 0 0 4.8 95.868 197.575 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 98.305 194.003 Tm
0.007 Tc
0.089 Tw
[( and 29 in the US. )-29(A)-11(G)-11(T)21( was considerably)]TJ
-4.7906 -1.2472 TD
-0.005 Tc
0.139 Tw
[(higher among )-102(African )]TJ
9.5811 0 TD
0.009 Tc
0.137 Tw
(Americans \(1919 vs.1396, p <)Tj
-9.5811 -1.2543 TD
-0.001 Tc
0.158 Tw
(.01\), while mean )Tj
7.5543 0 TD
0.01 Tc
(ACE was higher in Nigerians \(630)Tj
-7.5543 -1.2472 TD
0.007 Tc
0.125 Tw
[(vs. 517, p < .01\). )-75(A)49( )-6(substantial )-6(household )-6(ef)14(fect )-7(was)]TJ
0 -1.2543 TD
0.012 Tc
0.187 Tw
(observed among the Nigerian families, with spousal)Tj
0 -1.2472 TD
0.006 Tc
0.09 Tw
[(correlations of 0.35 for )-28(A)-8(G)-8(T)70(, )7(0.20 )7(for )-42(ACE, and 0.20)]TJ
T*
0.009 Tc
0.059 Tw
(for BMI, and correlations among first degree relatives)Tj
0 -1.2543 TD
0.007 Tc
0.188 Tw
[(were very substantial, viz, 0.5 for )-141(A)-11(G)-11(T)21( and 0.4 for)]TJ
0 -1.2472 TD
-0.001 Tc
0.082 Tw
[(ACE. Among )14(African )]TJ
9.2551 0 TD
0.009 Tc
0.06 Tw
(Americans, in contrast, no clear)Tj
-9.2551 -1.2472 TD
0.004 Tc
0 Tw
[(patterns of familial aggregation were observed for )54(AGT)]TJ
0 -1.2543 TD
-0.005 Tc
0.073 Tw
(and ACE. )Tj
4.3228 0 TD
0.009 Tc
0.054 Tw
(The familial resemblance of BMI was simi-)Tj
-4.3228 -1.2472 TD
-0.014 Tc
0.185 Tw
[(lar among )-161(African )]TJ
8.1921 0 TD
0.009 Tc
(Americans and Nigerians \(r=0.2\).)Tj
17.3126 69.2504 TD
0.003 Tw
(Additional analyses eliminating persons treated for hy-)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(pertension and adjusting traits by covariates showed)Tj
0 -1.2472 TD
0.006 Tc
0.113 Tw
[(that there is no spouse correlation for )-58(A)-8(G)-8(T)13( )]TJ
18.655 0 TD
-0.02 Tc
0.204 Tw
[(and A)-33(C)-33(E)]TJ
-18.655 -1.2543 TD
0.009 Tc
0.024 Tw
[(in the US. In summary)59(, a substantially lower degree of)]TJ
0 -1.2472 TD
0.006 Tc
0.108 Tw
[(familial aggregation was observed for )-58(A)-8(G)-8(T)13( )]TJ
18.6596 0 TD
-0.017 Tc
0.189 Tw
[(and A)-30(C)-30(E)]TJ
-18.6596 -1.2472 TD
-0.002 Tc
0 Tw
[(among )55(African )62(Americans, most likely reflecting greater)]TJ
0 -1.2543 TD
0.009 Tc
0.018 Tw
[(random environmental ef)23(fect at the individual level.)]TJ
/T33 1 Tf
14 0 0 14 264.019 540 Tm
-0.021 Tc
(56)Tj
/F5 1 Tf
8 0 0 8 264.019 524.013 Tm
0.009 Tc
0.005 Tw
[(T)95(esting quantitative traits for)16( association and)]TJ
T*
0 Tw
[(linkage in the pr)16(esence or)16( absence of par)16(ental data)]TJ
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.007 Tw
(X. Zhu)Tj
4.8 0 0 4.8 287.263 507.572 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 289.701 504 Tm
0.009 Tc
0.01 Tw
(, R.C. Elston)Tj
4.8 0 0 4.8 331.994 507.572 Tm
0 Tc
0 Tw
(2)Tj
-14.1614 -2.0787 TD
(1)Tj
8 0 0 8 266.457 494.022 Tm
0.009 Tc
0.016 Tw
(Department of Preventive Medicine and)Tj
-0.3047 -1.2543 TD
0.024 Tw
[(Epidemiology)66(, Loyola University Medical Center)37(,)]TJ
0 -1.2472 TD
0.017 Tw
(Maywood, IL, USA; )Tj
4.8 0 0 4.8 334.091 477.581 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 336.529 474.009 Tm
0.009 Tc
0.019 Tw
(Department of Epidemiology)Tj
-9.0638 -1.2543 TD
0.009 Tw
[(and Biostatistics, Case )8(W)81(estern Reserve University)52(,)]TJ
0 -1.2472 TD
0.01 Tc
0.007 Tw
(Cleveland, OH, USA.)Tj
1.4953 -1.6228 TD
-0.012 Tc
0.053 Tw
[(Zhu and Elston developed a )-48(TDT)16( method for quanti-)]TJ
-1.4953 -1.2543 TD
0.081 Tw
(tative traits by defining a linear transformation to condi-)Tj
0 -1.2472 TD
-0.013 Tc
0.102 Tw
[(tion out founder information. )-77(The method tests the joint)]TJ
T*
-0.011 Tc
0.129 Tw
(null hypothesis of no linkage or association and can be)Tj
0 -1.2543 TD
0.006 Tc
0.186 Tw
[(applied to general pedigree structures. However)41(, this)]TJ
0 -1.2472 TD
-0.011 Tc
0.175 Tw
(method requires both parental genotype and phenotype)Tj
0 -1.2543 TD
0.038 Tw
[(information, which may sometimes be dif)17(ficult to obtain.)]TJ
0 -1.2472 TD
-0.017 Tc
0 Tw
[(In this paper)40(, we describe a method to overcome this prob-)]TJ
T*
-0.011 Tc
0.064 Tw
(lem, for the case where nuclear families are sampled, by)Tj
0 -1.2543 TD
0.071 Tw
[(regressing the sib\222)67(s phenotype dif)17(ferences on their geno-)]TJ
0 -1.2472 TD
0.064 Tw
[(type dif)23(ference. )-47(W)82(e)-1( show that the method is not af)16(fected)]TJ
0 -1.2543 TD
0.039 Tw
[(by population stratification. )-18(The statistical power and va-)]TJ
0 -1.2472 TD
0.103 Tw
(lidity of the test are investigated by simulation. In prac-)Tj
T*
0.188 Tw
(tice, the data may contain some families with parental)Tj
0 -1.2543 TD
0.154 Tw
(phenotype and genotype information and some without)Tj
0 -1.2472 TD
0.037 Tw
[(such information. )-11(W)75(e)-1( show how all the data may be ana-)]TJ
T*
0.013 Tw
(lyzed together in a single analysis.)Tj
/T33 1 Tf
14 0 0 14 264.019 242.986 Tm
-0.021 Tc
(57)Tj
/F5 1 Tf
8 0 0 8 264.019 226.998 Tm
0.01 Tc
0.004 Tw
[(Color)17(ectal cancer)17( with defective DNA)60( mismatch)]TJ
T*
0.009 Tc
0.001 Tw
[(r)21(epair)9( is associated with alpha-1 antitr)-5(ypsin)]TJ
0 -1.2543 TD
0.01 Tc
0.007 Tw
[(deficiency heter)24(ozygosity and histor)10(y of cigar)24(ette)]TJ
0 -1.2472 TD
0.011 Tc
(smoking)Tj
/F14 1 Tf
T*
0.009 Tc
0.011 Tw
[(P)111(.)17( )15(Y)100(ang, J.M. Cunningham, J. Katzmann, T)74(.)0( Lesnick,)]TJ
0 -1.2543 TD
0.008 Tw
[(K. Halling, L. Bur)16(gart, E. )23(W)32(iegert, )37(A. Knutson,)]TJ
0 -1.2472 TD
0.01 Tc
0.009 Tw
[(E. Christensen, R. Kyle, N. Lindor)45(, S.N. )9(Thibodeau)]TJ
0 -1.2543 TD
0.011 Tw
[(Mayo Clinic and Foundation, Rochester)45(, MN, USA)]TJ
1.4953 -1.6228 TD
0.003 Tc
0 Tw
(Microsatellite instability \(MSI\) is a type of genomic)Tj
-1.4953 -1.2472 TD
0.008 Tc
(alteration observed in approximately 30% of colorectal)Tj
0 -1.2543 TD
-0.002 Tc
0.153 Tw
(cancer \(CRC\). )Tj
6.4488 0 TD
0.01 Tc
0.152 Tw
(Three MSI phenotypes have been de-)Tj
-6.4488 -1.2472 TD
0.008 Tc
0.049 Tw
[(fined for CRC. )-27(The MSI-H is characterized by MSI at)]TJ
/F17 1 Tf
T*
0 Tc
0 Tw
(\263)Tj
/F14 1 Tf
0.5598 0 TD
0.009 Tc
0.07 Tw
(30% of the loci, the MSI-L by MSI at 1\22630% of the)Tj
-0.5598 -1.2543 TD
0.01 Tc
0.054 Tw
(loci, and the MSS by an absence of MSI at any of the)Tj
0 -1.2472 TD
-0.004 Tc
0.178 Tw
(loci examined. )Tj
6.6118 0 TD
0.009 Tc
(The MSI-H is the result of defective)Tj
ET

endstream
endobj
343 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
341 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
342 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
340 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
339 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
332 0 obj
<</Length 12625>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(210)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.007 Tc
0.088 Tw
[(D)-8(N)-8(A)50( mismatch repair \(MMR\). )-78(W)79(e)-2( report that MSI-H)]TJ
0 -1.2543 TD
-0.002 Tc
0 Tw
(colorectal tumors are associated with alpha-1 antitrypsin)Tj
0 -1.2472 TD
0.004 Tc
(deficiency carrier \()Tj
/F17 1 Tf
7.6819 0 TD
0 Tc
(a)Tj
/F14 1 Tf
0.6449 0 TD
0.004 Tc
(1AD-ht\) status and cigarette smok-)Tj
-8.3268 -1.2543 TD
0.005 Tc
0.185 Tw
[(ing history of the patients. )-146(Among )-7(55 )-7(CRC )-7(patients)]TJ
0 -1.2472 TD
0.019 Tc
0.188 Tw
(with MSI-H tumors, the )Tj
/F17 1 Tf
11.2606 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6591 0 TD
0.029 Tc
0.187 Tw
(1AD-ht rate was 21.8%)Tj
-11.9197 -1.2472 TD
0.009 Tc
0.023 Tw
(whereas among 120 patients with MSI-L/MSS tumors,)Tj
0 -1.2543 TD
0.008 Tc
0.027 Tw
[(the rate was 9.2% \(p=0.02\). )15(A)57( similar dif)15(ference in the)]TJ
/F17 1 Tf
0 -1.2472 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6449 0 TD
0.01 Tc
0.05 Tw
(1AD-ht rate was also observed between the 55 MSI-)Tj
-0.6449 -1.2543 TD
0.009 Tc
0.153 Tw
(H CRC patients and 191 general population controls)Tj
0 -1.2472 TD
0.008 Tc
0.038 Tw
[(without CRC. )-27(The relative risk of having MSI-H CRC)]TJ
T*
-0.009 Tc
(among )Tj
/F17 1 Tf
3.1252 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
4.8 0 0 4.8 81.142 536.768 Tm
(1)Tj
8 0 0 8 83.636 538.016 Tm
0.01 Tc
0.093 Tw
(AD carriers was 3.0 \(95% CI 1.1-6.7\) com-)Tj
-4.0819 -1.2543 TD
0.009 Tc
0.134 Tw
[(pared to non-carriers, after adjusting for age, gender)30(,)]TJ
0 -1.2472 TD
0.042 Tw
[(and cigarette smoking history)59(. Cigarette smoking, past)]TJ
T*
0.176 Tw
(and current, was associated with a 2- and 5-fold el-)Tj
0 -1.2543 TD
0.14 Tw
(evated risk respectively for MSI-H CRC, but not for)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
(MSI-L/MSS CRC. Our finding of an >3.0-fold increase)Tj
0 -1.2543 TD
-0.034 Tc
(in )Tj
/F17 1 Tf
1.1409 0 TD
0 Tc
(a)Tj
/F14 1 Tf
4.8 0 0 4.8 65.268 476.787 Tm
(1)Tj
8 0 0 8 67.706 477.978 Tm
0.01 Tc
0.086 Tw
(AD-ht among MSI-H CRC patients over MSI-L/)Tj
-2.0906 -1.2472 TD
0.009 Tc
0.003 Tw
(MSS CRC patients was consistent in proximal and dis-)Tj
T*
0.007 Tc
0.191 Tw
[(tal )9(colon )9(and )9(rectum. )-174(These data suggest a possible)]TJ
0 -1.2543 TD
0.003 Tc
0.139 Tw
(etiologic link between )Tj
/F17 1 Tf
9.7724 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
4.8 0 0 4.8 134.32 446.797 Tm
(1)Tj
8 0 0 8 136.758 447.987 Tm
0.009 Tc
0.14 Tw
(AD-ht and the development)Tj
-10.722 -1.2472 TD
0.01 Tc
0.006 Tw
(of CRC with defective MMR.)Tj
/T34 1 Tf
14 0 0 14 50.981 402.973 Tm
-0.021 Tc
(58)Tj
/F5 1 Tf
8 0 0 8 50.981 386.986 Tm
0.009 Tc
0 Tw
(Recent Genetic Findings in Bipolar Disorder)Tj
/F14 1 Tf
4.8 0 0 4.8 50.981 380.58 Tm
0 Tc
(1)Tj
8 0 0 8 53.476 377.008 Tm
0.01 Tc
[(JINurnber)24(ger)38(,)19( )]TJ
4.8 0 0 4.8 100.814 380.58 Tm
0 Tc
(2)Tj
8 0 0 8 103.252 377.008 Tm
0.009 Tc
(JRDePaulo, )Tj
4.8 0 0 4.8 144.241 380.58 Tm
0 Tc
(3)Tj
8 0 0 8 146.679 377.008 Tm
0.009 Tc
[(MCBlehar)30(,)18( )]TJ
4.8 0 0 4.8 185.06 380.58 Tm
0 Tc
(4)Tj
8 0 0 8 187.498 377.008 Tm
0.01 Tc
0.012 Tw
(ES Gershon,)Tj
4.8 0 0 4.8 50.981 370.602 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 53.476 366.973 Tm
0.01 Tc
(T Reich, )Tj
4.8 0 0 4.8 83.693 370.602 Tm
0 Tc
(1)Tj
8 0 0 8 86.131 366.973 Tm
0.01 Tc
0.001 Tw
(T Foroud, NIMH Genetics Initiative)Tj
-4.3937 -1.2472 TD
0.031 Tw
(Bipolar Group)Tj
4.8 0 0 4.8 50.981 350.589 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 53.476 347.017 Tm
0.009 Tc
0.017 Tw
(Indiana University School of Medicine, )Tj
4.8 0 0 4.8 185.91 350.589 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 188.348 347.017 Tm
0.008 Tc
(Johns)Tj
-17.1709 -1.2543 TD
0.009 Tc
0.016 Tw
[(Hopkins University)52(,)21( )]TJ
4.8 0 0 4.8 119.183 340.611 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 121.621 336.983 Tm
0.009 Tc
0.016 Tw
(National Institute of Mental)Tj
-8.8299 -1.2472 TD
0.007 Tc
(Health, )Tj
4.8 0 0 4.8 77.117 330.576 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 79.554 327.005 Tm
0.009 Tc
0.02 Tw
(University of Chicago, )Tj
4.8 0 0 4.8 156.884 330.576 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 159.378 327.005 Tm
0.008 Tc
[(W)80(ashington)]TJ
-13.5496 -1.2472 TD
0.009 Tc
0.01 Tw
(University of St. Louis)Tj
1.5024 -1.6299 TD
0.008 Tc
0.043 Tw
[(Bipolar Af)15(fective Disorder \(BP\) clearly aggregates)]TJ
-1.5024 -1.2472 TD
0.007 Tc
0.096 Tw
[(within )6(families. )-76(The genetics of BP)35( is complex, how-)]TJ
0 -1.2543 TD
0.009 Tc
0.047 Tw
[(ever)37(, and not consistent with single major locus inher)16(-)]TJ
0 -1.2472 TD
0.012 Tc
0.188 Tw
(itance; no specific genes have yet been located and)Tj
T*
-0.006 Tc
0.268 Tw
[(confirmed. A)43( )]TJ
5.8929 0 TD
0.009 Tc
0.149 Tw
(collaborative study involving four sites)Tj
-5.8929 -1.2543 TD
0.187 Tw
(was supported as part of the NIMH Genetics Initia-)Tj
0 -1.2472 TD
-0.011 Tc
0.173 Tw
[(tive. A)38( )]TJ
3.1356 0 TD
0.009 Tc
0.099 Tw
(structured interview \(DIGS\) was developed to)Tj
-3.1356 -1.2472 TD
0 Tw
(provide a comprehensive phenotypic assessment of pa-)Tj
0 -1.2543 TD
0.186 Tw
(tients and relatives. Families included were required)Tj
0 -1.2472 TD
0.188 Tw
[(to have at least two af)9(fected subjects with bipolar I)]TJ
0 -1.2543 TD
0.021 Tc
(\(BPI\) disorder or one with BPI and a second with)Tj
0 -1.2472 TD
0.016 Tc
[(schizoaf)16(fective disorder)44(, bipolar type \(SA/BP\). Pro-)]TJ
T*
0.009 Tc
0.144 Tw
(bands and relatives were interviewed and provided a)Tj
0 -1.2543 TD
0.137 Tw
(blood sample for transformation and storage at a na-)Tj
0 -1.2472 TD
0.008 Tc
0.053 Tw
[(tional data bank. )-42(W)87(e)-1( present results from 540 subjects)]TJ
0 -1.2543 TD
0.009 Tc
0.029 Tw
(selected from 97 families. This group included 282 af-)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
[(fected sibling pairs, \(BP)35( & UP\), as well as 412 af)14(fected)]TJ
T*
0.009 Tc
0.02 Tw
[(relative pairs. )30(A)58( survey was completed with 319 mark-)]TJ
0 -1.2543 TD
-0.003 Tc
(ers. )Tj
2.0268 0 TD
0.045 Tc
0.188 Tw
[(Analysis was carried out using SIBP)95(A)-11(L)38( and)]TJ
-2.0268 -1.2472 TD
0.009 Tc
0.006 Tw
[(Genehunter Plus. )52(A)44( number of candidate areas are sup-)]TJ
T*
0.052 Tw
(ported especially areas on chromosomes 6, 10 and 16.)Tj
0 -1.2543 TD
0.009 Tw
(A summary of results of linkage analysis on individual)Tj
0 -1.2472 TD
(families from this dataset will also be presented.)Tj
/T34 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.021 Tc
(59)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.009 Tc
0.003 Tw
[(A)51( low level of r)16(esponse to alcohol and its r)9(elation to)]TJ
T*
0.01 Tc
(alcoholism)Tj
/F14 1 Tf
0 -1.2543 TD
-0.011 Tc
0.007 Tw
(L. Flury)Tj
4.8 0 0 4.8 280.587 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 282.969 596.976 Tm
-0.011 Tc
0.01 Tw
(, M. Schuckit)Tj
4.8 0 0 4.8 325.091 600.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 327.472 596.976 Tm
-0.01 Tc
0.009 Tw
[(, H. Edenber)18(g)]TJ
4.8 0 0 4.8 370.843 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 373.224 596.976 Tm
-0.011 Tc
0.013 Tw
(, Kalmijn)Tj
4.8 0 0 4.8 402.761 600.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 405.085 596.976 Tm
(,)Tj
-18.7583 -1.2472 TD
-0.009 Tc
[(T)78(.)0( Reich)]TJ
4.8 0 0 4.8 281.324 590.57 Tm
0 Tc
(3)Tj
8 0 0 8 283.649 586.998 Tm
-0.011 Tc
0.007 Tw
(, L. Bierut)Tj
4.8 0 0 4.8 315.68 590.57 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 318.061 586.998 Tm
-0.01 Tc
-0.051 Tw
[(, A. )-55(Goate)]TJ
4.8 0 0 4.8 349.753 590.57 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 352.077 586.998 Tm
-0.01 Tc
0.004 Tw
[(,)7( T)77(.)0( Smith)]TJ
4.8 0 0 4.8 382.578 590.57 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 384.959 586.998 Tm
-0.01 Tc
-0.005 Tw
[(,)7( T)77(.)0( )-11(Foroud)]TJ
4.8 0 0 4.8 419.428 590.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 421.753 586.998 Tm
(.)Tj
4.8 0 0 4.8 255.019 580.592 Tm
(1)Tj
8 0 0 8 257.343 577.02 Tm
-0.011 Tc
0.011 Tw
(Dept of Medical & Molecular Genetics, Indiana Univ)Tj
-0.2906 -1.2543 TD
(School of Medicine, Indianapolis, IN )Tj
4.8 0 0 4.8 373.394 570.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 375.775 566.986 Tm
-0.01 Tc
0.012 Tw
(Dept of Psychia-)Tj
-15.0945 -1.2472 TD
-0.011 Tc
0.008 Tw
[(try)60(, )17(V)116(eterans )39(Af)24(fairs Medical Center)32(, Univ of California,)]TJ
0 -1.2543 TD
-0.01 Tc
0.006 Tw
(San Diego, San Diego, CA, )Tj
4.8 0 0 4.8 343.403 550.602 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 345.728 546.973 Tm
-0.011 Tc
0.009 Tw
[(Dept of Psychiatry)60(, )18(W)76(ash-)]TJ
-11.3386 -1.2472 TD
-0.01 Tc
0.01 Tw
(ington Univ School of Medicine, St. Louis, MO.)Tj
1.4953 -1.7504 TD
-0.011 Tc
0.035 Tw
(Alcoholism is a complex genetic disorder with an es-)Tj
-1.4953 -1.2472 TD
-0.018 Tc
0 Tw
[(timated heritability of 40\22660%. )46(Although attempts to iden-)]TJ
0 -1.2543 TD
-0.009 Tc
0.187 Tw
(tify genes contributing to the risk for alcoholism have)Tj
0 -1.2472 TD
-0.011 Tc
0.139 Tw
(yielded several regions with evidence of linkage, genes)Tj
T*
0.046 Tw
[(have not yet been identified. )9(A)44( more powerful method to)]TJ
0 -1.2543 TD
0.097 Tw
(detect susceptibility genes for alcoholism may be to use)Tj
0 -1.2472 TD
0.086 Tw
(the biological endophenotype of a low level of response)Tj
0 -1.2543 TD
0.081 Tw
(to alcohol \(LR\), which is a significant predictor of alco-)Tj
0 -1.2472 TD
-0.009 Tc
0.188 Tw
(holism. LR is exhibited as a need for higher doses of)Tj
T*
-0.011 Tc
0.018 Tw
[(alcohol to produce ef)24(fects of intoxication.)]TJ
1.4953 -1.2543 TD
0.007 Tc
0 Tw
(Data were generated from families collected as part)Tj
-1.4953 -1.2472 TD
0.114 Tw
[(of a Collaborative Study on the Genetics of )-57(Alcohol-)]TJ
0 -1.2543 TD
0.009 Tc
0.008 Tw
(ism. LR was estimated using the Self-Rating of the Ef-)Tj
0 -1.2472 TD
0.008 Tc
0.068 Tw
[(fects )9(of Alcohol \(SRE\), a questionnaire which obtains)]TJ
T*
0.009 Tc
0.15 Tw
(the number of drinks required to achieve various ef-)Tj
0 -1.2543 TD
0.069 Tw
(fects of intoxication during the first five drinking epi-)Tj
0 -1.2472 TD
0.086 Tw
(sodes \(FIRST 5\), the period of heaviest drinking, and)Tj
T*
0.008 Tc
0.044 Tw
[(the most recent three months of drinking. )-27(The average)]TJ
0 -1.2543 TD
0.009 Tc
0.07 Tw
(number of drinks necessary to achieve alcohol-related)Tj
0 -1.2472 TD
0.013 Tw
[(ef)23(fects across all time periods was used as a composite)]TJ
0 -1.2543 TD
0.003 Tc
0 Tw
[(variable \(T)17(OT)81(AL\). FIRST)17( 5 and )24(T)19(O)-3(T)81(A)-3(L)31( were analyzed)]TJ
0 -1.2472 TD
0.015 Tc
0.188 Tw
(as both quantitative \(400\226700 pairs\) and qualitative)Tj
T*
0.009 Tc
0.136 Tw
(\(70\226100 pairs comprised of individuals in the lowest)Tj
0 -1.2543 TD
0.033 Tc
0.188 Tw
(1/3 of the SRE distribution\) variables. Multipoint)Tj
0 -1.2472 TD
0.009 Tc
0.13 Tw
(sibpair linkage analysis was performed. Evidence for)Tj
0 -1.2543 TD
0.01 Tc
0.181 Tw
[(genes af)17(fecting LR was found on two chromosomes)]TJ
0 -1.2472 TD
0.009 Tc
0.13 Tw
[(that had previously shown evidence for genes af)16(fect-)]TJ
T*
0.016 Tc
0.188 Tw
(ing risk for alcoholism: chromosomes 1 and 7 \(lod)Tj
/F17 1 Tf
0 -1.2543 TD
0 Tc
0 Tw
(\273)Tj
/F14 1 Tf
0.5598 0 TD
0.009 Tc
0.025 Tw
(1.5\2262.0\). In addition novel evidence of linkage to the)Tj
-0.5598 -1.2472 TD
0.01 Tc
0.035 Tw
(LR endophenotype was identified on chromosomes 15)Tj
T*
0.009 Tw
(and 16 \(lod)Tj
/F17 1 Tf
4.6772 0 TD
0 Tc
0 Tw
(\273)Tj
/F14 1 Tf
0.5669 0 TD
0.009 Tc
0.012 Tw
(2.5\) as well as 21 \(lod)Tj
/F17 1 Tf
9.1063 0 TD
0 Tc
0 Tw
(\273)Tj
/F14 1 Tf
0.5598 0 TD
0.009 Tc
(3.0\).)Tj
/T34 1 Tf
14 0 0 14 255.019 184.989 Tm
-0.021 Tc
(60)Tj
/F5 1 Tf
8 0 0 8 255.019 167.981 Tm
0.009 Tc
[(Evidence for)16( a shar)23(ed genetic susceptibility to)]TJ
0 -1.2472 TD
0.001 Tw
(epilepsy and febrile convulsions: a familial)Tj
T*
0.044 Tw
[(aggr)23(egation analysis)]TJ
/F14 1 Tf
0 -1.2543 TD
0.018 Tw
[(C. Barker)23(-Cummings, R. Ottman, Columbia Univ)73(.,)]TJ
0 -1.2472 TD
0.011 Tc
0.002 Tw
[(New )46(Y)95(ork, NY)131(, USA.)]TJ
1.4953 -1.7504 TD
0.009 Tc
0.15 Tw
(Febrile convulsions and epilepsy are each known)Tj
-1.4953 -1.2472 TD
0.089 Tw
(to be influenced by genetic factors, and children with)Tj
0 -1.2543 TD
0.037 Tw
(febrile convulsions have increased risk for later devel-)Tj
0 -1.2472 TD
0.016 Tw
[(opment of epilepsy)66(.)22( )-12(Thus we tested the hypothesis of a)]TJ
ET

endstream
endobj
354 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
353 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
352 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
345 0 obj
<</Length 11108>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(211)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.002 Tc
0 Tw
[(shared genetic susceptibility to these two disorders. )9(The)]TJ
0 -1.2543 TD
0.009 Tc
0.046 Tw
(study population comprised 2404 full siblings of adult)Tj
0 -1.2472 TD
0.054 Tw
(probands with either idiopathic/cryptogenic or postna-)Tj
0 -1.2543 TD
0.082 Tw
(tal symptomatic epilepsy whose mothers had been in-)Tj
0 -1.2472 TD
0.01 Tc
0.188 Tw
(terviewed to obtain a history of febrile convulsions,)Tj
T*
0.065 Tw
[(and who had survived to age 5 or older)53(. Epilepsy was)]TJ
0 -1.2543 TD
0.003 Tc
0 Tw
(defined as a lifetime history of )Tj
/F17 1 Tf
12.6142 0 TD
0 Tc
(\263)Tj
/F14 1 Tf
0.5598 0 TD
0.004 Tc
(2 unprovoked seizures,)Tj
-13.174 -1.2472 TD
0.009 Tc
0.104 Tw
(and a febrile convulsion as a seizure occurring in the)Tj
0 -1.2543 TD
0.07 Tw
[(setting of fever at age 5 or younger)37(, in the absence of)]TJ
0 -1.2472 TD
0.007 Tc
0 Tw
(a central nervous system infection or other acute cause.)Tj
T*
0.029 Tc
0.187 Tw
(Siblings with idiopathic/cryptogenic epilepsy were)Tj
0 -1.2543 TD
0.009 Tc
0.073 Tw
(more likely to have had a febrile convulsion than sib-)Tj
0 -1.2472 TD
0.173 Tw
(lings without [RR=2.6 \(95% CI 1.01, 6.66\)]. In sib-)Tj
T*
0.012 Tc
0.187 Tw
[(lings without idiopathic/cryptogenic epilepsy)62(, febrile)]TJ
0 -1.2543 TD
0.009 Tc
-0.001 Tw
[(convulsions were associated with the proband\222)59(s history)]TJ
0 -1.2472 TD
0.063 Tw
(of a febrile convulsion [RR=2.2 \(1.34, 3.72\)], indicat-)Tj
0 -1.2543 TD
0.016 Tw
(ing familial aggregation of febrile convulsions. Febrile)Tj
0 -1.2472 TD
0.183 Tw
(convulsions in siblings were not associated with the)Tj
T*
0.075 Tw
[(proband\222)52(s etiology of epilepsy \(idiopathic/cryptogenic)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
(vs. remote symptomatic\) [RR=1.0 \(0.55, 1.76\)], or with)Tj
0 -1.2472 TD
0.003 Tc
(a history of idiopathic/cryptogenic epilepsy in one first-)Tj
0 -1.2543 TD
0.009 Tc
0.073 Tw
(degree relative other than the proband [RR=1.2 \(0.52,)Tj
0 -1.2472 TD
0.158 Tw
[(2.89\)]. However)30(, they were independently associated)]TJ
T*
0.008 Tc
0.038 Tw
(with a history of idiopathic/cryptogenic epilepsy in )Tj
/F17 1 Tf
21.437 0 TD
0 Tc
0 Tw
(\263)Tj
/F14 1 Tf
0.5669 0 TD
(2)Tj
-22.0039 -1.2543 TD
0.009 Tc
0.101 Tw
(first-degree relatives in addition to the proband [RR=)Tj
0 -1.2472 TD
0.002 Tw
[(13.7 \(5.40, 34.73\)]. )16(These findings support the hypoth-)]TJ
0 -1.2543 TD
0.155 Tw
(esis of a shared genetic susceptibility to febrile con-)Tj
0 -1.2472 TD
0.023 Tc
0.187 Tw
[(vulsions and epilepsy)66(, and suggest that this shared)]TJ
T*
0.009 Tc
0.098 Tw
(susceptibility may be restricted to families containing)Tj
0 -1.2543 TD
0.028 Tw
[(many af)16(fected individuals.)]TJ
/T35 1 Tf
14 0 0 14 59.981 313.002 Tm
-0.021 Tc
(61)Tj
/F5 1 Tf
8 0 0 8 59.981 297.014 Tm
0.009 Tc
0 Tw
[(Evidence that diastolic blood pr)16(essur)9(e links to two)]TJ
T*
0.004 Tw
[(loci in Mexican )51(Americans)]TJ
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
-0.053 Tw
(LD Atwood)Tj
4.8 0 0 4.8 98.759 280.573 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 101.197 277.002 Tm
0.01 Tc
0.006 Tw
(, PB Samollow)Tj
4.8 0 0 4.8 150.52 280.573 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 153.014 277.002 Tm
0.01 Tc
0.006 Tw
(, JE Hixson)Tj
4.8 0 0 4.8 191.112 280.573 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 193.55 277.002 Tm
0.009 Tc
0.007 Tw
[(, MP)44( Stern)]TJ
4.8 0 0 4.8 228.529 280.573 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 231.024 277.002 Tm
(,)Tj
-21.3803 -1.2472 TD
0.009 Tc
(JW MacCluer)Tj
4.8 0 0 4.8 105.392 270.595 Tm
0 Tc
(2)Tj
-9.4606 -2.0787 TD
(1)Tj
8 0 0 8 62.476 256.989 Tm
0.008 Tc
0.021 Tw
(University of Minnesota, Minneapolis, )Tj
4.8 0 0 4.8 192.076 260.617 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 194.57 256.989 Tm
0.01 Tc
(Southwest)Tj
-16.8236 -1.2472 TD
0.009 Tc
0.017 Tw
[(Foundation for Biomedical Research, San )37(Antonio,)]TJ
4.8 0 0 4.8 59.981 240.605 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 62.476 236.976 Tm
0.009 Tc
0.007 Tw
[(University of )23(T)60(exas Health Science Center)37(, San)]TJ
-0.3118 -1.2472 TD
0.014 Tc
(Antonio)Tj
1.5024 -1.6228 TD
-0.011 Tc
0.023 Tw
[(W)83(e)0( performed a genome scan of diastolic blood pres-)]TJ
-1.5024 -1.2543 TD
0.085 Tw
(sure \(DBP\) on approximately 441 individuals in 10 ran-)Tj
0 -1.2472 TD
-0.013 Tc
0.187 Tw
[(domly ascertained families of the San )-134(Antonio Family)]TJ
T*
-0.011 Tc
0.068 Tw
[(Heart Study)60(.)61( A)45( likelihood-based Mendelian model incor)17(-)]TJ
0 -1.2543 TD
0.019 Tw
[(porating genotype-specific ef)17(fects of sex, age, age)]TJ
4.8 0 0 4.8 216.737 177.619 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 219.118 173.991 Tm
-0.01 Tc
0.025 Tw
(, BMI,)Tj
-19.8921 -1.2472 TD
-0.012 Tc
0 Tw
(and systolic blood pressure as covariates, gave strong evi-)Tj
0 -1.2543 TD
0.158 Tw
(dence that DBP is oligogenic. Using model parameters)Tj
0 -1.2472 TD
0.132 Tw
(that give the global maximum likelihood we performed)Tj
T*
0.032 Tw
(two-point linkage analysis using 401 highly polymorphic)Tj
0 -1.2543 TD
0.018 Tc
0.188 Tw
(markers. DBP was significantly linked to D2S1790)Tj
0 -1.2472 TD
-0.023 Tc
(\(Z=3.91, )Tj
/F17 1 Tf
3.9543 0 TD
0 Tc
0 Tw
(q)Tj
/F14 1 Tf
0.5173 0 TD
-0.027 Tc
(=0.00\). )Tj
3.3165 0 TD
0.001 Tc
0.187 Tw
(There was also linkage to D8S373)Tj
-7.7882 -1.2472 TD
-0.025 Tc
(\(Z=1.92, )Tj
/F17 1 Tf
3.7913 0 TD
0 Tc
0 Tw
(q)Tj
/F14 1 Tf
0.5031 0 TD
-0.011 Tc
0.124 Tw
(=0.00\) which is within 2cM of the candidate)Tj
-4.2945 -1.2543 TD
-0.016 Tc
0 Tw
(genes that cause glucocorticoid-remediable aldosteronism,)Tj
0 -1.2472 TD
-0.011 Tc
0.014 Tw
(a rare form of hypertension.)Tj
27 69.2504 TD
0.009 Tc
0.168 Tw
[(W)74(e)0( also performed four additional genome scans)]TJ
-1.4953 -1.2543 TD
0.097 Tw
(using model parameters of the local maxima with the)Tj
0 -1.2472 TD
0.078 Tw
(four highest likelihoods that were less than the global)Tj
0 -1.2543 TD
0.021 Tc
0.188 Tw
[(maximum. Maximum lodscores \(and recombination)]TJ
0 -1.2472 TD
0.009 Tc
0.008 Tw
(fractions\) for the two markers of interest were:)Tj
ET
0 0 0 1 K
0 J 0 j 0.51 w 10 M []0 d
/GS1 gs
1 i 
264.019 590.768 m
444.019 590.768 l
264.019 579.26 m
444.019 579.26 l
S
BT
8 0 0 8 277.001 582.009 Tm
/GS2 gs
0.014 Tc
[(Maximum)-3430(D2S1790)-3877(D8S373)]TJ
0.7299 -1.6299 TD
0.01 Tc
0.037 Tw
[(Global)-3831(3.91 \(0.00\))-2938(1.92 \(0.00\))]TJ
1.1409 -1.2472 TD
[(2)-4968(2.27 \(0.03\))-2938(2.71 \(0.01\))]TJ
T*
[(3)-4968(3.31 \(0.00\))-2938(1.29 \(0.00\))]TJ
0 -1.2543 TD
[(4)-4968(1.38 \(0.05\))-2938(3.19 \(0.00\))]TJ
ET
/GS1 gs
264.019 526.252 m
444.019 526.252 l
S
BT
8 0 0 8 291.968 529.002 Tm
/GS2 gs
[(5)-4968(3.79 \(0.00\))-2938(2.33 \(0.00\))]TJ
-1.9984 -1.6228 TD
0.013 Tc
0.188 Tw
(Over all five genome scans, there was only one)Tj
-1.4953 -1.2543 TD
0.035 Tc
0.187 Tw
(lodscore greater than 2 outside these two regions)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
(\(D16S3253, Z=2.28, )Tj
/F17 1 Tf
8.6315 0 TD
0 Tc
(q)Tj
/F14 1 Tf
0.5244 0 TD
0.004 Tc
[(=0.01\). )25(While it is not clear what)]TJ
-9.1559 -1.2543 TD
0.009 Tc
0.083 Tw
(significance level should be used for local maxima, it)Tj
0 -1.2472 TD
0.13 Tw
(is clear that loci in the two regions around D2S1790)Tj
T*
0.02 Tw
(and D8S373 dominate the likelihood surface.)Tj
1.4953 -1.2543 TD
0.01 Tc
0.023 Tw
(Supported by NIH HL54707 and HL45522.)Tj
/T35 1 Tf
14 0 0 14 264.019 414.992 Tm
-0.021 Tc
(62)Tj
/F5 1 Tf
8 0 0 8 264.019 397.02 Tm
0.009 Tc
0 Tw
[(A)51( Single, Sequential, Genome-W)23(ide )16(T)95(est to)]TJ
T*
0.002 Tw
[(Simultaneously Identify )59(All Pr)16(omising )51(Ar)16(eas in a)]TJ
0 -1.2472 TD
0 Tw
(Linkage Scan)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.009 Tw
[(M.A. Province, )10(W)82(ashington Univ)67(., St. Louis, USA)]TJ
1.4953 -1.6228 TD
0.009 Tc
0.076 Tw
(Inflation of type I error occurs when conducting a)Tj
-1.4953 -1.2472 TD
0.106 Tw
[(lar)16(ge number of statistical tests in genome-wide link-)]TJ
0 -1.2543 TD
0.007 Tc
0.096 Tw
(age scans. Some have advocated stringent )Tj
/F17 1 Tf
17.9858 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6449 0 TD
0.008 Tc
0.1 Tw
(-levels to)Tj
-18.6307 -1.2472 TD
0.002 Tc
0 Tw
(protect against the high numbers of expected false-posi-)Tj
T*
0.006 Tc
0.108 Tw
[(tives at the cost of more false-negatives. )-64(A)48( more bal-)]TJ
0 -1.2543 TD
0.009 Tc
0.081 Tw
[(anced tradeof)16(f is provided by the theory of sequential)]TJ
0 -1.2472 TD
0.005 Tc
0.184 Tw
(analysis, which can be used in a genome scan )Tj
ET
0.4 w 
444.019 293.209 m
428.655 293.209 l
S
BT
8 0 0 8 428.655 294.009 Tm
0.011 Tc
(even)Tj
ET
444.019 283.175 m
264.019 283.175 l
S
BT
8 0 0 8 264.019 283.975 Tm
0.009 Tc
0.124 Tw
(when the data are collected using a fixed sample de-)Tj
ET
277.512 273.197 m
264.019 273.197 l
S
BT
8 0 0 8 264.019 273.997 Tm
0.039 Tw
[(sign. Classical sequential tests give complete, simulta-)]TJ
T*
0.11 Tw
(neous control of both the type I and type II errors of)Tj
0 -1.2543 TD
0.119 Tw
(each individual test while using the smallest possible)Tj
0 -1.2472 TD
0.03 Tw
(sample size for analysis. For fixed samples, the excess)Tj
T*
0.01 Tc
0.131 Tw
[(N \223saved\224 can be used in a confirmatory)67(, replication)]TJ
0 -1.2543 TD
0.009 Tc
0.05 Tw
(phase of the original findings. Using the theory of Se-)Tj
0 -1.2472 TD
0.003 Tw
(quential Multiple Decision Procedures \(SMDP\) \(Bech-)Tj
0 -1.2543 TD
0.013 Tc
0.187 Tw
[(hof)20(fer)41(, Kiefer)34(, and Sobel, 1968\) we can replace the)]TJ
0 -1.2472 TD
0.008 Tc
0.05 Tw
(series of individual marker tests with a new )Tj
ET
444.019 193.203 m
411.817 193.203 l
S
BT
8 0 0 8 411.817 194.003 Tm
0.009 Tc
(single, si-)Tj
ET
363.515 183.225 m
264.019 183.225 l
S
BT
8 0 0 8 264.019 184.025 Tm
0.001 Tw
(multaneous genome-wide test, which has multiple pos-)Tj
0 -1.2543 TD
0.018 Tc
0.187 Tw
(sible outcomes, that partitions all markers into two)Tj
0 -1.2472 TD
0.009 Tc
0.169 Tw
(subsets: the \223signal\224 vs. the \223noise,\224 with an apriori)Tj
0 -1.2543 TD
0.016 Tc
0.189 Tw
[(specifiable genome-wide error rate. )-174(These tests are)]TJ
0 -1.2472 TD
0.188 Tw
(demonstrated for the Haseman-Elston approach, are)Tj
T*
0.009 Tc
0.024 Tw
(applied to real data, and are contrasted with traditional)Tj
0 -1.2543 TD
0.045 Tw
(fixed sampling tests in Monte Carlo simulations of re-)Tj
0 -1.2472 TD
0.008 Tc
0.077 Tw
[(peated genome-wide scans. )-56(The sequential tests allow)]TJ
T*
0.005 Tc
0 Tw
[(tighter control of both types of error)33(, and achieve fewer)]TJ
0 -1.2543 TD
0.007 Tc
(total misclassifications at smaller average sample num-)Tj
0 -1.2472 TD
0.008 Tc
0.059 Tw
[(bers than do the fixed sample ones. )-42(The SMDP)29( works)]TJ
ET

endstream
endobj
364 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
365 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
362 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
363 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
356 0 obj
<</Length 9840>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(212)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.17 Tw
(particularly well, making only one error in all 100 ge-)Tj
0 -1.2543 TD
0.075 Tw
(nome scans of 400 markers each, as compared to 24 us-)Tj
0 -1.2472 TD
-0.01 Tc
0.125 Tw
(ing Lander)Tj
4.3654 0 TD
-0.024 Tc
(-Kruglyak )Tj
/F17 1 Tf
4.3795 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6236 0 TD
-0.011 Tc
0.128 Tw
[( levels, and 13 using Bonferroni)]TJ
-9.3685 -1.2543 TD
0.052 Tw
[(corrections. )-32(The method allows ef)23(ficient identification of)]TJ
0 -1.2472 TD
0.07 Tw
(the true signals in a genome scan, uses the smallest pos-)Tj
T*
0 Tw
(sible sample sizes, saves the excess to confirm those find-)Tj
0 -1.2543 TD
-0.017 Tc
[(ings, controls both types of error)40(, and provides one elegant)]TJ
0 -1.2472 TD
-0.011 Tc
0.136 Tw
(solution to the debate over the best way to balance be-)Tj
0 -1.2543 TD
0.014 Tw
(tween false positives and negatives in genome scans.)Tj
/T36 1 Tf
14 0 0 14 50.981 521.972 Tm
-0.021 Tc
(63)Tj
/F5 1 Tf
8 0 0 8 50.981 505.02 Tm
0.009 Tc
0.006 Tw
(False positives and false negatives in variance)Tj
T*
(components linkage analysis of quantitative traits)Tj
0 -1.2472 TD
0 Tw
[(using SEGP)66(A)72(T)1(H)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.006 Tw
(I.B. Borecki, M.A. Province, D.C. Rao)Tj
0 -1.2472 TD
-0.011 Tc
0.014 Tw
[(W)83(ashington University School Medicine, St. Louis, MO)]TJ
1.5024 -1.7504 TD
0.009 Tc
0.052 Tw
(Simulation studies were used to explore the power)Tj
-1.5024 -1.2472 TD
0.093 Tw
(characteristics and type I error rates in variance com-)Tj
0 -1.2543 TD
0.186 Tw
(ponents linkage anlaysis as implemented in the pro-)Tj
0 -1.2472 TD
0.019 Tc
0.184 Tw
[(gram )-8(SEGP)83(A)103(TH \(Province et al. 1999\). )-140(A)47( )-6(diallelic)]TJ
T*
0.005 Tc
0 Tw
(quantitative trait locus \(QTL\) was simulated along with)Tj
0 -1.2543 TD
0.009 Tc
0.042 Tw
(a marker locus with eight equally-frequent alleles. For)Tj
0 -1.2472 TD
0.077 Tw
(assessment of empiric type II error rates, we assumed)Tj
/F17 1 Tf
0 -1.2543 TD
0 Tc
0 Tw
(q)Tj
/F14 1 Tf
0.5315 0 TD
0.005 Tc
0.162 Tw
(=0; for assessment of type I error rates, )Tj
/F17 1 Tf
17.6031 0 TD
0 Tc
0 Tw
(q)Tj
/F14 1 Tf
0.5315 0 TD
-0.025 Tc
0.35 Tw
[(=0.5. W)40(e)]TJ
-18.6661 -1.2472 TD
0.009 Tc
0.14 Tw
(simulated 100 replications under each condition, cal-)Tj
T*
0.164 Tw
(culating the proportion of samples in which the null)Tj
0 -1.2543 TD
0.078 Tw
(hypothesis \226 that the variance attributable to the QTL)Tj
0 -1.2472 TD
0.005 Tw
(is zero \226 is rejected.)Tj
1.5024 -1.2543 TD
0.015 Tc
0.187 Tw
(Several issues were explored in this framework.)Tj
-1.5024 -1.2472 TD
0.009 Tc
0.098 Tw
(First, since a common unit of analysis is sibpairs, we)Tj
T*
0.013 Tc
0.188 Tw
(attempted to determine the smallest detectable QTL)Tj
0 -1.2543 TD
0.004 Tc
0 Tw
[(ef)18(fectsize. It appears that even with unrealistically lar)25(ge)]TJ
0 -1.2472 TD
0.009 Tc
0.141 Tw
(samples, a QTL accounting for less than 10% of the)Tj
T*
0.177 Tw
(phenotypic variation may not be detectable with de-)Tj
0 -1.2543 TD
0.174 Tw
[(cent power using this design and methodology)52(. Sec-)]TJ
0 -1.2472 TD
0.173 Tw
(ond, simulating an increasing degree of skewness in)Tj
0 -1.2543 TD
(the phenotypic distribution while maintaining a con-)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
[(stant ef)8(fectsize reveals a modest increasing trend in the)]TJ
T*
0.009 Tc
0.095 Tw
[(power for QTL)30( discovery)59(, as well as good robustness)]TJ
0 -1.2543 TD
0.011 Tw
(against type I errors for modest to moderate degrees of)Tj
0 -1.2472 TD
0.115 Tw
[(non-normality)59(. Finally)66(, we will quantify the ef)16(fect on)]TJ
0 -1.2543 TD
0.008 Tc
0 Tw
(power when pooling data from heterogeneous samples.)Tj
/T36 1 Tf
14 0 0 14 50.981 164.976 Tm
-0.021 Tc
(64)Tj
/F5 1 Tf
8 0 0 8 50.981 148.025 Tm
0.009 Tc
[(Apolipopr)23(otein E fr)23(equencies in an elderly)]TJ
T*
0.008 Tc
(population)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.005 Tw
[(C.M.van Duijn, )51(A.J.C. Slooter)31(, M. Cruts, C. )9(V)115(a)-3(n)]TJ
0 -1.2543 TD
0.007 Tc
0.063 Tw
(Broeckhoven, A.Hofman)Tj
4.8 0 0 4.8 133.356 121.606 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 135.794 117.978 Tm
(.)Tj
-10.6016 -1.2472 TD
0.009 Tc
0.025 Tw
[(Erasmus UniversityRotterdam, )-5(The Netherlands.)]TJ
1.5024 -1.7504 TD
0.175 Tw
(The apolipoprotein E \(APOE\) gene plays an im-)Tj
-1.5024 -1.2472 TD
0.059 Tw
(portant role in lipid metabolism and the occurrence of)Tj
25.5047 69.2504 TD
-0.013 Tc
0.133 Tw
[(cardiovascular disease at early age. )-76(APOE also is a ge-)]TJ
0 -1.2543 TD
-0.014 Tc
0.145 Tw
[(netic )7(determinant )7(for )-89(Alzheimer)-42(\222)50(s)-3( disease \(AD\), an im-)]TJ
0 -1.2472 TD
0.007 Tc
0.187 Tw
[(portant cause of mortality in the elderly)57(. Due to the)]TJ
0 -1.2543 TD
-0.013 Tc
0.101 Tw
[(relationship to these major disorders, )-57(APOE frequencies)]TJ
0 -1.2472 TD
-0.01 Tc
0.134 Tw
[(are expected to change with age. However)47(, findings up)]TJ
T*
-0.008 Tc
0.188 Tw
(to date have been controversial. In a population-based)Tj
0 -1.2543 TD
-0.011 Tc
0.107 Tw
[(study of 6000 subjects aged 55 years )-20(o)-21(r)-21( )]TJ
16.5593 0 TD
0.01 Tc
0.106 Tw
(older we have)Tj
-16.5593 -1.2472 TD
0.007 Tc
0.075 Tw
[(studied )-20(APOE allele frequencies of the three common)]TJ
0 -1.2543 TD
-0.008 Tc
0.26 Tw
[(alleles, APOE*2, )-7(APOE*3 )104(and )]TJ
13.4504 0 TD
0.009 Tc
0.154 Tw
[(APOE*4, in dif)16(ferent)]TJ
-13.4504 -1.2472 TD
0.13 Tw
[(age categories. Further)37(, the potential influence of the)]TJ
T*
0.092 Tw
(change in frequencies with regard to bias in non age-)Tj
0 -1.2543 TD
0.041 Tc
0.187 Tw
[(matched case-control studies was examined. )-172(T)-7(h)-7(e)]TJ
0 -1.2472 TD
0.009 Tc
0.109 Tw
[(APOE*4 allele frequency decreased from 0.17 in 55-)]TJ
T*
0.08 Tw
[(years old to 0.12 in subjects 90 or over)66(.)79( )-62(The decrease)]TJ
0 -1.2543 TD
0 Tw
[(in )59(APOE*4 was to the benefit of )59(APOE*3 because also)]TJ
0 -1.2472 TD
0.008 Tc
0.047 Tw
[(the frequency of the )9(APOE*2 allele slightly decreased)]TJ
0 -1.2543 TD
0.007 Tc
0.06 Tw
[(with age. )-8(Although the decrease in the )-8(APOE*4 allele)]TJ
0 -1.2472 TD
0.009 Tc
0.03 Tw
(by age appeared to be limited, it resulted in false posi-)Tj
T*
0.021 Tw
(tive findings when conducting association analysis un-)Tj
0 -1.2543 TD
0.008 Tc
0.042 Tw
[(matched for age. )-28(The pattern of false positive findings)]TJ
0 -1.2472 TD
0.009 Tc
0.12 Tw
[(was that of an increasing ef)16(fect of the allele with in-)]TJ
0 -1.2543 TD
0.151 Tw
[(creasing with age. Our study implies that age dif)23(fer)16(-)]TJ
0 -1.2472 TD
0.031 Tc
0.188 Tw
(ences between cases and controls must always be)Tj
T*
0.008 Tc
0.035 Tw
[(adjusted for when studying late-onset disorders. )16(Allele)]TJ
0 -1.2543 TD
0.009 Tc
0.04 Tw
[(ef)23(fects that show an increasing ef)16(fect with age may be)]TJ
0 -1.2472 TD
0.017 Tw
(explained by age-related selection bias.)Tj
/T36 1 Tf
14 0 0 14 255.019 347.017 Tm
-0.021 Tc
(65)Tj
/F5 1 Tf
8 0 0 8 255.019 328.989 Tm
0.009 Tc
0.001 Tw
(Statistical Strategies to Distinguish the Effects of)Tj
T*
0.003 Tw
(Maternal and Offspring Genes in the Etiology of)Tj
0 -1.2543 TD
0.009 Tw
[(Nonsyndr)16(omic Oral Clefts)]TJ
/F14 1 Tf
0 -1.2472 TD
0.008 Tw
[(DF )15(W)60(yszynski, MH Khoshnevisan, )8(T)18( )19(W)39(u, )51(A)51( Miller)9(-)]TJ
T*
0.013 Tw
(Chisholm, SR Diehl)Tj
0 -1.2543 TD
0.022 Tw
(Craniofacial Epidemiology and Genetics Branch,)Tj
0 -1.2472 TD
0.013 Tw
(National Institute of Dental and Craniofacial)Tj
T*
0.012 Tw
(Research, National Institutes of Health, Bethesda,)Tj
0 -1.2543 TD
0.012 Tc
(Maryland)Tj
1.4953 -1.8709 TD
0.005 Tc
0 Tw
[(For disorders in which the mother)-38(\222)62(s)0( genotype might)]TJ
-1.4953 -1.2543 TD
0.009 Tc
0.165 Tw
(play a critical role, such as birth defects, the classic)Tj
0 -1.2472 TD
0.008 Tc
0.193 Tw
[(T)31(ransmission )9(Disequilibrium )-171(T)59(est \(TDT\) can be ex-)]TJ
0 -1.2543 TD
0.006 Tc
0 Tw
[(tended to separate the ef)20(fects of maternal genetic varia-)]TJ
0 -1.2472 TD
0.009 Tc
0.159 Tw
(tion from that of the af)Tj
10.0701 0 TD
-0.003 Tc
[(fected child. )-152(W)62(e)-13( )]TJ
7.3707 0 TD
0.01 Tc
(developed a)Tj
-17.4408 -1.2472 TD
0.009 Tc
0.026 Tw
(likelihood-based method of analysis, following the ap-)Tj
0 -1.2543 TD
0.014 Tw
[(proach proposed by W)81(einber)16(g et al. \(1998\) and )9(W)32(ilcox)]TJ
0 -1.2472 TD
0.107 Tw
[(et al. \(1998\), to discriminate these genetic ef)23(fects us-)]TJ
0 -1.2543 TD
0.177 Tw
(ing case-parent triad data. Our method may be used)Tj
0 -1.2472 TD
0.067 Tw
(with multiallelic markers. Since it can incorporate ad-)Tj
T*
0.003 Tc
0.001 Tw
(justment for environmental exposures, it is a useful tool)Tj
0 -1.2543 TD
0.009 Tc
0 Tw
[(to explore gene-environment interactions. )16(W)81(e)0( used this)]TJ
0 -1.2472 TD
0.017 Tw
(method to analyze four candidate gene polymorphisms)Tj
T*
0.017 Tc
0.188 Tw
(for nonsyndromic cleft lip with/without cleft palate)Tj
0 -1.2543 TD
-0.001 Tc
0.001 Tw
[(\(CL/P\): MTHFR C677T)84(, MTHFR )57(A1298C, )21(TGF)]TJ
/F17 1 Tf
19.5732 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6307 0 TD
-0.003 Tc
-0.013 Tw
[( T)69(aqI,)]TJ
-20.2039 -1.2472 TD
-0.039 Tc
0.317 Tw
[(and T)-51(G)-51(F)]TJ
/F17 1 Tf
3.7772 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6449 0 TD
-0.011 Tc
0.15 Tw
[( BAMHI. )]TJ
4.415 0 TD
0.009 Tc
[(Additionally)66(, maternal and child)]TJ
ET

endstream
endobj
375 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
373 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
374 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
367 0 obj
<</Length 11468>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(213)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.007 Tc
0 Tw
(gene-environment interactions were tested using an ex-)Tj
0 -1.2543 TD
-0.001 Tc
(tension of the case-only method of Khoury and Flanders)Tj
0 -1.2472 TD
0.029 Tc
0.187 Tw
(\(1996\). Periconceptional vitamin use and cigarette)Tj
0 -1.2543 TD
0.009 Tc
0.008 Tw
(smoking during the first trimester of gestation were in-)Tj
0 -1.2472 TD
0.041 Tw
(corporated into the case-only analyses of MTHFR and)Tj
T*
0.012 Tc
(TGF)Tj
/F17 1 Tf
1.9276 0 TD
0 Tc
0 Tw
(a)Tj
/F14 1 Tf
0.6449 0 TD
0.009 Tc
0.059 Tw
[(, respectively)66(. Strong evidence of both fetal and)]TJ
-2.5724 -1.2543 TD
0.061 Tw
[(maternal ef)16(fects were found for all four genetic mark-)]TJ
0 -1.2472 TD
0.183 Tw
(ers, with higher odds ratios when two copies of the)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(high-risk alleles were carried versus only one or no)Tj
0 -1.2472 TD
0.009 Tc
0.125 Tw
[(copies. Our results suggest that there is a dif)23(ferential)]TJ
T*
0.006 Tc
0 Tw
[(ef)13(fect of these polymorphisms on risk of nonsyndromic)]TJ
0 -1.2543 TD
0.01 Tc
0.176 Tw
(CL/P depending on whether the high risk genotypes)Tj
0 -1.2472 TD
0.008 Tc
0.044 Tw
[(are carried by the mother)36(, the child or both. )-35(This find-)]TJ
T*
0.009 Tc
0.136 Tw
(ing reinforces the view that the mother is not only a)Tj
0 -1.2543 TD
0.06 Tw
(genetic parent, but also provides an important compo-)Tj
0 -1.2472 TD
0.016 Tw
(nent of the fetal environment.)Tj
/T37 1 Tf
14 0 0 14 59.981 447.024 Tm
-0.021 Tc
(66)Tj
/F5 1 Tf
8 0 0 8 59.981 428.995 Tm
0.009 Tc
0 Tw
[(Shar)23(ed genes influence quantitative variation in)]TJ
T*
0.003 Tw
[(plasma levels of nitric oxide and LDL-r)16(elated)]TJ
0 -1.2543 TD
0 Tw
[(phenotypes in the San )59(Antonio Family Heart Study)52(.)]TJ
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.005 Tw
[(S.A. Czerwinski, M.C. Mahaney)60(, D.L. Rainwater)38(, J.)]TJ
T*
0.016 Tw
[(Blangero and J.W)88(. MacCluer)60(. Southwest Foundation)]TJ
0 -1.2543 TD
0.009 Tc
0.008 Tw
[(for Biomedical Research, San )51(Antonio, )9(TX USA.)]TJ
1.5024 -1.8709 TD
0.033 Tc
0.188 Tw
(Nitric oxide \(NO\) has been shown to regulate)Tj
-1.5024 -1.2543 TD
0.026 Tc
0 Tw
[(vascular tone and influence lipoprotein oxidation. )12(T)63(o)]TJ
0 -1.2472 TD
0.03 Tc
0.188 Tw
(determine the extent to which shared genes influ-)Tj
0 -1.2543 TD
0.026 Tc
0 Tw
(ence normal quantitative variation in plasma NO and)Tj
0 -1.2472 TD
0.029 Tc
0.064 Tw
(LDL-related phenotypes, we conducted a multivari-)Tj
T*
-0.001 Tw
[(ate quantitative genetic analysis. NO, )49(APOB, )49(APOE,)]TJ
0 -1.2543 TD
0.137 Tw
(total LDL, median LDL diameter and triglycerides)Tj
0 -1.2472 TD
0.148 Tw
(\(TG\) were measured in a sample of 364 Mexican-)Tj
0 -1.2543 TD
0.01 Tc
(Americans. )Tj
5.2866 0 TD
0.029 Tc
0.188 Tw
(After simultaneously adjusting for age)Tj
-5.2866 -1.2472 TD
0.018 Tw
(and sex using a maximum likelihood-based variance)Tj
T*
0.027 Tc
0 Tw
(components approach, we found significant \(p<0.05\))Tj
0 -1.2543 TD
0.04 Tc
0.187 Tw
(heritabilities \(h)Tj
4.8 0 0 4.8 115.597 257.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 118.205 253.984 Tm
0.041 Tc
0.187 Tw
(\) for all of the phenotypes: NOx)Tj
-7.278 -1.2472 TD
0.032 Tc
(\(h)Tj
4.8 0 0 4.8 67.124 247.578 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 69.676 244.006 Tm
0.006 Tc
(=0.25\), )Tj
3.4937 0 TD
0.031 Tc
0.168 Tw
(APOB \(h)Tj
4.8 0 0 4.8 130.734 247.578 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 133.285 244.006 Tm
0.006 Tc
(=0.49\), )Tj
3.4937 0 TD
0.031 Tc
0.168 Tw
(APOE \(h)Tj
4.8 0 0 4.8 193.89 247.578 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 196.441 244.006 Tm
0.029 Tc
0.169 Tw
(=0.45\), total)Tj
-17.0575 -1.2472 TD
0.027 Tc
0 Tw
(LDL \(h)Tj
4.8 0 0 4.8 85.493 237.6 Tm
0 Tc
(2)Tj
8 0 0 8 87.987 234.028 Tm
0.024 Tc
(=0.51\), median LDL diameter \(h)Tj
4.8 0 0 4.8 198.822 237.6 Tm
0 Tc
(2)Tj
8 0 0 8 201.373 234.028 Tm
0.024 Tc
(=0.33\), and)Tj
-17.674 -1.2543 TD
0.03 Tc
0.044 Tw
(TG \(h)Tj
4.8 0 0 4.8 80.901 227.622 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 83.452 223.994 Tm
0.028 Tc
0.05 Tw
[(=0.39\). )-20(W)72(e)-1( found significant positive genetic)]TJ
-2.9339 -1.2472 TD
0.03 Tc
0.187 Tw
(correlations indicative of pleiotropy between NOx)Tj
0 -1.2543 TD
-0.024 Tc
(and )Tj
1.9134 0 TD
0.032 Tc
0.156 Tw
(APOB \()Tj
/F17 1 Tf
3.5929 0 TD
0 Tc
0 Tw
(r)Tj
/F14 1 Tf
4.8 0 0 4.8 108.68 202.791 Tm
(G)Tj
8 0 0 8 112.309 203.981 Tm
0.007 Tc
(=0.58\), )Tj
3.4795 0 TD
0.032 Tc
0.156 Tw
(APOE \()Tj
/F17 1 Tf
3.5362 0 TD
0 Tc
0 Tw
(r)Tj
/F14 1 Tf
4.8 0 0 4.8 173.083 202.791 Tm
(G)Tj
8 0 0 8 176.712 203.981 Tm
0.03 Tc
0.159 Tw
(=0.37\), total LDL)Tj
-14.5913 -1.2472 TD
0 Tc
0 Tw
(\()Tj
/F17 1 Tf
0.3614 0 TD
(r)Tj
/F14 1 Tf
4.8 0 0 4.8 67.521 192.813 Tm
(G)Tj
8 0 0 8 71.15 194.003 Tm
0.011 Tc
0.186 Tw
[(=0.29\) and )-180(T)-21(G)-21( )-20(\()]TJ
/F17 1 Tf
7.4906 0 TD
0 Tc
0 Tw
(r)Tj
/F14 1 Tf
4.8 0 0 4.8 135.723 192.813 Tm
(G)Tj
8 0 0 8 139.351 194.003 Tm
0.004 Tc
0.375 Tw
[(=0.66\). W)55(e)-25( )]TJ
5.3827 0 TD
0.029 Tc
0.187 Tw
(infer from these)Tj
-15.3039 -1.2472 TD
0.044 Tc
0.188 Tw
(results that the genes that influence increases in)Tj
0 -1.2543 TD
0.029 Tc
0.141 Tw
(plasma NO also influence increases in these LDL-)Tj
0 -1.2472 TD
0.009 Tc
0.176 Tw
(related phenotypes. Consistent with the inverse rela-)Tj
0 -1.2543 TD
0.054 Tw
(tionship between particle size and LDL concentration,)Tj
0 -1.2472 TD
0.022 Tc
0.188 Tw
(we found a significant negative genetic correlation)Tj
T*
0 Tc
0 Tw
(\()Tj
/F17 1 Tf
0.3472 0 TD
(r)Tj
/F14 1 Tf
4.8 0 0 4.8 67.294 132.832 Tm
(G)Tj
8 0 0 8 70.809 134.022 Tm
0.015 Tc
0.186 Tw
[(=\2260.59\) between NO and median LDL)29( diameter)65(.)]TJ
-1.3535 -1.2543 TD
0.01 Tc
0.079 Tw
(These results show that genes shared with NO are re-)Tj
0 -1.2472 TD
0.009 Tc
0.045 Tw
(sponsible for between 8.4% and 43.5% of the additive)Tj
T*
0.089 Tw
(genetic variance in LDL-related traits, with the stron-)Tj
0 -1.2543 TD
0 Tw
[(gest evidence of pleiotropy occurring with )23(TG and me-)]TJ
0 -1.2472 TD
0.012 Tw
[(dian LDL)30( diameter)52(.)]TJ
/T37 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.021 Tc
(67)Tj
/F5 1 Tf
8 0 0 8 264.019 616.989 Tm
0.009 Tc
0.001 Tw
(Evaluation of Candidate Genes in Family Studies:)Tj
T*
0.01 Tc
0.002 Tw
[(GEE and Bootstrap )52(Appr)17(oaches)]TJ
/F14 1 Tf
0 -1.2543 TD
0.008 Tc
0.006 Tw
(J. Shin)Tj
4.8 0 0 4.8 286.356 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 288.794 596.976 Tm
0.01 Tc
0.006 Tw
(, S. Bull1,)Tj
4.8 0 0 4.8 322.016 600.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 324.453 596.976 Tm
0.01 Tc
0.006 Tw
(, G. Darlington)Tj
4.8 0 0 4.8 374.116 600.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 376.611 596.976 Tm
0.009 Tc
0.01 Tw
(, M. Corey)Tj
4.8 0 0 4.8 412.214 600.605 Tm
0.013 Tc
(1,3)Tj
-30.874 -2.0906 TD
0 Tc
0 Tw
(1)Tj
8 0 0 8 266.457 586.998 Tm
0.008 Tc
0.018 Tw
[(University of T)59(oronto, T)66(oronto, Canada; )]TJ
4.8 0 0 4.8 401.046 590.57 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 403.483 586.998 Tm
0.008 Tc
(Samuel)Tj
-17.4331 -1.2472 TD
0.009 Tc
0.015 Tw
(Lunenfeld Research Institute, Mount Sinai Hospital,)Tj
0 -1.2543 TD
0.008 Tc
0.013 Tw
[(T)66(oronto, Canada; )]TJ
4.8 0 0 4.8 322.923 570.614 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 325.417 566.986 Tm
0.009 Tc
0.017 Tw
(Research Institute, Hospital for)Tj
-7.6748 -1.2472 TD
0.018 Tw
[(Sick Children, )-6(T)67(oronto, Canada.)]TJ
1.4953 -1.7504 TD
-0.011 Tc
0.149 Tw
(Cohort studies can be used to examine the associa-)Tj
-1.4953 -1.2543 TD
0.011 Tw
(tion of genetic factors, such as candidate genes, and other)Tj
0 -1.2472 TD
0.04 Tw
(risk factors with the presence or absence of complex dis-)Tj
T*
0.059 Tw
(orders. If randomly ascertained families are investigated,)Tj
0 -1.2543 TD
0.037 Tw
(possible familial correlation among observations must be)Tj
0 -1.2472 TD
0.061 Tw
[(considered. )-39(T)68(wo statistical approaches for analyzing cor)16(-)]TJ
T*
0.09 Tw
[(related binary data from)10( )]TJ
9.9889 0 TD
0.009 Tc
0.092 Tw
(nuclear families are evaluated)Tj
-9.9889 -1.2543 TD
-0.003 Tc
0.187 Tw
(and compared. )Tj
6.6472 0 TD
0.011 Tc
(The generalized estimating equations)Tj
-6.6472 -1.2472 TD
0.01 Tc
0.114 Tw
(approach \(GEE\), an extension of a generalized linear)Tj
0 -1.2543 TD
0.009 Tc
0.135 Tw
(model, can be used to adjust for familial correlation.)Tj
0 -1.2472 TD
0.116 Tw
(The relationship between covariates and the response)Tj
T*
0.17 Tw
(is modeled, and the correlations among observations)Tj
0 -1.2543 TD
0.001 Tc
0 Tw
(are treated as nuisance parameters. For comparison, two)Tj
0 -1.2472 TD
0.009 Tc
0.079 Tw
(strategies from a hierarchical nonparametric bootstrap)Tj
0 -1.2543 TD
0.177 Tw
(approach are proposed. One strategy \(S1\) bootstraps)Tj
0 -1.2472 TD
0.1 Tw
(distinct families, preserving the structure and correla-)Tj
T*
0.161 Tw
[(tion within each family)59(.)160( )-104(A)51( second strategy \(S2\) uses)]TJ
0 -1.2543 TD
0.141 Tw
(bootstrapped families from S1 but randomly samples)Tj
0 -1.2472 TD
0.07 Tw
[(of)23(fspring with replacement in each family)59(. Each strat-)]TJ
T*
0.132 Tw
[(egy accounts dif)30(ferently for within-family variability)59(.)]TJ
0 -1.2543 TD
0.093 Tw
(A one-step logistic regression model is applied to the)Tj
0 -1.2472 TD
0.003 Tw
(bootstrap data, assuming that individuals within a fam-)Tj
0 -1.2543 TD
0.053 Tw
(ily are independent, thus allowing the bootstrap to de-)Tj
0 -1.2472 TD
0.019 Tw
(termine the variation.)Tj
1.4953 -1.2472 TD
0.158 Tw
(A simulation study is conducted in which family)Tj
-1.4953 -1.2543 TD
0.183 Tw
(data are generated from an underlying multifactorial)Tj
0 -1.2472 TD
-0.002 Tc
0.147 Tw
(genetic model. )Tj
6.548 0 TD
0.009 Tc
(The impact of sample size, degree of)Tj
-6.548 -1.2543 TD
0.017 Tw
(correlation and genetic model are investigated. Results)Tj
0 -1.2472 TD
0.001 Tc
0 Tw
(from this study indicate that the bootstrap approach out-)Tj
T*
0.009 Tc
0.024 Tw
(performs the GEE in terms of confidence interval cov-)Tj
0 -1.2543 TD
0.076 Tw
(erage probabilities for small sample sizes. In terms of)Tj
0 -1.2472 TD
0.115 Tw
[(ef)23(ficiency and bias, the bootstrap is only a slight im-)]TJ
T*
0.007 Tc
0 Tw
(provement over the GEE. One drawback with the boot-)Tj
0 -1.2543 TD
0.009 Tc
0.018 Tw
(strap approach is found in its computational demands.)Tj
/T37 1 Tf
14 0 0 14 264.019 170.986 Tm
-0.021 Tc
(68)Tj
/F5 1 Tf
8 0 0 8 264.019 153.978 Tm
0.009 Tc
0.003 Tw
(Genome wide linkage analysis using genetic)Tj
0 -1.2472 TD
0.011 Tw
[(variance effects of asthma-associated binary)55(,)]TJ
T*
0 Tw
[(censor)23(ed and continuous traits.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.004 Tw
[(LJ Palmer)38(, KB Jacobs, S Bhattacharrya, NI Leaves,)]TJ
0 -1.2472 TD
0.009 Tc
0.008 Tw
[(A)79(W)18( Musk, )51(AL)30( James, RC Elston, WOCM Cookson,)]TJ
T*
0.01 Tc
0.012 Tw
(PR Burton.)Tj
0 -1.2543 TD
0.009 Tc
0.006 Tw
(TVWT Institute for Child Health Research &)Tj
0 -1.2472 TD
0.012 Tw
[(University of )16(W)74(estern )51(Australia, )37(Australia. University)]TJ
ET

endstream
endobj
386 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
385 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
384 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
383 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
377 0 obj
<</Length 10945>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(214)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.009 Tc
0.009 Tw
[(of Oxford, UK. Case W)81(estern Reserve University)59(,)]TJ
0 -1.2543 TD
0.01 Tc
0.013 Tw
(Cleveland, USA.)Tj
1.5024 -1.7504 TD
0.009 Tc
0.168 Tw
[(W)74(e)0( used novel statistical techniques to analyse a)]TJ
-1.5024 -1.2472 TD
0.002 Tc
0 Tw
(whole genome screen for asthma-associated phenotypes)Tj
0 -1.2543 TD
0.023 Tc
0.187 Tw
(\(n=364 Caucasian subjects in 80 nuclear families\).)Tj
0 -1.2472 TD
-0.014 Tc
0.386 Tw
[(Methods: V)]TJ
4.9039 0 TD
0.01 Tc
0.187 Tw
(ariance component models were fitted to)Tj
-4.9039 -1.2472 TD
0.009 Tc
0.08 Tw
(the traits of interest using Gibbs sampling methods in)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(order to generate new phenotypes - additive genetic)Tj
0 -1.2472 TD
0.009 Tc
0.015 Tw
[(variance residual ef)9(fects \(at the level of the individual\))]TJ
0 -1.2543 TD
0.138 Tw
(- for linkage analysis. Linkage analyses for quantita-)Tj
0 -1.2472 TD
-0.001 Tc
0 Tw
(tive traits, right censored survival times and binary traits)Tj
T*
0.009 Tc
0.139 Tw
(were then based upon a novel implementation of the)Tj
0 -1.2543 TD
0.015 Tw
(Haseman-Elston IBD sib-pair method using the sib-sib)Tj
0 -1.2472 TD
0.054 Tw
(covariance as the dependent variable \(HE II\). In sepa-)Tj
T*
0.117 Tw
(rate analyses, a focussing technique was also used to)Tj
0 -1.2543 TD
0 Tw
(weight the IBD regression by the results of Gibbs sam-)Tj
0 -1.2472 TD
0.008 Tc
0.108 Tw
[(pling based segregation analyses. Results: )-99(The use of)]TJ
0 -1.2543 TD
0.009 Tc
0.078 Tw
(HE II together with additive genetic variance residual)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
[(ef)12(fects for asthma-associated traits greatly strengthened)]TJ
T*
0.009 Tc
0.058 Tw
(evidence of linkage versus use of standard HE regres-)Tj
0 -1.2543 TD
0.009 Tw
(sion and raw phenotypes. Mutual adjustment strategies)Tj
0 -1.2472 TD
0.03 Tw
(allowed definition of linkages to the component of ge-)Tj
0 -1.2543 TD
0.179 Tw
(netic variance in each phenotype that was shared or)Tj
0 -1.2472 TD
0.017 Tw
(unshared with the other phenotypes \(e.g., asthma inde-)Tj
T*
0.068 Tw
(pendent of atopy\). Use of the weighted regression ap-)Tj
0 -1.2543 TD
0.004 Tc
0 Tw
(proach greatly strengthened evidence of linkage to each)Tj
0 -1.2472 TD
0.009 Tc
0.178 Tw
(phenotype in specific chromosomal regions. Conclu-)Tj
T*
0.008 Tc
0.047 Tw
[(sions: )-27(This study suggests that these novel methods of)]TJ
0 -1.2543 TD
0.011 Tc
0.188 Tw
[(phenotype definition and linkage analysis may of)11(fer)]TJ
0 -1.2472 TD
0.001 Tc
0 Tw
(both the ability to correctly analyze right-censored traits)Tj
0 -1.2543 TD
0.009 Tc
0.088 Tw
[(for linkage and increased ef)16(ficiency and power to de-)]TJ
0 -1.2472 TD
0.187 Tw
(tect linkage in studies of asthma and other complex)Tj
T*
0.008 Tc
0.03 Tw
[(diseases. )-19(The use of weighted focussing may allow ef-)]TJ
0 -1.2543 TD
0.009 Tc
0.012 Tw
(ficient localisation of specific major genes.)Tj
/T38 1 Tf
14 0 0 14 50.981 264.983 Tm
-0.021 Tc
(69)Tj
/F5 1 Tf
8 0 0 8 50.981 247.975 Tm
0.007 Tc
0 Tw
(Influence of individuals or sibships in QTL linkage)Tj
0 -1.2472 TD
0.008 Tc
(studies)Tj
/F14 1 Tf
T*
0.01 Tc
(D.L. Koller)Tj
4.8 0 0 4.8 89.022 231.591 Tm
0 Tc
(1)Tj
8 0 0 8 91.46 228.019 Tm
0.009 Tc
0.007 Tw
(, M.J. Econs)Tj
4.8 0 0 4.8 132.279 231.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 134.717 228.019 Tm
0.009 Tc
0.003 Tw
(, J.C. Christian)Tj
4.8 0 0 4.8 183.756 231.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 186.194 228.019 Tm
0.01 Tc
0.006 Tw
(, S.L. Hui)Tj
4.8 0 0 4.8 218.452 231.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 220.89 228.019 Tm
(,)Tj
-21.2386 -1.2543 TD
0.009 Tc
0.006 Tw
[(P)104(.A. Morin)]TJ
4.8 0 0 4.8 87.151 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 89.589 217.984 Tm
0.01 Tc
0.009 Tw
(, M.E. Curran)Tj
4.8 0 0 4.8 135 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 137.438 217.984 Tm
0.01 Tc
0.009 Tw
(, G. Joslyn)Tj
4.8 0 0 4.8 172.701 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 175.139 217.984 Tm
0.01 Tc
0.012 Tw
(, C.C. Johnston)Tj
4.8 0 0 4.8 225.652 221.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 228.09 217.984 Tm
(,)Tj
-22.1386 -1.2472 TD
0.009 Tc
0.007 Tw
(M. Peacock)Tj
4.8 0 0 4.8 89.589 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 92.084 208.006 Tm
0.01 Tc
0.009 Tw
[(, P)116(.M. Conneally)]TJ
4.8 0 0 4.8 147.019 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 149.457 208.006 Tm
0.01 Tc
-0.008 Tw
[(,)9( T)68(.)0( )-17(Foroud)]TJ
4.8 0 0 4.8 185.74 211.578 Tm
0 Tc
0 Tw
(1)Tj
-28.0748 -2.0787 TD
(1)Tj
8 0 0 8 53.362 198.028 Tm
-0.011 Tc
0.016 Tw
[(Indiana Univ)60(. School of Medicine, Indianapolis, IN,)]TJ
-0.2976 -1.2543 TD
-0.008 Tc
(USA; )Tj
4.8 0 0 4.8 70.88 191.622 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 73.205 187.994 Tm
-0.01 Tc
0.004 Tw
(Axys Pharmaceuticals, Inc., La Jolla, CA, USA.)Tj
-1.2756 -1.7504 TD
-0.011 Tc
0.144 Tw
(Current searches for genes underlying complex dis-)Tj
-1.5024 -1.2472 TD
0.029 Tw
(orders typically focus on non-parametric linkage analysis)Tj
0 -1.2543 TD
-0.013 Tc
0.089 Tw
[(in sibships or families. )-33(Analyses of these data often rely)]TJ
0 -1.2472 TD
-0.011 Tc
0.075 Tw
[(on lar)17(ge-sample approximations for determination of the)]TJ
T*
-0.015 Tc
0 Tw
[(significance level associated with the linkage result\(s\). )20(W)79(e)]TJ
0 -1.2543 TD
-0.011 Tc
0.016 Tw
(report several situations where individuals or sibships ex-)Tj
0 -1.2472 TD
0.144 Tw
(erted a disproportionate influence on linkage results, as)Tj
T*
0.069 Tw
(computed by the ML variance estimation method imple-)Tj
0 -1.2543 TD
0.05 Tw
(mented in Mapmaker/SIBS, in a QTL mapping study in-)Tj
0 -1.2472 TD
0.016 Tw
(volving a genome screen of 425 sibling pairs.)Tj
27 69.2504 TD
0.011 Tc
0.188 Tw
(1\) Phenotypic outliers: Inclusion or exclusion of)Tj
-1.4953 -1.2543 TD
0.009 Tc
0.1 Tw
(an individual 4 SD below the mean altered the maxi-)Tj
0 -1.2472 TD
0.093 Tw
[(mum LOD score from 3.4 to 1.8, respectively)66(, in this)]TJ
0 -1.2543 TD
0.006 Tc
0 Tw
[(lar)20(ge sample. Inclusion of this individual also produced)]TJ
0 -1.2472 TD
0.009 Tc
0.061 Tw
(rapid increases/decreases in the multipoint LOD score)Tj
T*
0.018 Tw
(in intermarker intervals.)Tj
1.4953 -1.2543 TD
0.187 Tw
(2\) Half-siblings: Erroneous inclusion of two dis-)Tj
-1.4953 -1.2472 TD
0.091 Tw
(cordant half-sibling pairs as full siblings resulted in a)Tj
0 -1.2543 TD
0.013 Tw
(spurious increase in the lod score \(to 3.49 from 2.82\).)Tj
1.4953 -1.2472 TD
0.007 Tc
0.108 Tw
[(3\) )6(Unlinked )6(subsets: )-54(A)56( LOD score of 3.50 in 425)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.082 Tw
(sibling pairs was reduced to 2.16 upon addition of 84)Tj
0 -1.2543 TD
0.115 Tw
(sibling pairs with little evidence of linkage to the re-)Tj
0 -1.2472 TD
0.008 Tc
0.077 Tw
[(gion in question. )-57(The position of the peak LOD score)]TJ
T*
0.009 Tc
0.007 Tw
(was shifted by 18 cM as well.)Tj
1.4953 -1.2543 TD
0.004 Tc
0 Tw
[(4\) Marker informativeness: )61(A)53( highly phenotypically)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.138 Tw
[(variable five-sibling pedigree without genotyped par)16(-)]TJ
0 -1.2543 TD
0.082 Tw
(ents resulted in discrepant two-point \(LOD=1.31\) and)Tj
0 -1.2472 TD
0.044 Tw
(multipoint \(LOD=3.38\) results at the same marker po-)Tj
T*
0.025 Tw
(sition, due to the uninformativeness in this pedigree of)Tj
0 -1.2543 TD
0.013 Tw
(a single marker in this linked region.)Tj
/T38 1 Tf
14 0 0 14 255.019 413.008 Tm
-0.021 Tc
(70)Tj
/F5 1 Tf
8 0 0 8 255.019 397.02 Tm
0.01 Tc
0.001 Tw
(Detection of Interaction between Loci in Genome)Tj
T*
0.007 Tc
(Scans)Tj
/F14 1 Tf
0 -1.2472 TD
0.009 Tc
0.007 Tw
(J. Biernacka)Tj
4.8 0 0 4.8 295.498 380.58 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 301.677 377.008 Tm
0.01 Tc
0.009 Tw
(, S.B. Bull1,)Tj
4.8 0 0 4.8 342.383 380.58 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 344.877 377.008 Tm
0.01 Tc
0.009 Tw
[(, P)116(.)0( Nikolakakos)]TJ
4.8 0 0 4.8 398.225 380.58 Tm
0 Tc
0 Tw
(2)Tj
-29.8346 -2.0787 TD
(1)Tj
8 0 0 8 257.457 366.973 Tm
0.008 Tc
0.017 Tw
[(Univ)65(. of )8(T)59(oronto, T)73(oronto, Canada; )]TJ
4.8 0 0 4.8 375.378 370.602 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 377.872 366.973 Tm
0.008 Tc
(Samuel)Tj
-15.3567 -1.2472 TD
0.009 Tc
0.014 Tw
(Lunenfeld Research Inst., Mount Sinai Hospital,)Tj
T*
0.01 Tc
0.037 Tw
[(T)68(oronto, Canada)]TJ
1.4953 -1.6299 TD
0.009 Tc
0.103 Tw
(Genome scans are commonly used in the identifi-)Tj
-1.4953 -1.2472 TD
0.186 Tw
(cation of susceptibility genes for complex disorders.)Tj
T*
0 Tw
[(However)37(, such methods have had limited success, with)]TJ
0 -1.2543 TD
0.129 Tw
(many studies pointing out multiple regions with sug-)Tj
0 -1.2472 TD
0.038 Tw
(gestive evidence for linkage, but few resulting in defi-)Tj
0 -1.2543 TD
0.153 Tw
(nite implication of specific loci. Furthermore, results)Tj
0 -1.2472 TD
-0.001 Tc
0 Tw
[(cannot always be replicated by dif)27(ferent working groups)]TJ
T*
0.009 Tc
0.122 Tw
(looking for susceptibility genes for the same disease.)Tj
0 -1.2543 TD
0.017 Tc
0.188 Tw
(One reason for this may be that multipoint linkage)Tj
0 -1.2472 TD
0.009 Tc
0.042 Tw
(analysis fails to account for the interaction of multiple)Tj
T*
0.049 Tw
(genetic factors. Simultaneous consideration of suscep-)Tj
0 -1.2543 TD
0.051 Tw
(tibility for multiple regions may increase the power to)Tj
0 -1.2472 TD
0.03 Tw
(detect genes involved in the predisposition to complex)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
(disorders. Several methods to examine multiple regions)Tj
0 -1.2472 TD
0.033 Tc
0.188 Tw
(simultaneously have been proposed, including the)Tj
T*
0 Tc
0 Tw
(methods of Cox et al. \(1999\), who suggested using stan-)Tj
0 -1.2543 TD
0.003 Tc
(dard linkage analysis based on allele-sharing, with fam-)Tj
0 -1.2472 TD
0.009 Tc
0.136 Tw
(ily weighting based on the evidence of linkage at an)Tj
0 -1.2543 TD
0.131 Tw
(unlinked locus, believed to interact with the locus of)Tj
0 -1.2472 TD
0.007 Tc
0.09 Tw
[(interest. )-69(W)79(e)-2( investigated two issues in the application)]TJ
T*
0.006 Tc
0.151 Tw
[(of )8(this )8(approach. )-133(T)64(o)-3( identify loci that are potentially)]TJ
0 -1.2543 TD
0.009 Tc
0.086 Tw
(interacting, Cox et al. suggested examining the corre-)Tj
0 -1.2472 TD
0.008 Tc
0.065 Tw
[(lation of family NPL)36( scores at the two loci. )-6(As an ad-)]TJ
T*
0.009 Tc
0.145 Tw
(junct to this, we investigated the value of scatterplot)Tj
0 -1.2543 TD
0.015 Tc
0.187 Tw
(matrices and other more complex data visualization)Tj
0 -1.2472 TD
0.01 Tc
0.03 Tw
(techniques such as 3-d plots using XGOBI \(Swayne et)Tj
ET

endstream
endobj
399 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
398 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
397 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
396 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
388 0 obj
<</Length 13295>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(215)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.009 Tc
0.162 Tw
[(al, 1998\). Secondly)66(, the method proposed by Cox et)]TJ
0 -1.2543 TD
0.017 Tw
(al. focuses on evaluating linkage at a specified suscep-)Tj
0 -1.2472 TD
0.129 Tw
[(tibility locus identified in previous studies. However)30(,)]TJ
0 -1.2543 TD
0.026 Tw
(because genome-wide scans may only provide a rough)Tj
0 -1.2472 TD
0.053 Tw
(localization of susceptibility genes, we propose evalu-)Tj
T*
0.122 Tw
(ating chromosomal regions around a locus for poten-)Tj
0 -1.2543 TD
0.01 Tc
0.188 Tw
[(tial interactions. )-181(W)68(e)-11( )]TJ
9.2571 0 TD
0.021 Tc
0.187 Tw
(use simulation to evaluate the)Tj
-9.2571 -1.2472 TD
0.009 Tc
0.113 Tw
(significance of the maximum regional increase in the)Tj
0 -1.2543 TD
0.012 Tw
(LOD score, associated with weighting by other loci.)Tj
/T39 1 Tf
14 0 0 14 59.981 519.987 Tm
-0.021 Tc
(71)Tj
/F5 1 Tf
8 0 0 8 59.981 502.979 Tm
0.009 Tc
0 Tw
(Power of the affected-sib pair with assortative)Tj
0 -1.2472 TD
0.002 Tw
(mating and cultural transmission)Tj
/F14 1 Tf
T*
0.01 Tc
0.005 Tw
[(A. )45(A. )17(T)68(odorov)67(, N. L. Saccone, P)109(.A.F)88(. Madden, )52(A.C.)]TJ
0 -1.2543 TD
0.011 Tc
(Heath)Tj
0 -1.2472 TD
0.01 Tc
0.009 Tw
[(W)75(ashington University)67(, St. Louis, MO, USA)]TJ
1.5024 -1.7504 TD
0.009 Tc
0.115 Tw
[(T)67(ypically)59(, studies of the ef)23(fect of assortative mat-)]TJ
-1.5024 -1.2543 TD
0.016 Tw
(ing on linkage power assume that mating is assortative)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
(with respect to the phenotype under study and that there)Tj
T*
0.009 Tc
0.073 Tw
(is no residual \(e.g., cultural\) transmission from parent)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
[(to of)15(fspring. )22(W)80(e)0( have implemented a general algorithm)]TJ
0 -1.2472 TD
0.084 Tw
[(that relaxes these two assumptions. )-78(The joint parental)]TJ
T*
0.009 Tc
0.112 Tw
[(phenotypic distribution is modeled from the mar)9(ginal)]TJ
0 -1.2543 TD
0.1 Tw
(distributions using a copula, which permits the impo-)Tj
0 -1.2472 TD
0.01 Tc
0.187 Tw
(sition of a constant rank correlation between mates\222)Tj
0 -1.2543 TD
0.009 Tc
0.167 Tw
(phenotypes, independently of the mar)Tj
16.0724 0 TD
-0.015 Tc
0.295 Tw
[(ginals. A)-25(s)-25( )]TJ
4.6193 0 TD
0.01 Tc
(with)Tj
-20.6918 -1.2472 TD
0.009 Tc
0.172 Tw
(other approaches to this problem, we obtain f)Tj
4.8 0 0 4.8 217.814 352.573 Tm
(\(k+1\))Tj
8 0 0 8 228.756 349.002 Tm
0.003 Tc
(\(x)Tj
4.8 0 0 4.8 235.559 347.811 Tm
0 Tc
0 Tw
(0)Tj
8 0 0 8 237.997 349.002 Tm
(,)Tj
-22.252 -1.2472 TD
(g)Tj
4.8 0 0 4.8 64.12 337.776 Tm
(0)Tj
8 0 0 8 66.557 339.024 Tm
0.009 Tc
0.062 Tw
(\), the joint distribution of oligogenotype and pheno-)Tj
-0.822 -1.2543 TD
0.007 Tc
0.029 Tw
(type in generation )Tj
/F16 1 Tf
7.7315 0 TD
0.009 Tc
(k+1)Tj
/F14 1 Tf
1.6512 0 TD
0.031 Tw
(, by integrating/summing f)Tj
4.8 0 0 4.8 222.973 332.617 Tm
0.013 Tc
(\(k\))Tj
8 0 0 8 228.756 328.989 Tm
0.003 Tc
(\(x)Tj
4.8 0 0 4.8 235.559 327.798 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 237.997 328.989 Tm
(,)Tj
-22.252 -1.2472 TD
(x)Tj
4.8 0 0 4.8 64.12 317.82 Tm
(2)Tj
8 0 0 8 66.557 319.011 Tm
0.01 Tc
0.05 Tw
(, g)Tj
4.8 0 0 4.8 75.175 317.82 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 77.669 319.011 Tm
0.01 Tc
0.057 Tw
(, g)Tj
4.8 0 0 4.8 86.343 317.82 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 88.781 319.011 Tm
0.007 Tc
0.05 Tw
(\) f\(x)Tj
4.8 0 0 4.8 103.521 317.82 Tm
0 Tc
0 Tw
(0)Tj
8 0 0 8 106.016 319.011 Tm
0.01 Tc
0.057 Tw
(, g)Tj
4.8 0 0 4.8 114.69 317.82 Tm
0 Tc
0 Tw
(0)Tj
8 0 0 8 117.128 319.011 Tm
0.009 Tc
0.053 Tw
[( | x)]TJ
4.8 0 0 4.8 127.899 317.82 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 130.337 319.011 Tm
0.01 Tc
0.05 Tw
(, x)Tj
4.8 0 0 4.8 139.011 317.82 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 141.449 319.011 Tm
0.01 Tc
0.057 Tw
(, g)Tj
4.8 0 0 4.8 150.123 317.82 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 152.617 319.011 Tm
0.01 Tc
0.05 Tw
(, g)Tj
4.8 0 0 4.8 161.235 317.82 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 163.672 319.011 Tm
0.009 Tc
0.055 Tw
(\) over all parental phe-)Tj
-12.9614 -1.2543 TD
0.106 Tw
(notypes \(x)Tj
4.8 0 0 4.8 95.131 307.786 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 97.625 308.976 Tm
0.01 Tc
0.107 Tw
(, x)Tj
4.8 0 0 4.8 106.696 307.786 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 109.134 308.976 Tm
0.009 Tc
0.106 Tw
(\) and oligogenotypes \(g)Tj
4.8 0 0 4.8 189.184 307.786 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 191.622 308.976 Tm
0.01 Tc
0.107 Tw
(, g)Tj
4.8 0 0 4.8 200.75 307.786 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 203.187 308.976 Tm
0.01 Tc
0.199 Tw
[(\))56(.)56( The )90(pro-)]TJ
-17.9008 -1.2472 TD
0.009 Tc
0.125 Tw
(gram uses adaptive quadrature integration \(A. Genz\).)Tj
T*
0.008 Tc
0 Tw
(It computes f)Tj
4.8 0 0 4.8 103.124 292.592 Tm
0.006 Tc
(\(k+1\))Tj
8 0 0 8 114.066 289.021 Tm
0.003 Tc
(\(x)Tj
4.8 0 0 4.8 120.869 287.773 Tm
0 Tc
(0)Tj
8 0 0 8 123.307 289.021 Tm
0.01 Tc
(, g)Tj
4.8 0 0 4.8 131.528 287.773 Tm
0 Tc
(0)Tj
8 0 0 8 134.022 289.021 Tm
0.008 Tc
(\) for all g)Tj
4.8 0 0 4.8 164.75 287.773 Tm
0 Tc
(0)Tj
8 0 0 8 167.187 289.021 Tm
0.009 Tc
( \(including phase\) and)Tj
-13.4008 -1.2543 TD
0.051 Tw
(for a number of values of x)Tj
4.8 0 0 4.8 151.54 277.795 Tm
0 Tc
0 Tw
(0)Tj
8 0 0 8 153.978 278.986 Tm
0.009 Tc
0.051 Tw
[(.)50( At the moment, interme-)]TJ
-11.7496 -1.2472 TD
0.008 Tc
0.066 Tw
[(diate values are recovered using )-21(Akima splines. Users)]TJ
T*
0 Tw
(provide three separate functions that specify \(a\) the ge-)Tj
0 -1.2543 TD
0.009 Tc
0.108 Tw
[(netic model under study)59(, \(b\) the copula function, and)]TJ
0 -1.2472 TD
0.006 Tc
0.15 Tw
[(\(c\) )6(the )6(transmission )6(function. )-82(All three of which can)]TJ
0 -1.2543 TD
0.007 Tc
0.104 Tw
[(be made dependent upon k. )-86(W)72(e)-2( are currently running)]TJ
0 -1.2472 TD
0.015 Tc
0.187 Tw
(analyses to determine whether the power of the af-)Tj
T*
0.009 Tc
0.072 Tw
(fected-sib pair method can be adequately described in)Tj
0 -1.2543 TD
0.01 Tw
(terms of the basic parameters of the model.)Tj
1.5024 -1.2472 TD
0.003 Tc
0.187 Tw
(Supported in part by )Tj
9.3969 0 TD
-0.008 Tc
(AA-00728, )Tj
5.0315 0 TD
0.013 Tc
0.188 Tw
(AA-12232, and)Tj
-15.9307 -1.2543 TD
0.014 Tc
(MH-17104)Tj
/T39 1 Tf
14 0 0 14 59.981 140.995 Tm
-0.021 Tc
(72)Tj
/F5 1 Tf
8 0 0 8 59.981 123.987 Tm
0.01 Tc
0 Tw
(Age-dependent penetrances among carriers of)Tj
0 -1.2472 TD
0.009 Tc
[(NA)66(T2 polymor)9(hisms with mutations in DNA)]TJ
T*
0.006 Tw
[(mismatch r)16(epair)9( genes)]TJ
/F14 1 Tf
0 -1.2543 TD
0.004 Tw
[(Frederick T)74(.)0( O\222Donnell, Marsha L. Frazier)30(,)]TJ
0 -1.2472 TD
0.008 Tc
0.019 Tw
[(Christopher I. )37(Amos)]TJ
25.5047 69.2504 TD
0.009 Tc
0.01 Tw
[(The University of )9(T)67(exas M. D. )45(Anderson Cancer)]TJ
0 -1.2543 TD
0.008 Tc
0.022 Tw
[(Center)36(, Houston, T)59(exas 77030)]TJ
/F22 1 Tf
1.4953 -1.7504 TD
0.047 Tc
(Background)Tj
/F14 1 Tf
5.5913 0 TD
0.19 Tw
[( Mutations in N-acetyltransferase)]TJ
-7.0866 -1.2472 TD
0.009 Tc
0.124 Tw
[(\(NA)115(T2\), a highly polymorphic drug metabolizing en-)]TJ
0 -1.2543 TD
0.137 Tw
[(zyme expressed in the colorectal mucosa, may af)30(fect)]TJ
0 -1.2472 TD
0.042 Tw
(risk for colorectal cancer \(CRC\), especially among in-)Tj
T*
0.131 Tw
(dividuals with germline mutations in DNA mismatch)Tj
0 -1.2543 TD
0.009 Tw
(repair \(MMR\) genes.)Tj
/F22 1 Tf
1.4953 -1.2472 TD
0.012 Tc
(Methods)Tj
/F14 1 Tf
3.6425 0 TD
0.188 Tw
[( NA)118(T2 genotypes and allele frequencies)]TJ
-5.1378 -1.2543 TD
0.009 Tc
0.031 Tw
(were determined for 79 individuals with colorectal ad-)Tj
0 -1.2472 TD
0.024 Tc
0.188 Tw
(enocarcinoma who also had mutations in )Tj
/F16 1 Tf
18.8646 0 TD
0 Tc
0 Tw
(h)Tj
/F14 1 Tf
0.5386 0 TD
0.031 Tc
(MLH1,)Tj
/F16 1 Tf
-19.4031 -1.2472 TD
0 Tc
(h)Tj
/F14 1 Tf
0.5102 0 TD
-0.008 Tc
0.138 Tw
(MSH2, or )Tj
/F16 1 Tf
4.6134 0 TD
0 Tc
0 Tw
(h)Tj
/F14 1 Tf
0.5102 0 TD
-0.018 Tc
(PMS1. )Tj
3.1465 0 TD
0.009 Tc
0.138 Tw
(After each individual was tested)Tj
-8.7803 -1.2543 TD
0.008 Tc
0.061 Tw
[(for 3 possible NA)121(T2 polymorphisms M1 \(341 )-35(T)10( > C\);)]TJ
0 -1.2472 TD
0.007 Tc
0.054 Tw
[(M2 \(590 G > )6(A\); M3 \(857 G > )-8(A\), Kaplan-Meier sur)14(-)]TJ
T*
0.009 Tc
0.138 Tw
(vival curves were prepared to compare time to onset)Tj
0 -1.2543 TD
0.08 Tw
[(for carriers of each polymorphism. In addition, NA)115(T)-7(2)]TJ
0 -1.2472 TD
0.099 Tw
(genotype was used to determine acetylator phenotype)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
[(for all MMR mutation carriers. )14(W)86(e)0( then compared time)]TJ
0 -1.2472 TD
0.009 Tc
0.013 Tw
(to onset between rapid and slow acetylators.)Tj
/F22 1 Tf
1.4953 -1.2472 TD
-0.016 Tc
(Results )Tj
/F14 1 Tf
3.2031 0 TD
-0.011 Tc
0.043 Tw
(When individuals were grouped according to)Tj
-4.6984 -1.2543 TD
0.06 Tw
[(acetylator phenotype, no significant dif)24(ference in time to)]TJ
0 -1.2472 TD
0.105 Tw
(onset was observed between rapid and slow acetylators.)Tj
0 -1.2543 TD
-0.015 Tc
0 Tw
[(However)35(, when individuals were stratified by NA)113(T2 poly-)]TJ
0 -1.2472 TD
-0.011 Tc
0.075 Tw
(morphism \(M1, M2, M3\), those who were heterozygous)Tj
T*
-0.01 Tc
0.188 Tw
(for the mutant M3 allele \(WT/M3\) had a significantly)Tj
0 -1.2543 TD
-0.011 Tc
0.069 Tw
(higher risk of CRC \(n=7, mean age = 41\) than individu-)Tj
0 -1.2472 TD
0.164 Tw
(als homozygous for the wild type M3 allele \(WT/WT\))Tj
T*
-0.01 Tc
0.015 Tw
(\(n=70, mean age = 48\) \(p = 0.0186\).)Tj
/F22 1 Tf
1.4953 -1.2543 TD
0.028 Tc
(Conclusions )Tj
/F14 1 Tf
5.7047 0 TD
0 Tw
[(These findings suggest NA)106(T2 geno-)]TJ
-7.2 -1.2472 TD
0.029 Tc
0.156 Tw
(type to be an important factor in tumorigenesis of)Tj
0 -1.2543 TD
0.063 Tw
[(CRC. Further studies may be needed to better char)15(-)]TJ
0 -1.2472 TD
0.027 Tc
-0.001 Tw
[(acterize relationships between NA)119(T2 polymorphisms)]TJ
T*
0.03 Tc
0.056 Tw
(and age-dependent penetrances among HNPCC mu-)Tj
0 -1.2543 TD
0.029 Tc
0.012 Tw
(tation carriers.)Tj
/T39 1 Tf
14 0 0 14 264.019 264.983 Tm
-0.021 Tc
(73)Tj
/F5 1 Tf
8 0 0 8 264.019 247.975 Tm
0.009 Tc
0 Tw
(Childhood antisocial behavior and dopamine)Tj
0 -1.2472 TD
0.005 Tw
[(genes: )23(T)88(esting for)9( mediation via r)16(egr)23(ession-based)]TJ
T*
0.01 Tc
-0.001 Tw
[(extensions of the )16(TDT)]TJ
/F14 1 Tf
0 -1.2543 TD
0.008 Tc
-0.002 Tw
[(ID W)87(aldman)]TJ
4.8 0 0 4.8 305.518 221.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 308.013 217.984 Tm
0.009 Tc
0.009 Tw
(, JH Mohr)Tj
4.8 0 0 4.8 341.518 221.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 343.956 217.984 Tm
0.009 Tc
-0.032 Tw
[(,)11( A)51( )14(Abramowitz)]TJ
4.8 0 0 4.8 395.66 221.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 398.098 217.984 Tm
(,)Tj
-16.7598 -1.2472 TD
0.009 Tc
(SL Sherman)Tj
4.8 0 0 4.8 304.554 211.578 Tm
0 Tc
(3)Tj
8 0 0 8 306.992 208.006 Tm
0.01 Tc
(, HH Cleveland)Tj
4.8 0 0 4.8 358.072 211.578 Tm
0 Tc
(4)Tj
8 0 0 8 360.567 208.006 Tm
0.01 Tc
(, JMC Gard)Tj
4.8 0 0 4.8 398.891 211.578 Tm
0 Tc
(5)Tj
8 0 0 8 401.272 208.006 Tm
(,)Tj
-17.1567 -1.2472 TD
0.01 Tc
0.006 Tw
(LN Giedinghagen)Tj
4.8 0 0 4.8 322.809 201.6 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 325.247 198.028 Tm
0.009 Tc
0.01 Tw
(, C Stever)Tj
4.8 0 0 4.8 357.959 201.6 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 360.397 198.028 Tm
0.011 Tc
0.009 Tw
(, DC Rowe)Tj
4.8 0 0 4.8 397.077 201.6 Tm
0.013 Tc
(4,6)Tj
8 0 0 8 264.019 187.994 Tm
0.009 Tc
(Psychology)Tj
4.8 0 0 4.8 302.116 191.622 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 304.554 187.994 Tm
0.009 Tc
0.012 Tw
(, Psychiatry)Tj
4.8 0 0 4.8 343.276 191.622 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 345.77 187.994 Tm
0.009 Tc
0.019 Tw
(, and Genetics and Molecular)Tj
-10.2189 -1.2472 TD
(Medicine)Tj
4.8 0 0 4.8 294.803 181.587 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 297.241 178.016 Tm
0.009 Tc
0.015 Tw
(, Emory University; Family Studies)Tj
4.8 0 0 4.8 414.198 181.587 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 416.636 178.016 Tm
(,)Tj
-19.0772 -1.2543 TD
0.009 Tc
0.015 Tw
(Molecular and Cell Biology)Tj
4.8 0 0 4.8 355.861 171.61 Tm
0 Tc
0 Tw
(5)Tj
8 0 0 8 358.299 167.981 Tm
0.009 Tc
0.017 Tw
(, Graduate Committee on)Tj
-11.785 -1.2472 TD
(Genetics)Tj
4.8 0 0 4.8 292.592 161.632 Tm
0 Tc
0 Tw
(6)Tj
8 0 0 8 295.03 158.003 Tm
0.009 Tc
0.014 Tw
[(, University of )44(Arizona)]TJ
-2.3811 -1.7504 TD
0.008 Tc
0 Tw
(Understanding the etiology and development of an-)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.113 Tw
(tisocial behavior is an important, albeit controversial,)Tj
0 -1.2543 TD
0.091 Tw
(goal of psychiatric genetic research. Behavior genetic)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
(studies have found substantial heritability for childhood)Tj
T*
0.007 Tc
0.116 Tw
[(and )-7(adolescent )-7(antisocial )-7(behavior)35(, as well as for )-69(At-)]TJ
0 -1.2543 TD
0.009 Tc
0 Tw
(tention Deficit Hyperactivity Disorder \(ADHD\). Given)Tj
0 -1.2472 TD
[(the considerable overlap between )66(ADHD and disorders)]TJ
ET

endstream
endobj
410 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
408 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
409 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
407 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
401 0 obj
<</Length 10308>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(216)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.066 Tw
(representing childhood antisocial behavior \(e.g., Opposi-)Tj
0 -1.2543 TD
-0.01 Tc
0.028 Tw
(tional Defiant Disorder [ODD], Conduct Disorder [CD]\),)Tj
0 -1.2472 TD
-0.011 Tc
0.092 Tw
(it is reasonable to hypothesize that these disorders share)Tj
0 -1.2543 TD
-0.015 Tc
0 Tw
[(common causes. )56(A)48( number of previous studies have found)]TJ
0 -1.2472 TD
-0.014 Tc
0.176 Tw
[(association and linkage between childhood )-128(ADHD )-6(and)]TJ
T*
-0.01 Tc
0.027 Tw
[(the dopamine transporter gene \(DA)110(T1\) and the dopamine)]TJ
0 -1.2543 TD
0.053 Tw
[(receptor D4 gene \(DRD4\). In this study)61(, we examine the)]TJ
0 -1.2472 TD
0.055 Tw
[(etiological role of DA)103(T1 and DRD4 in childhood antiso-)]TJ
0 -1.2543 TD
-0.017 Tc
0 Tw
[(cial behavior)47(. )26(W)77(e)0( sampled DNA)54( and symptoms of )54(ADHD,)]TJ
0 -1.2472 TD
-0.012 Tc
(ODD, and CD from clinic-referred children, their parents,)Tj
T*
-0.013 Tc
0.103 Tw
[(and their siblings in 123 families. )-99(W)81(e)-2( examined linkage)]TJ
0 -1.2543 TD
-0.011 Tc
0.047 Tw
[(disequilibrium between DA)102(T1 and DRD4 and symptoms)]TJ
0 -1.2472 TD
0.181 Tw
(of these disorders using regression-based extensions of)Tj
T*
-0.033 Tc
0.14 Tw
[(the T)]TJ
2.0409 0 TD
-0.013 Tc
0.066 Tw
[(ransmission Disequilibrium )-47(T)67(est \(TDT\) designed to)]TJ
-2.0409 -1.2543 TD
-0.011 Tc
0.097 Tw
(accommodate multiple categorical and continuous traits.)Tj
0 -1.2472 TD
0.027 Tw
[(W)83(e)0( found evidence suggesting association and linkage of)]TJ
0 -1.2543 TD
-0.007 Tc
0.187 Tw
[(D)-9(A)113(T1, but not DRD4, with increasing levels of ODD)]TJ
0 -1.2472 TD
-0.011 Tc
0.149 Tw
(symptoms, CD symptoms, and the hyperactivity-impul-)Tj
T*
-0.013 Tc
0.056 Tw
[(sivity symptoms of )-12(ADHD. )9(After controlling for level of)]TJ
0 -1.2543 TD
-0.015 Tc
0 Tw
[(hyperactivity-impulsivity symptoms, the relation of DA)113(T1)]TJ
0 -1.2472 TD
-0.01 Tc
0.104 Tw
(with both ODD and CD symptoms was non-significant.)Tj
0 -1.2543 TD
0.188 Tw
[(These findings suggest that the relation of DA)103(T1 with)]TJ
0 -1.2472 TD
-0.011 Tc
0.053 Tw
(childhood antisocial behavior appears to be totally medi-)Tj
T*
0.04 Tw
[(ated by hyperactivity-impulsivity)60(.)]TJ
/T40 1 Tf
14 0 0 14 50.981 366.973 Tm
-0.021 Tc
(74)Tj
/F5 1 Tf
8 0 0 8 50.981 349.002 Tm
0.009 Tc
0 Tw
[(Measur)9(ed haplotype analysis of the )59(Angiotensin-I)]TJ
T*
0.01 Tc
0.006 Tw
(converting enzyme \(ACE\) gene in Jamaican)Tj
0 -1.2543 TD
0.007 Tc
(subjects)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0 Tw
(Zhu X)Tj
4.8 0 0 4.8 72.128 322.583 Tm
0 Tc
(1)Tj
8 0 0 8 74.565 319.011 Tm
0.009 Tc
0.003 Tw
(, Rieder M)Tj
4.8 0 0 4.8 109.828 322.583 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 112.266 319.011 Tm
0.009 Tc
0.003 Tw
(, McKenzie C)Tj
4.8 0 0 4.8 157.904 322.583 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 160.342 319.011 Tm
0.009 Tc
0.006 Tw
[(, Forrester )16(T)]TJ
4.8 0 0 4.8 201.047 322.583 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 203.485 319.011 Tm
(,)Tj
-19.063 -1.2543 TD
0.008 Tc
0.006 Tw
[(W)31(ilks R)]TJ
4.8 0 0 4.8 77.684 312.605 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 80.178 308.976 Tm
0.01 Tc
0.006 Tw
(, Cooper R)Tj
4.8 0 0 4.8 115.951 312.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 118.389 308.976 Tm
0.01 Tc
0.006 Tw
(, Guo X)Tj
4.8 0 0 4.8 144.638 312.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 147.132 308.976 Tm
0.009 Tc
0.006 Tw
(, Rotimi C)Tj
4.8 0 0 4.8 181.488 312.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 183.983 308.976 Tm
0.009 Tc
0.009 Tw
[(, Luke )51(A)]TJ
4.8 0 0 4.8 212.556 312.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 214.994 308.976 Tm
(.)Tj
4.8 0 0 4.8 50.981 302.627 Tm
(1)Tj
8 0 0 8 53.476 298.998 Tm
0.009 Tc
0.019 Tw
[(Loyola University Medical Center)37(, Maywood,)]TJ
-0.3118 -1.2472 TD
0.008 Tc
0.013 Tw
(Illinois, USA; )Tj
4.8 0 0 4.8 99.227 292.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 101.665 289.021 Tm
0.009 Tc
0.015 Tw
(Department of Molecular Biotechnol-)Tj
-6.3354 -1.2543 TD
0.008 Tc
0.02 Tw
[(ogy)51(, University of )-6(W)80(ashington, Seattle, )-6(W)80(ashington,)]TJ
0 -1.2472 TD
(USA; )Tj
4.8 0 0 4.8 71.731 272.58 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 74.169 269.008 Tm
0.009 Tc
0.013 Tw
[(T)32(ropical Metabolism Research Unit, University)]TJ
-2.8984 -1.2472 TD
0.01 Tw
[(of the W)81(est Indies, Kingston, Jamaica)]TJ
1.5024 -1.878 TD
0.027 Tw
(The definition of the relationship between multiple)Tj
-1.5024 -1.2472 TD
0.091 Tw
(polymorphisms in a small genomic region and an un-)Tj
0 -1.2543 TD
0.006 Tc
0 Tw
(derlying quantitative trait locus \(QTL\) represents a ma-)Tj
0 -1.2472 TD
0.038 Tc
0.188 Tw
(jor challenge. Pedigree analyses have shown that)Tj
0 -1.2543 TD
0.009 Tc
0.089 Tw
(angiotensin-I converting enzyme \(ACE\) levels are in-)Tj
0 -1.2472 TD
0.042 Tw
[(fluenced by a QTL)37( located within or close to the ACE)]TJ
T*
0.007 Tc
0 Tw
(gene. In addition, measured haplotype analyses in Cau-)Tj
0 -1.2543 TD
0.009 Tc
0.113 Tw
(casian families appear to have excluded upstream se-)Tj
0 -1.2472 TD
0.006 Tc
0.151 Tw
[(quences )7(including )7(the )-97(ACE promoter from harboring)]TJ
0 -1.2543 TD
0.008 Tc
0.07 Tw
[(the )8(major )-19(ACE-linked variant. It is possible that simi-)]TJ
0 -1.2472 TD
0.009 Tc
0.093 Tw
(lar analyses in unrelated individuals might be used to)Tj
T*
0.008 Tc
0.025 Tw
[(further refine the position of the )22(ACE-linked QTL. )-6(W)73(e)]TJ
0 -1.2543 TD
0.009 Tc
0.167 Tw
(have studied a random sample of 178 individuals of)Tj
0 -1.2472 TD
0.015 Tc
0.187 Tw
(Afro-Caribbean descent from Jamaica using linkage)Tj
T*
0 Tc
0 Tw
(disequilibrium \(LD\) analysis as well as a measured hap-)Tj
0 -1.2543 TD
0.007 Tc
0.112 Tw
[(lotype )7(analysis. )-54(An examination of 5 polymorphisms,)]TJ
0 -1.2472 TD
0.009 Tc
0.034 Tw
(including the insertion/deletion \(I/D\) polymorphism in)Tj
25.5047 69.2504 TD
0.161 Tw
(intron 16, spanning 22 kilobases shows a graded in-)Tj
0 -1.2543 TD
0 Tc
0 Tw
(crease in LD, from 5\264 to 3\264, between the polymorphisms)Tj
0 -1.2472 TD
-0.001 Tc
0.136 Tw
[(and the putative )-94(ACE QTL. )-80(A)41( )]TJ
13.2297 0 TD
0.009 Tc
0.137 Tw
(series of nested, mea-)Tj
-13.2297 -1.2543 TD
0.006 Tc
0 Tw
(sured haplotype analyses was performed which showed)Tj
0 -1.2472 TD
0.007 Tc
0.081 Tw
[(that the I/D polymorphism is unlikely to be the )-21(ACE-)]TJ
T*
0.008 Tc
0.061 Tw
[(linked QTL. In fact the variant which influences )-6(ACE)]TJ
0 -1.2543 TD
0.009 Tc
0.117 Tw
(levels is likely to lie further downstream. Our results)Tj
0 -1.2472 TD
0.094 Tw
(suggest that analysis of haplotypes, which summarize)Tj
0 -1.2543 TD
0.028 Tw
[(linkage disequilibrium relationships between polymor)16(-)]TJ
0 -1.2472 TD
0.049 Tw
(phisms in small genomic regions, is a useful approach)Tj
T*
0 Tc
0 Tw
(to localizing variants which influence quantitative traits.)Tj
/T40 1 Tf
14 0 0 14 255.019 496.97 Tm
-0.021 Tc
(75)Tj
/F5 1 Tf
8 0 0 8 255.019 480.019 Tm
0.009 Tc
(A new explicit algorithm to calculate identity by)Tj
0 -1.2543 TD
[(descent pr)16(obabilities for)16( pairs of r)16(elatives with)]TJ
0 -1.2472 TD
[(r)21(espect to two linked loci)]TJ
/F14 1 Tf
0 -1.2543 TD
0.005 Tw
[(H. )17(T)39(iwari, R. Elston)]TJ
/F20 1 Tf
0 -1.1976 TD
0.017 Tw
(Department of Epidemiology and Biostatistics)Tj
T*
0.005 Tw
[(Case )9(W)66(estern Reserve University)59(, Cleveland, OH.)]TJ
/F14 1 Tf
1.4953 -1.7504 TD
0.157 Tw
(Denniston \(1975\) gave a method to calculate ibd)Tj
-1.4953 -1.2543 TD
0.158 Tw
(sharing probabilities for any non-inbred pair of rela-)Tj
0 -1.2472 TD
0.001 Tc
0 Tw
[(tives with respect to two linked loci. However)44(, the com-)]TJ
T*
0.009 Tc
0.107 Tw
(putation of ibd sharing probabilities by his method is)Tj
0 -1.2543 TD
0.02 Tc
0.188 Tw
[(cumbersome and is not a recursive algorithm. )-171(T)-7(h)-7(e)]TJ
0 -1.2472 TD
0.009 Tc
0.112 Tw
(present paper first gives a simple recursive algorithm)Tj
T*
0.134 Tw
(for determining the joint probabilities that alleles are)Tj
0 -1.2543 TD
0.136 Tw
(identical by descent at two linked autosomal loci for)Tj
0 -1.2472 TD
0.023 Tw
[(any pair of relatives in a non-inbred pedigree. W)74(e)0( then)]TJ
0 -1.2543 TD
0.094 Tw
(indicate how the method can be extended to arbitrary)Tj
0 -1.2472 TD
0.111 Tw
(pairs of relatives and we give several examples to il-)Tj
T*
0.019 Tw
(lustrate the method.)Tj
/T40 1 Tf
14 0 0 14 255.019 265.323 Tm
-0.021 Tc
(76)Tj
/F5 1 Tf
8 0 0 8 255.019 248.315 Tm
0.009 Tc
0.008 Tw
[(Using Categorical Path )44(Analysis to Estimate Dir)23(ect)]TJ
0 -1.2543 TD
-0.001 Tw
[(and Indir)16(ect Ef)-5(fects of Genetic and Envir)16(onmental)]TJ
0 -1.2472 TD
0 Tw
(Risk Factors in Epidemiologic Studies)Tj
/F14 1 Tf
T*
0.01 Tc
0.003 Tw
[(T)75(.G. Lesnick, )24(W)89(.)0( Liu, D. Miller)38(, R. Marks, P)116(.)3( )24(Y)101(ang.)]TJ
0 -1.2543 TD
0.011 Tw
[(Mayo Clinic and Foundation, Rochester)38(, MN USA)]TJ
1.4953 -1.7504 TD
0.001 Tc
0 Tw
(Most epidemiologic studies of complex diseases use)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.173 Tw
(techniques such as multiple regression to investigate)Tj
T*
0.031 Tw
(relationships between outcomes of interest and several)Tj
0 -1.2543 TD
0.001 Tc
0 Tw
(risk factors. Often, we are interested in providing causal)Tj
0 -1.2472 TD
(interpretations to the estimated associations. Path analy-)Tj
0 -1.2543 TD
0.009 Tc
0.11 Tw
[(sis has been used as a method to provide these inter)16(-)]TJ
0 -1.2472 TD
0.008 Tc
0.072 Tw
[(pretations. )-12(A)50( conceptual model of causation based on,)]TJ
T*
0.009 Tc
0.143 Tw
(e.g., biological principles or temporal information, is)Tj
0 -1.2543 TD
0.137 Tw
(specified in the first step. Regular path analysis then)Tj
0 -1.2472 TD
0.08 Tw
(uses hierarchical systems of linear models to estimate)Tj
0 -1.2543 TD
0.163 Tw
[(direct, indirect, and total causal ef)23(fects. Spurious ef-)]TJ
0 -1.2472 TD
0.008 Tc
0 Tw
(fects are removed in the process. Considering categori-)Tj
ET

endstream
endobj
419 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
420 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
418 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
412 0 obj
<</Length 13012>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(217)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.009 Tc
0.126 Tw
(cal variables in the analysis involves additional chal-)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
(lenges, and is only incompletely analogous to the regu-)Tj
0 -1.2472 TD
0.009 Tc
0.188 Tw
(lar method. )Tj
5.478 0 TD
0.026 Tc
(Whereas the regular method partitions)Tj
-5.478 -1.2543 TD
0.009 Tc
0.048 Tw
(correlations between variables, categorical path analy-)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
[(sis uses systems of loglinear models to estimate ef)19(fects.)]TJ
T*
0.009 Tc
0.009 Tw
[(W)74(e)0( present the concepts, procedures, and pictorial rep-)]TJ
0 -1.2543 TD
0.09 Tw
(resentations used in this approach, and discuss poten-)Tj
0 -1.2472 TD
0.016 Tw
[(tial obstacles. )8(W)81(e)0( illustrate the methodology using two)]TJ
0 -1.2543 TD
0.013 Tc
0.187 Tw
(analyses of factors predicting short-term survival of)Tj
0 -1.2472 TD
0.005 Tc
0.192 Tw
[(lung )9(cancer )9(patients. )-132(A)47( combination of genotypes at)]TJ
T*
0.009 Tc
0.112 Tw
(glutathione-related loci \()Tj
/F16 1 Tf
10.3465 0 TD
0.011 Tc
(GSTP1)Tj
/F14 1 Tf
2.9409 0 TD
-0.02 Tc
0.113 Tw
[( and )]TJ
/F17 1 Tf
2.2181 0 TD
0 Tc
0 Tw
(g)Tj
/F14 1 Tf
0.4252 0 TD
(-)Tj
/F16 1 Tf
0.3472 0 TD
0.012 Tc
(GCS)Tj
/F14 1 Tf
1.9205 0 TD
0.009 Tc
0.112 Tw
(\) is exam-)Tj
-18.1984 -1.2543 TD
0.072 Tw
[(ined in the first, demonstrating a direct genetic ef)9(fect.)]TJ
0 -1.2472 TD
0.139 Tw
(Another combination of loci \()Tj
/F16 1 Tf
12.763 0 TD
-0.016 Tc
(GSTT1 )Tj
/F14 1 Tf
3.2882 0 TD
-0.036 Tc
(and )Tj
/F16 1 Tf
1.8709 0 TD
0.009 Tc
(GSTM1)Tj
/F14 1 Tf
3.1606 0 TD
0.008 Tc
0.144 Tw
(\) is)Tj
-21.0827 -1.2472 TD
0.03 Tc
0.188 Tw
[(in the second, demonstrating null ef)16(fects. Chemo-)]TJ
0 -1.2543 TD
0.009 Tc
0.107 Tw
[(therapy)59(, stage of disease at diagnosis, and pack years)]TJ
0 -1.2472 TD
0.019 Tw
(smoked are considered in both examples.)Tj
/T41 1 Tf
14 0 0 14 59.981 452.976 Tm
-0.021 Tc
(77)Tj
/F5 1 Tf
8 0 0 8 59.981 436.989 Tm
0.009 Tc
0.003 Tw
[(Identifying false linkage signals fr)23(om neural)]TJ
T*
(networks)Tj
/F14 1 Tf
0 -1.2543 TD
0.011 Tc
-0.001 Tw
[(NL)39( Saccone)]TJ
4.8 0 0 4.8 99.836 420.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 102.274 416.976 Tm
0.01 Tc
0.002 Tw
[(, JP)38( Rice)]TJ
4.8 0 0 4.8 130.961 420.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 133.398 416.976 Tm
0.009 Tc
0.005 Tw
[(, )17(TJ Downey Jr)]TJ
4.8 0 0 4.8 183.345 420.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 185.783 416.976 Tm
0.01 Tc
0.003 Tw
(, DJ Meyer)Tj
4.8 0 0 4.8 222.406 420.605 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 224.844 416.976 Tm
(,)Tj
-20.6079 -1.2472 TD
0.01 Tc
0.006 Tw
(RJ Neuman)Tj
4.8 0 0 4.8 98.305 410.627 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 100.743 406.998 Tm
0.01 Tc
0.013 Tw
[(, N Rochber)24(g)]TJ
4.8 0 0 4.8 144.624 410.627 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 147.118 406.998 Tm
0.009 Tc
-0.042 Tw
[(,)8( A)51( )-51(Goate)]TJ
4.8 0 0 4.8 177.959 410.627 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 180.397 406.998 Tm
0.01 Tc
0.013 Tw
[(, HJ Edenber)17(g)]TJ
4.8 0 0 4.8 227.055 410.627 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 229.493 406.998 Tm
(,)Tj
-21.189 -1.2472 TD
0.01 Tc
0.006 Tw
[(T)12( Foroud)]TJ
4.8 0 0 4.8 90.539 400.592 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 92.976 397.02 Tm
0.009 Tc
[(,)8( T)18( )-9(Reich)]TJ
4.8 0 0 4.8 123.08 400.592 Tm
0 Tc
(1)Tj
-13.1457 -2.0787 TD
(1)Tj
8 0 0 8 62.476 386.986 Tm
0.009 Tc
0.006 Tw
[(W)81(ashington Univ)59(., St. Louis, MO; )]TJ
4.8 0 0 4.8 176.768 390.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 179.206 386.986 Tm
0.009 Tc
0.01 Tw
(Partek Inc., St.)Tj
-14.9031 -1.2472 TD
0.008 Tc
0.009 Tw
(Peters, MO; )Tj
4.8 0 0 4.8 101.707 380.58 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 104.145 377.008 Tm
0.009 Tc
0.013 Tw
[(Indiana Univ)66(., Indianapolis, IN)]TJ
-4.0181 -1.6228 TD
0.083 Tw
(Neural networks have drawn attention as tools for)Tj
-1.5024 -1.2543 TD
0.005 Tc
0 Tw
(linkage analysis of complex traits. Current methods use)Tj
0 -1.2472 TD
0.009 Tc
(neural nets to classify subjects by phenotype, using ge-)Tj
0 -1.2543 TD
0.058 Tw
(netic information as input. Loci important for classifi-)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
[(cation are potentially linked to the trait. )15(These methods)]TJ
T*
0.009 Tc
0.117 Tw
(can produce high false positive rates, leading to con-)Tj
0 -1.2543 TD
0.017 Tw
(cerns about their usefulness.)Tj
1.5024 -1.2472 TD
-0.011 Tc
0.123 Tw
[(W)83(e)0( note that neural net classifiers do not inherently)]TJ
-1.5024 -1.2543 TD
0.131 Tw
(look for segregation of a genetic locus with a trait. For)Tj
0 -1.2472 TD
0.02 Tw
(example, we have used neural nets to classify sib pairs as)Tj
T*
0.014 Tw
[(phenotypically concordant or discordant, using IBD shar)17(-)]TJ
0 -1.2543 TD
-0.022 Tc
(ing. )Tj
1.715 0 TD
-0.011 Tc
0.045 Tw
[(Any locus at which sharing is markedly dif)17(ferent for)]TJ
-1.715 -1.2472 TD
0.056 Tw
(concordants versus discordants may lead to a signal; this)Tj
T*
0.032 Tw
(may include loci where discordants share more often due)Tj
0 -1.2543 TD
0.08 Tw
[(to )7(chance. )-60(T)68(o)-1( rule out such signals, we suggest a simple)]TJ
0 -1.2472 TD
0.011 Tw
(screen of the sharing patterns at signaled loci.)Tj
1.5024 -1.2543 TD
0.009 Tc
-0.001 Tw
[(W)81(e)0( illustrate using the COGA)59( \(Collaborative Study)]TJ
-1.5024 -1.2472 TD
0.008 Tc
0.07 Tw
[(on the Genetics of )-14(Alcoholism\) data. On chromosome)]TJ
T*
0.009 Tc
0.146 Tw
(1, neural nets indicated two signals; only the second)Tj
0 -1.2543 TD
0.006 Tc
0.175 Tw
[(was supported by traditional methods. )-173(When )-6(we )-6(ex-)]TJ
0 -1.2472 TD
0.012 Tc
0.187 Tw
(amined the first locus, 24% of the concordant pairs)Tj
0 -1.2543 TD
0.002 Tc
0 Tw
(showed low sharing, 49% medium and 27% high, while)Tj
0 -1.2472 TD
[(discordants gave 18% low)59(, 57% medium and 24% high.)]TJ
T*
0.009 Tc
0.041 Tw
(In contrast, the second signal corresponded to patterns)Tj
0 -1.2543 TD
0.112 Tw
(of 22%, 45%, 33% in concordants versus 34%, 47%,)Tj
0 -1.2472 TD
0.076 Tw
(19% in discordants, which appears more indicative of)Tj
T*
0.015 Tw
[(linkage. )9(W)81(e)0( are refining these tests, as neural net mod-)]TJ
0 -1.2543 TD
0.017 Tc
0.187 Tw
(els may detect interacting loci that may not appear)Tj
0 -1.2472 TD
0.009 Tc
0.014 Tw
(linked to the trait when examined alone.)Tj
/T41 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.021 Tc
(78)Tj
/F5 1 Tf
8 0 0 8 264.019 618.009 Tm
0.009 Tc
0 Tw
[(T)74(ransmission disequilibrium analysis to identify a)]TJ
0 -1.2543 TD
[(modifier)23( gene for)9( cystic fibr)23(osis \(CF\) in the)]TJ
0 -1.2472 TD
0.028 Tw
[(chr)16(omosome 19q13.2 r)16(egion.)]TJ
/F14 1 Tf
T*
0.006 Tw
(Corey M)Tj
4.8 0 0 4.8 293.272 591.59 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 299.395 588.019 Tm
0.009 Tc
0.009 Tw
(, Zielenski J)Tj
4.8 0 0 4.8 339.42 591.59 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 341.858 588.019 Tm
0.009 Tc
0.006 Tw
(, Markiewicz D)Tj
4.8 0 0 4.8 392.995 591.59 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 395.433 588.019 Tm
0.009 Tc
0.013 Tw
(, Rozmahel)Tj
-16.4268 -1.2543 TD
0 Tc
0 Tw
(R)Tj
4.8 0 0 4.8 269.461 581.613 Tm
(1)Tj
8 0 0 8 271.899 577.984 Tm
0.009 Tc
-0.055 Tw
[(, Aznarez )-59(I)]TJ
4.8 0 0 4.8 307.672 581.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 310.167 577.984 Tm
0.009 Tc
0.003 Tw
(, Shin J)Tj
4.8 0 0 4.8 334.601 581.613 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 337.039 577.984 Tm
0.009 Tc
0.003 Tw
(, Durie P)Tj
4.8 0 0 4.8 366.463 581.613 Tm
0.013 Tc
(1,2)Tj
8 0 0 8 372.586 577.984 Tm
0.01 Tc
-0.014 Tw
[(, T)68(sui )-18(LC1,)]TJ
4.8 0 0 4.8 409.266 581.613 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 411.76 577.984 Tm
(,)Tj
-18.4677 -1.2472 TD
0.009 Tc
0.016 Tw
(Collaborative CF Modifier Study Group.)Tj
4.8 0 0 4.8 264.019 561.6 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 266.457 557.972 Tm
0.009 Tc
0.014 Tw
(Hospital for Sick Children, )Tj
4.8 0 0 4.8 357.619 561.6 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 360.113 557.972 Tm
0.009 Tc
0.014 Tw
[(University of T)67(oronto,)]TJ
-12.0118 -1.2472 TD
0.01 Tc
0.037 Tw
[(T)68(oronto, Canada.)]TJ
1.4953 -1.6228 TD
0 Tc
0 Tw
(Clinical phenotype in CF is highly variable, depend-)Tj
-1.4953 -1.2543 TD
0.01 Tc
0.146 Tw
(ing on CFTR genotype as well as secondary factors.)Tj
0 -1.2472 TD
0.009 Tc
0.062 Tw
[(W)81(e)0( found evidence for a candidate locus \(Zielenski et)]TJ
T*
0.032 Tw
(al. Nature Genetics in press\) that modifies the severity)Tj
0 -1.2543 TD
0.081 Tw
(of the intestinal phenotype, characterized by the pres-)Tj
0 -1.2472 TD
0.023 Tc
0.188 Tw
(ence or absence of meconium ileus \(MI\), a severe)Tj
0 -1.2543 TD
0.009 Tc
0.082 Tw
[(bowel obstruction af)23(fecting 15\22620% of CF patients at)]TJ
0 -1.2472 TD
-0.005 Tc
(birth. )Tj
2.5158 0 TD
0.01 Tc
0.087 Tw
(The region with highest linkage was a 3.75 Mb)Tj
-2.5158 -1.2472 TD
0.025 Tw
(interval between markers D19S408 and D19S412 with)Tj
0 -1.2543 TD
0.004 Tc
-0.001 Tw
[(maximum at the D19S1)39(12 marker)54(. Since the region was)]TJ
0 -1.2472 TD
0.009 Tc
0.082 Tw
[(still too lar)16(ge for systematic transcript analysis, trans-)]TJ
T*
0.138 Tw
(mission disequilibrium testing \(TDT\) of markers and)Tj
0 -1.2543 TD
0.008 Tc
0.064 Tw
[(known genes in the region was undertaken. )-42(The study)]TJ
0 -1.2472 TD
0.009 Tc
0.042 Tw
(group consisted of 142 families with at least one child)Tj
0 -1.2543 TD
0.017 Tw
[(with MI. )9(W)81(e)-1( used GASSOC \(Schaid, Genet Epidemiol)]TJ
0 -1.2472 TD
0.05 Tw
(1996;13:423\22649\) to provide a general score test of as-)Tj
T*
0.01 Tc
0.058 Tw
(sociation for each marker tested, and GENEHUNTER)Tj
0 -1.2543 TD
-0.001 Tc
0.188 Tw
[(\(Spielman et al, )-142(A)-13(m)-13( )-12(J)-13( )]TJ
10.0713 0 TD
0.012 Tc
0.187 Tw
(Hum Genet 1993;52:506\22616\))Tj
-10.0713 -1.2472 TD
0.007 Tc
0.109 Tw
[(for )7(allele-specific )-82(TDT\222)50(s)51(.)51( )-82(T)58(o)-3( date we have performed)]TJ
0 -1.2543 TD
0 Tc
0 Tw
(TDT analysis for 13 microsatellite markers in the linked)Tj
0 -1.2472 TD
0.009 Tc
0.086 Tw
(region, and 2 single nucleotide polymorphisms \(SNP\))Tj
T*
0.033 Tw
[(in candidate genes CALM3 and STD. The most prom-)]TJ
0 -1.2543 TD
0.051 Tw
(ising detection of transmission disequilibrium was ob-)Tj
0 -1.2472 TD
0.008 Tc
0.056 Tw
(tained for the APOC2 marker \(GASSOC p=0.02, with)Tj
0 -1.2543 TD
0.01 Tc
0 Tw
(GENEHUNTER pointing to two 2 specific alleles with)Tj
0 -1.2472 TD
-0.009 Tc
(p<0.01\). )Tj
3.8622 0 TD
0.01 Tc
0.155 Tw
(These results were based on a subset of 33)Tj
-3.8622 -1.2472 TD
0.009 Tc
0.122 Tw
[(families and must be confirmed in the lar)16(ger sample.)]TJ
0 -1.2543 TD
0.008 Tc
0 Tw
(No association was suggested by SNP analysis for can-)Tj
0 -1.2472 TD
0.01 Tc
0.165 Tw
(didate genes CALM3 and STD \(93 families, p>0.3\).)Tj
T*
0.009 Tc
0.005 Tw
[(TDT)16( analysis continues with emphasis on markers sur)16(-)]TJ
0 -1.2543 TD
0.018 Tw
[(rounding the )37(APOC2 locus.)]TJ
1.4953 -1.2472 TD
0.021 Tw
[(Collaborative CF Modifier Group: )-13(T)74(.Casals, S.Lar)9(-)]TJ
-1.4953 -1.2543 TD
0.008 Tc
0.086 Tw
[(riba, B. Mercier)36(, G.Cutting, M. Macek, )-36(A. Krebsowa,)]TJ
0 -1.2472 TD
0.076 Tw
[(E. Bjorck, B. Strandvik, )-20(A. Palacio, E. Langfelder)43(, B.)]TJ
T*
0.009 Tc
0.046 Tw
[(Marshall, M. Claustres, D. Bozzn, )17(A. Nowakowska, J.)]TJ
0 -1.2543 TD
0.01 Tc
0 Tw
(Bal, C. Ferec, X. Estivill.)Tj
/T41 1 Tf
14 0 0 14 264.019 150.009 Tm
-0.021 Tc
(79)Tj
/F5 1 Tf
8 0 0 8 264.019 134.022 Tm
0.009 Tc
[(Evaluating )16(The Evidence For)16( )53(A)51( Relationship)]TJ
T*
0.01 Tc
-0.06 Tw
[(Between )-60(Fatty Acid )-59(Levels )-7(And Atopy )-60(In )7(A)-9(n)]TJ
0 -1.2472 TD
0.009 Tc
0.007 Tw
(Isolated Caucasoid Population.)Tj
/F14 1 Tf
T*
0 Tw
(R. Mathias)Tj
4.8 0 0 4.8 299.849 107.603 Tm
0 Tc
(1)Tj
8 0 0 8 302.287 104.032 Tm
0.009 Tc
0.006 Tw
[(, F)80(.)1( Chilton)]TJ
4.8 0 0 4.8 339.08 107.603 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 341.518 104.032 Tm
0.009 Tc
0.007 Tw
[(, L. Freidhof)16(f)]TJ
4.8 0 0 4.8 385.625 107.603 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 388.12 104.032 Tm
0.01 Tc
0.006 Tw
(, R. Nickell,)Tj
-15.5126 -1.2543 TD
0.009 Tc
0 Tw
(M. Beaver)Tj
4.8 0 0 4.8 298.431 97.625 Tm
0 Tc
(2)Tj
8 0 0 8 300.869 93.997 Tm
0.01 Tc
0.006 Tw
(, B. Barham)Tj
4.8 0 0 4.8 340.554 97.625 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 342.992 93.997 Tm
0.009 Tc
0.006 Tw
(, C.Bickel)Tj
4.8 0 0 4.8 376.044 97.625 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 378.482 93.997 Tm
0.008 Tc
-0.002 Tw
[(, T)73(.)-1( )-9(Beaty)]TJ
4.8 0 0 4.8 410.173 97.625 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 412.668 93.997 Tm
(,)Tj
-18.5811 -1.2472 TD
0.01 Tc
0.006 Tw
(K. Barnes)Tj
4.8 0 0 4.8 296.731 87.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 299.168 84.019 Tm
(.)Tj
ET

endstream
endobj
428 0 obj
<</Subtype/Type1C/Length 344>>stream
  KGMAAH+Symbol-Bold /ø øøøøûŸøûhûÍúçú—óö÷»÷º Symbol-BoldSymbol   b  C ³øˆø¸ø‡Î¯É‘áwĞwĞpºK¯´°§”Ä’½yÁd¬?Ê%¢1ZOjc_Dı#R€S„S÷šŞˆÖŒâ÷H÷(˜Î÷û÷Q”^Šc„gy1G>§s”~™y›ø…‘™®¸¯’¹i©u˜egbƒp€|‡†††‡…‰‰‰Š‰l’j’nxpq‰m®u˜…˜‰˜™©ˆ–ˆ‡‘ƒ¥kf“_ãz	?  “ÿø¤÷5 cÿH©hÿToû‰£/	ú|
ú|Œ

endstream
endobj
433 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
434 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
432 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
422 0 obj
<</Length 10401>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(218)-2523(Abstracts)]TJ
/F14 1 Tf
4.8 0 0 4.8 50.981 641.594 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 53.476 638.022 Tm
0.009 Tc
0.017 Tw
[(Johns Hopkins Univ)59(., Baltimore,MD,USA; )]TJ
4.8 0 0 4.8 196.965 641.594 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 199.403 638.022 Tm
0.008 Tc
[(W)73(ake)]TJ
-18.5528 -1.2543 TD
0.009 Tc
0.006 Tw
[(Forest Univ)52(., )9(W)39(inston-Salem, NC, USA.)]TJ
1.5024 -1.7504 TD
0.092 Tw
[(A)51( number of mediators that play a role in aller)9(gic)]TJ
-1.5024 -1.2472 TD
0.023 Tw
[(airway disease are synthesized from )30(Arachadonic )37(Acid)]TJ
0 -1.2543 TD
0.118 Tw
(\(AA\), which belongs to the n-6 series of polyunsatu-)Tj
0 -1.2472 TD
0.049 Tw
[(rated fatty acids \(PUF)73(As\). Epidemiologic data suggest)]TJ
T*
0.042 Tw
(that an increase in the prevalence of asthma and atopy)Tj
0 -1.2543 TD
0.054 Tw
(in developed countries parallels an increase in n-6:n-3)Tj
0 -1.2472 TD
0.071 Tw
[(PUF)66(As, the former giving rise to potent inflammatory)]TJ
0 -1.2543 TD
0 Tc
0.379 Tw
[(mediators. W)65(e)-18( )]TJ
6.6159 0 TD
0.018 Tc
0.188 Tw
(studied the relationship between n-6)Tj
-6.6159 -1.2472 TD
0.007 Tc
0.095 Tw
[(PUF)64(A)56( levels and atopy in the isolated )-85(T)72(angier Island,)]TJ
T*
0.009 Tc
0.133 Tw
[(V)122(A)58( population, where the prevalence of self-reported)]TJ
0 -1.2543 TD
0.007 Tc
0.065 Tw
[(aller)14(gic rhinitis \(AR\) is 59%. )-49(W)72(e)-2( tested for linkage of)]TJ
0 -1.2472 TD
0.006 Tc
0.181 Tw
[(skin )10(test )10(confirmed )-125(AR and \221high\222)70( IgE to 16 micro-)]TJ
T*
0.009 Tc
0.061 Tw
(satellite markers spanning 70cM on chromosome 12q.)Tj
0 -1.2543 TD
0 Tc
0 Tw
[(Using )14(T)37(ransmission Disequillibrium )21(T)65(est, we found evi-)]TJ
0 -1.2472 TD
0.008 Tc
0.191 Tw
[(dence )10(of )10(linkage )10(to )-137(AR \(n=33\) and \221high\222)72( total IgE)]TJ
0 -1.2543 TD
0.039 Tc
0.188 Tw
(\(n=43\) at D12S1052 \(AR: global P=0.01; allelic,)Tj
0 -1.2472 TD
0.002 Tc
0.001 Tw
[(P=0.01; \221high\222IgE: allelic, P=0.04\). Categorizing PUF)66(A)]TJ
T*
0.009 Tc
0.035 Tw
(levels into extreme quartiles, we observed modest evi-)Tj
0 -1.2543 TD
0.01 Tc
0.052 Tw
[(dence for dif)10(ferences in mean Log[IgE] \(AA)60( p=0.016;)]TJ
0 -1.2472 TD
0.001 Tc
0 Tw
(Linoleic acid p=0.053; Dihomo-gamma-linoleic acid p=)Tj
0 -1.2543 TD
0.01 Tc
0.035 Tw
(0.020\) \(n=217\). No such trends were observed for any)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
[(of the n-3 PUF)71(As examined. )57(Association analyses were)]TJ
T*
0.014 Tc
0.188 Tw
[(done for the extreme quartiles of the PUF)71(As and 7)]TJ
0 -1.2543 TD
0.009 Tc
0.068 Tw
(markers on 12q. Modest evidence for associations be-)Tj
0 -1.2472 TD
0.137 Tw
(tween the same marker alleles in linkage disequillib-)Tj
T*
-0.001 Tw
[(rium with )58(AR and \221high\222)80( IgE were observed for several)]TJ
0 -1.2543 TD
0.008 Tc
0.185 Tw
[(of )-7(the )-7(n-6 )-7(PUF)72(As \(n=153\) \(D12S58, allele 83: )-136(AA,)]TJ
0 -1.2472 TD
0.039 Tc
0.188 Tw
(p=0.035; LA, p=0.053; allele 89: GLA, p=0.046;)Tj
0 -1.2543 TD
0 Tc
[(D12S1052, allele 157: )-148(AA, p=0.049\). )]TJ
16.5969 0 TD
0.01 Tc
(This indicates)Tj
-16.5969 -1.2472 TD
0.009 Tc
0.05 Tw
[(an association between elevated n-6 PUF)73(As and atopy)]TJ
T*
0.007 Tc
-0.001 Tw
[(in residents from )13(T)72(angier and supports the putative role)]TJ
0 -1.2543 TD
0.009 Tc
0.013 Tw
[(of diet in atopy)59(.)]TJ
/T42 1 Tf
14 0 0 14 50.981 264.983 Tm
-0.021 Tc
(80)Tj
/F5 1 Tf
8 0 0 8 50.981 247.975 Tm
0.01 Tc
0 Tw
(Effect of apoE polymorphism on )Tj
/F24 1 Tf
14.4425 0 TD
0 Tc
(b)Tj
/F5 1 Tf
0.5598 0 TD
0.009 Tc
0.006 Tw
[(-lipopr)16(oteins in)]TJ
-15.0024 -1.2472 TD
-0.025 Tw
(Mexican Americans)Tj
/F14 1 Tf
T*
-0.01 Tc
0.006 Tw
[(W)91(.-C. Hsueh, B.D. Mitchell, D.L. Rainwater)40(, J.E. Hixson)]TJ
0 -1.2543 TD
0.009 Tc
0.015 Tw
(Southwest Foundation for Biomedical Research, San)Tj
0 -1.2472 TD
0.007 Tc
0.032 Tw
[(Antonio, T)-6(X)]TJ
1.5024 -1.7504 TD
0.009 Tc
0.084 Tw
(The apolipoprotein E \(apo E\) isoforms are associ-)Tj
-1.5024 -1.2472 TD
0.022 Tw
(ated with variation in serum lipids and apolipoproteins)Tj
0 -1.2543 TD
0.008 Tc
0.052 Tw
[(and may influence risk of CVD. )-42(W)80(e)-1( evaluated the im-)]TJ
0 -1.2472 TD
0.009 Tc
0.087 Tw
(pact of these isoforms on lipid metabolism relative to)Tj
0 -1.2543 TD
0.166 Tw
(that of other known CVD risk factors \(e.g., lifestyle)Tj
0 -1.2472 TD
0.006 Tc
0.155 Tw
[(factors and other genetic effects\) )9(in )9(the )9(San )-83(Antonio)]TJ
T*
0.009 Tc
0.116 Tw
[(Family Heart Study)59(, a population-based study of ath-)]TJ
0 -1.2543 TD
0.008 Tc
0.016 Tw
[(erosclerosis and its determinants in Mexican )30(American)]TJ
0 -1.2472 TD
0.009 Tc
0.005 Tw
(families. This study is based on 859 subjects, aged 16\226)Tj
T*
0.017 Tw
[(92 yr)52(. from 41 families examined between 1991\2261996,)]TJ
0 -1.2543 TD
0.006 Tc
0 Tw
(who possessed at least one )Tj
/F17 1 Tf
11.0905 0 TD
0 Tc
(e)Tj
/F14 1 Tf
0.4535 0 TD
0.006 Tc
-0.001 Tw
[(3 allele. )19(W)78(e)0( measured con-)]TJ
-11.5441 -1.2472 TD
0.009 Tc
0.01 Tw
(centrations of apoE and the major constituents of HDL)Tj
25.5047 69.2504 TD
0.012 Tc
0.188 Tw
(\(cholesterol, apoAI, and apoAII\) and )Tj
/F17 1 Tf
16.611 0 TD
0 Tc
0 Tw
(b)Tj
/F14 1 Tf
0.574 0 TD
0.017 Tc
(-lipoproteins)Tj
-17.185 -1.2543 TD
0.009 Tc
0.022 Tw
(\(cholesterol and apoB\).)Tj
1.4953 -1.2472 TD
-0.011 Tc
0.104 Tw
(The heritability of these traits ranged from 34\22655%.)Tj
-1.4953 -1.2543 TD
0.057 Tw
(The distribution of apoE isoforms was E2/E3: 6.3%, E3/)Tj
0 -1.2472 TD
0.068 Tw
(E3: 81.4%, and E3/E4: 12.3%. After adjustment for age,)Tj
T*
0.179 Tw
(sex, and lifestyle risk factors, subjects with E2/E3 had)Tj
0 -1.2543 TD
0.166 Tw
(significantly higher concentrations of apoE and signifi-)Tj
0 -1.2472 TD
-0.01 Tc
0.01 Tw
(cantly lower concentrations of non-HDLC and apoB than)Tj
0 -1.2543 TD
-0.011 Tc
0.082 Tw
[(E3/E4 individuals; there was no ef)17(fect of apoE isoforms)]TJ
0 -1.2472 TD
0.065 Tw
[(on HDL)38( )7(measures. )-53(The ef)23(fect of apoE isoforms was sig-)]TJ
T*
0.092 Tw
(nificantly greater on apoB levels in women than in men)Tj
0 -1.2543 TD
0.028 Tw
(\(sex \327 apoE interaction p value < 0.05\). Using maximum)Tj
0 -1.2472 TD
0.08 Tw
(likelihood methods, we partitioned variation in lipid and)Tj
T*
0.027 Tw
[(lipoproteins into components attributable to the ef)17(fects of)]TJ
0 -1.2543 TD
0.093 Tw
(age, sex, lifestyle variables, apoE isoforms, and residual)Tj
0 -1.2472 TD
0.038 Tw
[(genetic factors. )-18(T)69(ogether)46(, these factors accounted for 40\226)]TJ
0 -1.2543 TD
-0.001 Tc
0.186 Tw
[(60% of the total variability in these traits. )-180(The apoE)]TJ
0 -1.2472 TD
-0.009 Tc
0.187 Tw
(isoforms accounted for 4.4%, 12.4%, and 4.8% of the)Tj
T*
(total genetic variation in apoB, apoE, and non-HDLC,)Tj
0 -1.2543 TD
-0.011 Tc
0.182 Tw
[(respectively)60(.)181( )-166(W)83(e)0( conclude that apoE isoforms accounts)]TJ
0 -1.2472 TD
0.062 Tw
(for a modest, albeit significant, proportion of phenotypic)Tj
0 -1.2543 TD
0.007 Tw
(variation in )Tj
/F17 1 Tf
4.6984 0 TD
0 Tc
0 Tw
(b)Tj
/F14 1 Tf
0.5386 0 TD
-0.011 Tc
0.006 Tw
(-lipoprotein in this population and that these)Tj
-5.237 -1.2472 TD
0.087 Tw
[(isoforms have a greater ef)17(fect on apoB levels in women)]TJ
T*
0.016 Tw
(than in men.)Tj
/T42 1 Tf
14 0 0 14 255.019 366.973 Tm
-0.021 Tc
(81)Tj
/F5 1 Tf
8 0 0 8 255.019 349.002 Tm
0.009 Tc
0.001 Tw
[(Estimation of variance components in an inbr)23(ed)]TJ
T*
0.007 Tc
[(pedigr)14(ee)]TJ
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
-0.052 Tw
(M. Abney)Tj
4.8 0 0 4.8 287.674 332.617 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 290.112 328.989 Tm
0.01 Tc
0.003 Tw
(, M.S. McPeek)Tj
4.8 0 0 4.8 338.981 332.617 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 341.419 328.989 Tm
0.01 Tc
0.006 Tw
(, C. Ober)Tj
4.8 0 0 4.8 371.58 332.617 Tm
0 Tc
0 Tw
(1)Tj
-24.2835 -2.0905 TD
(1)Tj
8 0 0 8 257.457 319.011 Tm
0.009 Tc
0.007 Tw
(Dept of Human Genetics, )Tj
4.8 0 0 4.8 343.233 322.583 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 345.728 319.011 Tm
0.009 Tc
0.009 Tw
(Dept of Statistics,)Tj
-11.3386 -1.2543 TD
0.01 Tc
0.004 Tw
(University of Chicago, Chicago, IL USA)Tj
1.4953 -1.8709 TD
0.029 Tc
0.183 Tw
(Inbred pedigrees present special challenges for)Tj
-1.4953 -1.2543 TD
0.027 Tc
0 Tw
(variance component estimation. First, there are more)Tj
0 -1.2472 TD
0.029 Tc
0.095 Tw
(genetic variance components to be estimated in the)Tj
T*
0.149 Tw
(inbred case because of the non-zero probability of)Tj
0 -1.2543 TD
0.065 Tw
(being homozygous by descent, even for a relatively)Tj
0 -1.2472 TD
0.071 Tw
(simple genetic model. Second, there are more iden-)Tj
T*
0.033 Tw
[(tity coef)22(ficients that must be calculated in an inbred)]TJ
0 -1.2543 TD
0.019 Tc
0 Tw
(pedigree in order to perform the estimation, and these)Tj
0 -1.2472 TD
0.029 Tc
0.15 Tw
[(are computationally more dif)22(ficult to obtain in the)]TJ
0 -1.2543 TD
0.01 Tw
[(inbred than in the outbred case. )43(As a result, inbreed-)]TJ
0 -1.2472 TD
0.083 Tw
[(ing ef)15(fects have generally been ignored in practice.)]TJ
T*
0.043 Tw
[(W)80(e)0( describe here the estimation of variance compo-)]TJ
0 -1.2543 TD
0.017 Tw
[(nents of quantitative traits in lar)15(ge inbred pedigrees,)]TJ
0 -1.2472 TD
0.025 Tc
0.175 Tw
[(using the example of the Hutterites. )-166(W)76(e)-4( use addi-)]TJ
0 -1.2543 TD
0.029 Tc
0.159 Tw
(tional simulated examples to give an indication of)Tj
0 -1.2472 TD
0.13 Tw
(under what conditions one has the power to detect)Tj
T*
0.092 Tw
(the additional variance components and to examine)Tj
0 -1.2543 TD
0.027 Tc
0.086 Tw
[(their impact on variance component estimation. )-73(W)78(e)]TJ
0 -1.2472 TD
0.029 Tc
0.121 Tw
(discuss the implications for mapping and heritabil-)Tj
T*
0.028 Tc
0.025 Tw
(ity estimation.)Tj
1.4953 -1.2543 TD
0.029 Tc
0.185 Tw
[(M.A. was supported by the )-144(Alfred )-7(Sloan/DOE)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.031 Tw
[(postdoctoral fellowship in computational biology)59(.)]TJ
ET

endstream
endobj
445 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
443 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
444 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
442 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
436 0 obj
<</Length 10378>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(219)]TJ
/T43 1 Tf
14 0 0 14 59.981 633.997 Tm
-0.021 Tc
(82)Tj
/F5 1 Tf
8 0 0 8 59.981 616.989 Tm
0.009 Tc
0 Tw
(Multipoint disequilibrium mapping by the decay of)Tj
0 -1.2472 TD
0.01 Tc
(haplotype sharing)Tj
/F14 1 Tf
0 -1.2543 TD
(M.S. McPeek)Tj
4.8 0 0 4.8 104.655 600.605 Tm
0 Tc
(1)Tj
8 0 0 8 107.093 596.976 Tm
0.009 Tc
-0.059 Tw
[(, A. )-59(Strahs)]TJ
4.8 0 0 4.8 141.222 600.605 Tm
0 Tc
0 Tw
(1)Tj
-16.9252 -2.0906 TD
(1)Tj
8 0 0 8 62.476 586.998 Tm
0.009 Tc
0.012 Tw
(Dept of Statistics, University of Chicago, Chicago,)Tj
-0.3118 -1.2472 TD
0.011 Tc
0 Tw
(IL, USA)Tj
1.5024 -1.7504 TD
0.02 Tc
[(W)85(e)0( propose a multilocus model, the decay of hap-)]TJ
-1.5024 -1.2543 TD
0.046 Tc
0.188 Tw
(lotype sharing model, for linkage disequilibrium)Tj
0 -1.2472 TD
0.026 Tc
0.152 Tw
[(around a mutation of relatively recent origin. )-138(This)]TJ
0 -1.2543 TD
0.029 Tc
0.018 Tw
(allows a likelihood approach to disequilibrium map-)Tj
0 -1.2472 TD
0.11 Tw
(ping explicitly incorporating chance sharing, muta-)Tj
T*
0.06 Tc
0.188 Tw
[(tions, heterogeneity)60(, and multiple origin of the)]TJ
0 -1.2543 TD
0.035 Tc
(variant. Our )Tj
5.8954 0 TD
0.015 Tc
(implementation uses a hidden Markov)Tj
-5.8954 -1.2472 TD
0.009 Tc
0.155 Tw
(method that permits application not only when com-)Tj
T*
0.088 Tw
(plete haplotype data are available, but also allows for)Tj
0 -1.2543 TD
0.024 Tc
0.187 Tw
(missing data, partially determined haplotypes from)Tj
0 -1.2472 TD
0.009 Tc
0.058 Tw
(nuclear family data, and for the case when only geno-)Tj
0 -1.2543 TD
0.015 Tc
0.188 Tw
(type data, rather than haplotype data, are available.)Tj
0 -1.2472 TD
0.009 Tc
0.073 Tw
(While the dependence among nearby loci is explicitly)Tj
T*
0.134 Tw
(modeled in the likelihood, dependence among haplo-)Tj
0 -1.2543 TD
0.05 Tw
(types due to population structure is taken into account)Tj
0 -1.2472 TD
0.131 Tw
(using a quasi-likelihood approach, based on first and)Tj
0 -1.2543 TD
-0.002 Tc
0.167 Tw
[(second moments. )-173(W)77(e)-11( )]TJ
9.4113 0 TD
0.009 Tc
(implement the quasi-likelihood)Tj
-9.4113 -1.2472 TD
0.019 Tc
0.188 Tw
(approach with a conditional coalescent assumption,)Tj
T*
0.009 Tc
0.113 Tw
[(which should ar)16(guably yield conservative results in a)]TJ
0 -1.2543 TD
0.185 Tw
(growing or stable-size population. Extensive simula-)Tj
0 -1.2472 TD
0 Tw
(tion results and application to published data sets show)Tj
T*
0.136 Tw
(that this approach works extremely well for gene lo-)Tj
0 -1.2543 TD
0.14 Tw
[(calization, and that the coverage of confidence inter)9(-)]TJ
0 -1.2472 TD
0.011 Tw
(vals for gene localization is excellent.)Tj
/T43 1 Tf
14 0 0 14 59.981 294.973 Tm
-0.021 Tc
(83)Tj
/F5 1 Tf
8 0 0 8 59.981 278.022 Tm
0.008 Tc
0 Tw
[(Linkage disequilibrium between IL-4 r)15(eceptor)]TJ
0 -1.2543 TD
0.009 Tc
0.005 Tw
(polymorphisms in various samples of populations)Tj
/F14 1 Tf
0 -1.2472 TD
0.008 Tc
0.007 Tw
(J Xu)Tj
4.8 0 0 4.8 75.231 261.581 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 77.726 258.009 Tm
0.011 Tc
-0.012 Tw
[(,)7( TD )-18(Howard)]TJ
4.8 0 0 4.8 121.039 261.581 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 123.477 258.009 Tm
0.01 Tc
0.01 Tw
(, C Ober)Tj
4.8 0 0 4.8 151.654 261.581 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 154.091 258.009 Tm
0.01 Tc
0.009 Tw
(, G Koppelman)Tj
4.8 0 0 4.8 204.378 261.581 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 206.872 258.009 Tm
(,)Tj
-18.3614 -1.2543 TD
0.009 Tc
(DS Postma)Tj
4.8 0 0 4.8 96.378 251.603 Tm
0 Tc
(3)Tj
8 0 0 8 98.872 247.975 Tm
0.009 Tc
(, ER Bleecker)Tj
4.8 0 0 4.8 144.454 251.603 Tm
0 Tc
(1)Tj
8 0 0 8 146.891 247.975 Tm
0.009 Tc
(, DA Meyers)Tj
4.8 0 0 4.8 189.298 251.603 Tm
0 Tc
(1)Tj
8 0 0 8 191.735 247.975 Tm
0.009 Tc
(, and CSGA)Tj
4.8 0 0 4.8 59.981 241.625 Tm
0 Tc
(1)Tj
8 0 0 8 62.476 237.997 Tm
0.009 Tc
0.011 Tw
[(Univ)73(. of Maryland, Baltimore, MD; )]TJ
4.8 0 0 4.8 181.814 241.625 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 184.252 237.997 Tm
0.011 Tc
0.011 Tw
[(Univ)68(. of)]TJ
-15.5339 -1.2472 TD
0.009 Tc
0.018 Tw
(Chicago, Chicago, IL, )Tj
4.8 0 0 4.8 135.042 231.591 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 137.48 228.019 Tm
0.01 Tc
0.018 Tw
[(Univ)67(. Hospital Groningen,)]TJ
-9.6874 -1.2543 TD
0.009 Tc
0.04 Tw
[(Groningen, The )11(Netherlands)]TJ
1.5024 -1.7504 TD
0.075 Tw
(Interleukin-4 receptor \(IL-4R\) is a key component)Tj
-1.5024 -1.2472 TD
0.071 Tw
[(in the induction of IgE production. Multiple polymor)9(-)]TJ
T*
0.01 Tc
0.187 Tw
(phisms of the IL-4R gene have been identified, and)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
(some have been reported to be associated with a higher)Tj
0 -1.2472 TD
0.007 Tc
0.094 Tw
[(risk of atopy or atopic asthma. )-78(W)79(e)-2( studied four bi-al-)]TJ
0 -1.2543 TD
0.038 Tc
0.188 Tw
[(lelic polymorphisms \(E400A, C431R, S503P)116(, and)]TJ
0 -1.2472 TD
0.01 Tc
0.108 Tw
[(Q576R\) within a single exon of IL-4R in four dif)17(fer)17(-)]TJ
T*
0.009 Tc
0.008 Tw
[(ent ethnic samples. The distance between the polymor)16(-)]TJ
0 -1.2543 TD
0.147 Tw
[(phisms is 93bp, 216bp, and 219bp, respectively)59(.)152( )-132(The)]TJ
0 -1.2472 TD
0.148 Tw
(Dutch sample was from Groningen in Northern Hol-)Tj
T*
0.005 Tc
0.186 Tw
[(land, ascertained through an asthmatic proband. )-179(The)]TJ
0 -1.2543 TD
0.009 Tc
0.094 Tw
(Hispanic sample was ascertained in New Mexico, the)Tj
0 -1.2472 TD
-0.001 Tc
0.098 Tw
[(Caucasian and )-47(African )]TJ
9.737 0 TD
0.009 Tc
0.095 Tw
[(American samples were ascer)9(-)]TJ
15.7677 69.2504 TD
0.026 Tw
(tained in the Baltimore area, all through asthmatic sib-)Tj
0 -1.2543 TD
0.01 Tc
0.082 Tw
(pairs, as part of the CSGA \(NHLBI\) study on the ge-)Tj
0 -1.2472 TD
0.047 Tc
0.188 Tw
[(netics of asthma. Standardized pair)19(-wise linkage)]TJ
0 -1.2543 TD
0.008 Tc
0 Tw
[(disequilibrium \(LD\) coef)22(ficient \(D\264\) between polymor)22(-)]TJ
0 -1.2472 TD
0.003 Tc
(phisms was estimated from unrelated pedigree founders)Tj
T*
0.009 Tc
0.029 Tw
(and its significance was evaluated using the Fisher ex-)Tj
0 -1.2543 TD
-0.008 Tc
0.143 Tw
(act test. )Tj
3.6567 0 TD
0.009 Tc
(The Dutch sample \(2n=516\) showed highest)Tj
-3.6567 -1.2472 TD
0.128 Tw
(LD between all pairs of polymorphisms, with D\264 be-)Tj
0 -1.2543 TD
0.007 Tc
0.104 Tw
[(tween 0.85 to 1, p<1E-5. )-93(The Hispanic \(2n=130\) and)]TJ
0 -1.2472 TD
0.01 Tc
0.042 Tw
(Caucasian \(2n=141\) samples showed less LD between)Tj
T*
0.009 Tc
0.181 Tw
(polymorphisms, with D\264 from 0.72 to 1.00, p<1E-5.)Tj
0 -1.2543 TD
-0.033 Tc
(The )Tj
1.7717 0 TD
-0.011 Tc
0.065 Tw
(African-American sample \(2n=77\) generally did not)Tj
-1.7717 -1.2472 TD
0.074 Tw
[(show significant LD, with D\264 from 0.19 to 0.58. )-54(The D\264)]TJ
T*
-0.01 Tc
0.097 Tw
(between E400A and C431R \(93bp\) was estimated to be)Tj
0 -1.2543 TD
-0.011 Tc
0.044 Tw
[(0.35, p=0.43. )-19(These results provide useful information in)]TJ
0 -1.2472 TD
-0.018 Tc
0 Tw
[(designing LD mapping studies using dif)25(ferent populations.)]TJ
0 -1.2543 TD
-0.011 Tc
0.025 Tw
(Relatively homogeneous populations such as Dutch, His-)Tj
0 -1.2472 TD
-0.01 Tc
0.018 Tw
(panic, and US Caucasians can be used to show whether a)Tj
T*
-0.011 Tc
0.155 Tw
(specific candidate gene is associated with a phenotype,)Tj
0 -1.2543 TD
-0.028 Tc
0.147 Tw
[(while the )-97(African )]TJ
7.3772 0 TD
-0.011 Tc
0.145 Tw
(American population may be used to)Tj
-7.3772 -1.2472 TD
0.031 Tw
(pinpoint the causal polymorphism.)Tj
/T43 1 Tf
14 0 0 14 264.019 397.02 Tm
-0.021 Tc
(84)Tj
/F5 1 Tf
8 0 0 8 264.019 378.992 Tm
-0.011 Tc
0.004 Tw
(Evaluating evidence for association of IL-4 and IL-4)Tj
T*
0.005 Tw
[(r)22(eceptor)17( \(IL-4r\) polymorphisms with occupational)]TJ
0 -1.2543 TD
-0.009 Tc
(allergy)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
[(DG )17(W)40(iesch, J Xu, PJ )52(Amelung, ER Bleecker)38(,)]TJ
T*
0.004 Tc
0 Tw
(DA Meyers)Tj
0 -1.2543 TD
0.009 Tc
0.015 Tw
[(Univ)73(. Maryland, Baltimore MD)]TJ
1.4953 -1.8709 TD
0.13 Tw
(A case-control study of genetic susceptibility and)Tj
-1.4953 -1.2543 TD
0.005 Tc
0 Tw
[(gene-environment interaction to Laboratory )55(Animal )55(Al-)]TJ
0 -1.2472 TD
0 Tc
[(ler)21(gy \(LAA\), aller)21(gy from occupational exposure to ani-)]TJ
0 -1.2543 TD
0.017 Tc
0.186 Tw
[(mals, was performed in employees of )-176(The )-6(Jackson)]TJ
0 -1.2472 TD
0.01 Tc
0.018 Tw
[(Laboratory)67(, Bar Harbor)38(, Maine. LAA)53( af)24(fords an excel-)]TJ
T*
0.009 Tc
0.143 Tw
[(lent opportunity to study the genetics of aller)23(gy as a)]TJ
0 -1.2543 TD
0.088 Tw
(simplified disease model, especially in these workers,)Tj
0 -1.2472 TD
0.064 Tw
(due to the ubiquitousness of the environmental mouse)Tj
T*
0.185 Tw
(exposure and the relative ethnic homogeneity of the)Tj
0 -1.2543 TD
0.025 Tw
[(population. )37(Association of genotypes in the IL-4\(-590\))]TJ
0 -1.2472 TD
-0.001 Tc
0 Tw
(promoter polymorphism and three IL-4r polymorphisms)Tj
0 -1.2543 TD
0.008 Tc
(\(Q576R, E400A, and I75V\) were compared in 46 LAA)Tj
0 -1.2472 TD
0.009 Tc
0.125 Tw
(cases, employees with LAA symptoms and sensitiza-)Tj
T*
0.144 Tw
(tion to mice, and 85 LAA controls, workers with no)Tj
0 -1.2543 TD
0.053 Tw
(LAA symptoms or sensitization. No evidence of asso-)Tj
0 -1.2472 TD
0.01 Tc
0.038 Tw
(ciation with LAA was found for any of the genotypes.)Tj
0 -1.2543 TD
0.034 Tc
0.188 Tw
(Association was also investigated in an expanded)Tj
0 -1.2472 TD
0.009 Tc
0.139 Tw
(sample of 192 employees with atopic phenotypes in-)Tj
T*
0.039 Tw
[(cluding skintest reactivity)59(, total serum IgE, and mouse)]TJ
0 -1.2543 TD
0.109 Tw
[(specific IgE. Mar)23(ginally significant associations were)]TJ
0 -1.2472 TD
0.081 Tw
(observed for codominant genotypes in IL-4\(-590\) and)Tj
T*
0 Tc
0 Tw
(quantitative total serum IgE \(p=0.05\) and for IL-4r\(576\))Tj
0 -1.2543 TD
0.011 Tc
0.187 Tw
(and the presence of mouse specific IgE \(p=0.02 for)Tj
0 -1.2472 TD
0.01 Tc
0.109 Tw
[(A)-6(A)60( vs GG or GA)60( genotypes\). However)38(, Bonferroni\222)53(s)]TJ
ET

endstream
endobj
456 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
457 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
454 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
455 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
447 0 obj
<</Length 10964>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(220)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.121 Tw
(correction for multiple comparisons resulted in non-sig-)Tj
0 -1.2543 TD
-0.013 Tc
0 Tw
(nificant p-values. Haplotype association analyses with IL-)Tj
0 -1.2472 TD
-0.011 Tc
0.056 Tw
(4r polymorphisms did not show significance for LAA or)Tj
0 -1.2543 TD
-0.01 Tc
0.085 Tw
(any atopic phenotype. No evidence was found for gene-)Tj
0 -1.2472 TD
-0.016 Tc
0 Tw
(gene or for gene-environment interactions considering dif-)Tj
T*
-0.001 Tc
0.184 Tw
[(ferent mouse exposure levels. )-175(The )-6(sample )-6(size )-6(limits)]TJ
0 -1.2543 TD
-0.003 Tc
0.187 Tw
(definitive conclusions regarding these polymorphisms.)Tj
0 -1.2472 TD
-0.014 Tc
0 Tw
(Thus, more employees will be collected to increase power)Tj
0 -1.2543 TD
-0.011 Tc
0.014 Tw
(and additional candidates will be tested.)Tj
/T44 1 Tf
14 0 0 14 50.981 516.983 Tm
-0.021 Tc
(85)Tj
/F5 1 Tf
8 0 0 8 50.981 499.011 Tm
0.009 Tc
0.004 Tw
[(Maternal Multivitamin Use, Genetic )16(V)86(ariation in)]TJ
T*
0.005 Tw
(Folate Metabolism and Risk of Oral Clefts)Tj
/F14 1 Tf
0 -1.2472 TD
0.007 Tw
(M. H. Khoshnevisan,)Tj
4.8 0 0 4.8 120.827 482.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 123.265 478.998 Tm
0.01 Tc
0.01 Tw
[( D. F)81(.)8( )19(W)61(yszynski,)]TJ
4.8 0 0 4.8 181.262 482.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 183.699 478.998 Tm
-0.065 Tc
0.063 Tw
[( T.)-67( )-10(W)-42(u)-75( )-20(,)]TJ
4.8 0 0 4.8 209.778 482.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 50.981 469.02 Tm
0.009 Tc
0.012 Tw
[(A. Miller)16(-Chisholm,)]TJ
4.8 0 0 4.8 117.879 472.592 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 120.317 469.02 Tm
0.01 Tc
0.012 Tw
[( D. Ruggles,)]TJ
4.8 0 0 4.8 161.476 472.592 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 163.913 469.02 Tm
0.008 Tc
0.01 Tw
[( E. )6(T)31(uron,)]TJ
4.8 0 0 4.8 196.909 472.592 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 50.981 458.986 Tm
0.009 Tc
0.006 Tw
(M. Mazaheri,)Tj
4.8 0 0 4.8 95.258 462.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 97.696 458.986 Tm
0.01 Tc
0.006 Tw
[( R. Long,)]TJ
4.8 0 0 4.8 128.764 462.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 131.202 458.986 Tm
0.009 Tc
0.01 Tw
[( E. O\222Connell,)]TJ
4.8 0 0 4.8 179.107 462.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 181.545 458.986 Tm
0.01 Tc
0.009 Tw
[( L. Lukes,)]TJ
4.8 0 0 4.8 214.937 462.614 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 50.981 449.008 Tm
0.009 Tc
[(P)104(.)0( Le,)]TJ
4.8 0 0 4.8 69.52 452.579 Tm
0 Tc
(1)Tj
8 0 0 8 71.958 449.008 Tm
0.009 Tc
( J. Jones,)Tj
4.8 0 0 4.8 101.608 452.579 Tm
0 Tc
(1)Tj
8 0 0 8 104.046 449.008 Tm
0.01 Tc
0.003 Tw
( S.R. Diehl)Tj
4.8 0 0 4.8 140.556 452.579 Tm
0 Tc
0 Tw
(1)Tj
-18.6614 -2.0787 TD
(1)Tj
8 0 0 8 53.476 438.973 Tm
0.009 Tc
0.022 Tw
(Craniofacial Epidemiology and Genetics Branch,)Tj
-0.3118 -1.2472 TD
0.013 Tw
(National Institute of Dental and Craniofacial)Tj
T*
0.011 Tw
(Research, National institutes of Health, Bethesda,)Tj
0 -1.2543 TD
0.008 Tc
(Maryland; )Tj
4.8 0 0 4.8 87.095 412.611 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 89.532 408.983 Tm
0.009 Tc
0.006 Tw
[(Lancaster Cleft Palate Clinic, Lancaster)30(,)]TJ
-4.8189 -1.2472 TD
0.012 Tc
(Pennsylvania)Tj
/F5 1 Tf
1.5024 -1.8779 TD
0.025 Tc
(Purpose:)Tj
/F14 1 Tf
4.0394 0 TD
0 Tw
[( )20(The purpose of this study was to evalu-)]TJ
-5.5417 -1.2472 TD
0.029 Tc
0.119 Tw
(ate the association between single nucleotide poly-)Tj
T*
0.07 Tw
(morphisms \(SNPs\) at the methylenetetrahydrofolate)Tj
0 -1.2543 TD
0.009 Tc
0.068 Tw
(reductase \(MTHFR\) gene, maternal multivitamin con-)Tj
0 -1.2472 TD
0.173 Tw
(sumption and risk of nonsyndromic cleft lip with or)Tj
0 -1.2543 TD
0.011 Tw
(without cleft palate \(CL/P\) in a Caucasian population.)Tj
/F5 1 Tf
1.5024 -1.2472 TD
(Methods:)Tj
/F14 1 Tf
4.1315 0 TD
0.104 Tw
[( )16(W)81(e)0( studied 234 families \(933 individu-)]TJ
-5.6339 -1.2472 TD
0.078 Tw
[(als\) with one or more CL/P)30( af)23(fected member)59(.)77( )-13(A)51( ques-)]TJ
0 -1.2543 TD
0.187 Tw
(tionnaire was used to collect clinical, family history)Tj
0 -1.2472 TD
0.1 Tw
(and risk factors information. Blood samples were ob-)Tj
0 -1.2543 TD
0.047 Tw
[(tained from both af)16(fected and unaf)9(fected family mem-)]TJ
0 -1.2472 TD
-0.009 Tc
0.395 Tw
[(bers. T)28(w)-39(o)-39( )]TJ
4.8318 0 TD
0.03 Tc
0.187 Tw
[(SNPs in the MTHFR gene \(C677T)16( and)]TJ
-4.8318 -1.2472 TD
0.01 Tc
0.128 Tw
(A1298C\) were assayed by standard PCR-RFLP tech-)Tj
0 -1.2543 TD
-0.001 Tc
0 Tw
[(niques. )13(W)78(e)0( performed a transmission disequilibrium test)]TJ
0 -1.2472 TD
0.008 Tc
(\(TDT\) and a case-case analysis to evaluate linkage dis-)Tj
T*
0.009 Tc
0.105 Tw
[(equilibrium \(association\) and interactions with mater)9(-)]TJ
0 -1.2543 TD
0.04 Tw
(nal multivitamin consumption.)Tj
/F5 1 Tf
1.5024 -1.2472 TD
-0.011 Tc
(Results:)Tj
/F14 1 Tf
3.3591 0 TD
0.026 Tw
[( )24(W)33(ithout considering multivitamin consump-)]TJ
-4.8614 -1.2543 TD
0.104 Tw
(tion, we found significant \(p<0.05\) evidence of disequi-)Tj
0 -1.2472 TD
0.096 Tw
[(librium with risk of cleft lip for the C677T)10( SNP)109(, but no)]TJ
T*
-0.013 Tc
0.118 Tw
[(association )6(with )6(the )-68(A1298C polymorphism for all sub-)]TJ
0 -1.2543 TD
-0.011 Tc
0.046 Tw
[(jects. However)24(, when we incorporated multivitamin con-)]TJ
0 -1.2472 TD
0.17 Tw
(sumption into our analyses, we found a much stronger)Tj
0 -1.2543 TD
-0.01 Tc
0.031 Tw
(association of CL/P risk for the C677T MTHFR SNP for)Tj
0 -1.2472 TD
-0.011 Tc
0.093 Tw
(mothers who did use multivitamins during their first tri-)Tj
T*
-0.013 Tc
0.123 Tw
[(mester of pregnancy \(p< 0.005\). )-105(W)81(e)-3( also found a weak)]TJ
0 -1.2543 TD
-0.014 Tc
0.128 Tw
[(association with the )-88(A1298T)14( )-7(MTHFR )-7(SNP)29( )-6(for )-6(mothers)]TJ
0 -1.2472 TD
-0.011 Tc
0.019 Tw
(who did not use multivitamins.)Tj
/F5 1 Tf
1.5024 -1.2472 TD
0.01 Tc
(Conclusion:)Tj
/F14 1 Tf
5.2228 0 TD
0.009 Tc
0.133 Tw
[( )23(These findings indicate the presence)]TJ
-6.7252 -1.2543 TD
0.047 Tc
0.205 Tw
(of a strong gene by environment interaction for)Tj
0 -1.2472 TD
0.001 Tc
0 Tw
(MTHFR SNPs and maternal multivitamin consumption.)Tj
/T44 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.021 Tc
(86)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.009 Tc
0.004 Tw
(Genetic Epidemiology of the GENNID study I:)Tj
T*
0.003 Tw
(covariate-adjustment and linkage analysis in the)Tj
0 -1.2543 TD
0.01 Tc
0.018 Tw
(Mexican-American cohort.)Tj
/F14 1 Tf
0 -1.2472 TD
0.005 Tw
[(M. M. Barmada, C. E. )53(Aston)]TJ
T*
0.011 Tw
[(Dept. of Human Genetics, Univ)74(. of Pittsbur)17(gh,)]TJ
0 -1.2543 TD
0.009 Tc
0.003 Tw
[(Pittsbur)16(gh, P)87(A, USA.)]TJ
1.4953 -1.7504 TD
-0.01 Tc
0.09 Tw
[(W)84(e)0( have begun an analysis of the GENNID \(Genet-)]TJ
-1.4953 -1.2472 TD
-0.011 Tc
0.162 Tw
(ics of Non-Insulin Dependent Diabetes\) study by com-)Tj
0 -1.2543 TD
-0.007 Tc
0.187 Tw
(paring the results of univariate linkage analysis in the)Tj
0 -1.2472 TD
-0.01 Tc
0.097 Tw
(GENNID Mexican-American cohort with previously re-)Tj
T*
-0.006 Tc
0.188 Tw
[(ported genome-wide analyses in other type 2 diabetes)]TJ
0 -1.2543 TD
-0.03 Tc
(studies. )Tj
3.3095 0 TD
-0.011 Tc
0.151 Tw
(The significant amount of data collected in the)Tj
-3.3095 -1.2472 TD
0.133 Tw
(GENNID study enabled quantitative trait analysis to be)Tj
T*
0.01 Tw
[(undertaken. )11(The specific quantitative traits analyzed were)]TJ
0 -1.2543 TD
-0.009 Tc
0.187 Tw
(fasting insulin and glucose measurements, baseline-ad-)Tj
0 -1.2472 TD
-0.011 Tc
0.148 Tw
(justed 1- and 2-hour glucose and insulin measurements)Tj
0 -1.2543 TD
0.081 Tw
(\(two of the time points measured during an oral glucose)Tj
0 -1.2472 TD
0.021 Tw
(tolerance test\), and two derivative measures of insulin re-)Tj
T*
0.154 Tw
(sistance and secretion. Quantitative traits were adjusted)Tj
0 -1.2543 TD
0.073 Tw
[(before analysis to compensate for the ef)17(fects of environ-)]TJ
0 -1.2472 TD
0.007 Tc
0 Tw
(mental variables: smoking status, age, sex, BMI \(body-)Tj
0 -1.2543 TD
0.009 Tc
0.169 Tw
[(mass index\), dietary measures, and physical activity)66(.)]TJ
0 -1.2472 TD
0.071 Tw
(Due to the observed collinearity between the environ-)Tj
T*
0.144 Tw
(mental variables, principal component transformation)Tj
0 -1.2543 TD
0.161 Tw
(was applied to allow standard regression methods to)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
[(be employed for covariate-adjustment. )19(This method ad-)]TJ
T*
0.009 Tc
0.062 Tw
(ditionally allowed us to assess the relative importance)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
(of each environmental variable in accounting for varia-)Tj
0 -1.2472 TD
0.005 Tc
(tion in the given quantitative trait. Following covariate-)Tj
0 -1.2543 TD
0.01 Tc
0.188 Tw
(adjustment, the residual values in each trait and the)Tj
0 -1.2472 TD
0.013 Tc
(genotype data provided in the GENNID study were)Tj
T*
0.008 Tc
0 Tw
[(analyzed using Haseman-Elston regression. )22(The results)]TJ
0 -1.2543 TD
0.009 Tc
0.023 Tw
(highlight a number of regions previously implicated in)Tj
0 -1.2472 TD
0.011 Tc
0.188 Tw
(type 2 diabetes, as well as some interesting regions)Tj
0 -1.2543 TD
0.009 Tc
0.019 Tw
[(unique to this study)59(.)]TJ
/T44 1 Tf
14 0 0 14 255.019 234.992 Tm
-0.021 Tc
(87)Tj
/F5 1 Tf
8 0 0 8 255.019 217.984 Tm
0.009 Tc
0.002 Tw
[(The estimation of family corr)23(elations under)]TJ
0 -1.2472 TD
0.007 Tw
(nonrandom sampling)Tj
/F14 1 Tf
T*
0.01 Tc
0.001 Tw
[(J. P)116(.)0( Rice, N. L. Saccone, J. Corbett)]TJ
0 -1.2543 TD
0.012 Tw
[(W)82(ashington Univ)60(., St. Louis, MO)]TJ
1.4953 -1.7504 TD
0.019 Tc
0 Tw
[(W)77(e)0( assume a set of variables X)]TJ
4.8 0 0 4.8 371.239 172.8 Tm
0 Tc
(1)Tj
8 0 0 8 373.734 173.991 Tm
0.021 Tc
(,...,X)Tj
4.8 0 0 4.8 390.515 172.8 Tm
0 Tc
(n)Tj
8 0 0 8 393.009 173.991 Tm
0.019 Tc
( have a stan-)Tj
-17.2488 -1.2472 TD
0.024 Tc
(dard normal distribution. If values of X)Tj
4.8 0 0 4.8 388.531 162.822 Tm
0 Tc
(n)Tj
8 0 0 8 391.025 164.013 Tm
0.023 Tc
( are selected,)Tj
-17.0008 -1.2543 TD
0.029 Tc
0.163 Tw
(then the correlations before selection may be esti-)Tj
0 -1.2472 TD
0.056 Tw
(mated from the \(normal\) conditioned distribution in)Tj
T*
0.028 Tc
0.057 Tw
(the selected sample. Although this is well known in)Tj
0 -1.2543 TD
0.029 Tc
0.124 Tw
(the literature, it has not been widely recognized in)Tj
0 -1.2472 TD
0.161 Tw
(human family studies where probands are selected)Tj
T*
0.017 Tw
(\(either directly on the measure or for related disease)Tj
0 -1.2543 TD
0.183 Tw
(status\), and their relatives subsequently examined.)Tj
0 -1.2472 TD
0.127 Tw
[(W)80(e)0( discuss this problem and consider an estimator)]TJ
ET

endstream
endobj
467 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
466 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
465 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
459 0 obj
<</Length 10520>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(221)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.029 Tc
0.148 Tw
[(that can be used in situations where the proband\222)50(s)]TJ
0 -1.2543 TD
0.138 Tw
(score is not available, or only the variance-covari-)Tj
0 -1.2472 TD
0.154 Tw
(ance matrix in the selected population is available)Tj
0 -1.2543 TD
0.018 Tc
-0.001 Tw
[(for analysis. W)83(e)0( performed a set of simulations where)]TJ
0 -1.2472 TD
0.029 Tc
0.07 Tw
(observations were sampled from a trivariate normal)Tj
T*
0.057 Tc
0.187 Tw
[(distribution and compared the ef)14(ficiency of the)]TJ
0 -1.2543 TD
0.029 Tc
0.139 Tw
[(method omitting the proband\222)57(s score to the full it-)]TJ
0 -1.2472 TD
0.031 Tc
0.183 Tw
[(erative likelihood method. )-186(The )-9(average )-9(ef)17(ficiency)]TJ
0 -1.2543 TD
0.029 Tc
0.018 Tw
(ranged from 64 to 86%.)Tj
/T45 1 Tf
14 0 0 14 59.981 516.983 Tm
-0.021 Tc
(88)Tj
/F5 1 Tf
8 0 0 8 59.981 499.011 Tm
0.009 Tc
0 Tw
(Robustness of the single-locus model for a two-)Tj
T*
0.003 Tw
(locus quantitative trait)Tj
/F14 1 Tf
0 -1.2472 TD
[(C.M. V)107(achon)]TJ
4.8 0 0 4.8 103.294 482.57 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 105.732 478.998 Tm
0.01 Tc
0.012 Tw
[( and L.D. )45(Atwood)]TJ
4.8 0 0 4.8 164.92 482.57 Tm
0 Tc
0 Tw
(2)Tj
-21.8622 -2.0787 TD
(1)Tj
8 0 0 8 62.476 469.02 Tm
0.009 Tc
0.008 Tw
[(Mayo Clinic, Rochester)44(, MN, USA. )]TJ
4.8 0 0 4.8 182.154 472.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 184.592 469.02 Tm
0.009 Tc
0.013 Tw
(University of)Tj
-15.5764 -1.2543 TD
0.01 Tc
0.012 Tw
(Minnesota, Minneapolis, MN, USA.)Tj
1.5024 -1.8709 TD
0.009 Tc
0.127 Tw
(In the investigation of a quantitative trait \(QT\), a)Tj
-1.5024 -1.2543 TD
0.007 Tc
0 Tw
(linkage analysis is often performed using initial param-)Tj
0 -1.2472 TD
0.009 Tc
0.128 Tw
[(eter estimates from a segregation analysis of the QT)66(.)]TJ
0 -1.2543 TD
0.156 Tw
[(However)44(, the segregation analysis assumes a one-lo-)]TJ
0 -1.2472 TD
0.006 Tc
0 Tw
(cus, two-allele underlying model and is often misspeci-)Tj
T*
0.009 Tc
0.037 Tw
(fied with multiple genes responsible for the variability)Tj
0 -1.2543 TD
0.166 Tw
[(in the QT)80(.)164( )-153(W)88(e)0( address the question of robustness of)]TJ
0 -1.2472 TD
0.162 Tw
[(the single-locus model with respect to linkage infor)9(-)]TJ
T*
0.024 Tw
[(mation when the QT)16( is actually af)16(fected by two genes.)]TJ
0 -1.2543 TD
0.077 Tw
[(Specifically)66(, using maximum likelihood parameter es-)]TJ
0 -1.2472 TD
0.038 Tw
(timates from a single-locus model, we performed two-)Tj
0 -1.2543 TD
0.128 Tw
(point linkage analysis of markers flanking two genes)Tj
0 -1.2472 TD
0.01 Tc
0.023 Tw
[(that had an additive ef)17(fect on the QT)74(.)24( W)82(e)0( examined 24)]TJ
T*
-0.001 Tc
0 Tw
(generating models comprising all possible combinations)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(of: allele frequency \(q\) set to .1 or .3, the mode of)Tj
0 -1.2472 TD
0.009 Tc
0.092 Tw
[(transmission set to additive or dominant, and the per)9(-)]TJ
0 -1.2543 TD
0.112 Tw
[(centage of variation af)9(fecting the trait due to the two)]TJ
0 -1.2472 TD
0.01 Tc
0.13 Tw
(genes varied in six ways i.e. 60-0, 50-10, 40-20, 30-)Tj
T*
0.029 Tc
0.188 Tw
(30, 30-30polygenic and 30-0. For each generating)Tj
0 -1.2543 TD
0.009 Tc
0.156 Tw
(model, 100 replications of 200 nuclear families with)Tj
0 -1.2472 TD
0.006 Tw
[(three of)9(fspring were generated using GASP)115(. Maximum)]TJ
T*
0.035 Tw
(likelihood estimates were found using REGCHunt and)Tj
0 -1.2543 TD
0.01 Tc
0.142 Tw
(linkage was performed using LODLINK. Our results)Tj
0 -1.2472 TD
0.001 Tc
0 Tw
(show that the single-locus model is robust and that link-)Tj
0 -1.2543 TD
0.012 Tc
0.187 Tw
(age was detectable when the model is misspecified.)Tj
0 -1.2472 TD
0.188 Tw
(Among the two gene models \(50-10, 40-20, 30-30\),)Tj
T*
0.009 Tc
0.142 Tw
(the worst case for detecting any single gene was the)Tj
0 -1.2543 TD
0.048 Tw
(30-30 case; the average lodscores ranged from 1.35 to)Tj
0 -1.2472 TD
0.031 Tc
0.188 Tw
(2.87. Unlinked markers had an average maximum)Tj
0 -1.2543 TD
0.009 Tc
0.028 Tw
(lodscore of 0.09. In general, across models, those with)Tj
0 -1.2472 TD
0.004 Tc
0 Tw
(smaller allele frequencies had greater LOD scores, with)Tj
T*
0.02 Tc
0.187 Tw
(the dominant loci higher than the codominant loci.)Tj
0 -1.2543 TD
0.006 Tc
0 Tw
(Power curves for the two gene models showed decreas-)Tj
0 -1.2472 TD
0.009 Tc
0.023 Tw
(ing power to detect linkage from the 50-10 to 40-20 to)Tj
T*
0.008 Tc
0.076 Tw
[(30-30 )6(models. )-61(The polygene model \(30% to one gene)]TJ
0 -1.2543 TD
0.009 Tc
0.024 Tw
(and 30% polygenes\) had slightly lower power than the)Tj
0 -1.2472 TD
0.01 Tc
0.025 Tw
(30-30 case.)Tj
/T45 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.021 Tc
(89)Tj
/F5 1 Tf
8 0 0 8 264.019 616.989 Tm
0.009 Tc
0 Tw
(Linkage disequilibrium of 10 SNPs within a 10 kb)Tj
T*
0.01 Tc
0.001 Tw
[(r)22(egion of the )59(AI-CIII-AIV)17( gene cluster)17( in Familial)]TJ
0 -1.2543 TD
0.009 Tc
0 Tw
[(Combined Hyperlipidemia \(FCH\) pr)16(obands and)]TJ
0 -1.2472 TD
(spouses)Tj
/F14 1 Tf
T*
0.01 Tc
0.012 Tw
(R.M. Cantor)Tj
4.8 0 0 4.8 305.178 580.592 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 307.616 577.02 Tm
0.01 Tc
0.012 Tw
(, M. Groenendijk)Tj
4.8 0 0 4.8 364.195 580.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 366.633 577.02 Tm
0.009 Tc
0.013 Tw
(, G.M. Dallinga-Thie)Tj
4.8 0 0 4.8 436.138 580.592 Tm
0 Tc
0 Tw
(2)Tj
-35.8583 -2.0787 TD
(1)Tj
8 0 0 8 266.457 566.986 Tm
0.01 Tc
0.006 Tw
[(Univ)74(. CA, Los )52(Angeles, USA; )]TJ
4.8 0 0 4.8 367.597 570.614 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 370.035 566.986 Tm
0.01 Tc
0.005 Tw
[(Univ)67(. Med Ctr)60(.,)]TJ
-13.252 -1.2472 TD
0.009 Tc
0.025 Tw
(Utrecht, Netherlands.)Tj
1.4953 -1.7504 TD
-0.011 Tc
0.055 Tw
(Successful application of SNP technology to identify)Tj
-1.4953 -1.2543 TD
0.164 Tw
(complex disease gene variants is contingent upon mul-)Tj
0 -1.2472 TD
-0.005 Tc
0.188 Tw
(tiple factors, including informative patterns of linkage)Tj
T*
-0.011 Tc
0.066 Tw
(disequilbrium \(ld\). Disease mutation haplotypes increase)Tj
0 -1.2543 TD
0.016 Tw
[(in frequency and narrow with recombination in af)24(fecteds,)]TJ
0 -1.2472 TD
-0.015 Tc
0 Tw
(which may lead to distorted patterns of ld on disease chro-)Tj
T*
-0.012 Tc
[(mosomes. )16(W)82(e)0( have reported increases in specific )52(AI-CIII-)]TJ
0 -1.2543 TD
-0.01 Tc
0.107 Tw
(AIV haplotypes in FCH probands and are examining ld)Tj
0 -1.2472 TD
-0.011 Tc
0.152 Tw
(patterns within this region in probands and informative)Tj
0 -1.2543 TD
-0.017 Tc
0 Tw
(controls \(marrying-in spouses with at least two haplotyped)Tj
0 -1.2472 TD
-0.011 Tc
0.053 Tw
[(of)17(fspring\). Simwalk was used to haplotype 10 SNPs in a)]TJ
T*
0.018 Tw
[(10 kb region of the )53(AI-CIII-AIV)17( gene cluster)46(. From these)]TJ
0 -1.2543 TD
0.176 Tw
(haplotypes, 45 measures of pairwise ld were estimated)Tj
0 -1.2472 TD
0.144 Tw
(separately in 52 disease and 192 control chromosomes,)Tj
0 -1.2543 TD
0.016 Tc
0.188 Tw
(using a statistic that summarizes ld for all possible)Tj
0 -1.2472 TD
-0.011 Tc
0.145 Tw
(haplotypes. Fishers\222 exact test assessed the significance)Tj
T*
0.046 Tw
[(of )7(ld. As expected, ld did not correlate with physical dis-)]TJ
0 -1.2543 TD
0.139 Tw
(tance and was increased in FCH chromosomes; ld esti-)Tj
0 -1.2472 TD
0.001 Tc
0.187 Tw
(mates ranged between .02 and .92 \(median = .21\) in)Tj
T*
-0.011 Tc
0.047 Tw
(controls and .18 and 1.0 \(median = .49\) in probands. For)Tj
0 -1.2543 TD
-0.01 Tc
0.018 Tw
[(1)44(1)0( control and 10 proband ld tests, p>.05. SNP)40( pairs hav-)]TJ
0 -1.2472 TD
-0.011 Tc
0.124 Tw
(ing non-significant ld were fairly consistent across both)Tj
0 -1.2543 TD
0.009 Tc
0.042 Tw
[(samples. However)37(, one pair of adjacent SNPs had sig-)]TJ
0 -1.2472 TD
0.113 Tw
(nificant ld in the proband sample \(p=.003\), while the)Tj
T*
0.067 Tw
(p-value was .85 in controls. Comparison of SNP ld in)Tj
0 -1.2543 TD
0.139 Tw
(disease chromosomes with background ld in controls)Tj
0 -1.2472 TD
0.047 Tw
(may be used to help focus the search for complex dis-)Tj
0 -1.2543 TD
0.013 Tw
(ease gene variants.)Tj
/T45 1 Tf
14 0 0 14 264.019 234.992 Tm
-0.021 Tc
(90)Tj
/F5 1 Tf
8 0 0 8 264.019 217.984 Tm
0.008 Tc
0 Tw
(Evidence for genetic influences on the change in)Tj
0 -1.2472 TD
0.009 Tc
0.003 Tw
[(per)16(cent body fat over)9( time in Mexican )52(Americans.)]TJ
/F14 1 Tf
T*
0.01 Tc
0.006 Tw
(A.G. Comuzzie)Tj
4.8 0 0 4.8 315.099 201.6 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 317.537 198.028 Tm
0.009 Tc
0.009 Tw
(, B.D. Mitchell)Tj
4.8 0 0 4.8 367.03 201.6 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 369.468 198.028 Tm
0.009 Tc
0.01 Tw
(, J. Blangero)Tj
4.8 0 0 4.8 411.08 201.6 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 413.518 198.028 Tm
(,)Tj
-18.6874 -1.2543 TD
0.009 Tc
[(J.W)94(. MacCluer)]TJ
4.8 0 0 4.8 312.888 191.622 Tm
0 Tc
(1)Tj
8 0 0 8 315.326 187.994 Tm
0.009 Tc
[(, M.P)108(. Stern)]TJ
4.8 0 0 4.8 353.82 191.622 Tm
0 Tc
(2)Tj
8 0 0 8 356.258 187.994 Tm
(.)Tj
4.8 0 0 4.8 264.019 181.587 Tm
(1)Tj
8 0 0 8 266.457 178.016 Tm
0.009 Tc
0.015 Tw
(Southwest Foundation for Biomedical Research, San)Tj
-0.3047 -1.2543 TD
0.008 Tc
0.002 Tw
[(Antonio, TX, )-9(and )]TJ
4.8 0 0 4.8 323.887 171.61 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 326.324 167.981 Tm
0.008 Tc
0.013 Tw
[(The University of )-6(T)73(exas Health)]TJ
-7.7882 -1.2472 TD
0.01 Tc
0.006 Tw
[(Science Center)38(, San )44(Antonio, )8(TX.)]TJ
1.4953 -1.7504 TD
0.006 Tc
0.171 Tw
[(As part of the ongoing work in the San )-115(Antonio)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.052 Tw
(Family Heart Study \(SAFHS\), follow-up data is being)Tj
0 -1.2543 TD
0.123 Tw
(collected on a variety of phenotypes in order to look)Tj
0 -1.2472 TD
0.139 Tw
(for genes related to their change over time. Here we)Tj
T*
(have examined changes in percent body fat \()Tj
/F17 1 Tf
19.2331 0 TD
0 Tc
0 Tw
(D)Tj
/F14 1 Tf
0.6236 0 TD
0.008 Tc
(%FM\))Tj
-19.8567 -1.2543 TD
0.009 Tc
0.181 Tw
(using data on 395 SAFHS participants \(244 M; 151)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
(F\). Delta values were obtained by subtracting the value)Tj
ET

endstream
endobj
478 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
477 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
476 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
475 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
469 0 obj
<</Length 10730>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(222)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.009 Tc
0.17 Tw
(at time 1 from the value at time 2 \(mean time span)Tj
0 -1.2543 TD
0.008 Tc
0.093 Tw
[(between measurements = 4.7 years\). )-43(A)50( highly signifi-)]TJ
0 -1.2472 TD
0.009 Tc
0.088 Tw
(cant \(p < 0.0001\) additive genetic heritability of 47%)Tj
0 -1.2543 TD
0.03 Tw
[(was detected for this trait. Subsequently)59(, complex seg-)]TJ
0 -1.2472 TD
0.106 Tw
(regation analysis of this phenotype revealed evidence)Tj
T*
0.035 Tc
0.184 Tw
[(of an anonymous major gene. )-181(The )-7(environmental)]TJ
0 -1.2543 TD
0.009 Tc
0.08 Tw
(model, which allows for no genetic transmission, was)Tj
0 -1.2472 TD
0.084 Tw
(rejected as being a worse fit to the data than the gen-)Tj
0 -1.2543 TD
0.017 Tc
0.188 Tw
(eral model \(p = 0.007\) while the mixed Mendelian)Tj
0 -1.2472 TD
0.009 Tc
0.102 Tw
(model could not be rejected \(p = 0.58\). Based on the)Tj
T*
0.188 Tw
(Mendelian model, homogygous recessive individuals)Tj
0 -1.2543 TD
0.18 Tw
(\(aa\) gained approximately 9 to 10 times the percent)Tj
0 -1.2472 TD
0.01 Tc
0.188 Tw
(body fat of homogygous dominant individuals \(AA\))Tj
T*
-0.002 Tc
0.144 Tw
[(\(Males means: )-94(A)-18(A)33( )13(=)13( )]TJ
9.1941 0 TD
-0.015 Tc
0.258 Tw
[(4%, A)-25(a)-25( )90(=)-25( )]TJ
4.5964 0 TD
0.01 Tc
0.143 Tw
(17%, aa = 30%; Fe-)Tj
-13.7905 -1.2543 TD
0.009 Tc
0.017 Tw
[(male means: )37(A)-7(A)59( = 4%, )30(Aa = 4%, aa = 36%\). Based on)]TJ
0 -1.2472 TD
0.136 Tw
(the analysis of this preliminary data set we conclude)Tj
0 -1.2543 TD
0.037 Tw
(that changes in body composition appear to be signifi-)Tj
0 -1.2472 TD
-0.001 Tc
0 Tw
[(cantly influenced by genetic ef)13(fects. )20(These findings sug-)]TJ
T*
0.008 Tc
(gest that these phenotypes could be informative for use)Tj
0 -1.2543 TD
0.009 Tc
0.077 Tw
(in future linkage analyses in order to identify specific)Tj
0 -1.2472 TD
0.146 Tw
(genes involved in changes in body composition over)Tj
0 -1.2543 TD
0.01 Tc
0.017 Tw
(time. Supported by NIH grant HL45522.)Tj
/T46 1 Tf
14 0 0 14 50.981 383.981 Tm
-0.021 Tc
(91)Tj
/F5 1 Tf
8 0 0 8 50.981 366.009 Tm
0.01 Tc
0.003 Tw
[(Sibling Corr)24(elations of Echocardiographic Left)]TJ
T*
0 Tw
[(V)87(entricular)17( \(L)88(V\) Measur)17(ements Derived fr)24(om)]TJ
0 -1.2472 TD
0.001 Tw
[(Factor)17( Models: )17(The HyperGEN Study)]TJ
/F14 1 Tf
T*
0.008 Tc
-0.017 Tw
[(W)9( T)59(ang)]TJ
4.8 0 0 4.8 76.72 339.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 79.158 336.019 Tm
0.01 Tc
0.009 Tw
(, R Devereux)Tj
4.8 0 0 4.8 122.698 339.591 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 125.136 336.019 Tm
0.009 Tc
0.01 Tw
(, M Province)Tj
4.8 0 0 4.8 167.769 339.591 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 170.206 336.019 Tm
0.01 Tc
0.01 Tw
[(, L)38( )57(Atwood)]TJ
4.8 0 0 4.8 207.113 339.591 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 209.551 336.019 Tm
(,)Tj
-19.8213 -1.2543 TD
0.009 Tc
-0.038 Tw
(D Arnett)Tj
4.8 0 0 4.8 79.441 329.613 Tm
0 Tc
0 Tw
(1)Tj
-5.9291 -2.0906 TD
(1)Tj
8 0 0 8 53.476 316.006 Tm
0.009 Tc
0.011 Tw
[(Univ)73(. of Minnesota, MN; )]TJ
4.8 0 0 4.8 138.685 319.578 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 141.123 316.006 Tm
0.01 Tc
0.012 Tw
[(Cornell Univ)74(. Medical)]TJ
-11.2677 -1.2472 TD
[(College, NY)88(;)19( )]TJ
4.8 0 0 4.8 96.165 309.6 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 98.603 306.028 Tm
0.009 Tc
0.016 Tw
[(W)74(ashington Univ)66(., MO.)]TJ
-4.4504 -1.8779 TD
0.017 Tc
0.188 Tw
[(W)82(e)0( evaluated whether factor analysis scores for)]TJ
-1.5024 -1.2472 TD
0.009 Tc
0.051 Tw
[(echocardiographic measures of L)87(V)22( structure and func-)]TJ
0 -1.2543 TD
0.014 Tc
0.188 Tw
(tion exhibited greater familial correlation than indi-)Tj
0 -1.2472 TD
0.009 Tc
0.064 Tw
[(vidual measures of wall thickness, L)87(V)22( dimension, and)]TJ
0 -1.2543 TD
0.018 Tw
(systolic and diastolic function. Factor models were de-)Tj
0 -1.2472 TD
0.006 Tc
0.172 Tw
[(rived for Caucasian \(C\) and )-132(African-American )-7(\(AA\))]TJ
T*
0.009 Tc
0.155 Tw
(hypertensive sibships \(907 sibpairs\) and 476 random)Tj
0 -1.2543 TD
0.008 Tc
0 Tw
[(subjects. Sibling correlation coef)15(ficients \(SCCs\) for in-)]TJ
0 -1.2472 TD
0.011 Tc
0.188 Tw
(dividual measurements and the factors derived from)Tj
0 -1.2543 TD
0.009 Tc
0.02 Tw
[(the models are listed in the table. Factor 1 \(in )37(AA\) and)]TJ
0 -1.2472 TD
0.022 Tw
(factor 2 \(in C\) exhibit higher SCCs than the individual)Tj
T*
0.015 Tw
(components, but SCCs for factor 3 and 4 are similar to)Tj
0 -1.2543 TD
0.021 Tw
(those of individual measures.)Tj
ET
0 0 0 1 K
0 J 0 j 1.02 w 10 M []0 d
/GS1 gs
1 i 
50.981 161.518 m
230.981 161.518 l
S
BT
7 0 0 7 102.005 150.009 Tm
/GS2 gs
0.012 Tc
0 Tw
[(SCC for Individual )20(V)118(ariables)]TJ
ET
/GS1 gs
50.981 138.501 m
230.981 138.501 l
S
BT
7 0 0 7 69.01 140.995 Tm
/GS2 gs
[(SCC)-2790(Loading to Factor)]TJ
/F5 1 Tf
0 -1.717 TD
0.009 Tc
[(Factor 1)-1060(PWT)-1125(IVSD)-1003(L)93(VID)]TJ
/F14 1 Tf
-2.5755 -1.2796 TD
0.011 Tc
[(C)-1897(0.17)-2921(0.20)-1633(0.16)-1641(0.22)]TJ
0 -1.2877 TD
[(AA)-1107(0.30)-2921(0.17)-1633(0.15)-1641(0.29)]TJ
/F5 1 Tf
2.5755 -1.2877 TD
0.01 Tc
-0.001 Tw
[(Factor 2)-1059(ESSM)-654(FS)-2242(L)94(VID)]TJ
/F14 1 Tf
-2.5755 -1.2796 TD
0.011 Tc
[(C)-1897(0.29)-2921(0.13)-1633(0.15)-1641(0.22)]TJ
0 -1.2877 TD
[(AA)-1107(0.14)-2921(0.15)-1633(0.12)-1641(0.29)]TJ
/F5 1 Tf
31.7156 79.281 TD
0.01 Tc
[(Factor 3)-1059(MVI3)-832(MV)115(A)-1981(Factor 4)-1059(M)-6(V)-6(E)-1051(MV)115(A)]TJ
/F14 1 Tf
-2.5674 -1.2877 TD
0.011 Tc
[(C)-1889(0.15)-2921(0.1)27(1)-1668(0.33)-2492(0.32)-2921(0.32)-1633(0.33)]TJ
ET
/GS1 gs
255.019 618.52 m
435.019 618.52 l
S
BT
7 0 0 7 255.019 621.014 Tm
/GS2 gs
[(AA)-1099(0.26)-2921(0.20)-1641(0.30)-2492(0.25)-2921(0.28)-1633(0.30)]TJ
8 0 0 8 266.981 607.975 Tm
0.005 Tc
0 Tw
[(Structural measures: PWT)69(, posterior wall thickness;)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.166 Tw
[(IVSD, interventricular septum dimension; L)94(VID, left)]TJ
T*
0.013 Tc
0.188 Tw
(ventricular internal dimension. Functional measures:)Tj
0 -1.2543 TD
0.012 Tc
0.187 Tw
(ESSM, meridional end-systolic stress; FS, fractional)Tj
0 -1.2472 TD
0.004 Tc
0 Tw
(shortening; MVE, mitral valve \(MV\) early filling phase)Tj
0 -1.2543 TD
0.009 Tc
0.073 Tw
[(peak; MV)129(A, MV)9( atrial filling phase peak; MVI3, MV)]TJ
0 -1.2472 TD
0.014 Tw
(1st third filling fraction.)Tj
/T46 1 Tf
14 0 0 14 255.019 510.973 Tm
-0.021 Tc
(92)Tj
/F5 1 Tf
8 0 0 8 255.019 494.986 Tm
0.009 Tc
-0.001 Tw
[(Kinship Infer)23(ence Using Identity-By-State)]TJ
T*
0.01 Tc
(Information)Tj
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.01 Tw
[(Jef)16(f)15( )8(T)67(.)17( W)39(illiams and John Blangero)]TJ
0 -1.2472 TD
0.017 Tw
(Department of Genetics, Southwest Foundation for)Tj
T*
0.01 Tw
[(Biomedical Research, San )52(Antonio, )9(T)67(exas USA.)]TJ
1.4953 -1.5661 TD
-0.011 Tc
0.092 Tw
(A measure of relationship between individuals is re-)Tj
-1.4953 -1.1835 TD
0.094 Tw
(quired for many kinds of genetic analysis. For example,)Tj
0 -1.1906 TD
-0.01 Tc
0.188 Tw
(in variance component analysis the relationship matrix)Tj
T*
0 Tc
0 Tw
(2)Tj
/F17 1 Tf
0.489 0 TD
(F)Tj
/F14 1 Tf
0.7441 0 TD
-0.016 Tc
0.04 Tw
(, where )Tj
/F17 1 Tf
3.1961 0 TD
0 Tc
0 Tw
(F)Tj
/F14 1 Tf
0.7512 0 TD
-0.011 Tc
0.044 Tw
[( is the kinship matrix, is the structuring ma-)]TJ
-5.1803 -1.1835 TD
0.185 Tw
(trix for the component of variance due to additive ge-)Tj
0 -1.1905 TD
-0.002 Tc
0.187 Tw
(netic factors. If pedigree relationships are known, the)Tj
0 -1.1835 TD
-0.011 Tc
0.068 Tw
(relationship matrix 2)Tj
/F17 1 Tf
8.2276 0 TD
0 Tc
0 Tw
(F)Tj
/F14 1 Tf
0.7512 0 TD
-0.011 Tc
0.07 Tw
[( can be computed easily using es-)]TJ
-8.9787 -1.1906 TD
-0.01 Tc
0.188 Tw
[(tablished algorithms. Common practice, however)40(, is to)]TJ
0 -1.1835 TD
-0.012 Tc
0 Tw
(assume that founders are unrelated. For many populations)Tj
0 -1.1906 TD
0.188 Tw
(the assumption of noninbred founders is probably sus-)Tj
0 -1.1835 TD
0.022 Tw
(pect, but the extent to which the assumption is violated is)Tj
0 -1.1906 TD
0.187 Tw
[(dif)17(ficult to quantify)67(.)180( )-159(W)83(e)0( describe a bias-corrected rela-)]TJ
T*
-0.018 Tc
0.103 Tw
(tionship matrix )Tj
/F17 1 Tf
6.3567 0 TD
0 Tc
0 Tw
(T)Tj
/F14 1 Tf
0.5953 0 TD
-0.011 Tc
0.103 Tw
[( based on identity-by-state information)]TJ
-6.952 -1.1835 TD
0.009 Tc
0.188 Tw
(that estimates accurately the relationship matrix 2)Tj
/F17 1 Tf
21.4724 0 TD
0 Tc
0 Tw
(F)Tj
/F14 1 Tf
0.7724 0 TD
(.)Tj
-22.2449 -1.1906 TD
-0.011 Tc
0.007 Tw
(Knowledge of pedigree relationships is not required, con-)Tj
0 -1.1835 TD
0 Tw
(sequently the method is especially useful for genetic stud-)Tj
0 -1.1906 TD
-0.022 Tc
(ies of inbred and wild populations. Results from simulation)Tj
0 -1.1835 TD
-0.019 Tc
(studies and real data sets illustrate the accuracy with which)Tj
0 -1.1906 TD
-0.011 Tc
0.143 Tw
(the expected relationship matrix can be recovered from)Tj
T*
0.079 Tw
(identity-by-state information at a series of genetic mark-)Tj
0 -1.1835 TD
0.02 Tc
0.188 Tw
(ers. Genotypic information was simulated for 5\22690)Tj
0 -1.1906 TD
-0.011 Tc
0.078 Tw
(microsatellite loci using pedigree structures with various)Tj
0 -1.1835 TD
0.066 Tw
(degrees of inbreeding. Markers were simulated based on)Tj
0 -1.1906 TD
0.029 Tw
[(human genetic data to be highly polymorphic. )-12(The corre-)]TJ
0 -1.1835 TD
0.05 Tw
(lation between the estimated \(T\) and expected \(2)Tj
/F17 1 Tf
19.3535 0 TD
0 Tc
0 Tw
(F)Tj
/F14 1 Tf
0.7512 0 TD
-0.012 Tc
0.05 Tw
(\) rela-)Tj
-20.1047 -1.1906 TD
0.051 Tw
(tionship matrices increases rapidly with number of typed)Tj
T*
-0.016 Tc
0 Tw
(markers, and nearly complete relationship information can)Tj
0 -1.1835 TD
-0.011 Tc
0.055 Tw
(be inferred from identity-by-state information when only)Tj
0 -1.1905 TD
0.017 Tw
(30\22640 microsatellite markers are used.)Tj
/T46 1 Tf
14 0 0 14 255.019 140.485 Tm
-0.021 Tc
(93)Tj
/F5 1 Tf
8 0 0 8 255.019 124.498 Tm
0.009 Tc
0 Tw
[(Identifying a functional polymorphism thr)23(ough)]TJ
0 -1.2472 TD
0.004 Tw
[(linkage analysis conditional on measur)23(ed genotype)]TJ
/F14 1 Tf
0 -1.2543 TD
0.011 Tw
[(L. )45(Almasy)59(, J. Blangero)]TJ
0 -1.2472 TD
0.03 Tc
0.013 Tw
(Southwest Foundation for Biomed. Res., San)Tj
T*
0.026 Tc
0.034 Tw
[(Antonio T)-9(X)]TJ
ET

endstream
endobj
41 0 obj
<</Filter/FlateDecode/Type/ObjStm/Length 4241/First 1898/N 200>>stream
xœÍœmoİ¶Ç¿Š^n2“<|PHÒº-¶nAcl‚¼pœÛÔCb¶´ß~ÿ?©gQ×¾7²\Šh]‘:"<<:‡¤©T¥ª‚Ã)VbÎ¾²HkÑ•×gUy+¸^W>züm« q¿„ªvÈ.¸¦¬­´eYÂ5KAIÅà2§‘ÀWã?‹û‚Âe^­5nfY5³ZuÍ+¾2Êzæ¨Œ(äp±2ÖàáŞTÆk”ã5,Ş+$jæ‘+^Ä#WP˜Ç›©ˆ\ÁàùAW"ÚP$<¯„J¬ÆÍW¼CÈ)òF©¤vÈ‘½x«„W"ø‚WVW•µ‘	T£G]»ÊÅ{,(Ç(Üj¾œTN¡n2•ã{å+'–?9$ /* rÖà­‘øIãJ€ğµæ¢â•Py…F{$ĞpäÄ4†­ˆf5¨5/x]ƒ²|*ì}H {@aMïC°¨l‹¶Öz¨‚
¨u´r`ı´r@áJ*Ü •ƒ¶ÈÀ‹!\²¼Iˆ À q£B¼dT‚g¡f£Šxj$&ƒÆÂ§»PEÔ[¸Š	d÷5ïAöàxÅW1¢nĞæU­(2Ôl+)kAÍä¬Ñ<H($ˆL ³¨ƒV®ƒGvˆ[GVrj¥@­a£)…64lkEÀª	)d7h`ànx­¬H3„UÃ_™78”B^•2…Ê4¼Ö©YjäÕİNp‡FG!¢È«­æ}š)ÈÎ£:‚°‹€I°HnA€E£÷¢…„€]äG
5'hz´<Ë3¼fQIbØ‘ñ‡´Ú°
Ä°”€÷“Ô Úƒ)4¼saça6ø[R¿¶h\Iİİ²_QˆÃ=’;;:¹°÷HD›‰Mj,iş„Ş}aG·FŠİÌ²>ÅQI€|¤×z”%>i	<óF¾‡K„§nlkÖ)˜Ğ4‹§¾´û*o(È…ä`w@Š’j/ìòÌ)_HºŠ‚Dø¤H„gç„ ²áÙ’Ôc­‘ïÑÇ…¼ Sêê$ê—šê°!%Lám,Ù š)AÉ–Dö«¨¢<ZĞ*ê1*:Kí‰ŞŠû ¢¢aëG…º³ä%²-•xdXò%İGåe™—”Dú“^­gÉKŒ”€l@‡*© En©_”Xj<ÅK6Ô]ÔŸĞ‚Iiã¨{­eïV2[æ­©	¡GŒV†÷ÕL^£.‹•uüU<¯Ej<¾{ªÒ;*?O-LU ©íyRĞò–C¬(; Á®nH¡e‡ZƒôT†ï•tá=–Ê
$©ljH¾eRˆÊQiK‡P§Ô„Â¡1é;¡Ş±T9¨”Â.ÏT”P“ÕW_¼ùíıİ¿îNÎğŸNÿŸœ^_İ¼<¿İ¥ÄÙåçİí³¯?Ÿ_|suqıáòêãÉ/¯^\İ^¶?Î¢^áöİÕİí[¼ƒª~dOg¼Nïrá¯Ï?îN~Üİ^ÿvs±»E®×7×ovwÕÛ“×_ŸV'g»ßïª“ï?ã¶—ÍùUsşşİÉ7¿ß}ûæîün‡Œß¾¡]õüyO“öID:i˜œ¦q)y–Ô’oòıôï÷ÿÛ]0ëO—€=_Åõ×ç7xê ”é‡İ‡Ëó—×¿¿UøcWjó.¿vóIş$ş#ˆ™Ÿô¯óÏ;^5šœœ^ŞÜŞ½úåüÃõ y…²İ&+)•Ë/ù¾zæ’ÍJß¥Ë?œßİ\âíş®Ğa*¾dŸ|×µ{²»XR×€É"ã•·2Ğñáî—Û·Ğ™Ô›¥jÊíÛü’DîĞúúòçŸw¨{şïs‘¶*jI•É«HK® Ñgş$Õ$Ææ-ùëóŒ,~Ò°æ ğ7cî~ÑFœùeÎ¤Ì”ëˆ³9sGpVO9³jÂ™›pö¥¬	ˆâaq¸7ıºáMÒcršŸ%öl£ûlfÏnªû’M2S*gézØÏ!«Í8<LÌ“a‘IËLÚºÈäºÏÍtŸ›ê¾0eRş}9£xÇ‹tÔ•ó€GèPå§h‹'-Ç<¼\¤¯[Û¤iGº¶´Ò·.ä³ÖO3hŸñûÙ5zd”Eˆñéùø¡"€Ë@×e ½*ææp ½-·Ğz]%‹wºàá‡òá îZùıå´ú­±Q²>ÃŸHÉéìÇy0Ÿ¶ò›ñy˜˜#&ëƒ™e&øÃŒÉ0eÒ™(ÖUØ¤ız‘dtˆ¦Ïß~ì¶·Aƒëq¾€«kìÑÚ rOe•ˆ{uUØÑ‘8ÀÒ¨ƒ±Œz-{4kœ!–Yé,ı³Q%8MÒÒÈ[ é/q½¿…2œ1à.©%ª°¡.=£›§nTi¨›ö¢ÂªM“¾ïKy°¯âf ¯#şr}°[Û1äñh·vSÈk?\­lt-GşgÖeè­×:ö×uá\Ùt¦s½)Ã&EJ²WCUoÆêab˜4Ë Ud’ñ¡’=p8“ôj™d4jÌ¤˜üRg€jmÔÖF5lÒÏ«bgUw6¬ÉßSSÇ¨ÍœêÌk¶m·âTRlîÁl¢ß©Íà¼_¶r0Ú•äá– £™ u˜ éæ–ÀZHVÉ=5uQİRh‘PhJºF[æf¨Ü¦Ú2…<Ó–ŒNN‰4M¦Õ‰<LÎöĞ!Ü¿–ºl:è€N÷Û©SOÕZƒzÕëĞ²³Ê˜TÏ V¯RE÷ ·¾~ÜŠ¾~İèRÓ8ûµŞÔPİ—æ&ÌfäÜlÄğC„q»WZø¾2SÿÑ®(3ó÷›™¿+W”±şZ?§Áıı>Û›ÆßïŸèÛ~ÔÀyK>Ïš¾p#úöD›ÊQMNÖ)ÑwÄ˜ngô¹)}öŒL=40'Ş&ãZ
9÷¨uëƒÎÖ­OƒÓÙ‘uCdãuªŸÌÛÒ¤©½C:gÍâN¹$ÜˆÈåXÓ‘®g?‚H?5¿7Ö´¦¯)s¹ìk2¾Å‘ÜZ=§<ö˜–ıöÍ÷Oë·ßğûgìˆYˆ@š˜fìíG–s@7Cöx¡G(ï‰2-˜¤ı#LÒ™GßÌ<úÓ)#Ugš®æ[jüúÆœwÙ‡œLëÏ§9ğç›¢??æX©iüùqÃPéç´uNó? xÏ, õh_P‡	:Âu9 µ¤y§şãqyúÍÌÓ_r8­fm€8P¨SäÆ•¶÷c¦Òn:î¢œ÷‡uÆTrxÜŠÊ‘p‡Q)Ëñ'´\‘ÊºLåö@=£²RéŠßõ_ÂeÒ˜§ºEæi=@³.¡Ù(J“ùUVO`’Jä¾GÍ6Ãq ĞC<8:$j-Å(jŠ W	ì1I§Ñùõ§@u‘ú²ƒITË¨GºeTö¯¢ú8“¨>Î$ªgÊVy%º™Ø¼åÀÏåÚìEeÌ1´Û,ºôhß/Üˆãƒ#J¢×Š(‰F”D?uDItQİG”dàË—¢/_gÙÓ"9•ÜŸûg\Xs¬7_s!Æf|&èˆÕ=Á¦ò4h1“`ÓÑÓNÄLƒMbö›q´˜–KÖeË¥­DÊ\æ¡^¤årÃ1ÿLlZv—\ø3åRä‘¸<LĞ—‡™DüZ\Ê4Ì$rO˜iì Z3ÌÔ»`Hf«z†mï`•ÎÍÏõE7ƒsëæ,š¡ÿ€qiÙâQd„ƒì•…Q~pPJ¦şõËlÂ¿Ì&üÏÂç«„¦š¯g ÚÅ`tSüa°c¶Á¶‰ØM?¼îki´®Oi¨2¼‘>TĞG­dµÌb2‹lµ’.4 R»Ğ ôCà’èò”ß.@Ù48ğ BZ¸]`•ûü™X:buO<Ë–YW¥³ €Ì‚ ~eC¶s[qè²¡YIèİXJ\6.+	ËúÉ\W1­ıß?À3l¼‰÷7¢ïà”Ä	}Ç›«qF_œÒwÏìıu‚Q_*Ÿ81TcË%7rpÙzşiœ=ÿZ5º³qıkµ¥îä.K½<ÛıŒ{X´3åéå¾)[ÑûB¨>LŞ³ÂËëO¾¿;ÿty1à²6}k6İäàµWÒV0(Ÿş ›4ııŞ†•mŞÁäƒ¡Ö®[§-¬‰vq màÁâ ).È*¾²Íâ€°iß®
)×ÜC™Rp•™ÅÅ­?ô‚$zĞ'š=8.f–¬-°³åEd×ˆŒ-8Êl·<€Ûæô³m·<€›ãfªùLkæ´jµi·<×ä•nY8v¡ÚˆÛ±p÷O–Ydx9°~ŠOWmØÙŠ;[Q0¬}!¿KS»l|àvL½ãÌƒíLƒ&öÿŞ…³´{”Lµì©ÉHhåşh›Ñ:îş/¹‘Ğ#«ÃN¬VU²@şñí/^|÷·7|~ı)Y"é†¯w·7—¿Ş]ß¤-µøÈÊiœÁôzÔ)ú¥âÀJÉ)5¼–îYáàD\zÈ¹µ`ûÜÈ¿CH{yñ7íoÆõgn¬÷àçp=ŞŸŒô|X+éĞŞû|ÖÜºoì…›¦k|¾•Ü°NétxîCˆg ¹:çõ±N²ó7o ²é:Ëáşf©<×ËÎ²;™¸Kò:îQFYTÆğÜÉ|ú½û»Ió”7øTŸ”ÕÂzÌg›wËÛ@NÚ÷ØlO·³Í5Ëm0Û–$3ÃCS3Ö…7Öé;‡ö\zé´Ëdl„²ÉL6T*Z±¦”4	îÖØ4«—å¥¦ÀÛfáÁ>½t´¿ã€GäaL‡WªB%ÍCáùG{¦ l›¶€óÛóC¯t¤6¬%IÓèrµÇCò#o£¨ØË©ÓëÓø­õ—“÷=yuşëw»Ë¿ÜU¾†	w·ûüŸTyI7œ^~ÚIÚr5iÕV§ô*ãäôÓùGNK6&ûOMI!º~D|ÆuÏò‘Ü'U™Æ¤Å
J)½¸úøiEö"Ë¼ÔËSüvºûÙÑ¤íl÷3;ÛılæÅö‡•wÿénôßÁB)+}XÀJ),;3«°åœ´Eczˆ9É‰9›Ğ÷7‚ñà…¨VÖÚŠÏÚŒö^×úZÏf)àØí“¦Ó0Ú}÷ØÖ¯Å‰KşV×|­çxaå¶\"móÎG“{áNÑ´Müqu4ïn„æòô€…i+Ö­µ[ŠuÓ©‚ÖM§
Ñ\sêÊÄëoÛ-ĞH§ë'Z×ú•P¿mˆoLdôgsà®r[Nú³.íûĞOÚñfh´6£ó0AG¤î	ñ/ŒèM”qJêJ´‰QHm"•÷FÑâ¥™+Ö÷ûøXßîãƒñİ÷ñi0õÍ>>…é}“=¬OÛ‡,wÀdWz„ïò€½|·Âß°ß¹Qº®×~Ó²íZ*Ú¡Õ´üÄl§]ÃD±€³Îh¨€ÌµV‚TG~û¶Ô.@Ì½ã7Ò»‡
:wÏ|€¿},‡š 7NCM6NCM{©ŞìÿŠ^
endstream
endobj
489 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
488 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
487 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
480 0 obj
<</Length 9925>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(223)]TJ
/F14 1 Tf
8 0 0 8 72 638.022 Tm
0.014 Tc
0.188 Tw
(Association analyses in regions showing linkage)Tj
-1.5024 -1.2543 TD
0.008 Tc
0 Tw
(may help to narrow the candidate region around a QTL)Tj
0 -1.2472 TD
0.015 Tc
0.188 Tw
(as linkage disequilibrium is likely to extend over a)Tj
0 -1.2543 TD
0.009 Tc
0.13 Tw
(shorter distance than linkage. Several markers within)Tj
0 -1.2472 TD
0.014 Tc
0.187 Tw
(a candidate region may be in disequilibrium with a)Tj
T*
0.009 Tc
0.175 Tw
[(QTL, making it necessary to dif)16(ferentiate between a)]TJ
0 -1.2543 TD
0.003 Tc
0 Tw
(functional polymorphism and variants in disequilibrium)Tj
0 -1.2472 TD
0.009 Tc
0.038 Tw
(with it. If there is a single functional polymorphism in)Tj
0 -1.2543 TD
0.033 Tw
(a QTL, we expect that linkage analyses conditional on)Tj
0 -1.2472 TD
0.041 Tw
[(a fixed-ef)16(fect measured genotype analysis of the poly-)]TJ
T*
0.007 Tc
0.099 Tw
[(morphism would yield a LOD score of zero. )-50(Alterna-)]TJ
0 -1.2543 TD
0.009 Tc
0.188 Tw
[(tively)59(, if there are multiple polymorphisms or if the)]TJ
0 -1.2472 TD
0.033 Tw
(genotyped marker is merely in disequilibrium with the)Tj
T*
0.003 Tc
0 Tw
(sole functional variant, we expect linkage analyses con-)Tj
0 -1.2543 TD
0.009 Tc
0.105 Tw
(ditional on measured genotype to produce a non-zero)Tj
0 -1.2472 TD
0.008 Tc
0.07 Tw
[(LOD )6(score. )-55(W)80(e)-1( have tested these hypotheses in simu-)]TJ
0 -1.2543 TD
0.009 Tc
0.017 Tw
[(lated data from Genetic )44(Analysis )-6(W)88(orkshop 10, re-bin-)]TJ
0 -1.2472 TD
0.111 Tw
(ning the 20 alleles used to produce the diallelic QTL)Tj
T*
0.052 Tw
(to form new markers in varying degrees of disequilib-)Tj
0 -1.2543 TD
0.143 Tw
(rium with the QTL. In analyses with the QTL itself,)Tj
0 -1.2472 TD
0.01 Tc
0.055 Tw
[(the conditional LODs ranged from 0 - 1.91, with 92%)]TJ
0 -1.2543 TD
0.014 Tc
0.188 Tw
(under 0.588 and 43% being zero. Conditional LOD)Tj
0 -1.2472 TD
0.009 Tc
0.07 Tw
(scores increased rapidly for markers in disequilibrium)Tj
T*
0.052 Tw
(with the QTL. For a marker with a correlation of 0.73)Tj
0 -1.2543 TD
0.01 Tc
0.169 Tw
(with the QTL, only 17% of conditional LOD scores)Tj
0 -1.2472 TD
0.008 Tc
0.066 Tw
[(were under 0.588 and only 1.5% were zero. )-49(These re-)]TJ
0 -1.2543 TD
0.009 Tc
0.014 Tw
(sults suggest that linkage analyses conditional on mea-)Tj
0 -1.2472 TD
0.095 Tw
[(sured genotype will be a useful tool in dif)23(ferentiating)]TJ
T*
0.005 Tw
(between functional polymorphisms and variants in dis-)Tj
0 -1.2543 TD
0.025 Tw
(equilibrium with them.)Tj
1.5024 -1.2472 TD
0.006 Tc
0 Tw
(Supported by NIH grants GM18897 and MH59490.)Tj
/T47 1 Tf
14 0 0 14 59.981 297.014 Tm
-0.021 Tc
(94)Tj
/F5 1 Tf
8 0 0 8 59.981 278.986 Tm
0.009 Tc
0.005 Tw
[(A)51( survey of genome scan linkage r)16(esults fr)23(om)]TJ
T*
0 Tw
(human complex diseases and traits: do loci cluster)Tj
T*
0.01 Tc
(and why?)Tj
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.005 Tw
[(A.D. Paterson, )52(A. Petronis)]TJ
0 -1.2472 TD
0.01 Tc
0.014 Tw
(Neurogenetics Section, CAMH, University of)Tj
0 -1.2543 TD
0.009 Tc
0.027 Tw
[(T)60(oronto, T)67(oronto, Ontario, Canada.)]TJ
1.5024 -1.8709 TD
0.091 Tw
(Numerous genome-wide linkage studies of human)Tj
-1.5024 -1.2543 TD
0.114 Tw
(complex disease and traits have been performed with)Tj
0 -1.2472 TD
0.028 Tw
(the aim of assisting in the identification of susceptibil-)Tj
T*
0.087 Tw
(ity loci. Previously it has been suggested that loci for)Tj
0 -1.2543 TD
0.175 Tw
[(a variety of autoimmune diseases cluster)37(, suggesting)]TJ
0 -1.2472 TD
0.01 Tc
0.188 Tw
[(either closely linked loci, or pleiotropy)53(.)187( )-124(A)45( confound)]TJ
0 -1.2543 TD
0.007 Tc
0 Tw
(that may also produce clustering of loci is that of trans-)Tj
0 -1.2472 TD
0.009 Tc
0.154 Tw
(mission ratio distortion \(meiotic drive or segregation)Tj
T*
0.001 Tw
[(distortion\). )16(W)81(e)0( have searched the literature for genome)]TJ
0 -1.2543 TD
0.102 Tw
(scans in human complex diseases and traits that have)Tj
0 -1.2472 TD
0.006 Tc
0 Tw
[(used > 150 microsatellite markers. )13(W)78(e)-1( documented any)]TJ
T*
0.004 Tc
0.053 Tw
(lod scores )Tj
/F17 1 Tf
4.4929 0 TD
0 Tc
0 Tw
(\243)Tj
/F14 1 Tf
0.5598 0 TD
0.009 Tc
0.055 Tw
[( 2 \(or equivalent statistic\), and listed their)]TJ
-5.0528 -1.2543 TD
0.118 Tw
(position on a sex-averaged genetic map. 169 genome)Tj
0 -1.2472 TD
0.079 Tw
(scans in complex diseases and traits were identified \226)Tj
25.5047 69.2504 TD
-0.011 Tc
0.013 Tw
(eight did not produce a single lod score )Tj
/F17 1 Tf
15.6614 0 TD
0 Tc
0 Tw
(\243)Tj
/F14 1 Tf
0.5386 0 TD
-0.012 Tc
0.013 Tw
[( 2. W)82(e)-1( observed)]TJ
-16.2 -1.2543 TD
-0.013 Tc
0.042 Tw
(the pattern of lod scores )Tj
/F17 1 Tf
9.7795 0 TD
0 Tc
0 Tw
(\243)Tj
/F14 1 Tf
0.5386 0 TD
-0.011 Tc
0.042 Tw
[( 2 across all chromosomes. On)]TJ
-10.3181 -1.2472 TD
0 Tw
(many chromosomes no clear pattern of clustering of posi-)Tj
0 -1.2543 TD
0.014 Tw
[(tive lod scores was observed. )39(As expected, a wide variety)]TJ
0 -1.2472 TD
0 Tc
0.187 Tw
(of autoimmune diseases clustered on chromosome 6p)Tj
T*
-0.011 Tc
0.002 Tw
[(around the HLA)67( region. Interestingly)60(, the pericentromeric)]TJ
0 -1.2543 TD
0.073 Tw
(region of chromosome 10 also demonstrated a cluster of)Tj
0 -1.2472 TD
0.064 Tw
[(linkage results in schizophrenia, bipolar)46(, type 1 diabetes,)]TJ
0 -1.2543 TD
0.08 Tw
[(Crohn\222)59(s disease, obesity and blood pressure. )-34(Analysis of)]TJ
0 -1.2472 TD
0.076 Tw
(40 CEPH families showed weak excess allele sharing in)Tj
T*
0.112 Tw
(females at the same region on chromosome 10 suggest-)Tj
0 -1.2543 TD
-0.013 Tc
0.186 Tw
[(ing possible transmission ratio distortion. )-170(T)31(ransmission)]TJ
0 -1.2472 TD
-0.011 Tc
0.07 Tw
(ratio distortion should be excluded for regions that dem-)Tj
T*
-0.017 Tc
0 Tw
(onstrate clustering of linkages since it may confound map-)Tj
0 -1.2543 TD
-0.011 Tc
0.031 Tw
(ping studies.)Tj
/T47 1 Tf
14 0 0 14 264.019 463.011 Tm
-0.021 Tc
(95)Tj
/F5 1 Tf
8 0 0 8 264.019 447.024 Tm
0.009 Tc
0.007 Tw
[(Gene-envir)16(onment interaction models for)16( complex)]TJ
T*
0.003 Tw
[(traits with molecular)16( discr)23(ete data: application of)]TJ
0 -1.2472 TD
(structural modelling to Mood Disorders.)Tj
/F14 1 Tf
0 -1.2543 TD
0.012 Tw
(Fabio Macciardi)Tj
4.8 0 0 4.8 317.82 420.605 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 320.315 416.976 Tm
0.009 Tc
-0.029 Tw
[(,)14( Alberto )-45(Morabito)]TJ
4.8 0 0 4.8 381.657 420.605 Tm
0 Tc
0 Tw
(2)Tj
-24.5079 -2.0787 TD
(1)Tj
8 0 0 8 266.457 406.998 Tm
0.009 Tc
0.014 Tw
[(CAMH, Univ)59(. of )9(T)67(oronto, T)67(oronto, Canada; )]TJ
4.8 0 0 4.8 412.894 410.627 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 415.332 406.998 Tm
0.011 Tc
0.018 Tw
[(Univ)68(. of)]TJ
-18.9142 -1.2472 TD
0.009 Tc
0.004 Tw
[(Milan , Milan , Italy)59(.)]TJ
1.4953 -1.6299 TD
0.099 Tw
(It is well known that both genes and environment)Tj
-1.4953 -1.2472 TD
0.073 Tw
(factors may play a role in the aetiology of psychiatric)Tj
T*
0.021 Tw
[(disorders, like schizophrenia or bipolar mood disorder)59(.)]TJ
0 -1.2543 TD
0.063 Tw
(Advancement in molecular genetic techniques and the)Tj
0 -1.2472 TD
0.013 Tc
0.187 Tw
(contemporary development of statistical genetics al-)Tj
0 -1.2543 TD
0.009 Tc
0.047 Tw
(lowed formulating a theory suitable for the hypothesis)Tj
0 -1.2472 TD
0.129 Tw
(testing of specific transmission mechanisms from the)Tj
T*
0.007 Tc
0 Tw
[(single major locus to polygenic models. Moreover)42(, epi-)]TJ
0 -1.2543 TD
0.009 Tc
0.09 Tw
(demiological investigations showed that also environ-)Tj
0 -1.2472 TD
0.152 Tw
(mental risk factors seem to be correlated with major)Tj
0 -1.2543 TD
0.007 Tc
0.08 Tw
[(psychiatric disorders. )-62(Thus moving toward a more in-)]TJ
0 -1.2472 TD
0.009 Tc
0.062 Tw
(tegrated approach of genetic and non-genetic risk fac-)Tj
T*
0.11 Tw
(tors is now the major task that the investigators have)Tj
0 -1.2543 TD
0.042 Tw
(to accomplish in the search for the causes of psychiat-)Tj
0 -1.2472 TD
0.01 Tc
0.187 Tw
(ric disorders. Usually the investigations in this field)Tj
T*
0.009 Tc
0.188 Tw
(are restricted to situations in which the genetic trait)Tj
0 -1.2543 TD
0 Tw
(and the environmental variables are continuous and as-)Tj
0 -1.2472 TD
0.186 Tw
(ymptotically gaussian. Our current approach extends)Tj
0 -1.2543 TD
0.143 Tw
(the possibility of modelling the interaction under the)Tj
0 -1.2472 TD
0.13 Tw
(hypothesis that the genetic mechanism would be dis-)Tj
T*
0.056 Tw
(crete, using genotypes or alleles at potential candidate)Tj
0 -1.2543 TD
0.007 Tc
0 Tw
[(loci. )28(W)79(e)0( genotyped 100 cases \(patients with Mood Dis-)]TJ
0 -1.2472 TD
0.009 Tc
0.179 Tw
(orders, bipolar\) and 100 healthy controls for several)Tj
0 -1.2543 TD
0.159 Tw
(genes potentially related to bipolar disorders and we)Tj
0 -1.2472 TD
0.006 Tc
0 Tw
[(investigated dimensional non-genetic variables also )6(p)24(o)24(-)]TJ
T*
-0.011 Tc
0.077 Tw
(tentially related to the disease expression, i.e. the degree)Tj
0 -1.2543 TD
-0.021 Tc
0 Tw
(of social adjustment and the self esteem. Information about)Tj
0 -1.2472 TD
-0.011 Tc
0.165 Tw
(the number of depressive and manic events and symp-)Tj
T*
-0.014 Tc
0.167 Tw
[(toms )6(were )6(also )6(available. )-103(A)49( causal model with observ-)]TJ
0 -1.2543 TD
-0.009 Tc
0.188 Tw
(able and latent variables describing environmental and)Tj
0 -1.2472 TD
-0.011 Tc
0.152 Tw
(genetic components and a latent ordinal variable repre-)Tj
ET

endstream
endobj
500 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
498 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
499 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
497 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
491 0 obj
<</Length 9980>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(224)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
-0.011 Tc
0.128 Tw
(senting the bipolar trait was adopted and analyzed with)Tj
0 -1.2543 TD
-0.013 Tc
0.192 Tw
[(structural )9(modelling. )-171(The generalized linear model has)]TJ
0 -1.2472 TD
-0.011 Tc
0.013 Tw
(been used to check the validity of the model.)Tj
/T48 1 Tf
14 0 0 14 50.981 579.968 Tm
-0.021 Tc
(96)Tj
/F5 1 Tf
8 0 0 8 50.981 563.017 Tm
-0.011 Tc
0.003 Tw
[(Power)17( of Quantitative )17(T)75(ransmission Disequilibrium)]TJ
0 -1.2543 TD
0.001 Tw
[(T)89(est in evaluating the genetic components of)]TJ
0 -1.2472 TD
0.004 Tw
[(pharmacological r)17(esponse in psychiatric disorders.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.019 Tw
(Fabio Macciardi, Emanuela Mundo)Tj
0 -1.2472 TD
0.017 Tw
[(CAMH, Univ)59(. )6(of T)60(oronto, T)74(oronto, Canada)]TJ
1.5024 -1.7504 TD
0.028 Tw
(One of the problems in genetic studies on complex)Tj
-1.5024 -1.2472 TD
0.107 Tw
(traits, and particularly on psychiatric disorders, is the)Tj
0 -1.2543 TD
0.064 Tw
(definition of the phenotype. In most cases, the pheno-)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
(type has been identified with the clinical diagnosis, but)Tj
T*
0.009 Tc
0.035 Tw
(there are alternative possibilities for a better definition)Tj
0 -1.2543 TD
0.025 Tw
(of a psychiatric phenotype, considering also biological)Tj
0 -1.2472 TD
0.036 Tw
(elements \(e.g. hormonal response to challenge studies,)Tj
0 -1.2543 TD
0.081 Tw
(determination of peripheral markers of neurotransmit-)Tj
0 -1.2472 TD
0.117 Tw
(ters etc.\). Using the clinical response to psychotropic)Tj
T*
0.062 Tw
(compounds as a way to define a phenotype of interest)Tj
0 -1.2543 TD
0.133 Tw
(in psychiatric diseases represents an innovative strat-)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
[(egy)60(. In such an approach, the analytical methods should)]TJ
T*
0.009 Tc
0.145 Tw
(include both qualitative and quantitative measures of)Tj
0 -1.2543 TD
0.146 Tw
(the pharmacological response and should include the)Tj
0 -1.2472 TD
0.119 Tw
(polymorphisms of the genes potentially implicated in)Tj
0 -1.2543 TD
0.106 Tw
(the pharmacological response to the compound of in-)Tj
0 -1.2472 TD
0.008 Tc
0.068 Tw
[(terest. )-54(The qualitative analysis of the pharmacological)]TJ
T*
0.009 Tc
0.178 Tw
(response by genotypes and alleles can be performed)Tj
0 -1.2543 TD
0.005 Tc
0.186 Tw
[(with classical association and )-181(T)35(ransmission )-6(Disequi-)]TJ
0 -1.2472 TD
-0.014 Tc
0.321 Tw
[(librium T)]TJ
3.9543 0 TD
0.01 Tc
0.158 Tw
(est \(TDT\), and it does not present method-)Tj
-3.9543 -1.2543 TD
0.009 Tc
0.062 Tw
(ological problems. On the other hand, the quantitative)Tj
0 -1.2472 TD
-0.011 Tc
0.018 Tw
(analysis of the pharmacological response would require a)Tj
T*
-0.021 Tc
0 Tw
[(more complex strategy)57(. )22(The quantitative )14(T)30(ransmission Dis-)]TJ
0 -1.2543 TD
-0.012 Tc
0.06 Tw
[(equilibrium )-39(T)68(est \(Q-TDT\) is a model recently developed)]TJ
0 -1.2472 TD
-0.031 Tc
0.141 Tw
(by some )Tj
3.7559 0 TD
-0.014 Tc
0.135 Tw
[(Authors and is a )-133(T)-9(D)-9(T)21( )-8(procedure )-8(modified )-8(for)]TJ
-3.7559 -1.2472 TD
-0.011 Tc
0.162 Tw
[(quantitative phenotype \(e.g. severity of symptoms, per)17(-)]TJ
0 -1.2543 TD
0.124 Tw
(centage of improvement of symptoms induced by treat-)Tj
0 -1.2472 TD
0.114 Tw
[(ment\). Current available quantitative methods, however)39(,)]TJ
0 -1.2543 TD
0.024 Tw
[(only approximate the qualitative T)-7(D)-7(T)16( design. W)75(e)-2( present)]TJ
0 -1.2472 TD
-0.013 Tc
0.186 Tw
[(a comparison of the relative power of )-177(T)-8(D)-8(T)15( )-6(versus )-6(Q-)]TJ
T*
-0.011 Tc
0.153 Tw
(TDT in a simulated set of data, where genotypes for a)Tj
0 -1.2543 TD
0.11 Tw
(candidate gene and both a qualitative and a quantitative)Tj
0 -1.2472 TD
-0.015 Tc
0 Tw
(measure for the phenotype \(i.e., pharmacological response)Tj
0 -1.2543 TD
-0.011 Tc
0.016 Tw
(to a given psychotropic drug\) are available.)Tj
/T48 1 Tf
14 0 0 14 50.981 140.995 Tm
-0.021 Tc
(97)Tj
/F5 1 Tf
8 0 0 8 50.981 123.987 Tm
0.009 Tc
0.007 Tw
(Comparison of Generalized Estimating Equations,)Tj
0 -1.2472 TD
0.01 Tw
[(Logistic Regr)9(ession and Haseman-Elston)]TJ
T*
0.009 Tw
[(Regr)23(ession for)16( a Dichotomous )9(T)67(rait.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.005 Tw
[(M. Nicolaou, )44(A. DeStefano, L. Farrer)30(, L. )51(Adrienne)]TJ
0 -1.2472 TD
0.012 Tc
(Cupples.)Tj
25.5047 69.2504 TD
0.009 Tc
0.013 Tw
[(Boston Univ)59(. Schools of Public Health and Medicine,)]TJ
0 -1.2543 TD
0.011 Tc
(USA.)Tj
1.4953 -1.7504 TD
0.187 Tw
(Multiple sibling families are common in linkage)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.051 Tw
(studies, resulting in correlated data. If this issue is not)Tj
0 -1.2543 TD
0.012 Tw
(addressed in the analysis, an increased number of false)Tj
0 -1.2472 TD
0.008 Tc
0.035 Tw
[(positive linkages may be observed. )-13(W)80(e)-1( used simulated)]TJ
T*
0.085 Tw
[(data to compare the )-56(T)59(ype I error and power of gener)15(-)]TJ
0 -1.2543 TD
0.009 Tc
0.094 Tw
(alized estimating equations \(GEE\), logistic regression)Tj
0 -1.2472 TD
0.005 Tc
0.183 Tw
[(and Haseman-Elston regression \(H-E\). )-171(The data sets)]TJ
0 -1.2543 TD
0.009 Tc
0.02 Tw
(generated consisted of nuclear families with 2, 3 and 5)Tj
0 -1.2472 TD
0.162 Tw
[(siblings. Dif)23(ferent models were studied with varying)]TJ
T*
0.024 Tw
(penetrance and heterogeneity among families resulting)Tj
0 -1.2543 TD
0.007 Tc
0.114 Tw
[(in dif)14(ferent within family correlations. )-92(The three cor)14(-)]TJ
0 -1.2472 TD
0.008 Tc
0.101 Tw
[(relations studied were 0, 0.25 and 0.4. )-85(W)80(e)-2( found that)]TJ
T*
0.007 Tc
0.116 Tw
[(logistic and H-E regression exhibited nominal )-92(T)58(ype I)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
(error with the independent data while GEE was slightly)Tj
0 -1.2472 TD
0.009 Tc
0.02 Tw
[(conservative. )8(W)32(ith lar)16(ger families and increased corre-)]TJ
0 -1.2543 TD
0.008 Tc
0.04 Tw
[(lation, the )-21(T)59(ype I error of logistic and H-E regressions)]TJ
0 -1.2472 TD
0.009 Tc
0.169 Tw
(increased to higher values than expected while GEE)Tj
T*
0.013 Tc
0.188 Tw
(with both independent and exchangeable correlation)Tj
0 -1.2543 TD
0.007 Tc
0.094 Tw
[(structures performed at the nominal )-78(T)72(ype I error rate.)]TJ
0 -1.2472 TD
0.009 Tc
0 Tw
(The power was similar among these methods, although)Tj
0 -1.2543 TD
-0.007 Tc
0.161 Tw
[(the higher )-163(T)]TJ
5.237 0 TD
0.009 Tc
(ype I error of logistic and the H-E with)Tj
-5.237 -1.2472 TD
0.033 Tw
[(lar)16(ger correlations suggest GEE is more appropriate in)]TJ
T*
0.025 Tw
(this situation.)Tj
/T48 1 Tf
14 0 0 14 255.019 355.011 Tm
-0.021 Tc
(98)Tj
/F5 1 Tf
8 0 0 8 255.019 338.003 Tm
0.009 Tc
0.008 Tw
[(A)51( stepwise oligogenic segr)16(egation analysis showed)]TJ
T*
0 Tw
(the existence of a second major locus underlying)Tj
0 -1.2543 TD
0.005 Tw
(serum angiotensin I-converting enzyme levels.)Tj
/F14 1 Tf
0 -1.2472 TD
0.011 Tc
(Guo X)Tj
4.8 0 0 4.8 277.073 311.584 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 279.51 308.013 Tm
0.01 Tc
0.006 Tw
(, Cooper R)Tj
4.8 0 0 4.8 315.284 311.584 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 317.778 308.013 Tm
0.01 Tc
-0.011 Tw
[(,)6( W)82(ard )-17(R)]TJ
4.8 0 0 4.8 346.805 311.584 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 349.243 308.013 Tm
0.01 Tc
0.006 Tw
[(, Luke )52(A)]TJ
4.8 0 0 4.8 377.816 311.584 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 380.254 308.013 Tm
0.01 Tc
0.009 Tw
(, Zhu X)Tj
4.8 0 0 4.8 405.652 311.584 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 408.09 308.013 Tm
(,)Tj
-19.1339 -1.2543 TD
0.009 Tc
0.012 Tw
(Rotimi C)Tj
4.8 0 0 4.8 285.236 301.606 Tm
0 Tc
0 Tw
(1)Tj
-6.2953 -2.0787 TD
(1)Tj
8 0 0 8 257.457 288 Tm
0.009 Tc
0.015 Tw
[(Loyola University Medical Center)37(, Maywood, IL;)]TJ
4.8 0 0 4.8 255.019 281.594 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 257.457 278.022 Tm
0.01 Tc
0.018 Tw
[(Oxford University)67(, Oxford, UK)]TJ
1.1906 -1.7504 TD
0.009 Tc
0.174 Tw
(Human serum angiotensin I - converting enzyme)Tj
-1.4953 -1.2543 TD
0.159 Tw
(\(ACE\) levels are highly heritable and are influenced)Tj
0 -1.2472 TD
0.138 Tw
(by major genetic factors. One quantitative trait locus)Tj
T*
0.007 Tc
0.096 Tw
[(\(QTL\) is located within or close to the )-36(ACE locus it-)]TJ
0 -1.2543 TD
0.009 Tc
0.1 Tw
(self. Some studies have demonstrated evidence of as-)Tj
0 -1.2472 TD
0.159 Tw
(sociation between the I/D polymorphism and plasma)Tj
0 -1.2543 TD
0.077 Tw
[(ACE levels and/or blood pressure, although the ef)30(fect)]TJ
0 -1.2472 TD
-0.016 Tc
0.152 Tw
(of the )Tj
2.8701 0 TD
0.009 Tc
0.153 Tw
(ACE I/D polymorphism has been reported in-)Tj
-2.8701 -1.2472 TD
0.005 Tc
0 Tw
[(consistently)62(. Rigat et al. \(1990\) found that the I/D poly-)]TJ
0 -1.2543 TD
0.024 Tc
0.188 Tw
(morphism in the )Tj
7.9016 0 TD
0.037 Tc
(ACE gene accounts for half the)Tj
-7.9016 -1.2472 TD
0.009 Tc
0.025 Tw
[(variance of serum enzyme levels and that plasma )29(ACE)]TJ
0 -1.2543 TD
0.094 Tw
(activity increases in a codominant fashion with the D)Tj
0 -1.2472 TD
0.179 Tw
(allele. McKenzie et al. \(1995\) found that two QTLs)Tj
T*
0.027 Tc
0.191 Tw
[(jointly )8(influence )8(serum )-125(ACE levels in a Jamaican)]TJ
0 -1.2543 TD
0.008 Tc
0.027 Tw
[(sample. )31(As part of an ongoing study on the genetics of)]TJ
0 -1.2472 TD
0.007 Tc
0.046 Tw
[(hypertension we examined 1060 )8(African )8(Americans in)]TJ
T*
0.008 Tc
0.056 Tw
[(267 families from Maywood, IL. )-6(As expected, the I/D)]TJ
0 -1.2543 TD
0.005 Tc
0 Tw
(polymorphism was significantly correlated with plasma)Tj
0 -1.2472 TD
0.007 Tc
(ACE levels, with the D allele associated with increased)Tj
ET

endstream
endobj
509 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
510 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
508 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
502 0 obj
<</Length 10700>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(225)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.01 Tc
0.151 Tw
(ACE levels, both in men and women \(p=0.0062 and)Tj
0 -1.2543 TD
0.161 Tw
[(0.0001 for men and women, respectively\). However)31(,)]TJ
0 -1.2472 TD
0.028 Tc
0.187 Tw
[(only mar)14(ginal associations were found for SBP)35( in)]TJ
0 -1.2543 TD
0.008 Tc
0.073 Tw
[(women \(p=0.0354\) and for DBP)29( in men \(0.0498\). )-29(Af-)]TJ
0 -1.2472 TD
0.009 Tc
0.057 Tw
[(ter controlling for the ef)16(fect of the I/D polymorphism,)]TJ
T*
0.003 Tc
0 Tw
(a stepwise oligogenic segregation analysis indicated the)Tj
0 -1.2543 TD
0.009 Tc
0.114 Tw
(existence of an additional major locus in the residual)Tj
0 -1.2472 TD
0.019 Tw
[(phenotype in this )29(African-American sample.)]TJ
/T49 1 Tf
14 0 0 14 59.981 525.997 Tm
-0.021 Tc
(99)Tj
/F5 1 Tf
8 0 0 8 59.981 508.025 Tm
0.009 Tc
0.004 Tw
(Rheumatoid arthritis severity and dosage of the)Tj
0 -1.2543 TD
[(shar)23(ed epitope: Results of a meta-analysis.)]TJ
/F14 1 Tf
0 -1.2472 TD
0.007 Tw
(J.J. Chen)Tj
4.8 0 0 4.8 89.858 491.584 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 92.296 488.013 Tm
0.01 Tc
0.009 Tw
(, J.D. Gorman)Tj
4.8 0 0 4.8 138.614 491.584 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 141.052 488.013 Tm
0.009 Tc
0.008 Tw
[(, G. )8(Thomson)]TJ
4.8 0 0 4.8 186.009 491.584 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 188.447 488.013 Tm
0.01 Tc
0.009 Tw
(, M.E. Suarez-)Tj
-16.0583 -1.2543 TD
0.009 Tc
(Almazor)Tj
4.8 0 0 4.8 88.498 481.606 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 90.935 477.978 Tm
0.009 Tc
0.007 Tw
(, L.A. Criswell)Tj
4.8 0 0 4.8 139.975 481.606 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 142.469 477.978 Tm
(.)Tj
4.8 0 0 4.8 59.981 471.572 Tm
(1)Tj
8 0 0 8 62.476 468 Tm
0.009 Tc
0.005 Tw
[(Saint Louis University)66(, MO, )]TJ
4.8 0 0 4.8 157.55 471.572 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 159.987 468 Tm
0.01 Tc
0.006 Tw
(UC San Francisco, CA,)Tj
4.8 0 0 4.8 59.981 461.594 Tm
0 Tc
0 Tw
(3)Tj
8 0 0 8 62.476 458.022 Tm
0.01 Tc
0.012 Tw
[(UC Berkeley)74(, CA, )]TJ
4.8 0 0 4.8 124.724 461.594 Tm
0 Tc
0 Tw
(4)Tj
8 0 0 8 127.219 458.022 Tm
0.009 Tc
0.014 Tw
[(University of )37(Alberta, Edmonton.)]TJ
-6.9024 -1.878 TD
0 Tc
0 Tw
[(T)65(o)0( determine whether the risk of severe RA)57( depends)]TJ
-1.5024 -1.2472 TD
0.02 Tc
0.187 Tw
(upon the dosage of the HLA-DRB1 shared epitope)Tj
0 -1.2543 TD
0.009 Tc
0.082 Tw
(\(SE\), we performed an electronic literature search us-)Tj
0 -1.2472 TD
0.01 Tc
0.107 Tw
[(ing MEDLINE, followed by hand searches of 6 jour)10(-)]TJ
0 -1.2543 TD
0.009 Tc
0.113 Tw
(nals. Studies reporting molecular typing methods and)Tj
0 -1.2472 TD
0.008 Tc
0.059 Tw
[(at least 1 of 6 outcomes of interest were selected. )-14(Au-)]TJ
T*
0.009 Tc
0.136 Tw
(thors were contacted for incomplete data and to pro-)Tj
0 -1.2543 TD
0.006 Tc
0.15 Tw
[(vide original data sets. )-139(W)78(oolf)-58(\222)56(s)-3( )-7(weighted )-7(odds )-7(ratios)]TJ
0 -1.2472 TD
0.009 Tc
0.059 Tw
(\(OR\) were pooled across studies and tested for homo-)Tj
T*
0.158 Tw
[(geneity)59(.)156( )-132(When possible, ethnic and clinical subgroup)]TJ
0 -1.2543 TD
0.027 Tw
(analyses were performed. 41 studies met inclusion cri-)Tj
0 -1.2472 TD
0.132 Tw
(teria, with a total of 5433 patients from 17 countries)Tj
0 -1.2543 TD
0.06 Tw
(on 5 continents. ORs for the association of 1 SE copy)Tj
0 -1.2472 TD
0.011 Tc
(\(OR)Tj
4.8 0 0 4.8 74.041 311.811 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 76.479 313.002 Tm
0.01 Tc
0.013 Tw
(\) and 2 SE copies \(OR)Tj
4.8 0 0 4.8 150.52 311.811 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 152.957 313.002 Tm
0.009 Tc
0.015 Tw
(\) vs 0 SE copies with each)Tj
-11.622 -1.2472 TD
0.01 Tc
0.142 Tw
[(outcome are shown below)60(.)151( )-98(A)59( strong dosage ef)17(fect of)]TJ
0 -1.2543 TD
0.009 Tc
0.099 Tw
[(the SE was apparent only for joint sur)16(gery [OR for 2)]TJ
0 -1.2472 TD
0 Tw
(vs. 1 SE copies = 2.07 \(1.27\2263.37\)]. Breslow-Day tests)Tj
0 -1.2543 TD
0.02 Tc
0.187 Tw
[(for homogeneity indicated substantial heterogeneity)]TJ
0 -1.2472 TD
0.011 Tc
[(across studies for all outcomes except joint sur)18(gery)61(.)]TJ
T*
0.009 Tc
0.135 Tw
(Subgroup analyses indicated that ethnic variation ex-)Tj
0 -1.2543 TD
0.01 Tw
[(plains at least part of this heterogeneity)59(.)]TJ
ET
0 0 0 1 K
0 J 0 j 1.02 w 10 M []0 d
/GS1 gs
1 i 
59.981 235.502 m
239.981 235.502 l
S
BT
7 0 0 7 109.247 223.994 Tm
/GS2 gs
3.647 Tc
[(##)332(O)3635(R)]TJ
4.2 0 0 4.2 174.898 222.973 Tm
0 Tc
0 Tw
(1)Tj
7 0 0 7 209.99 223.994 Tm
0.012 Tc
(OR)Tj
4.2 0 0 4.2 219.912 222.973 Tm
0 Tc
(2)Tj
ET
/GS1 gs
59.981 212.485 m
239.981 212.485 l
S
BT
7 0 0 7 100.403 214.98 Tm
/GS2 gs
0.012 Tc
[(Studies)-1997(Pts)-2013(\(95%CI\))-2847(\(95%CI\))]TJ
-5.7746 -1.7089 TD
[(RF+)-5034(18)-2693(2295)-668(1.8 \(1.4\2262.4\))-1098(2.6 \(1.8\2263.8\))]TJ
0 -1.2877 TD
0.01 Tc
0.002 Tw
[(RA )8(Course)-2849(8)-3199(8)-9(3)-9(2)-670(1.5 \(1.0\2262.2\))-1100(1.7 \(1.0\2262.8\))]TJ
T*
0.012 Tc
0 Tw
[(Erosion)-3673(23)-2693(2872)-668(1.8 \(1.4\2262.2\))-1098(2.2 \(1.6\2262.9\))]TJ
0 -1.2796 TD
-0.001 Tw
[(Joint sur)20(gery)-2037(7)-3197(5)-7(0)-7(3)-668(1.8 \(1.0\2263.3\))-1098(3.7 \(1.9\2267.4\))]TJ
0 -1.2877 TD
0 Tw
[(Nodules)-3438(22)-2693(2221)-668(1.5 \(1.2\2262.0\))-1098(1.7 \(1.3\2262.3\))]TJ
ET
/GS1 gs
59.981 154.488 m
239.981 154.488 l
S
BT
7 0 0 7 59.981 156.983 Tm
/GS2 gs
-0.001 Tw
[(Other EAMs)-1608(13)-2693(1269)-668(1.2 \(0.8\2261.8\))-1098(1.8 \(1.1\2262.8\))]TJ
8 0 0 8 72 144 Tm
0.009 Tc
0.075 Tw
(This meta-analysis demonstrates a dose-dependent)Tj
-1.5024 -1.2472 TD
0.144 Tw
[(increased risk for joint sur)9(gery according to # of SE)]TJ
0 -1.2543 TD
0.008 Tc
0.048 Tw
[(copies. )10(Although not observed for the other outcomes,)]TJ
0 -1.2472 TD
0.009 Tc
0.082 Tw
[(caution should be exercised given their heterogeneity)59(.)]TJ
T*
0.144 Tw
(Further identification of important sources of hetero-)Tj
0 -1.2543 TD
0.022 Tw
(geneity will require thorough examination of covariate)Tj
0 -1.2472 TD
[(ef)16(fects.)]TJ
/T49 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.017 Tc
(100)Tj
/F5 1 Tf
8 0 0 8 264.019 616.989 Tm
0.01 Tc
0.004 Tw
(Penetrances of BRCA1 mutations)Tj
/F14 1 Tf
T*
0.009 Tc
0.006 Tw
(P\345l M\370ller and Ketil Heimdal)Tj
0 -1.2543 TD
0.011 Tw
(Unit of Medical Genetics, The Norwegian Radium)Tj
0 -1.2472 TD
-0.01 Tc
0.027 Tw
[(Hospital, N-0310 Oslo, Norway)61(. pmoller@ulrik.uio.no)]TJ
1.4953 -1.7504 TD
0.01 Tc
0.187 Tw
(Genetic drift is supposed to underly the BRCA1)Tj
-1.4953 -1.2472 TD
0.008 Tc
0.05 Tw
[(founder mutations. )15(Additional mechanisms may be in-)]TJ
0 -1.2543 TD
0.016 Tc
0.187 Tw
(strumental: Lower penetrances in the most frequent)Tj
0 -1.2472 TD
0.009 Tc
0.044 Tw
(mutations and deviating phenotypes in newborn muta-)Tj
0 -1.2543 TD
0.019 Tw
(tion carriers indicate possible fitness variation and dis-)Tj
0 -1.2472 TD
0.005 Tc
0 Tw
(torted segregation. Our previous reports of later disease)Tj
T*
0.009 Tc
0.002 Tw
(and excess of carriers in founder mutation kindreds are)Tj
0 -1.2543 TD
0.016 Tc
0.187 Tw
(in keeping with this. Paternal inheritance combined)Tj
0 -1.2472 TD
0.009 Tc
0.188 Tw
(with phenocopies in maternal aunts, may erronously)Tj
T*
0.011 Tw
(be interpreted as low penetrance. Early reports on pen-)Tj
0 -1.2543 TD
0.01 Tc
0.188 Tw
(etrance underestimated ascertainment problems. Few)Tj
0 -1.2472 TD
0.017 Tc
0.187 Tw
(have discussed the impact of informative censoring)Tj
0 -1.2543 TD
0.009 Tc
0.008 Tw
[(present when considering breast cancer as af)23(fected and)]TJ
0 -1.2472 TD
0.066 Tw
(the mutation carrying women die from ovarian cancer)Tj
T*
0.033 Tw
(or another mutation-associated phenotype.)Tj
1.4953 -1.2543 TD
0.021 Tc
0.188 Tw
[(W)79(e)0( have information on a number of extensive)]TJ
-1.4953 -1.2472 TD
0.009 Tc
0.096 Tw
(kindreds with the same mutations on the same haplo-)Tj
0 -1.2543 TD
0.106 Tw
(types, presumably averaging out putative influence\(s\))Tj
0 -1.2472 TD
0.1 Tw
(of modifying genes and/or environment and therefore)Tj
T*
0.02 Tw
(suitable to examine the problems mentioned above.)Tj
1.4953 -1.2543 TD
0.009 Tw
(It will be demonstrated how calculated penetrances)Tj
-1.4953 -1.2472 TD
0.103 Tw
[(in the data sets vary according to assumptions under)16(-)]TJ
T*
0.051 Tw
(lying the calculations. Frequent mutations may be fre-)Tj
0 -1.2543 TD
0.042 Tc
0.188 Tw
(quent because of lower penetrance, and complex)Tj
0 -1.2472 TD
0.009 Tc
0.062 Tw
[(patterns of dif)16(ferent factors influencing fitness are not)]TJ
0 -1.2543 TD
0.002 Tc
0 Tw
[(excluded. )59(Ascertainment problems are significant if cal-)]TJ
0 -1.2472 TD
0.009 Tc
0.104 Tw
[(culating on small sibships and have lar)23(ger impact the)]TJ
T*
0.093 Tw
(lower the penetrance, while informative censoring re-)Tj
0 -1.2543 TD
0.014 Tw
[(mains a problem in lar)23(ge sibships.)]TJ
/T49 1 Tf
14 0 0 14 264.019 255.005 Tm
-0.017 Tc
(101)Tj
/F5 1 Tf
8 0 0 8 264.019 237.997 Tm
0.009 Tc
0.004 Tw
(Genetic factors may influence latent class)Tj
0 -1.2472 TD
0.01 Tc
0.001 Tw
[(membership for)24( )48(ADHD and its comorbid traits.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.007 Tw
[(R.J. Neuman, )44(A.C. Heath, K. Bucholz, P)116(.)1( Madden,)]TJ
0 -1.2472 TD
0.006 Tw
[(W)97(.)0( Reich, L. Sun, R.D. )10(T)68(odd)]TJ
T*
0.012 Tw
[(W)82(ashington Univ)60(., St. Louis, MO)]TJ
1.4953 -1.7504 TD
0.009 Tc
0.057 Tw
(The goal of this study was to define homogeneous)Tj
-1.4953 -1.2543 TD
0.045 Tw
[(phenotypes of )23(ADHD and its comorbid traits in which)]TJ
0 -1.2472 TD
0.175 Tw
(there would be increased evidence for genetic influ-)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
[(ences. )55(ADHD commonly co-occurs with disorders such)]TJ
0 -1.2472 TD
0.009 Tc
0.025 Tw
[(as anxiety)66(, mood, or ODD. )-13(W)74(e)0( used latent class analy-)]TJ
T*
0.087 Tw
(sis \(LCA\) on a population based sample of young fe-)Tj
0 -1.2543 TD
0.104 Tw
[(male twins \(N=2,904\), to simultaneously dif)23(ferentiate)]TJ
0 -1.2472 TD
0.035 Tc
0.186 Tw
[(among phenotypes with co-occurrence of )-129(ADHD,)]TJ
T*
0.003 Tc
0 Tw
[(ODD, separation anxiety)67(, or potentially depression phe-)]TJ
0 -1.2543 TD
-0.008 Tc
0.272 Tw
[(notypes. T)50(o)-17( )]TJ
5.2704 0 TD
0.009 Tc
0.137 Tw
(determine whether classes could be con-)Tj
-5.2704 -1.2472 TD
0.002 Tc
0 Tw
(sidered familial, concordance for class membership was)Tj
ET

endstream
endobj
521 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
522 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
520 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
518 0 obj
<</Length 598>>stream
142 0 6 173 132 -5 d1
q
126 0 0 178 6 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼–K’„ †c¹pÉ8
G£ÆQ8‚K–ÎÈ³ÚUSÃÆşªáOBÍqœ« ¤CÖ
¿+Ÿ3cC–¥s0ÛåÀ6˜¬ÄÑgXB˜¬ÜlÂÉÈU8s ‹17
¢Áı»9ÔºĞf83i¸—Ç3öçD:±»;“Ğİ]È¯Á‘â]7QœKçì˜¯}î2œÅÎ“â®Ò¼ãÎÜyÃ]óP¾ÃQòŒ^D©ƒ[œ¾àõç?ãI3ÜaµK&îñÆ™é«]ğ*™ÁUsá®f óÁzÎVÜqpÛU¸'r8Ôs‹ãè89Î–Y~·rÄñ‚ı~ğìí{ÿ¼ÿ>¾É1xN£ãÀ÷·:>lcƒªŸ LæâèÚô“`Şû‚y*¨rÁÕˆ}â«ğìèû†»lPWÿÁó7üxÏÛàIñrƒAsn/80sÂW)šú‚c3W<±*ŠÓµ´Ê…a=6¹ÇX¿¹™CòÆ]€õ¯^{OE2?ñgû@}ïgy/¢Ü"sC\ú³·| ñ&õG4ãÌŠ›ælÆ)´ëç=Íä÷XÅ5Vä¸Ùœq ó½‰¼28K^pÉ›È)ÁQ7›=Î‘¸šídQµr5w“¹ÿú` §^æ
EI
Q

endstream
endobj
519 0 obj
<</Length 359>>stream
142 0 6 168 134 0 d1
q
128 0 0 168 6 0 cm
BI
/W 128
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÔ½†0„á=R×ÉµràÒ\ŠKpH`™ÃàE³Ãõe0	ûd¯`Yê‚ˆ,0Ovdyv&'òÜp$‡†=Ù‘åÙ™œÉ‘öd×°Xgrjx&GrhØ“]ÃbÉéÂßà’û.¹áÁëı…^s;´;»G¯ç ÎÁ%÷\r'p¼0~_%íÉ%—Ü£K8_xo¹à™¼å’ñÈ[®u‡ŞrÁb½çZàDŞs­'p$×ãğkÜ¡yÏ5À™\s×\ã	Éü¬¹·®¹‡kî5W­¹jÍ½³æ^ë5W­¹j9»'äwlÑÄë×ÿÓ ¨]<È
EI
Q

endstream
endobj
512 0 obj
<</Length 9519>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(226)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.03 Tc
0.003 Tw
(computed separately for the MZ and DZ twins. LCA)Tj
0 -1.2543 TD
0.029 Tc
0.188 Tw
(identified several clinically important classes with)Tj
0 -1.2472 TD
0.023 Tc
0 Tw
(high endorsements of symptoms for just one trait and)Tj
0 -1.2543 TD
0.03 Tc
0.115 Tw
[(none other)51(. For example, we observed a class con-)]TJ
0 -1.2472 TD
0.049 Tc
0.186 Tw
[(sisting of subjects exhibiting )-137(ADHD )-7(inattention)]TJ
T*
0.064 Tc
0.187 Tw
(symptoms without ODD, anxiety or depression)Tj
0 -1.2543 TD
0.029 Tc
0.009 Tw
(symptoms \(10%\) and another where over 70% of in-)Tj
0 -1.2472 TD
0.036 Tc
0.187 Tw
(dividuals endorsed only the depression symptoms)Tj
0 -1.2543 TD
0.021 Tc
0 Tw
[(\(13%\). )49(A)56( substantial proportion of the MZ twin pairs,)]TJ
0 -1.2472 TD
0.029 Tc
0.054 Tw
(68.3%, was assigned to the same latent class versus)Tj
T*
0.028 Tc
0 Tw
(38.9% of the DZ twins, consistent with a genetic hy-)Tj
0 -1.2543 TD
0.029 Tc
0.154 Tw
(pothesis for latent class membership. Of the twins)Tj
0 -1.2472 TD
0.18 Tw
(assigned to the depression-only class, almost 33%)Tj
T*
0.049 Tw
(of the MZ sibs and only 18.3% of the DZ sibs were)Tj
0 -1.2543 TD
0.026 Tc
0.185 Tw
[(concordant for class membership. )-175(The )-6(comparable)]TJ
0 -1.2472 TD
0.054 Tc
0.187 Tw
(figures for the inattention class was 65.7% and)Tj
0 -1.2543 TD
0.029 Tc
0.029 Tw
[(28.6% for the MZ and DZs, respectively)57(.)26( )-6(These pat-)]TJ
0 -1.2472 TD
0.037 Tc
0.187 Tw
(terns of class membership assignments is the ex-)Tj
T*
0.022 Tc
0 Tw
(pected pattern for a genetically influenced and highly)Tj
0 -1.2543 TD
0.029 Tc
0.169 Tw
[(heritable phenotype and ar)15(gues for the importance)]TJ
0 -1.2472 TD
0.028 Tw
(of phenotypic classification.)Tj
/T50 1 Tf
14 0 0 14 50.981 397.02 Tm
-0.017 Tc
(102)Tj
/F5 1 Tf
8 0 0 8 50.981 378.992 Tm
0.009 Tc
0 Tw
[(Infer)16(ence in Genetic )59(Association Studies with)]TJ
T*
0.003 Tw
(highly polymorphic Markers.)Tj
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
[(J.P)109(. Lewinger)38(, S.B. Bull)]TJ
0 -1.2472 TD
0.009 Tc
0.015 Tw
(Samuel Lunenfeld Research Institute, University of)Tj
T*
0.01 Tc
0.019 Tw
[(T)61(oronto, ON, Canada.)]TJ
1.5024 -1.878 TD
0.008 Tc
0 Tw
(Genetic association studies with population or fam-)Tj
-1.5024 -1.2472 TD
0.009 Tc
0.028 Tw
(ily control designs are routinely analyzed using the lo-)Tj
0 -1.2543 TD
0.058 Tw
(gistic regression model, based on the unconditional or)Tj
0 -1.2472 TD
0.159 Tw
(the conditional likelihood. Small samples and highly)Tj
0 -1.2543 TD
0.017 Tw
(polymorphic markers, such as the HLA loci, can result)Tj
0 -1.2472 TD
0.012 Tc
0.187 Tw
(in sparse and unbalanced data. In this situation, the)Tj
T*
0.005 Tc
0 Tw
[(maximum likelihood estimates \(MLE\222)55(s\) of the log odds)]TJ
0 -1.2543 TD
0.009 Tc
0.029 Tw
(ratios are biased away from the null. In extreme cases,)Tj
0 -1.2472 TD
0.036 Tw
(for example in which a specific allele appears in cases)Tj
T*
0.01 Tw
[(but not in controls, the MLE\222)52(s can be infinite.)]TJ
1.5024 -1.2543 TD
0.004 Tc
0.188 Tw
(Although overall score statistics can still be con-)Tj
-1.5024 -1.2472 TD
-0.011 Tc
0.025 Tw
(structed, when there is an infinite MLE there is no mean-)Tj
0 -1.2543 TD
-0.017 Tc
0 Tw
(ingful point estimate available as a measure of association,)Tj
0 -1.2472 TD
-0.011 Tc
0.133 Tw
(and the corresponding confidence interval has only one)Tj
T*
0.019 Tw
(finite bound and can be quite uninformative.)Tj
1.5024 -1.2543 TD
0.009 Tc
0.084 Tw
(In this study we conducted a series of simulations)Tj
-1.5024 -1.2472 TD
0.014 Tc
0.187 Tw
(to evaluate inference methods based on a penalized)Tj
0 -1.2543 TD
0.02 Tc
0.188 Tw
[(likelihood function proposed by Firth \(1993\). )-171(This)]TJ
0 -1.2472 TD
0.011 Tc
0.187 Tw
(modified likelihood removes first order bias and al-)Tj
T*
0.009 Tc
0.067 Tw
(ways yields finite estimates of the log odds ratios and)Tj
0 -1.2543 TD
0.034 Tw
(corresponding standard errors.)Tj
1.5024 -1.2472 TD
0.029 Tc
0 Tw
(Application of these methods to sparse data from)Tj
-1.5024 -1.2472 TD
0.023 Tc
(a study of HLA and inflammatory bowel disease pro-)Tj
0 -1.2543 TD
0.029 Tc
0.168 Tw
(vided conclusions that would have otherwise been)Tj
0 -1.2472 TD
0.032 Tc
(unavailable.)Tj
/T50 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.017 Tc
(103)Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.01 Tc
-0.001 Tw
[(Phenotypic assortment for)24( height r)24(econsider)24(ed)]TJ
/F14 1 Tf
T*
0.006 Tw
(J.D. Grant)Tj
4.8 0 0 4.8 288.978 610.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 291.416 607.011 Tm
0.01 Tc
-0.046 Tw
[(,)6( A.C. )-53(Heath)]TJ
4.8 0 0 4.8 332.235 610.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 334.729 607.011 Tm
0.01 Tc
0.006 Tw
(, K.K. Bucholz)Tj
4.8 0 0 4.8 384.165 610.583 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 386.603 607.011 Tm
(,)Tj
-16.448 -1.2543 TD
0.009 Tc
[(P)111(.A.F)80(. Madden)]TJ
4.8 0 0 4.8 303.378 600.605 Tm
0 Tc
(1)Tj
8 0 0 8 305.872 596.976 Tm
0.009 Tc
0.006 Tw
(, & N.G. Martin)Tj
4.8 0 0 4.8 358.71 600.605 Tm
0 Tc
0 Tw
(2)Tj
-21.6024 -2.0906 TD
(1)Tj
8 0 0 8 257.457 586.998 Tm
0.009 Tc
0.015 Tw
[(W)81(ashington University School of Medicine, St.)]TJ
-0.3047 -1.2472 TD
0.01 Tc
0.008 Tw
(Louis, MO, USA; )Tj
4.8 0 0 4.8 315.85 580.592 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 318.288 577.02 Tm
0.009 Tc
0.01 Tw
(Queensland Institute of Medical)Tj
-7.9087 -1.2543 TD
0.012 Tw
[(Research, Brisbane, )44(Australia.)]TJ
1.4953 -1.7504 TD
0.141 Tw
(Pearson and Lee \(1903\) reported spousal correla-)Tj
-1.4953 -1.2472 TD
0.018 Tw
[(tions for height that informed Fisher)-41(\222)59(s)0( \(1918\) paper on)]TJ
0 -1.2543 TD
0.019 Tc
0.187 Tw
(the correlation between relatives. Fisher considered)Tj
0 -1.2472 TD
0.009 Tc
0.145 Tw
(models for assortment that implied either direct phe-)Tj
T*
0.015 Tw
(notypic assortment for a trait or phenotypic assortment)Tj
0 -1.2543 TD
0.054 Tw
[(for a correlated character)30(, concepts that were revisited)]TJ
0 -1.2472 TD
0.008 Tc
0.106 Tw
[(by Morton, Rao and others in the 1970s. )-92(The present)]TJ
T*
0.009 Tc
0.108 Tw
(analyses represent an examination of assortative mat-)Tj
0 -1.2543 TD
0.006 Tc
0.161 Tw
[(ing for height in a sample of )-110(Australians. )-6(4845 )-6(hus-)]TJ
0 -1.2472 TD
0 Tw
(band-wife pairs were identified from respondents in the)Tj
0 -1.2543 TD
0.004 Tc
[(Australian )18(T)69(win Study \(4162 twin/spouse pairs and 683)]TJ
0 -1.2472 TD
0.009 Tc
0.08 Tw
(parent-of-twin pairs\). Modest \(but statistically signifi-)Tj
T*
0.05 Tw
(cant\) assortative mating was observed for height, with)Tj
0 -1.2543 TD
0.01 Tc
0.187 Tw
(a husband-wife correlation of 0.23. Further analyses)Tj
0 -1.2472 TD
0.002 Tw
(were conducted using data from 1388 twin pairs where)Tj
0 -1.2543 TD
0.188 Tw
(both twins had spouses and all four individuals had)Tj
0 -1.2472 TD
0.002 Tc
0 Tw
(height data \(479 MZF; 243 MZM; 243 DZF; 122 DZM;)Tj
T*
0.009 Tc
0.175 Tw
(and 301 DZO pairs\). Under the hypothesis of direct)Tj
0 -1.2543 TD
0.188 Tw
(phenotypic assortment for height, one would predict)Tj
0 -1.2472 TD
0.071 Tw
[(that the correlation between the twin and the cotwin\222)52(s)]TJ
T*
0.178 Tw
(spouse would be the product of the twin correlation)Tj
0 -1.2543 TD
0.005 Tc
0 Tw
(for height \(about .9 for MZ twins and .45 for DZ twins\))Tj
0 -1.2472 TD
0.009 Tc
0.017 Tw
(and the marital correlation, and that the correlation be-)Tj
0 -1.2543 TD
0.168 Tw
(tween the spouses of twins would be the product of)Tj
0 -1.2472 TD
0.161 Tw
(the twin correlation for height and the square of the)Tj
T*
0.006 Tc
0 Tw
[(marital correlation. However)34(, observed correlations be-)]TJ
0 -1.2543 TD
0.02 Tc
0.187 Tw
(tween the spouses of MZ twin pairs \(MZF r=0.14;)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
(MZM r=0.17\) were higher than would be predicted un-)Tj
0 -1.2543 TD
0.037 Tc
0.187 Tw
(der phenotypic assortment, while the twin-cotwin)Tj
0 -1.2472 TD
0.009 Tc
0.033 Tw
(spouse correlations did not show the expected MZ-DZ)Tj
T*
0.029 Tc
0.188 Tw
[(dif)15(ference in magnitude \(e.g., MZM r=0.26, DZM)]TJ
0 -1.2543 TD
0.008 Tc
0.09 Tw
[(r=0.25; MZF r=0.16, DZF r=0.12\). )-78(The hypothesis of)]TJ
0 -1.2472 TD
0 Tw
(direct or indirect phenotypic assortment for height may)Tj
T*
0.009 Tc
0.017 Tw
(need to be reconsidered.)Tj
/T50 1 Tf
14 0 0 14 255.019 184.989 Tm
-0.017 Tc
(104)Tj
/F5 1 Tf
8 0 0 8 255.019 167.981 Tm
0.009 Tc
0.006 Tw
(Incorporation of covariates in multipoint model-)Tj
T*
0.01 Tc
0.001 Tw
[(fr)24(ee linkage analysis of binary traits using the MLB)]TJ
T*
(method.)Tj
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.012 Tw
[(Alexandre )44(Alca\357s and Laurent )37(Abel.)]TJ
0 -1.2472 TD
0.01 Tc
0.002 Tw
(INSERM U.436, Paris, France)Tj
1.4953 -1.7504 TD
0.009 Tc
0.025 Tw
(When the mode of inheritance is unknown, genetic)Tj
-1.4953 -1.2472 TD
0 Tw
(linkage analysis of binary trait is commonly performed)Tj
0 -1.2543 TD
0.008 Tc
0.08 Tw
[(using af)15(fected-sib-pair \(ASP\) approaches. )-63(When there)]TJ
0 -1.2472 TD
0.009 Tc
0.096 Tw
(is evidence that some covariates influence the pheno-)Tj
ET

endstream
endobj
533 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
534 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
531 0 obj
<</Length 498>>stream
142 0 7 168 133 -5 d1
q
126 0 0 173 7 -5 cm
BI
/W 126
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ÜÔKnÄ  P£,²©Är–-GÉX²ˆ C3“™*šEYõUƒm‚q)èK)ë‡½|Øp¿CÑ•_ğ|£÷\ntúmw§ãµ‡;½]{¼Óë™>‚WûzÇ0©cµScKö—6£mw×7OÇÎ®3ô®[@k_?Ÿ¡³ë½çÖş53)p¢2fíğjA™ëHøGæ:3´ó¹ŠñÌwÍ/–Œı[Á;ğE$1^-FÚo¶%œ§C‡ò|ÅÔ'É*¡Î½ØÇ7àØºWŞÿàá‰ó?÷KßËì¹r»EÇç™½q|`xàÖ_«ökïõÄaÓ&^ØN<kfñ(Ç…¢Æ÷–àø«û÷
RëŞ÷PdôÒ ù°£i,PxOs†ÂÕ€?øOæÌ ”âhÍÇ¢å¸Z×IkäÏFËó¹hM|nMw(@¿£¤³	G½oí¯¹¯òq»ìxø9oŸS†bÖ*É¾ ´—
EI
Q

endstream
endobj
532 0 obj
<</Length 640>>stream
142 0 8 173 135 -5 d1
q
127 0 0 178 8 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö»mä0 Ğ0T	,…­\	™*M¥¨…
ÍAó'MÃç5pL´»œ~µˆÔV€ŠŞv ˜‚áiÙxgóFöLëpŠSÓİ3Hw°ªñVÂB¾Ì©	¯íæ©Ğ†—„NJxç&Ğ›Ó+èàJ-hç@·z“Ä«¸És—ç*qN)¸É+ÎZgÕ‡|!¶qêæóP(loŸ·Lu'[&ö2ôIŸvĞ…v—àÍ|™kğÚ8‘ÑÖı³­ü±ïu£|AÜÈZÄ¿û´éxÍÄƒõ{ûôÿÈ›N2û°Yáå{öw£åã#Ì;Ì+X‡ÇL÷ãw±†7±îş?b=%ÖJçÜ9u;O¡wí\¾qÖËcâ[`Áö‡	-ñä8ÏhAşÖ¡÷‚Ö)÷ê¸$ j8¹/ª”’ Zx¾ŠT‡’°X:Š<4ÚVÈ2-hyö­Ù;Y¹\ğĞûxşÎ+Øy¸_uqOÁøŠ·ÿìıuÓxn>~êÓ}©—¯®ã~èîoÚ_#Çıˆ­sğF~¬w%óRúCkyñîÏW•¬hïëâùdOZÎä¯yıÀÇVÒÏâ,á“?/yÊ½Á×Ã"Öû'K^W¿‘µUŒ—ØG°ÕÍm²qq›mÜÜ›'nÙæ,}LXmİ<|H(ëj	dŸXÀ‚Øj ­Çj¼ƒ‘3ø×A6İ_ 6?‰
EI
Q

endstream
endobj
530 0 obj
<</Length 325>>stream
142 0 10 168 135 0 d1
q
125 0 0 168 10 0 cm
BI
/W 125
/H 168
/BPC 1
/IM true
/F /Fl
ID H‰ìÒ±Ã ĞŸK‘Ò#xF£1ŠG ¤àìà*‚ÓñÁş¥é^…$©ÎG[z9ş'¯àTìÀ±øŞŠGy¡½È}^Ügû8•½m¼t!z ^e©ã¶ñv²^/n$qÑZ\-¾ÌÅÏ“kG¥ÎÖ8èëÏÔÙI4«ƒN¤Ú¢ÚÏz­Ûº½úY©Ÿê£7bÊ<lÖÀ+óÌÎ…fsõæ‹^Ál¾ÖÌæìyd^4™wÆ#ó£µù-§çH¼ÜğÈsöˆ¡ıÍï1ò}4Wı` ²Jâ
EI
Q

endstream
endobj
524 0 obj
<</Length 11032>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(227)]TJ
/F14 1 Tf
8 0 0 8 59.981 638.022 Tm
0.009 Tc
0.13 Tw
(type, incorporation of this information is expected to)Tj
0 -1.2543 TD
0.073 Tw
(increase the power of the analysis since it allows 1\) a)Tj
0 -1.2472 TD
0.007 Tc
0 Tw
(better specification of the phenotype and 2\) to take into)Tj
0 -1.2543 TD
0.01 Tc
0.003 Tw
[(account unaf)24(fected subjects. Here, we show how to ac-)]TJ
0 -1.2472 TD
0.009 Tc
0.025 Tw
(count for covariates in the sibship-oriented Maximum-)Tj
T*
0.006 Tw
(Likelihood-Binomial \(MLB\) linkage method by means)Tj
0 -1.2543 TD
0.018 Tc
0.188 Tw
[(of Pearson\222)53(s logistic regression residuals which are)]TJ
0 -1.2472 TD
0.009 Tc
0.081 Tw
(computed using phenotypic and covariate information)Tj
0 -1.2543 TD
0.13 Tw
[(on both af)16(fected and unaf)]TJ
10.9417 0 TD
-0.002 Tc
0.131 Tw
(fected sibs. )Tj
5.1094 0 TD
0.009 Tc
0.13 Tw
(These residuals)Tj
-16.0512 -1.2472 TD
0.069 Tw
(are subsequently analysed as a quantitative phenotype)Tj
T*
0.006 Tc
0 Tw
(with the corresponding extension of the MLB approach)Tj
0 -1.2543 TD
[(\(Alca\357s and )55(Abel, )]TJ
/F16 1 Tf
7.3205 0 TD
(Genet Epidemiol)Tj
/F14 1 Tf
6.8315 0 TD
(, in press\) which can)Tj
-14.152 -1.2472 TD
0.009 Tc
0.066 Tw
(be used without any assumption on the distribution of)Tj
T*
0.179 Tw
(residuals. Simulation studies compared the power of)Tj
0 -1.2543 TD
0.028 Tc
0.187 Tw
(this method to the standard MLB approach \(using)Tj
0 -1.2472 TD
0.011 Tc
[(af)11(fecteds only\) in the multipoint analysis of nuclear)]TJ
0 -1.2543 TD
0.009 Tc
0.074 Tw
[(family data under dif)16(ferent generating models accord-)]TJ
0 -1.2472 TD
0.107 Tw
(ing to genetic and covariate \(with or without familial)Tj
T*
0.105 Tw
(correlation\) ef)Tj
5.9173 0 TD
-0.008 Tc
(fects. )Tj
2.537 0 TD
0.009 Tc
(These studies also investigate the)Tj
-8.4543 -1.2543 TD
0.006 Tc
0 Tw
[(interest of collecting families with a single af)13(fected sib.)]TJ
0 -1.2472 TD
0.009 Tc
0.179 Tw
(Power results will be discussed as a function of the)Tj
0 -1.2543 TD
0.008 Tc
0.019 Tw
[(familial ascertainment strategy)51(.)]TJ
/T51 1 Tf
14 0 0 14 59.981 386.986 Tm
-0.017 Tc
(105)Tj
/F5 1 Tf
8 0 0 8 59.981 369.014 Tm
0.009 Tc
0.002 Tw
[(A)51( genome-wide linkage analysis of blood pr)16(essur)9(e)]TJ
T*
0 Tw
(and heart rate in the Qu\351bec Family Study using a)Tj
0 -1.2472 TD
0.01 Tc
0.006 Tw
[(variance components appr)17(oach \(SEGP)81(A)66(TH\))]TJ
/F14 1 Tf
T*
0.008 Tc
0 Tw
[(T)66(.)0( Rice)]TJ
4.8 0 0 4.8 83.509 342.595 Tm
0 Tc
(1)Tj
8 0 0 8 85.946 339.024 Tm
0.009 Tc
0.006 Tw
[(, M. )51(A. Province)]TJ
4.8 0 0 4.8 140.258 342.595 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 142.696 339.024 Tm
0.01 Tc
0.006 Tw
[(, L)38( P\351russe)]TJ
4.8 0 0 4.8 178.696 342.595 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 181.134 339.024 Tm
0.01 Tc
-0.025 Tw
[(,)6( Y)30( )-32(Chagnon)]TJ
4.8 0 0 4.8 222.236 342.595 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 224.674 339.024 Tm
(,)Tj
-20.5866 -1.2543 TD
0.009 Tc
0.006 Tw
[(T)67(.)0( Rankinen)]TJ
4.8 0 0 4.8 99.893 332.617 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 102.331 328.989 Tm
0.01 Tc
0.006 Tw
(, I. B. Borecki)Tj
4.8 0 0 4.8 148.989 332.617 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 151.427 328.989 Tm
0.01 Tc
0.009 Tw
(, C. Bouchard)Tj
4.8 0 0 4.8 197.121 332.617 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 199.559 328.989 Tm
0.011 Tc
0.008 Tw
(, D. C. Rao)Tj
4.8 0 0 4.8 236.693 332.617 Tm
0 Tc
0 Tw
(1)Tj
-36.815 -2.0905 TD
(1)Tj
8 0 0 8 62.476 319.011 Tm
0.009 Tc
0.009 Tw
[(W)81(ashington University)66(, St. Louis, MO USA; )]TJ
4.8 0 0 4.8 211.408 322.583 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 213.846 319.011 Tm
0.008 Tc
(Laval)Tj
-19.2331 -1.2543 TD
0.01 Tc
0.015 Tw
[(University)60(, Qu\351bec City)60(, Qu\351bec, Canada)]TJ
1.5024 -1.8709 TD
0.009 Tc
0.022 Tw
(A genome-wide scan for heart rate \(HR\) and blood)Tj
-1.5024 -1.2543 TD
0.003 Tc
0 Tw
[(pressure \(both systolic and diastolic BP\) genes was per)10(-)]TJ
0 -1.2472 TD
0.005 Tc
(formed using a multi-point variance components model)Tj
T*
0.009 Tc
0.142 Tw
[(\(SEGP)87(A)107(TH\) in over 200 families participating in the)]TJ
0 -1.2543 TD
0.017 Tc
0.188 Tw
[(Qu\351bec Family Study)60(.)187( )-138(A)52( total of 293 microsatellite)]TJ
0 -1.2472 TD
-0.001 Tc
0 Tw
(markers were used with an average between-marker dis-)Tj
T*
0.009 Tc
0.043 Tw
[(tance of 1)30(1.9 cM. Relatively few dif)23(ferences in results)]TJ
0 -1.2543 TD
0.093 Tw
(were observed depending on whether or not the traits)Tj
0 -1.2472 TD
0.03 Tc
0.187 Tw
[(were adjusted for body mass index. )-176(T)67(wo markers)]TJ
0 -1.2543 TD
0.01 Tc
0.125 Tw
(showed good evidence for linkage \(P = 0.0007\) with)Tj
0 -1.2472 TD
0.004 Tc
0 Tw
[(HR \(D1S1653 at 1q22 and D19S247 at 19p13.3\). )11(There)]TJ
T*
0.029 Tc
0.05 Tw
(was suggestive linkage \(P < 0.01\) with one or more)Tj
0 -1.2543 TD
0.045 Tc
0.188 Tw
(of the phenotypes on regions of chromosomes 1)Tj
0 -1.2472 TD
0.036 Tc
0.187 Tw
[(\(1p22.1\226p21.2, 1p1)36(1.2, 1q22\226q25.2\) and 2 \(2p14,)]TJ
0 -1.2543 TD
0.029 Tc
0.113 Tw
(2q21.3\226q22.1\), and other isolated markers at 3q28,)Tj
0 -1.2472 TD
0.03 Tc
0.009 Tw
[(4q35.1, 6q13, 10p14, 21q22.3, 22q13.1. )8(These chro-)]TJ
T*
0.049 Tc
0.187 Tw
(mosomal regions contain a number of candidate)Tj
0 -1.2543 TD
0.029 Tc
0.137 Tw
(genes that are related to HR and/or BP regulation.)Tj
0 -1.2472 TD
0.019 Tc
0 Tw
[(T)63(ogether)40(, these results and those from 2 recently pub-)]TJ
T*
0.029 Tc
0.149 Tw
(lished genome-wide studies of BP provide a focus)Tj
0 -1.2543 TD
0.034 Tc
0.188 Tw
(for future studies to identify genes that influence)Tj
0 -1.2472 TD
0.029 Tc
0.014 Tw
[(interindividual variation in HR and BP)107(.)]TJ
/T51 1 Tf
14 0 0 14 264.019 633.997 Tm
-0.017 Tc
(106)Tj
/F5 1 Tf
8 0 0 8 264.019 616.989 Tm
0.01 Tc
0.002 Tw
[(Pr)24(ecision Mapping of Human QTLs by)]TJ
T*
0.009 Tc
0 Tw
[(Combined Linkage/Disequilibrium )59(Analysis)]TJ
/F14 1 Tf
0 -1.2543 TD
0.01 Tc
0.007 Tw
(Chi Gu, M.A. Province and D.C. Rao)Tj
0 -1.2472 TD
0.008 Tc
0.02 Tw
[(Division of Biostatistics, )-6(W)73(ashington University)]TJ
T*
0.01 Tc
0.005 Tw
(School of Medicine, St. Louis, MO, USA.)Tj
1.4953 -1.7504 TD
0.009 Tc
(The variance components method is a powerful ap-)Tj
-1.4953 -1.2543 TD
0.166 Tw
(proach for detecting linkage to quantitative trait loci)Tj
0 -1.2472 TD
0.014 Tw
[(\(QTLs\). However)37(, the resolution may be compromised)]TJ
0 -1.2543 TD
0.011 Tc
0.187 Tw
(and power reduced for complex traits. On the other)Tj
0 -1.2472 TD
0.009 Tc
0 Tw
[(hand, it is well known that incorporating ef)16(fect of link-)]TJ
T*
0.183 Tw
(age-disequilibrium \(LD\) enhances power in standard)Tj
0 -1.2543 TD
0.112 Tw
(linkage analysis because of the added information on)Tj
0 -1.2472 TD
0.005 Tc
0.105 Tw
[(phase, as in the )-89(T)-12(D)-12(T)19( and its extensions. )-96(W)77(e)-4( )-6(consider)]TJ
T*
0.009 Tc
0.147 Tw
(an extension of the variance components method us-)Tj
0 -1.2543 TD
0.01 Tc
0.038 Tw
[(ing SEGP)95(A)115(TH \(Province et al., 1998\), and incorporate)]TJ
0 -1.2472 TD
0.009 Tc
0.041 Tw
[(both the allelic association and the linkage ef)16(fects in a)]TJ
0 -1.2543 TD
0.011 Tc
0.185 Tw
[(combined, comprehensive model. )-176(The )-6(calculation )-6(is)]TJ
0 -1.2472 TD
0.009 Tc
0.028 Tw
[(conditional on family by decomposing the mean ef)30(fect)]TJ
T*
0.071 Tw
(of allelic association into an overall among-family ef-)Tj
0 -1.2543 TD
0.144 Tw
(fect and deviations of individuals in the family from)Tj
0 -1.2472 TD
0.008 Tc
0.031 Tw
[(the family mean. )30(As noted by others, procedures using)]TJ
0 -1.2543 TD
0.01 Tc
0.187 Tw
(such a conditional framework avoid detecting spuri-)Tj
0 -1.2472 TD
0.007 Tc
0.084 Tw
[(ous associations due to population stratification. )-63(V)112(ari-)]TJ
T*
0.009 Tc
0.167 Tw
(ous hypotheses can be tested by likelihood-ratio test)Tj
0 -1.2543 TD
0.08 Tw
(of appropriate submodels. For example, if the linkage)Tj
0 -1.2472 TD
0.01 Tc
0.155 Tw
[(ef)24(fect disappears when the LD ef)17(fect is incorporated)]TJ
T*
-0.011 Tc
0.058 Tw
(in the submodel, we may conclude that the marker locus)Tj
0 -1.2543 TD
0.095 Tw
(should be in close proximity to the disease gene. Power)Tj
0 -1.2472 TD
-0.014 Tc
0 Tw
(analysis using simulated data will be presented along with)Tj
0 -1.2543 TD
-0.011 Tc
0.176 Tw
(a careful examination of practical issues. For example,)Tj
0 -1.2472 TD
0.035 Tw
[(when marker loci have a lar)17(ge number of functional alle-)]TJ
T*
0.18 Tw
(les, a randomization procedure is introduced on top of)Tj
0 -1.2543 TD
0.012 Tw
(the above modeling to reduce the degrees of freedom and)Tj
0 -1.2472 TD
0.014 Tw
[(to obtain a closer)24(-to-real p-value.)]TJ
/T51 1 Tf
14 0 0 14 264.019 245.027 Tm
-0.017 Tc
(107)Tj
/F5 1 Tf
8 0 0 8 264.019 228.019 Tm
0.009 Tc
0.005 Tw
[(MILC: a new statistic to sear)23(ch for)16( multifactorial)]TJ
0 -1.2543 TD
0.008 Tc
0 Tw
(diseases susceptibility genes in founder populations)Tj
/F14 1 Tf
0 -1.2472 TD
0.01 Tc
0.025 Tw
[(Bour)31(gain Catherine)]TJ
4.8 0 0 4.8 328.309 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 330.746 208.006 Tm
0.009 Tc
0.025 Tw
(, Genin Emmanuelle)Tj
4.8 0 0 4.8 398.494 211.578 Tm
0 Tc
0 Tw
(1)Tj
8 0 0 8 400.932 208.006 Tm
(,)Tj
-17.1142 -1.2472 TD
0.009 Tc
0.019 Tw
(Quesneville Hadi)Tj
4.8 0 0 4.8 321.165 201.6 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 323.603 198.028 Tm
0.009 Tc
0.019 Tw
[( and Cler)23(get-Darpoux Fran\347oise)]TJ
4.8 0 0 4.8 429.052 201.6 Tm
0 Tc
0 Tw
(1)Tj
-34.3819 -2.0787 TD
(1)Tj
8 0 0 8 266.457 187.994 Tm
0.009 Tc
0.009 Tw
(Inserm U155, Paris, France; )Tj
4.8 0 0 4.8 360.85 191.622 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 363.288 187.994 Tm
0.01 Tc
0.012 Tw
(Laboratoire de)Tj
-12.4087 -1.2472 TD
0.009 Tc
0.022 Tw
(Dynamique du G\351nome et Evolution, Institut)Tj
0 -1.2543 TD
0.01 Tw
(J.Monod, Paris, France.)Tj
1.4953 -1.7504 TD
0.014 Tc
0.188 Tw
(A method \(Maximum Identity Length Constrast,)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.168 Tw
(MILC\) is proposed to locate susceptibility genes for)Tj
T*
0.11 Tw
(multifactorial diseases in founder populations. It uses)Tj
0 -1.2543 TD
0.041 Tw
(characteristics of such populations: linkage disequilib-)Tj
0 -1.2472 TD
0.008 Tc
0 Tw
[(rium spanning lar)15(ge regions and significant kinship co-)]TJ
T*
-0.008 Tc
0.337 Tw
[(e)-18(f)-1(ficients. A)-23(f)]TJ
5.5417 0 TD
0.013 Tc
0.187 Tw
(fected individuals and their parents are)Tj
-5.5417 -1.2543 TD
0.009 Tc
0.151 Tw
(typed for linked markers and two groups of parental)Tj
0 -1.2472 TD
0.004 Tc
0 Tw
[(haplotypes are considered: those transmitted to af)18(fected)]TJ
ET

endstream
endobj
549 0 obj
<</Length 103>>stream
74 0 0 0 1 -1 d1
q
1 0 0 1 0 -1 cm
BI
/W 1
/H 1
/BPC 1
/IM true
/F /Fl
ID H‰ú`   
EI
Q

endstream
endobj
555 0 obj
<</Length 521>>stream
142 0 8 173 134 -5 d1
q
126 0 0 178 8 -5 cm
BI
/W 126
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ì–K’„ @C¹pé8
GÃ£qÀÒ…¥3’í–îùÔ,&›öu‘/šdßI n/²Â§T·Á/™Á«ã•"J½ u1˜2'gæQ™g›°)É hwä0Îca«ÜS -çpÆYBO+´Ñ´‘b ^Éq¢ W
Œ—ZÏã¹ıŞÈq8_â´È–ó²ò·œwB¹.¾b©+æe¤îgŞ>E	œy¹×™ëxÇSyOüÒÁù(€Oš];ätÁ6v°¿æå‚§ğŒˆ¥ºáqşy6x{ƒøç?Íí}}á¾åıl¿‡¾Ÿ·¾Ïøœ/ûƒCN=œàa¿ŠĞÑïÚ~Yq€~[õç\ê»~~7Z¾›?yLf¦y5Ãóù@ÏÃ z^FĞó4r‚t0Ç‰äv/ šû¤|n*ûBfŠÛ°İjß8í#ù	eä8I&ÎƒÄrŞ$ëBâ¹$Rg#÷‚2”{-îÏûœ8tÈí>Øî‹í>yÚ7“2wŞWÛ}=úÂGMHûC€ _to
EI
Q

endstream
endobj
556 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
546 0 obj
<</Length 625>>stream
142 0 9 173 134 -5 d1
q
125 0 0 178 9 -5 cm
BI
/W 125
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰Ü–Íq„0…ÅøÀÑ%¸J3¥Q
%pä°‰ÑÓ“íe²ä˜èÀò±FÿÒpE‘tºlò-™x”±ı»:0+Çæ¸H ï`¯ÆSó:Ââ‹ZuP¸9çF=,Î©1ƒ—Á£âĞ˜Èi1ŞõæemP<Ã¡¬àçöêy0»“º;š_I9šß‰?üc¶8WeæaSEÌÓ~ËÂĞÀz–õ¬c€Vãá–#ûà¯ñ{¼Oø§üÈR‘×=Ïu=ã=çÂ›÷ÓTxuN…ïÇ#Âµ~f¿f5Ã¹¨~›çĞ3Ø{èÃ€´|¿°‹%ªØ‘¨Wó’,H¶8!Ì‹ÊÀ¼« T˜”©0+¯Æë¬Y•gû¨÷vçç}S©÷ıRPouÙş@_±¾|`ŞôF¯êr0ĞÙõ°Ëiµr[Á­ìÖótqv>È>’W3Í¶
ëÔsqhZ„uZ-=g¯sš[w¬¨ô‰¥å‘ác@ÿ7ñı6?Oò]s_¯'õMÊ×mßwıTõÛ´µœ÷ıYõsŞ™½»®ÙÜ•ûùHf~àú³Á;Dª¹ØVê°ß9Çlóm½\q]çô2AI~ç~¿ôû§ßOı÷ÒÛ~«˜˜š«gW_ˆ^GWW)DŸôß›ı÷¨½ö8dçŒ}	0 }½õ½
EI
Q

endstream
endobj
542 0 obj
<</Length 649>>stream
142 0 7 173 134 -5 d1
q
127 0 0 178 7 -5 cm
BI
/W 127
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰¼Ö]¤  àbIÖG/0	ÙÄ£ÁÑ8ŠGàÑ#+õŒÉôl–—öëÖª¢DìZÛÈ ±ÚØáÆ«VuA;uBÃ6œnlßGï2$1— „€<ÕëNµ“¹	’9á©â«sÒQÂ£ó¢Z@¡Ì‡°ó…âÌ‰2$Ÿ…Jçäó$ÏÕy•º}dì(m])Œö¥÷í“ÙkŸ=^µèmœí8ªÜ'ÇYõ¾¡ƒİ×OÎ ¥Æ'G['³·ôÚE\Íá»skÍ
¶ĞßñòŸíßp?ÿONo8’Ûıq_9?x#çWäÊí^ÉğäV¤­çŞ§ÚwŸ²=_àğ¬(å³7)—¤<p˜u•ôwhàÎÎNÂßG‰äŞA¶1Gß{Ù¦ï®Œuì‡ı­ùœ|M®³Óä<yŸ¬	‘5áo²&ü k‚?@’€'ô;2x1XÅ\QTó^­Æ¡ó…ø<W?u]ªÿÄ­ÛÜÚ¿r¶ı¢u©~Ã ËóÙ×ƒ}çó¥©HzÍŞÕÛo“½c;wmjÆ£¢7-á™O^d:w&}^f'åBµ÷/ÿ ûÅN–×<¦—Õ¿rxoŸøıÂš×ÊºëÎÀAÓ6¥qelu|#·EFí¤n^çEcÑyÓXµ/–®/ jß-]—ĞÙ}¶ğ]‚Àë(á5 ş=‡Ëµ¢ .ÃéµûeäÏê_ 	(
EI
Q

endstream
endobj
550 0 obj
<</Length 574>>stream
164 0 -1 178 165 0 d1
q
166 0 0 178 -1 0 cm
BI
/W 166
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰”Õ±‘† †aBKğJ¸léÂË¤4K¡CFîö“Åıôf^•â±*¥Æ ‡åĞˆPq8Hğ`QKĞŸ¨$¸ó¸pãq »pàÊã(@Ë£àeØ£…Gõ;úªwÜ."üB<}c¤&‰~Zø‹‘šx&Ú±Ç‰^„ÿ‰´ÇH'ˆŠÁáÀH×5àÁ¡	)¢¥ŸÛÒHMŒk±>qºpAt7çgÄ¢»q¢¸´q§¸Ş8RˆqÖş:¢yÁ¸æP.^	0_‘rùİ è{HÊå©Ì“&åXœó’“r¹A×CR.¿×
GÄ1 Ú
¢ÔTˆu¹ûœEX—+7U%‹#™™²-‘
VåÊÚ²8#VåÎÓrLŸâJpì }GÓAb¹‡ŠúCô;àòn€sSƒÒØ©òEº< ‰+à˜qI¸uÑšŒÉÊ×ÙD8$¼{ùë<D¨ütó¨üš˜Ÿoà‚{KZˆM†3ívgpœ:8ß˜†¬;¸Ü˜Ğ>ĞÀÖ’QLå8ÔˆÅXÅj[cüUi·TN´[*Çâ„è ¯rM¤‰¼Ê5‘v‹h7i·éO€ àkÒÜ
EI
Q

endstream
endobj
552 0 obj
<</Length 122>>stream
70 0 20 178 51 0 d1
q
31 0 0 178 20 0 cm
BI
/W 31
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰b```dÅ£xˆc€  ù ³
EI
Q

endstream
endobj
561 0 obj
<</Length 325>>stream
162 0 19 178 153 0 d1
q
134 0 0 178 19 0 cm
BI
/W 134
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ìÕ½Ã `%#0ŠG‹Gó(!e
ä‹!Š…ŞC\ì”æÊ¯0wÏÆ|ËI)SG0Á#Xó@˜‚Gpa_`R!"¯‚C°òÙŞ^/Y‹Td.‡©`E(Ÿ*HBÙd¬aFXòº¡OòVı9H×Àua»4ïãßKşí)OöG³ÇúmI«6jPwÄò"4¦õ / ùd0  ü È¡P" £èSÓ’ò”7ª©-ZòÓ¿!"@@€ãÅ×0`À€›À[€ ½Å:À
EI
Q

endstream
endobj
559 0 obj
<</Length 698>>stream
166 0 11 182 156 -4 d1
q
145 0 0 186 11 -4 cm
BI
/W 145
/H 186
/BPC 1
/IM true
/F /Fl
ID H‰´–M’ã …åò‚¥ÀQ|4s4ÂXzA™é úCv&3İ­MRŸáéIÂ$µ¶È ®ª8á+6… Å!HîHn“2ìó>¹3"Z¦|2ga„b'#t›¹Yõ£aöd¤,ísB ¯ËaI"7{ X…Ÿ„1ÜØúÉdìÂõ¡B¹z-d:¡×“J;eJM™VD‰Êhún ÛëÆçÎCX5Ê<½ehVƒpTe `tî°Ó;TĞÑÓá¡Hh“h×(=¡òï(ß#ÿ?è|‡Ü·Q"ıˆ®{´XŸ¡C3:öy‹œE“±`S«ñ5™.é5áigG*g³l ¹o!QİUŒèF…"]vY´Ë!2’Á,×#ªÉ{Õ¸à¢İ™íNy#ïVl{Îh.7Î¸LÒ9©ßÁ¤n¹„xx´LœãBØeDIFèmË’E×dŸ{´IT,¢_¤9F§.’rŞ¼OŠ`ŞıdQ¶è´¨L«ŸŞ#õ	i¿/ûÇ¡ø€‚ªê7üÅ{t(T5
(©³øyBp‹–v¶7è"ä4:e§ûÒ¢†õçêHuá†°ÈÔP;RXQlBû¡›áu<öŠ;»Àÿp]ä"§LÃPbı ÑJê€@RKÅËÆã¾3¿¾õg+!pøY§ÿÌ#·FÜPìØ$ƒÊ àb1ÄßTŒ•§<hç¢<è”bìJ]éãôDI8v!†„Ån~=£$T97z7¦ë3‰m Tİ©T
EI
Q

endstream
endobj
562 0 obj
<</Length 142>>stream
94 0 30 178 85 -49 d1
q
55 0 0 227 30 -49 cm
BI
/W 55
/H 227
/BPC 1
/IM true
/F /Fl
ID H‰b` FúSìÿÿÿ¥F©Qj”¥È¦ ô0 ÅüFE
EI
Q

endstream
endobj
557 0 obj
<</Length 143>>stream
94 0 10 178 65 -49 d1
q
55 0 0 227 10 -49 cm
BI
/W 55
/H 227
/BPC 1
/IM true
/F /Fl
ID H‰b` F:Sÿÿÿ?0JR£Ô(5J‘M1€İ)€  XŞÒ
EI
Q

endstream
endobj
547 0 obj
<</Length 520>>stream
141 0 9 133 138 -4 d1
q
129 0 0 137 9 -4 cm
BI
/W 129
/H 137
/BPC 1
/IM true
/F /Fl
ID H‰´Ö;rÃ àe(Tê…k¥ƒ£q@©‚‘´–u%3	Íg¼ü°}]£@¸TË°Ê1úà&”æû°­ïøh•!ê9FÛ×R¤8S“«Ö	IÇšÓä	WºÌ{Zè
6ŞÄ@h)KÔ†óuJ™g/T½i<'0Èœ¬:á^ "lòA-ĞN^õ+‚@ø¢lXÀ‡gHÿ³ıĞ¡ZÈ:(î¾‚+ğ¹¦ÏP¨ãÌ€×$¢†f¡X §…ÃB³P-È$o™úïõ>§£ÉÎÑJ’x	Ü¹î£!*hXq¯a$ß-…kjH.ùpà¿ø	Ğwsû=ÔßCy„llt'˜å÷	N»@› tfç@AäIO;ÂÎ5Ç³JQAƒ“ãºQÈWÀx¹E9-jdzş§…y]FÈ 0ì•!„&åæ…ŠÀA<Mr“wš&âØ$_ó×²S	Üš¤vdŒ•iG'"òéJ·w ºd,Õ
EI
Q

endstream
endobj
560 0 obj
<</Length 476>>stream
153 0 10 178 136 -4 d1
q
126 0 0 182 10 -4 cm
BI
/W 126
/H 182
/BPC 1
/IM true
/F /Fl
ID H‰ìÖ1’Ã  @1*(ı?Å÷3ó4Â\ºğ˜„ˆLœwÅİ„*;c#AJÎ:" æ?şóàz' ğêÊX›·ê¹9Vc3Ğì…½±'vd{v`;ò	2ÈGóWõİ@^œŒ£q0†GŸCû$¦tä5¤t¼„EJg–´Ù«ìÖç\–e×M¤]Ljßvëcsñ®^ÚWÂ,Ó_\áIÙJÀj×à!á)¡=¹$„%‹iì]<wŞÔ‡x»¤†iàuì,ÎãÃØîÎáÆ‘Œ¿i¸Ú?súg~µŞwü“ß#¼çÛóÔÆ~v~Ûù·^Ç>Ì}zuÿì}µ÷yOÆ¼á%T_/¢;wõ'HıjËÔ· 	êYÒéëgRk×ºÖßÄ¨ÎkıŞÙ¶¾ÛúOÖş`û‡í/—ş“ñflûŸöÇı“ûiˆl	(ıXÌl™peó„®õ{šĞ_şÈ ²²¤©sÖKó-À %µ	Ü
EI
Q

endstream
endobj
563 0 obj
<</Length 495>>stream
142 0 10 133 134 -4 d1
q
124 0 0 137 10 -4 cm
BI
/W 124
/H 137
/BPC 1
/IM true
/F /Fl
ID H‰ä–1’Ã EÅ¤ ô8
GÃGã(>¥Ù5Ò—D’$“rÕ8/ı/À"½_Q‰r·hô/¤¨¸¶sš†Û„C8ÌÓ‰Ê4]-Tğ2¥CÂS9Léá¨—)½Tãáx5^î8NòD7•Oşp‚wITÅĞ.Fš{ê¼ÂönĞÉÌê#qßÂu-<¬ î…Óè2ÇÁ¶NÏ!|B~üÂ°3”Âï¤9{ÊÙöy¸t\é9hïğ6sŞHâş×ùŞsr|¼Ãë#ß¾àåÚN/™şc½F|Êë÷¾áúšéŞèñ¼—œK3nqrìŞï!}ñòœ‡Ué:Zêa²¢oZÿaÊÜ¸@I(Èú–~·Â`c'†6ã{‰¿"&‘»7y¢g”ş^pıÈ5ÑÁq¤	İ_W®ÏKDYÄ_	¾%2ê’(¨[¢÷îïC[G'çİ¾Yz'Pú”PÏéœNgğıÿƒîÕT¡»¨:ûG€ °ë 
EI
Q

endstream
endobj
553 0 obj
<</Length 128>>stream
62 0 16 178 45 0 d1
q
29 0 0 178 16 0 cm
BI
/W 29
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰b```g 1şOc@k÷âÁ :"c×
EI
Q

endstream
endobj
543 0 obj
<</Length 483>>stream
134 0 16 178 131 0 d1
q
115 0 0 178 16 0 cm
BI
/W 115
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ìÕÍqƒ0†áeÈ„£J JC¥QŠKàÈÁƒ"öÛÉ ±/æ‰¿^[²ˆhJ~£/¿ü—ÌW4Ï‹«ñ}ÑŸ|ä«Á¹ç«Ñùâ+ã–¯‚3^çõÂ‹Y#²FdÈ‘5"kDÖˆ¬R²JÉ*%«”¬R²ÊeD'ù“®ğ”ğ-á!á^¼õ	ÙàÔ¬P³É>Î‚–-ZÔñ„›fÁ¨Ù¤ß9²ÌÓ²Ì·e™‡e™»e™ez–éY¦g/şRõèUÿKœº»jRŸk—KÍ¹ËĞåÔäHÅ÷‹op†XqäK%¿Á­âº‘¯«üÀ‹|ÕåWÙKÌY‰ufÌ œyQ¦íÛ•W°nÙ¨ÊÁïôÏ±ÚVIG"ß°k“:ùŞÿàì<îNá™:Ò3‹Éì×¬M™¡A©AI)34(34(3”,~½Ó1C‹˜¡EÌP±8bö;‹óè¨‰*GÛygq¦;‹C#9y†šËŸ  brí
EI
Q

endstream
endobj
545 0 obj
<</Length 122>>stream
62 0 17 178 46 0 d1
q
29 0 0 178 17 0 cm
BI
/W 29
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰b```gÅ£xˆc€  Âüß
EI
Q

endstream
endobj
558 0 obj
<</Length 290>>stream
147 0 16 132 131 0 d1
q
115 0 0 132 16 0 cm
BI
/W 115
/H 132
/BPC 1
/IM true
/F /Fl
ID H‰ìÑ;Ã  PGèP•#pFÖ£p„Qİø¡Š¢]*áñËF¤xÌØb _µEÚv|œ™ŞÈâ×D¹ ,Ê(ÌJ/\”N¨¢\Ûú0ó^™ˆ·Êˆ°/†¾§;ål”º'åDİjˆO®Òª“¡ŞE,Îº™ì©äJZºtM™lBı-ñ2¼lt=ı_ÆĞ3V†ÆbL§Ä3NW¸sşİààààÿó#À §+BF
EI
Q

endstream
endobj
564 0 obj
<</Length 494>>stream
153 0 17 133 144 -52 d1
q
127 0 0 185 17 -52 cm
BI
/W 127
/H 185
/BPC 1
/IM true
/F /Fl
ID H‰ìÕKrƒ0 P1^¸‹N}ÅG‹ÆQ8B–,\l},4P’t×Æ›ğ2 ÿ¥Rj[\Q-@è\6ÂĞ=UCªíÅÜìÙk#~P=£áFÈ‘<’9“ú‹Øn?Ÿl@ˆSsoÑ8{cg<ƒ8æ]™i†ÒqÆık‹LdVö¸u€<NŒL¼'¾p8è
ckw1îÔÜº±ã=ß¾äîµiç[OÊ™z¬Êûvì:à(Ã¿vP€~­—;e¯¼Ø?èº@î‡W¯=¼àøÇüÓ|µşOz5ûÿìy²¶çõÈú|_İ™îûê¾MÖ÷w<°ÎNòE”åÓùÆæ£¯¬LGç»;ìóá’/wïU>Å ó¯+ûüNòy2ùİc‰”üoë5[Ol½±õ(\Ô³d|3õ°ìë%ÕO©§¾ìëm(ûzœÈ÷¾yéá°ş÷pèQ>GÏò:º-^T^åÔ‡òöÛÿÏß a|¿Ø
EI
Q

endstream
endobj
548 0 obj
<</Length 208>>stream
89 0 16 132 86 0 d1
q
70 0 0 132 16 0 cm
BI
/W 70
/H 132
/BPC 1
/IM true
/F /Fl
ID H‰ìÈ»À CÑ‡(H……ÑÈhŒÂ)œÏMhhÒD¸¹Gîe±O«(ÊñE%¢™Ø	QlÄJ,„|Š„Vğh0P8"‘€Â–p„ïˆØ!uÀf v nbâw8 - 
EI
Q

endstream
endobj
551 0 obj
<</Length 514>>stream
129 0 8 133 120 -4 d1
q
112 0 0 137 8 -4 cm
BI
/W 112
/H 137
/BPC 1
/IM true
/F /Fl
ID H‰Œ•Íµ„ …ãqÁ’(…Ò 4J¡–.<2#!!wæ½9f÷Hn~ÔŞßÖˆB;èmQèÚ­‹(1&oÊÑsõmD­Bãbr&Ñö†K‰lÈ‘ÿXM‚QG]äUåL‘íŸÄ÷+§¿ìC&	ÍRDD:­ÜtĞìÁ;Rf
Ò‚Ğ„šP”#ùF³ç'ĞĞWšMşEwîåÇ$…¤¨}Q
@ÈmJÙ ƒ<åu	@âœ‹€ÄÉ$a'­gg
"{Ø®ÒH´¯M6-)XO…‹\\¯‡‡‹òo¢ğÔ­œÎØ­söªØúÅ)(+½:uY›¡QêH…ìÈĞ	tu¤üIfo±_Tÿ"÷Œò'íh[ÊË­)OJB{Ñ!Şİ­2ÄKÈ¡÷X\“a4!]E¯ï_V
œ€Â9«?Ñìfät¼Àq­üˆf	¾É|½wø²ï¬ošƒ?B€¿E„?Iêæ#3oSô0/‘&ÌZ)ÒÁ5sPönœAèNÉõ` ÷¾fô
EI
Q

endstream
endobj
554 0 obj
<</Length 196>>stream
76 0 1 165 72 -2 d1
q
71 0 0 167 1 -2 cm
BI
/W 71
/H 167
/BPC 1
/IM true
/F /Fl
ID H‰úÿÿÃeÉ`€ÆÁÆ$á3ÊeBF=n†=Œ!cğÃŒ?€ÙêÉøÁøƒ›ñÆøg4À`Œ0ÆãŒVÍb dş` ²F:C
EI
Q

endstream
endobj
544 0 obj
<</Length 437>>stream
125 0 0 129 125 0 d1
q
125 0 0 129 0 0 cm
BI
/W 125
/H 129
/BPC 1
/IM true
/F /Fl
ID H‰ŒÕK–ƒ Ğ²0t	.…¥ÉÒX
K`èÀ£«ø< èt‰×Sğ(­¼n"2hI¾>ŞÚWŸŸË]ó!¯CkÛ›ßÄüÕ7s1—şf´˜§ÖûVlÄôFÕûilòİçèhªTœFâGSñN3h›RÑœ’‹è£Ü<Ñµlñ•íG/uÅ%`'Áh6àğìsòşnSw2®é<`Ş}jNcŸ3®KomÙW·ÎµÕwé›íÊFW,}Ù÷q²ëú¼xÃ¾ñyßìºCŞwÕ²/­î7©oJî¤æÜ@óelm#5çšK…öœÛÁ<t?ÏÍÌÑ¸ÑlĞï5µ^kœ²”j|Ò±è ÛÎu3Ÿº39ÀÑËÔ·êuêGµ©vš·¹½æ}î ÙVÇÿø¨>5?s_Š—?|+†øàOêù` ò£
EI
Q

endstream
endobj
536 0 obj
<</Length 9697>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(228)-2523(Abstracts)]TJ
/F14 1 Tf
8 0 0 8 50.981 638.022 Tm
0.009 Tc
0.006 Tw
(individuals and those not transmitted, representative of)Tj
0 -1.2543 TD
-0.001 Tc
0 Tw
(the population. Similarly to the \223Haplotype Sharing Sta-)Tj
0 -1.2472 TD
0.008 Tc
0.006 Tw
(tistic\224 \()Tj
/F16 1 Tf
3.0543 0 TD
0.011 Tc
(HSS)Tj
/F14 1 Tf
1.7575 0 TD
0.009 Tc
0.012 Tw
[(\), \(V)108(an der Meulen et al, 1997\), the lengths)]TJ
-4.8118 -1.2543 TD
0.173 Tw
(of identity are compared between the two groups of)Tj
0 -1.2472 TD
0.007 Tc
0.067 Tw
(haplotypes. In contrast with )Tj
/F16 1 Tf
11.8984 0 TD
-0.014 Tc
(HSS )Tj
/F14 1 Tf
2.0764 0 TD
0.009 Tc
0.068 Tw
[(that tests dif)9(ferences)]TJ
-13.9748 -1.2472 TD
0.002 Tw
[(of identity at each marker)30(, MILC is based on the maxi-)]TJ
0 -1.2543 TD
0.011 Tc
0.187 Tw
[(mum of this dif)25(ference. For a given genetic disease)]TJ
0 -1.2472 TD
0.005 Tc
0 Tw
(model, the power of this method was evaluated through)Tj
0 -1.2543 TD
0.009 Tc
0.078 Tw
(simulations as a function of population characteristics)Tj
0 -1.2472 TD
0.006 Tc
0.155 Tw
[(and )11(marker )11(map. )-146(W)36(ith dense map, the power of this)]TJ
T*
0.153 Tw
[(method is generally higher than that of the )-136(T)-11(D)-11(T)20( )-6(be-)]TJ
0 -1.2543 TD
0.009 Tc
0.006 Tw
(cause it uses information on several markers. For fixed)Tj
0 -1.2472 TD
0.036 Tc
0.188 Tw
(population parameters, results are highly variable)Tj
T*
0.009 Tc
0.124 Tw
(among simulations. In fact, the power of our method)Tj
0 -1.2543 TD
0.043 Tc
0.188 Tw
(strongly depends on linkage disequilibrium \(LD\))Tj
0 -1.2472 TD
-0.002 Tc
0.187 Tw
[(among markers. )-151(A)-14(s)-14( )-14(L)-14(D)-14( )]TJ
10.5739 0 TD
0.012 Tc
(mostly results from random)Tj
-10.5739 -1.2543 TD
0.001 Tc
0 Tw
(processes it is not predictable and therefore not a simple)Tj
0 -1.2472 TD
0.009 Tc
0.017 Tw
(decreasing function of the genetic distance.)Tj
1.5024 -1.2472 TD
0.016 Tw
(In a context of multifactorial disease, one has to be)Tj
-1.5024 -1.2543 TD
0.094 Tw
(very cautious in the interpretation of LD mapping re-)Tj
0 -1.2472 TD
0.081 Tw
(sults even in founder populations. Our results suggest)Tj
0 -1.2543 TD
0.136 Tw
(that one way to increase our power to detect genetic)Tj
0 -1.2472 TD
0.006 Tw
(risk factor in these populations can be the use of mark-)Tj
T*
0.01 Tc
0.011 Tw
(ers showing strong LD one with the others.)Tj
/T52 1 Tf
14 0 0 14 50.981 366.973 Tm
-0.007 Tc
0.098 Tw
(108 [Presidential Address])Tj
/F5 1 Tf
8 0 0 8 50.981 349.002 Tm
0.01 Tc
0.005 Tw
(Genetic Epidemiology with a Capital E)Tj
/F14 1 Tf
T*
0.009 Tc
0.024 Tw
[(D)6(.)6( Thomas)]TJ
0 -1.2543 TD
0.01 Tc
0.006 Tw
[(Univ of Southern Calif, Los )37(Angeles, CA, USA)]TJ
1.5024 -1.8709 TD
0.001 Tc
0 Tw
(Three characteristics of genetic epidemiology which)Tj
-1.5024 -1.2543 TD
0.009 Tc
0.034 Tw
(distinguish it from its parent disciplines are a focus on)Tj
0 -1.2472 TD
0.068 Tw
[(population-based research, a focus on the joint ef)9(fects)]TJ
0 -1.2543 TD
0.165 Tw
(of genes and the environment, and the incorporation)Tj
0 -1.2472 TD
0.122 Tw
(of the underlying biology of the disease into its con-)Tj
T*
-0.003 Tc
0.182 Tw
(ceptual models. )Tj
7.0228 0 TD
0.009 Tc
(These principles are illustrated by a)Tj
-7.0228 -1.2543 TD
0.034 Tc
0.188 Tw
(review of the genetic epidemiology of breast and)Tj
0 -1.2472 TD
0.029 Tc
0.06 Tw
[(ovarian cancer)50(. Descriptive and mechanistic models)]TJ
T*
0.177 Tw
[(for the joint ef)15(fects of genes and \223environmental\224)]TJ
0 -1.2543 TD
0.057 Tc
0.187 Tw
(risk factors such as hormones and reproductive)Tj
0 -1.2472 TD
0.029 Tc
0.067 Tw
[(events are compared to illustrate the need to under)8(-)]TJ
0 -1.2543 TD
0.188 Tw
[(stand the biology)57(.)192( )-169(The contribution of population-)]TJ
0 -1.2472 TD
0.138 Tw
(based research to the development of the evidence)Tj
T*
0.166 Tw
(for the involvement of major genes, the discovery)Tj
0 -1.2543 TD
0.034 Tw
(of BRCA1/2, and their characterization is reviewed.)Tj
0 -1.2472 TD
0.011 Tw
(Interactions of major susceptibility genes, metabolic)Tj
0 -1.2543 TD
0.045 Tc
0.187 Tw
(genes, hormones, and radiation will also be dis-)Tj
0 -1.2472 TD
0.029 Tc
0.046 Tw
(cussed. I conclude with some suggestions for future)Tj
T*
0.045 Tw
[(directions for the field, the journal, and the Society)57(,)]TJ
0 -1.2543 TD
0.121 Tw
(including recent bioethics initiatives. I believe that)Tj
0 -1.2472 TD
0.041 Tw
(the Society should reach out more to the epidemiol-)Tj
T*
0.076 Tw
(ogy community and that the journal should shift its)Tj
0 -1.2543 TD
0.129 Tw
(emphasis from pure methodology to more substan-)Tj
0 -1.2472 TD
0.011 Tw
(tive papers that illustrate these principles.)Tj
/T52 1 Tf
14 0 0 14 255.019 633.997 Tm
-0.007 Tc
0.033 Tw
(109 [Invited Speaker])Tj
/F5 1 Tf
8 0 0 8 255.019 616.989 Tm
0.01 Tc
0 Tw
[(Under)17( what conditions ar)24(e association studies mor)17(e)]TJ
T*
0.009 Tc
(efficient than family studies for gene mapping?)Tj
/F14 1 Tf
0 -1.2543 TD
0.008 Tc
-0.003 Tw
[(E.M. W)31(ijsman)]TJ
0 -1.2472 TD
0.009 Tc
0 Tw
[(University )-8(of W)81(ashington, )-9(Seattle, W)110(A, )-11(USA)]TJ
1.4953 -1.7504 TD
0.171 Tw
[(A)44( major challenge is how to ef)23(ficiently and suc-)]TJ
-1.4953 -1.2472 TD
0.064 Tw
(cessfully map and identify genes contributing to com-)Tj
0 -1.2543 TD
-0.003 Tc
0.14 Tw
[(plex traits. )-138(W)]TJ
5.7685 0 TD
0.009 Tc
(ith the advent of automated genotyping)Tj
-5.7685 -1.2472 TD
0.01 Tc
0.188 Tw
(methods, discussions have turned from family-based)Tj
0 -1.2543 TD
0.009 Tc
0.013 Tw
(studies to the potential of population-based designs for)Tj
0 -1.2472 TD
0.102 Tw
(initial gene localization, both in the context of candi-)Tj
T*
0.007 Tc
-0.001 Tw
[(date-gene and whole-genome screens. However)42(, before)]TJ
0 -1.2543 TD
0.009 Tc
0.126 Tw
(major investment is made in association studies, it is)Tj
0 -1.2472 TD
0.128 Tw
(useful to determine the conditions needed to succeed)Tj
T*
0.003 Tc
0 Tw
(with such studies, and to compare these to requirements)Tj
0 -1.2543 TD
0.009 Tc
0.021 Tw
(for family-based designs. In this context, it is useful to)Tj
0 -1.2472 TD
0.031 Tw
(consider sample sizes needed to achieve similar poste-)Tj
0 -1.2543 TD
0.013 Tw
(rior probabilities of linkage for the two designs.)Tj
1.4953 -1.2472 TD
0.004 Tc
0 Tw
(Power and sample size requirements for a case-con-)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.101 Tw
(trol study for markers with arbitrary numbers of alle-)Tj
0 -1.2543 TD
0.004 Tc
0 Tw
(les can be obtained by considering a measure of genetic)Tj
0 -1.2472 TD
0.009 Tc
0.019 Tw
(distance \(G)Tj
4.8 0 0 4.8 292.663 416.579 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 295.101 413.008 Tm
0.01 Tc
0.018 Tw
(\) between cases and controls. G)Tj
4.8 0 0 4.8 399.529 416.579 Tm
0 Tc
0 Tw
(2)Tj
8 0 0 8 402.024 413.008 Tm
0.009 Tc
0.021 Tw
[( is a func-)]TJ
-18.3756 -1.2543 TD
0.035 Tw
(tion of age of disease mutation\(s\), recombination frac-)Tj
0 -1.2472 TD
0.168 Tw
(tion, number and frequencies of marker alleles, case)Tj
T*
0.187 Tw
(ascertainment procedures, and fraction of case chro-)Tj
0 -1.2543 TD
0.113 Tw
(mosomes carrying a particular disease allele. General)Tj
0 -1.2472 TD
0.01 Tc
0.188 Tw
(conclusions are that multiallelic markers are usually)Tj
T*
0.009 Tc
0.039 Tw
[(more ef)23(ficient in case-control studies than are diallelic)]TJ
0 -1.2543 TD
-0.001 Tc
0 Tw
(markers, and become increasingly more so with increas-)Tj
0 -1.2472 TD
0.009 Tc
(ingly complex traits, with increasing mutation age, and)Tj
0 -1.2543 TD
0.008 Tc
0.05 Tw
[(with increasing recombination fractions. )-35(W)38(ith increas-)]TJ
0 -1.2472 TD
0.009 Tc
0.062 Tw
(ing etiologic heterogeneity and ascertainment that is a)Tj
T*
0.01 Tc
0.187 Tw
[(function of number of cases per family)60(, sample-size)]TJ
0 -1.2543 TD
0.009 Tc
0.09 Tw
(requirements also increase more rapidly for case-con-)Tj
0 -1.2472 TD
0.056 Tw
(trol than for family-based studies. In general, with the)Tj
0 -1.2543 TD
0 Tw
(exception of young, monogenetic diseases, population-)Tj
0 -1.2472 TD
0.13 Tw
[(based studies may be considerably less ef)23(ficient than)]TJ
T*
0.017 Tw
(are family-based studies, especially when the posterior)Tj
0 -1.2543 TD
0 Tc
0 Tw
(probability of a correct conclusion is taken into account.)Tj
/T52 1 Tf
14 0 0 14 255.019 205.002 Tm
-0.007 Tc
0.033 Tw
(110 [Invited Speaker])Tj
/F5 1 Tf
8 0 0 8 255.019 187.994 Tm
0.009 Tc
0 Tw
(Methods for detecting gene-gene interaction using)Tj
0 -1.2472 TD
(affected sib pairs.)Tj
/F14 1 Tf
0 -1.2543 TD
0.011 Tw
[(P)111(.)0( Holmans, )8(W)81(ashington Univ)59(. School of Medicine, St)]TJ
0 -1.2472 TD
0.012 Tc
(Louis.)Tj
1.4953 -1.7504 TD
0.009 Tc
0.175 Tw
(It is likely that several loci contribute to the ge-)Tj
-1.4953 -1.2472 TD
0.074 Tw
(netic susceptibility to complex diseases, and that con-)Tj
0 -1.2543 TD
0.113 Tw
(siderable interactions between these loci exist. If two)Tj
0 -1.2472 TD
0.023 Tw
[(disease loci interact epistatically)66(, a positive correlation)]TJ
T*
0.087 Tw
(between the number of alleles shared identical by de-)Tj
0 -1.2543 TD
0.04 Tw
(scent \(IBD\) at each locus is expected, whereas hetero-)Tj
0 -1.2472 TD
0.022 Tw
(geneity should produce a negative correlation.)Tj
ET

endstream
endobj
576 0 obj
<</Length 103>>stream
74 0 0 0 1 -1 d1
q
1 0 0 1 0 -1 cm
BI
/W 1
/H 1
/BPC 1
/IM true
/F /Fl
ID H‰ú`   
EI
Q

endstream
endobj
580 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
583 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
577 0 obj
<</Length 122>>stream
70 0 20 178 51 0 d1
q
31 0 0 178 20 0 cm
BI
/W 31
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰b```dÅ£xˆc€  ù ³
EI
Q

endstream
endobj
584 0 obj
<</Length 698>>stream
166 0 11 182 156 -4 d1
q
145 0 0 186 11 -4 cm
BI
/W 145
/H 186
/BPC 1
/IM true
/F /Fl
ID H‰´–M’ã …åò‚¥ÀQ|4s4ÂXzA™é úCv&3İ­MRŸáéIÂ$µ¶È ®ª8á+6… Å!HîHn“2ìó>¹3"Z¦|2ga„b'#t›¹Yõ£aöd¤,ísB ¯ËaI"7{ X…Ÿ„1ÜØúÉdìÂõ¡B¹z-d:¡×“J;eJM™VD‰Êhún ÛëÆçÎCX5Ê<½ehVƒpTe `tî°Ó;TĞÑÓá¡Hh“h×(=¡òï(ß#ÿ?è|‡Ü·Q"ıˆ®{´XŸ¡C3:öy‹œE“±`S«ñ5™.é5áigG*g³l ¹o!QİUŒèF…"]vY´Ë!2’Á,×#ªÉ{Õ¸à¢İ™íNy#ïVl{Îh.7Î¸LÒ9©ßÁ¤n¹„xx´LœãBØeDIFèmË’E×dŸ{´IT,¢_¤9F§.’rŞ¼OŠ`ŞıdQ¶è´¨L«ŸŞ#õ	i¿/ûÇ¡ø€‚ªê7üÅ{t(T5
(©³øyBp‹–v¶7è"ä4:e§ûÒ¢†õçêHuá†°ÈÔP;RXQlBû¡›áu<öŠ;»Àÿp]ä"§LÃPbı ÑJê€@RKÅËÆã¾3¿¾õg+!pøY§ÿÌ#·FÜPìØ$ƒÊ àb1ÄßTŒ•§<hç¢<è”bìJ]éãôDI8v!†„Ån~=£$T97z7¦ë3‰m Tİ©T
EI
Q

endstream
endobj
586 0 obj
<</Length 142>>stream
94 0 30 178 85 -49 d1
q
55 0 0 227 30 -49 cm
BI
/W 55
/H 227
/BPC 1
/IM true
/F /Fl
ID H‰b` FúSìÿÿÿ¥F©Qj”¥È¦ ô0 ÅüFE
EI
Q

endstream
endobj
581 0 obj
<</Length 143>>stream
94 0 10 178 65 -49 d1
q
55 0 0 227 10 -49 cm
BI
/W 55
/H 227
/BPC 1
/IM true
/F /Fl
ID H‰b` F:Sÿÿÿ?0JR£Ô(5J‘M1€İ)€  XŞÒ
EI
Q

endstream
endobj
574 0 obj
<</Length 520>>stream
141 0 9 133 138 -4 d1
q
129 0 0 137 9 -4 cm
BI
/W 129
/H 137
/BPC 1
/IM true
/F /Fl
ID H‰´Ö;rÃ àe(Tê…k¥ƒ£q@©‚‘´–u%3	Íg¼ü°}]£@¸TË°Ê1úà&”æû°­ïøh•!ê9FÛ×R¤8S“«Ö	IÇšÓä	WºÌ{Zè
6ŞÄ@h)KÔ†óuJ™g/T½i<'0Èœ¬:á^ "lòA-ĞN^õ+‚@ø¢lXÀ‡gHÿ³ıĞ¡ZÈ:(î¾‚+ğ¹¦ÏP¨ãÌ€×$¢†f¡X §…ÃB³P-È$o™úïõ>§£ÉÎÑJ’x	Ü¹î£!*hXq¯a$ß-…kjH.ùpà¿ø	Ğwsû=ÔßCy„llt'˜å÷	N»@› tfç@AäIO;ÂÎ5Ç³JQAƒ“ãºQÈWÀx¹E9-jdzş§…y]FÈ 0ì•!„&åæ…ŠÀA<Mr“wš&âØ$_ó×²S	Üš¤vdŒ•iG'"òéJ·w ºd,Õ
EI
Q

endstream
endobj
585 0 obj
<</Length 476>>stream
153 0 10 178 136 -4 d1
q
126 0 0 182 10 -4 cm
BI
/W 126
/H 182
/BPC 1
/IM true
/F /Fl
ID H‰ìÖ1’Ã  @1*(ı?Å÷3ó4Â\ºğ˜„ˆLœwÅİ„*;c#AJÎ:" æ?şóàz' ğêÊX›·ê¹9Vc3Ğì…½±'vd{v`;ò	2ÈGóWõİ@^œŒ£q0†GŸCû$¦tä5¤t¼„EJg–´Ù«ìÖç\–e×M¤]Ljßvëcsñ®^ÚWÂ,Ó_\áIÙJÀj×à!á)¡=¹$„%‹iì]<wŞÔ‡x»¤†iàuì,ÎãÃØîÎáÆ‘Œ¿i¸Ú?súg~µŞwü“ß#¼çÛóÔÆ~v~Ûù·^Ç>Ì}zuÿì}µ÷yOÆ¼á%T_/¢;wõ'HıjËÔ· 	êYÒéëgRk×ºÖßÄ¨ÎkıŞÙ¶¾ÛúOÖş`û‡í/—ş“ñflûŸöÇı“ûiˆl	(ıXÌl™peó„®õ{šĞ_şÈ ²²¤©sÖKó-À %µ	Ü
EI
Q

endstream
endobj
587 0 obj
<</Length 495>>stream
142 0 10 133 134 -4 d1
q
124 0 0 137 10 -4 cm
BI
/W 124
/H 137
/BPC 1
/IM true
/F /Fl
ID H‰ä–1’Ã EÅ¤ ô8
GÃGã(>¥Ù5Ò—D’$“rÕ8/ı/À"½_Q‰r·hô/¤¨¸¶sš†Û„C8ÌÓ‰Ê4]-Tğ2¥CÂS9Léá¨—)½Tãáx5^î8NòD7•Oşp‚wITÅĞ.Fš{ê¼ÂönĞÉÌê#qßÂu-<¬ î…Óè2ÇÁ¶NÏ!|B~üÂ°3”Âï¤9{ÊÙöy¸t\é9hïğ6sŞHâş×ùŞsr|¼Ãë#ß¾àåÚN/™şc½F|Êë÷¾áúšéŞèñ¼—œK3nqrìŞï!}ñòœ‡Ué:Zêa²¢oZÿaÊÜ¸@I(Èú–~·Â`c'†6ã{‰¿"&‘»7y¢g”ş^pıÈ5ÑÁq¤	İ_W®ÏKDYÄ_	¾%2ê’(¨[¢÷îïC[G'çİ¾Yz'Pú”PÏéœNgğıÿƒîÕT¡»¨:ûG€ °ë 
EI
Q

endstream
endobj
578 0 obj
<</Length 128>>stream
62 0 16 178 45 0 d1
q
29 0 0 178 16 0 cm
BI
/W 29
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰b```g 1şOc@k÷âÁ :"c×
EI
Q

endstream
endobj
572 0 obj
<</Length 483>>stream
134 0 16 178 131 0 d1
q
115 0 0 178 16 0 cm
BI
/W 115
/H 178
/BPC 1
/IM true
/F /Fl
ID H‰ìÕÍqƒ0†áeÈ„£J JC¥QŠKàÈÁƒ"öÛÉ ±/æ‰¿^[²ˆhJ~£/¿ü—ÌW4Ï‹«ñ}ÑŸ|ä«Á¹ç«Ñùâ+ã–¯‚3^çõÂ‹Y#²FdÈ‘5"kDÖˆ¬R²JÉ*%«”¬R²ÊeD'ù“®ğ”ğ-á!á^¼õ	ÙàÔ¬P³É>Î‚–-ZÔñ„›fÁ¨Ù¤ß9²ÌÓ²Ì·e™‡e™»e™ez–éY¦g/şRõèUÿKœº»jRŸk—KÍ¹ËĞåÔäHÅ÷‹op†XqäK%¿Á­âº‘¯«üÀ‹|ÕåWÙKÌY‰ufÌ œyQ¦íÛ•W°nÙ¨ÊÁïôÏ±ÚVIG"ß°k“:ùŞÿàì<îNá™:Ò3‹Éì×¬M™¡A©AI)34(34(3”,~½Ó1C‹˜¡EÌP±8bö;‹óè¨‰*GÛygq¦;‹C#9y†šËŸ  brí
EI
Q

endstream
endobj
582 0 obj
<</Length 290>>stream
147 0 16 132 131 0 d1
q
115 0 0 132 16 0 cm
BI
/W 115
/H 132
/BPC 1
/IM true
/F /Fl
ID H‰ìÑ;Ã  PGèP•#pFÖ£p„Qİø¡Š¢]*áñËF¤xÌØb _µEÚv|œ™ŞÈâ×D¹ ,Ê(ÌJ/\”N¨¢\Ûú0ó^™ˆ·Êˆ°/†¾§;ål”º'åDİjˆO®Òª“¡ŞE,Îº™ì©äJZºtM™lBı-ñ2¼lt=ı_ÆĞ3V†ÆbL§Ä3NW¸sşİààààÿó#À §+BF
EI
Q

endstream
endobj
588 0 obj
<</Length 494>>stream
153 0 17 133 144 -52 d1
q
127 0 0 185 17 -52 cm
BI
/W 127
/H 185
/BPC 1
/IM true
/F /Fl
ID H‰ìÕKrƒ0 P1^¸‹N}ÅG‹ÆQ8B–,\l},4P’t×Æ›ğ2 ÿ¥Rj[\Q-@è\6ÂĞ=UCªíÅÜìÙk#~P=£áFÈ‘<’9“ú‹Øn?Ÿl@ˆSsoÑ8{cg<ƒ8æ]™i†ÒqÆık‹LdVö¸u€<NŒL¼'¾p8è
ckw1îÔÜº±ã=ß¾äîµiç[OÊ™z¬Êûvì:à(Ã¿vP€~­—;e¯¼Ø?èº@î‡W¯=¼àøÇüÓ|µşOz5ûÿìy²¶çõÈú|_İ™îûê¾MÖ÷w<°ÎNòE”åÓùÆæ£¯¬LGç»;ìóá’/wïU>Å ó¯+ûüNòy2ùİc‰”üoë5[Ol½±õ(\Ô³d|3õ°ìë%ÕO©§¾ìëm(ûzœÈ÷¾yéá°ş÷pèQ>GÏò:º-^T^åÔ‡òöÛÿÏß a|¿Ø
EI
Q

endstream
endobj
575 0 obj
<</Length 208>>stream
89 0 16 132 86 0 d1
q
70 0 0 132 16 0 cm
BI
/W 70
/H 132
/BPC 1
/IM true
/F /Fl
ID H‰ìÈ»À CÑ‡(H……ÑÈhŒÂ)œÏMhhÒD¸¹Gîe±O«(ÊñE%¢™Ø	QlÄJ,„|Š„Vğh0P8"‘€Â–p„ïˆØ!uÀf v nbâw8 - 
EI
Q

endstream
endobj
579 0 obj
<</Length 196>>stream
76 0 1 165 72 -2 d1
q
71 0 0 167 1 -2 cm
BI
/W 71
/H 167
/BPC 1
/IM true
/F /Fl
ID H‰úÿÿÃeÉ`€ÆÁÆ$á3ÊeBF=n†=Œ!cğÃŒ?€ÙêÉøÁøƒ›ñÆøg4À`Œ0ÆãŒVÍb dş` ²F:C
EI
Q

endstream
endobj
573 0 obj
<</Length 437>>stream
125 0 0 129 125 0 d1
q
125 0 0 129 0 0 cm
BI
/W 125
/H 129
/BPC 1
/IM true
/F /Fl
ID H‰ŒÕK–ƒ Ğ²0t	.…¥ÉÒX
K`èÀ£«ø< èt‰×Sğ(­¼n"2hI¾>ŞÚWŸŸË]ó!¯CkÛ›ßÄüÕ7s1—şf´˜§ÖûVlÄôFÕûilòİçèhªTœFâGSñN3h›RÑœ’‹è£Ü<Ñµlñ•íG/uÅ%`'Áh6àğìsòşnSw2®é<`Ş}jNcŸ3®KomÙW·ÎµÕwé›íÊFW,}Ù÷q²ëú¼xÃ¾ñyßìºCŞwÕ²/­î7©oJî¤æÜ@óelm#5çšK…öœÛÁ<t?ÏÍÌÑ¸ÑlĞï5µ^kœ²”j|Ò±è ÛÎu3Ÿº39ÀÑËÔ·êuêGµ©vš·¹½æ}î ÙVÇÿø¨>5?s_Š—?|+†øàOêù` ò£
EI
Q

endstream
endobj
566 0 obj
<</Length 9781>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 366.123 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
[(Abstracts)-2524(229)]TJ
/F14 1 Tf
8 0 0 8 72 638.022 Tm
0.009 Tc
0.138 Tw
[(W)81(e)0( consider three methods for detecting such in-)]TJ
-1.5024 -1.2543 TD
0.083 Tw
[(teractions. Firstly)52(, one can calculate the correlation in)]TJ
0 -1.2472 TD
0.185 Tw
(estimated IBD sharing for each sib pair at locations)Tj
0 -1.2543 TD
0.001 Tc
0 Tw
(corresponding to lod-score peaks obtained under single-)Tj
0 -1.2472 TD
0.009 Tc
0.003 Tw
(locus analysis, and test for a significant departure from)Tj
T*
0.085 Tw
[(zero. Secondly)66(, one can select the pairs for which the)]TJ
0 -1.2543 TD
0.009 Tw
(estimated IBD is greater \(if testing for epistasis\) than a)Tj
0 -1.2472 TD
0 Tw
[(pre-determined value \(e.g. 1\) at the first locus. )8(The test)]TJ
0 -1.2543 TD
0.127 Tw
(statistic for the second locus is calculated using only)Tj
0 -1.2472 TD
0.007 Tc
0.078 Tw
[(these sib pairs. )-57(The significance of the result is deter)7(-)]TJ
T*
0.001 Tc
0 Tw
(mined by comparing it to those obtained from randomly)Tj
0 -1.2543 TD
0.008 Tc
0.086 Tw
[(selected samples of equivalent size. )-71(The third method)]TJ
0 -1.2472 TD
0.009 Tc
0.066 Tw
[(models the probability that an af)9(fected sib pair inherit)]TJ
T*
0.075 Tw
(an allele IBD from a given parent at the second locus)Tj
0 -1.2543 TD
0.024 Tc
0.188 Tw
[(as a logistic regression with the number of alleles)]TJ
0 -1.2472 TD
0.009 Tc
0.008 Tw
(shared IBD at the first locus included as a covariate.)Tj
1.5024 -1.2543 TD
-0.011 Tc
0.113 Tw
(Expected lod scores were calculated under a variety)Tj
-1.5024 -1.2472 TD
0.023 Tw
(of two-locus disease models in order to determine which,)Tj
T*
0.057 Tw
[(if any)60(, might yield a significant increase under the meth-)]TJ
0 -1.2543 TD
-0.014 Tc
0.159 Tw
[(ods )9(being )9(tested. )-138(The statistical powers of the methods)]TJ
0 -1.2472 TD
-0.011 Tc
0.108 Tw
(were compared by applying them to datasets containing)Tj
0 -1.2543 TD
0.132 Tw
(sibships of varying sizes simulated under these models.)Tj
0 -1.2472 TD
0.077 Tw
(The increase in precision in disease locus location given)Tj
T*
0.015 Tw
(by each method was also investigated.)Tj
/T53 1 Tf
14 0 0 14 59.981 369.978 Tm
-0.007 Tc
0.033 Tw
(111 [Invited Speaker])Tj
/F5 1 Tf
8 0 0 8 59.981 353.027 Tm
0.009 Tc
0.013 Tw
(Gamete Competition Models)Tj
/F14 1 Tf
0 -1.2543 TD
0.019 Tw
(Kenneth Lange, Departments of Biomathematics and)Tj
0 -1.2472 TD
0.01 Tc
0 Tw
(Human Genetics, UCLA School of Medicine)Tj
1.5024 -1.7504 TD
0.009 Tc
0.148 Tw
(This talk presents joint work with John Blangero)Tj
-1.5024 -1.2543 TD
0.063 Tw
(and Janet Sinsheimer on a gamete competition model.)Tj
0 -1.2472 TD
0.087 Tw
(The simplest version of the model is an adaptation of)Tj
T*
0.15 Tw
[(the Bradley-T)66(erry model for ranking sports teams. If)]TJ
0 -1.2543 TD
0.008 Tc
0.039 Tw
(one assigns to allele i of a marker locus a parameter )Tj
/F19 1 Tf
21.8835 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
4.8 0 0 4.8 238.62 277.795 Tm
(i)Tj
/F14 1 Tf
8 0 0 8 59.981 269.008 Tm
0.009 Tc
0.058 Tw
(> 0, then one can express the probability that a parent)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
(with heterozygous genotype )Tj
/F16 1 Tf
11.622 0 TD
0.001 Tc
(i/j)Tj
/F14 1 Tf
0.8433 0 TD
0.002 Tc
( transmits allele )Tj
/F16 1 Tf
6.626 0 TD
0 Tc
(i)Tj
/F14 1 Tf
0.2764 0 TD
0.002 Tc
( as Pr\()Tj
/F16 1 Tf
2.5795 0 TD
-0.003 Tc
(i/)Tj
-21.9472 -1.2543 TD
-0.14 Tc
(j )Tj
/F17 1 Tf
0.6874 0 TD
0 Tc
(\256)Tj
/F14 1 Tf
0.9992 0 TD
( )Tj
/F16 1 Tf
0.4181 0 TD
(i)Tj
/F14 1 Tf
0.2835 0 TD
-0.044 Tc
0.15 Tw
(\) = )Tj
/F19 1 Tf
1.7362 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4465 0 TD
(i)Tj
/F14 1 Tf
0.2906 0 TD
0.007 Tc
0.15 Tw
[( / \()]TJ
/F19 1 Tf
1.4386 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4535 0 TD
(i)Tj
/F14 1 Tf
0.2835 0 TD
-0.065 Tc
0.15 Tw
[( + )]TJ
/F19 1 Tf
1.3961 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4535 0 TD
(j)Tj
/F14 1 Tf
0.2835 0 TD
0.009 Tc
0.15 Tw
(\). Mendelian segregation corre-)Tj
-9.1701 -1.2472 TD
0.003 Tc
0.125 Tw
(sponds to the choice )Tj
/F19 1 Tf
9.0921 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4465 0 TD
(i)Tj
/F14 1 Tf
0.2906 0 TD
-0.001 Tc
0.125 Tw
[( = 1 for all )]TJ
/F16 1 Tf
5.2228 0 TD
0 Tc
0 Tw
(i)Tj
/F14 1 Tf
0.2906 0 TD
0.009 Tc
0.125 Tw
[(.)124( )-104(T)67(o)0( test whether)]TJ
-15.3425 -1.2543 TD
0.008 Tc
0.034 Tw
(Mendeliain segregation is true, one can estimate the )Tj
/F19 1 Tf
21.7772 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4465 0 TD
(i)Tj
/F14 1 Tf
-22.2236 -1.2472 TD
0.009 Tc
0.073 Tw
(from pedigree data and perform a likelihood ratio test)Tj
T*
0.008 Tc
0.018 Tw
(under the constraint that one )Tj
/F19 1 Tf
12.0047 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4465 0 TD
(i)Tj
/F14 1 Tf
0.2906 0 TD
0.009 Tc
0.017 Tw
[( equals 1. )36(Although this)]TJ
-12.7417 -1.2543 TD
0.006 Tc
0 Tw
(procedure generates an interesting method for perform-)Tj
0 -1.2472 TD
0.009 Tc
0.096 Tw
(ing segregation analysis with a marker locus, the real)Tj
25.5047 56.126 TD
0.082 Tw
(promise of the gamete competition model lies in gen-)Tj
0 -1.2543 TD
0.018 Tc
0.188 Tw
(eralizing the transmission / disequilibrium test. For)Tj
0 -1.2472 TD
0.006 Tc
0 Tw
(a candidate disease gene, one invokes Mendelian trans-)Tj
0 -1.2543 TD
0.009 Tc
0.033 Tw
(mission of alleles to normal children and gamete com-)Tj
0 -1.2472 TD
0.003 Tc
0 Tw
[(petition transmission of alleles to af)17(fected children. )24(The)]TJ
T*
0.009 Tc
0.051 Tw
(resulting method has the virtues of using full pedigree)Tj
0 -1.2543 TD
0.161 Tw
(data and giving an estimate of the strength of trans-)Tj
0 -1.2472 TD
0.091 Tw
[(mission distortion to af)23(fected children for each allele.)]TJ
0 -1.2543 TD
0.172 Tw
(The impact of covariates can be incorporated by re-)Tj
0 -1.2472 TD
-0.008 Tc
(writing )Tj
/F19 1 Tf
3.3307 0 TD
0 Tc
0 Tw
(t)Tj
/F16 1 Tf
0.4465 0 TD
(i)Tj
/F14 1 Tf
0.2906 0 TD
0.009 Tc
0.119 Tw
[( = exp\()]TJ
/F19 1 Tf
3.1394 0 TD
0 Tc
0 Tw
(b)Tj
/F16 1 Tf
4.8 0 0 4.8 326.211 551.622 Tm
(1)Tj
8 0 0 8 328.649 547.994 Tm
(x)Tj
4.8 0 0 4.8 332.277 546.803 Tm
(k)Tj
/F14 1 Tf
8 0 0 8 334.488 547.994 Tm
-0.005 Tc
0.118 Tw
(\), where )Tj
/F17 1 Tf
3.848 0 TD
0 Tc
0 Tw
(b)Tj
/F14 1 Tf
0.5669 0 TD
0.009 Tc
0.119 Tw
[( is a parameter vector)]TJ
-13.2236 -1.2472 TD
-0.011 Tc
(and )Tj
/F16 1 Tf
1.7929 0 TD
0 Tc
0 Tw
(x)Tj
4.8 0 0 4.8 281.99 536.768 Tm
(k)Tj
/F14 1 Tf
8 0 0 8 284.201 538.016 Tm
0.007 Tc
0.069 Tw
[( is a covariate vector for the )]TJ
/F16 1 Tf
12.1819 0 TD
0 Tc
0 Tw
(k)Tj
/F14 1 Tf
0.4535 0 TD
0.008 Tc
0.069 Tw
(th transmitted ga-)Tj
-15.1583 -1.2543 TD
-0.005 Tc
0.13 Tw
[(mete. T)]TJ
3.0969 0 TD
0.009 Tc
0.069 Tw
(ypical covariates include disease severity indi-)Tj
-3.0969 -1.2472 TD
0.011 Tw
(cators for the child or repeat number for tandem repeat)Tj
T*
-0.004 Tc
(alleles. )Tj
3.2102 0 TD
0.009 Tc
0.099 Tw
(These ideas will be illustrated by applications)Tj
-3.2102 -1.2543 TD
0.011 Tw
(to specific genetic diseases.)Tj
/T53 1 Tf
14 0 0 14 264.019 460.006 Tm
-0.007 Tc
0.033 Tw
(112 [Invited Speaker])Tj
/F5 1 Tf
8 0 0 8 264.019 442.998 Tm
0.009 Tc
0.006 Tw
(Whole-genome association studies: which strategy)Tj
0 -1.2472 TD
0.01 Tc
(to develop ?)Tj
/F14 1 Tf
0 -1.2543 TD
0.003 Tw
[(Laurence )16(T)33(iret, INSERM U525, Paris, France)]TJ
1.4953 -1.7504 TD
0.017 Tc
0.187 Tw
(Whole-genome association studies have recently)Tj
-1.4953 -1.2472 TD
0.009 Tc
0.088 Tw
[(been proposed as an ef)23(ficient approach for the identi-)]TJ
T*
0.003 Tc
0 Tw
(fication of susceptibility genes underlying common dis-)Tj
0 -1.2543 TD
-0.003 Tc
(eases. )Tj
2.9764 0 TD
0.028 Tc
0.187 Tw
[(There are two dif)14(ferent strategies: direct or)]TJ
-2.9764 -1.2472 TD
0.008 Tc
0.049 Tw
[(indirect. )-33(The direct strategy is to characterize all com-)]TJ
0 -1.2543 TD
0.009 Tc
0.055 Tw
(mon variants of human genes and to test directly their)Tj
0 -1.2472 TD
0.006 Tc
0.175 Tw
[(association )7(with )7(disease. )-161(The indirect strategy is de-)]TJ
T*
0.02 Tc
0.188 Tw
(velop very dense maps of neutral single-nucleotide)Tj
0 -1.2543 TD
0.026 Tc
(polymorphisms \(SNPs\) and to detect susceptibility)Tj
0 -1.2472 TD
0.009 Tc
0 Tw
(genes through linkage disequilibrium with unidentified)Tj
0 -1.2543 TD
-0.012 Tc
0.035 Tw
[(functional variants. )-11(The choice of a strategy is dependent)]TJ
0 -1.2472 TD
0.139 Tw
(on a number of critical elements, including the number)Tj
T*
0.145 Tw
(of functional polymorphisms within a gene, the combi-)Tj
0 -1.2543 TD
0.033 Tw
[(nation of their ef)24(fects, their allele frequencies and the ex-)]TJ
0 -1.2472 TD
0.021 Tw
(tent of linkage disequilibrium among them.)Tj
1.4953 -1.2472 TD
-0.01 Tc
0.187 Tw
[(W)84(e)0( performed an extensive molecular screening of)]TJ
-1.4953 -1.2543 TD
-0.011 Tc
0.117 Tw
(the coding and flanking regions of 36 genes for cardio-)Tj
0 -1.2472 TD
-0.006 Tc
0.187 Tw
(vascular genes. )Tj
6.7748 0 TD
0.006 Tc
(All polymorphisms identified by this)Tj
-6.7748 -1.2543 TD
-0.011 Tc
0.079 Tw
(screening were further genotyped in 750 subjects of Eu-)Tj
0 -1.2472 TD
0.026 Tw
(ropean descent. This study provides new insights into the)Tj
T*
0.103 Tw
(type and amount of DNA sequence variation that might)Tj
0 -1.2543 TD
0.083 Tw
(be expected in human genes, as well as on the extent of)Tj
0 -1.2472 TD
0.027 Tw
(linkage disequilibrium within candidate regions.)Tj
ET

endstream
endobj
590 0 obj
<</Subtype/Type1C/Filter/FlateDecode/Length 635>>stream
H‰TMLÓp Å[6ê_Y@‰SHÑz7œÔD&†Å(.‰Iø
Pì2:º~nƒmÅñ1`[»uİFçd8¶„Ï¡¼¡ñæÅÄ˜xô@âÁYC:ôäñååıŞ{0dn€`¶>~Ğußf»ŞËÙ‡Dg75HàÃ§Æ-½ÒQXïhĞ¯˜ôËæKƒÑn1å,f½ÃrÉ¸gLv˜å_c9_kj©µ^(èF+dª'›/şû' 2Ù èéßrÈı€ğw}®Yß¯İİ²òwfúØ'dOûm$³/®$ïâå•Õc=Ø¦¦ö2ë™b¡PÉ€le[ŞC«QÄŠDlÔ?0ëğ’¬“uNÒ8÷mğÍ#öF`„#q'NãàÆÆ8JÓËƒ1•$s@Ú¶¾¦
‚æbZªh¹”\«ÓÖV«Êis±\§KLˆStP@YïrDÄÄğ|4EÂáh„£ñ¥šÎ%¬ü6[•wäİ¹AšàRìèè„ğÂq´÷=§Õ¬†Ï8j¼‰Ô¾è¡jè@ÜğªíªW”åE¯€ñí³QŞ¯î”J@Óòñª©~^Á2¤Ôz1~¶……qÅÜJ:E³j$‘ÂR‰xN*‚2ï_˜]ú8|’Cùœ(ÅÅ²Ì“÷>×—të3z¯Õmk4:‘‰k®®À°H„(ÙÜrRTÑ¤–L‰ÅR²2ˆĞGR4`\S¾)”d•ü46_ÜK|Œh_+Ç !]/ı<Æû8&ëË7?­okiÒŠRmÒzo²ÖŸBûÒ™«¯F~[Î¸Ï¸›ş0 G~¿

endstream
endobj
593 0 obj
<</Subtype/Type1C/Filter/FlateDecode/Length 5781>>stream
H‰tTPT×Ş»÷•‡å²¹Ÿ-Q²ËÃŠ"X•‚¢q‘ Dvå±ˆòFàr¼ä!Ëky]‚H£‚Ë "¶QL­ÑT2bÔ&©­Ó4gá,´wÑÎ¤étæùÏ9óİïÿÿïÿÏñø&<Ãe~;|ƒŞİ—£rÉpS&F)Ä7‰³ÄÅİÙ¢ßl¢ßbª_ÁG*3ÓÌøz3[äfÈ±V@µğvü«¬ì1#àÜr½ÈReU)Z™gÍ[‹a|b™…µĞîmÇÕë6Š]¥^[üü·†ìŞ'?— Teôê¾I]e®2‰ØUææ&“HÜdîœá–Ø]æ¶I¶iwâŒT&•Ê<¤2O)w–Ê6yp nI<d›<eRO™§'wa\bîR,“J¸­DæêÂ¸­‹D&u‘yp'±ñÆ%H©P¦f&Åx-
É	¹(@dXÌGi	Q)^{cRTqJE¤K¤SP\tŠR¥ŒMuúøÿ‰ÇÃ–;ò6ğœy~¦2“ ^/çíãEñ¢ùq¼~
?“ƒh1;ƒ•c•X-vkÁ:°b¬
kÀ:±ŒÁª±³˜kÂZ±.¬û«Ã±f¬c±2ì4VÕ`õX;o5WK#o5¯ˆ7u™„˜<6­àl”à"|”(Š%Ô’o—N/‹5[gÖk`qÁr›eËò{VeÖ"ëŸŞ*³Ùfs^¸MxÑ6ZÃK¶"şü#B¦Á²Â¹0b!L„6ãû¸ïGôTx‰¸Ó:ÖÛ?ú‡štcdméÙÂjª¼øÔ™Sö'
³SŠr²K²íã“«›3ÔMy}dOmWG;Õ®í©íc†èu_¸£ù ˜PÊC)ù®-«âAÁy€õ0RxîÊiMZÕÙ¤2>O™šN¥¦&åÆÛ'(k´i©-9]ç9ÒN­–jméªı„1şë8ç=ë%ü{úİcÃQàóà?wr{z`Tu8dW¤oPnE‚l´Á~Ş†Õáãô@SÛ 8×^5öˆœıø&ÿººJîm3@Îê§qÈ£ŸLeıòåá±`0úÛ÷½IÿŒà÷PÑá!ÑŞ)œKCçUaGQWqOiOÉºŸyAß¯Ñµ´öo—«FÆÉ™Ä»A7¨ I	‹Ì˜@:´àƒÀ0@Ìù_©ä?` %ı¬sê¸5Şóù9vbD¡£uúw°;»¼ê˜(ú(H+hU‰º&¸,EüOE‚h!kˆ(ğh¸&ìŸ[oùŞtéYÃ¸Ò›Uş‡ü#öøF¯ÑëÓ‘ú‰–7;öK¨~É¤ÿƒƒÓò¿¨^0Oè?kn÷İîıâOÓ/{N®ÜÀfwÉ>îâ˜Œ,íQ2Ú:½¹ƒZ‚k¡7	íºáòOı
fşôÙËÏ àhÉ<§Ÿ«Ÿ}Ô™Ó\TË4Òåµ5µ5ÍU€Å-ªY[VGLĞÍÚAP¯­ıÚ(ó·ù×3ÛeŞ¿(ó8£høêÕ¡W·Ü~L9ö KäH¢]¡H‚ ²¦Ğ;ÈÉP“½âzó'Â§÷ò'èJÃ×^BSÀ­Qèw“0t|w4¥VA‘Èƒ	¢ıó6«%,Jï$˜	7á$ñ=VÓ¡íëj=ó%`2ÿ‡¼¼Æœ–²NY{¸2”hÒpşøHEU~òl^}a]AGq?`.>MOV\¨é«ém;áÓË—ÿxù¯à2ÌÑ?ƒìŞCwWujZjÎi*µ R{fø1ùg“™­T*{äÜD°sWğz4)8ŒŸ˜>1¦î>Î&k6$Õ¨ğg€ÁšSPÄüºÒ\¥ã^E<Ü=á=½vY1È‡F¶.èmà‹–Æ"äJ¢•íÈLçH Ş”÷CùÃı3)O˜újÅPİpí•¦Kí@O÷OérµT®ö¸FU—Z]Á%Éê{ÉD8£Îˆ'•…áŞ¤á×„O”Â7¨}=òÅö¨ÉgàoÈa´Ú×@O.e¡`bÔhóì\z÷‡ëp	IÎã•âÁ¢ÁÂëY÷ÓúsÚ¹Æ¨£kÊ«ÏVW—7Ÿî^l½Óìá¬X/ÂïëòÛ¨¢†“uJMbu²ú›Šƒx­(Pf¥çœÌ,Lª’ƒşäü÷ÄÖ3òª4ªR]—ÕœÃf²Ü»Vn²ÃÆç¬iÿhh©ºö©wšœˆ­åòJ#ºCw½F_5¢‡ğkô ¦í?h®0¿Œã˜±<\ŞÄ‘ñ:BÕ).ƒˆ°˜ïÖ¿b…‹dÄ8G¶èºòYÉU¬P“ı?d{é#ÇS‚¬Ô‚İî?Oççâğùì#[C¯ˆŸ$X0'œ«Ã4iT{BÖèb²G¸d'èAãìªo­{bô8U8œİMå7oRÕ§œ‹®7VÕŠĞ—-ëKç†zB‡ÑªU± ;¥p¯‡Ñ9GÜ˜FµqÄcz­â$7µÜPl­äˆçÌ	.
TÎõEõl‘±a 7î€¶È@!²›B^HN¢¨hZì)dÏ—(Ø… —[ĞÙ8 · m ô±$Œ¿ıàz(¢ ¸ñ0mu¨YĞN~ FDG© QÚ0òı2£î;?€ËhC¿yô#øúÅEè$Ì€ÛŞƒK(¿ïÖ!Û×Ó_$H²5˜à†#³üØ’:•±Ë§sËr›ËœÎq0,jÙ˜NµëËÒ1`Ô˜²7¨¶‹ ¾¥rô±QËïò'şk@•âp=y¹w2î¤İˆÑ…ƒ«am;}HiÒû{B¨İÁÿ&ºÊƒšÊï¸
äıÚµvÚNºøBÖuİµV»«[¼`ÑEWq­r*7!ä>!çó’áØ…(E	.‚¨°ÚõØqÕ§Z;ú¾`ûbw¦¿ù~æ3¿÷ıßÉ$àÁ/½¿œùİå#çrÎ³®ˆnQ™‹¼a/ï¡ãÆº³:†¯=[M@şÜv}
Üp÷Ş~‚.q_Æ¢/‡un#Rñhù<à½JyÔÓ×›}íMg#ÊÄ·Ø—Ù—SGbzcì'Sñ+HNÉ‰Âøh4Ñ˜nÍÄb}ƒ?Èşû1£Ì±G²5´ÇccÑ÷Ò>ŞíÛµ9“ü#=£R›,ªL2|Ş|¨9E/%dxA±J­VIJØ€íI³Ñ7YöÚâlq#ÉîlwæŒì&q¿j£#­ãÓh¦GÚ‡I{òìÌn¾ùàĞog7ÎìqÆ¤äÎhÁø$úş_/`ó?ôCb¿%»›İ/k×ÔSñ`ÔôÎ\İıÖ^çl¡Û<iìx$Oåå‚¢“{Qï0B)6röaœ°˜C¡± &”\•O1È-d@ÛÅ=Á{.D_Ï~„n%\?A=ÍÈ#¥[hÃLõÓ|b;Ió9µïò<ML(ê}†Dk£t0ısŒ5İšæ`q]Ü©Â›Äcü¾yŞyÓáºĞ1Ú¿2¾€ q_P‰Û0î{@[ç9„‚ĞÙHÎ.

„<QVOxœ½İ»öÍ7)4r|y‰,]Y
ØOó¾÷ú?¹÷Åcš†õ…mâ&¾‘oÈ©Iõéò,›K!p4b)ÈT"Ê3°…`°e¥Yf¤@„õTa—wIÚ×kê”†½Ì ÕI««Dy¾ù6v&’AÍK¤@*SòÑÌ†£¶4®ğ q¹8ÀvÏ4iGëKŒªzLm,Ğ+´\]¶6Å7ºYçğ¼‚ëè†Næ*,=U“ÄˆŒnNNNÎ£ÃúæÌvîâĞ¼sÁ	ßqÁnà@Iç²û±ì¾„¦Ï‰Sxº2Ø\‡VD°Š¸
&—ˆ4<‚‹kåM@Ñ¨±v£î®‰¯\Ø´k±ú‹øÅ%Î  +ËœŒ9ÕGÿ„’È¶Šè*V)¬VÔ×éÊt„×WÔjMµ-ƒ‡ü1,âL$#›kh‹ZÔø$¥õYø!ı’ÃóXòc9)9ù,Àcdf ñ©]9˜ø 1‰ßê}2çsïÄòwğ9Kş*á‡ÁáOCs·36m~´'xïRü)Ü‚ÂMCğ'c‹ŸŸ£üæ{üÏ}
¸:ããĞ|P*Çd2~›HÃ9uòN™QÕQ6TêTØù~3KŸBDâ1Ü”xÉÙNU¿-!ØÄ…”'Ä,>Õ<îì·õ»ûÚäë– BOŒNLOaòiU<ãÃƒßí{WÁ@¾;ßù®Á¾…«_N@:qŸãŒÇŠ¼*¿VjÅJ­Ejº¶P« ¸¨˜«VÙ!AÀĞª‚øU¬äaZ^L§Ò©¥FÂ„7kÛ:v I  n¢İô÷œBÊ\…#"‡¨?¿“ÕÌjbésˆ¿à'óOÇ‚/öçn&Q2È¶i2sG\eÎWğÉK×ş÷˜í¹CÇÉvrÍÜ®ÙĞ;©ßSŸÇë‡»Gº¾tÛm¢@ÅïSC"#@xdHÖûrõÖ¡‡»ƒw/¦A¾ÂmNøó»°{Kÿk‰á‹Ù³‡ÀldÏÇä*tÅŸæö÷ì¤•º‹•íÒ~nW¶…eÉÒ3‰x¼0)11‰U´×Gce„j§{_"[)SçS9f—9	pŸííµ9i¸µÚb²Ô7˜kÛ€®­êü<êyI†»aøä©ém³Íœ¿xe`zàzómÊ¦fS‰À™kfe "X"Ã$±FHÈq©VZ'5¬\G¾CĞ.¨yÕùDÎQd‰<_ÍjfñVªfÏ#)bĞïĞw$9r/€\—üÒ4ú¤÷î9ìÆµ¥WÄ#üo¼ÙS ÆĞlx#®-×–W–W”ª¢
••”–•`å¥ee%xq¹gSt-Íßt$İÎ
?x;õQ.éGœÁOW'Ô1¹\aJŠä…¨²FiPauÊÖâÒæ²ø=~Pú¬l¤|NõW“	ÒÍ§£Ñ½ÌˆğCØ–ä†2ŒA®'ı;'·ÇÙó{ûÑ†*Suf°¶öÚ‡µÕöş©Y¦™Û(k
“¦É‚Zíæn¬¥klø¶O‚0Ü³@Æ…ÌT‘"‰
AÉÕÖ?»¾ÀgFùnâ~ŞÜçı¦é(\Å]Œ»Š1GZù¢šŒHÏÉäÊØ@NÕ+ÊjÉäa©_¿Á |÷YËğtğôp×yÚ'iO¯ÇÒMût$­’© YıQÍÛCñ7ĞPI·ãJ‹€ºÔ¥ÈR²©KQÀËS²Î1ğÛ ¿Ei³£İ†KÖjé0ôø<÷òè+bä¨6­FŒÕŠê
Lj“ª³d lïN2„wjëu¦ZC}mĞ5WL¡ğ9òï²¹;Vj)©Wé4”üäÔ~ˆKøêBJ~•”üœ4Š”çg>RAänähUZ„7(Ş‚ı>H›tõµuÿ_¾îÓv‰+ûQÛJJÛr\RÌWË)ğ

|ê…~pa¹ˆ>73à0è»Ûìæ^SŸ±·¦—r:—l0{(»ã”1êÆ7î‹£ÖQëX‹páÃÿ-»ÚcÚ*£¸­÷[L5’áíü:]tÑ,™Q„Mc_ÛC$Œ‰8PF¡Ğ»µ¥ÚŞ¾yİÜÑöÒí-}¬.¥¼{ÀÆ,nqÂtF¶h6cLœÙ_Æ˜ÜÎø•ÍdÆÿ¿œóû~çwÎùÓˆŒ¨ú+¢…À/e>Ù…§¶ _K™Èè|Æ 5hîk} ŒÅ†©^&ô{<AgèğÒÉKøòVìëÅ¦¨œ,‹Ğ5TµµJ'k:Róùávsf–úÛß!u …c­İf®e<n'‡¦.ÖD'!zh.mÉ<«IBb¼"RDWSÕ–ª¦ƒDY­BR-X#]¦Ñ‹Êá·r-§26Nõ:Y7ëFŒ…Aç£åH r4¬”Cc5ş[¡qvc¥-ƒ_Ç?ı×Õ?èêâcTÅ•#:Ø
&Ññ¢£¢s-«‰}T,6FÅ]~?Ûå9{A‡›NÎâËÏbwÌWÔc°~´2THgS9eÙY eÁr•Nºµ^ò?Ğ»±3T¿/XçÙëiÔüãí-1Ø³ñÿÃÎGf£kõƒ^Bñë>»ıøşõ¡­Àw6æHwBiNQîrP¾g·ö-± …'fù'wIöşVó'ğ;áÛ·áÄíKWÇÇn„—Òb¯+È¨¡d–jMµ†8ª)š"óÔ®°WxjæUxqÛ·%?Ó_S{'æÀ©ÙÈ]^Œóo×ğ›>º“?ğşš¹æV3x7‚7(¢©§æ§¦Î³3ô]ê¦ìê‡`éĞêË*6íxf¿·½\‰K¸ü2‰Ò­Õ$€0„h’ºôÑ£° ËµNˆ‰Ô!®Ab‰º—apŒ_ÃW7`óí#-AØ°û,†têĞÂÓµhmé…7)dg÷Ò'”³z¤1ù(1ª˜2Ì£i>Ÿ¼æúîñÏàü–:ş±ıKğÈLQ<Í„[­Ai¬ä¯m‘~şbZ0b7ù·nıDS	SL	b*ŸB+l*}Ôi-ZZC)
NÁÕû´™"íRQ'/‘ï©w±FæSCwSÀ5FÉDóZ§â°I*Á„YÖë:cÀúinMëÚZ£°-bX<V·É©§uTR€ıÊ(m¼ÿÖÊ‹i\ó¦ú]~M:$,~‚œW•‰P=t^•ŞÚˆF‰	âª‚ßöQ&¿yßÂ›[ğœÚ}¹Å°øÀªwÄ…¹Şè{—¶ÑAŠ&’°Jş2'
íÎ›•Î–¥] ÏQcı}Á	|ÚpJ‘„ŠäS¯M½vîãÉÚQ ÒŸ½Œ¿ra^˜^Œ¥):m½ 4lñ"³æîp:]NÆ‹:“KÏ?şÆæusÂe^^ ÈS+ØwEPƒš¨%NG©¨+ì‹ø‚İŞ8˜©sk¿(«uå¥†R±BÑ$$DPÓC&9`?_Ù(dõbã]ã±‰ÁSÉá	n:Ğ9¿N´ºaõ•ŒÔ&<Ñ±Ï¡†uçC»ãE‡FØíò!»sÙ
>_´+'¯¸¹­²RËâ¢/ı\¥¤²ÿø˜ş ÏÚ¾ù_Şní·uC;kòë=Àm8æ¨südê>–,H(áÀñQã:A¹ÇºÇºÏÍÎ€åvÉ6Ú†úPµ·è@Ï±Q„jy7qL¤BÆŒ4£ÉŞÔ€«™cş:ÈW¥Nğ²åÈúÀ0Ã…ñÎöÎfÚİVÆì0;êi2èü:.ÚÔ6£Y]¯•5}.,Şe*DÂÒJ!ãFöy#«ëÒøÌ.Kî¶±5ğ}B+"¨z»ŞH£Mßˆ÷É"¥oLâ+—Íë½½Î¾>ÜÛîie`³Ëæ29ÍÆŠtÂ^$°¶ÆfÒn²H}C³Å¬n:šÚğ÷S™UÛï.(ÅUÅ•u¾¸R¢ê1ö'ñ„'
ÃP8îŸ°[Æ%Ö¾î6F‰ºC=’X¨g$vi‘ÏÊ~]Ùnëz´Éçu'É€Ùmğ¨=Õî4êUö¹Íëg2şEÒÁ¬

endstream
endobj
596 0 obj
<</Type/Catalog/Pages 594 0 R>>
endobj
606 0 obj
<</Subtype/Type1C/Filter/FlateDecode/Length 4099>>stream
H‰”–P×Çï„ãPáÎUØÅ·WcÔÆQÓ1Æ ‰cÆhDü1 ¿;à¸ã~ÿæ×ıØ»ã–»ãÇqÀ	A„¢VL¦¦I§±­úOÇ¤íŒÕ¤™LíÌ[|8íi#ÎØ&Ù?vŞÛù¼Ïû¾ï.—?‡ÃåròÖÎ½ÛvîXı†´*_¹+O’/—JÅùÛ¬Ù_PX%Î«ŒÊd“Áe–Îa–Æ1‹âŸOŠ»™Ï€¤Åh3Ò?r>:Äƒ`[J$#õëTN<—›X¬tgemÈÌÊZ·]Z®¬,.,’‹ÖmÚ”µ†½­åÉDyQ•¤¼ê¤¸XVT/ª‘V–ŠN*EÛŠå2yeA^™èç’2E¢×ÄbÑÌl™¨²@VPY]Ï>İ.•œ*Î/È‹óÄ™3è¢'ìÿ}).{q–q8Ë8kâ9â8/s8‹Xœ9œ8n÷Æ*îñ_ñ¾å¯â'*çNÍO%É–\]pq¡/eD ¸lî€ê	feG*=¥ZÂ¬œÚ‡ù¬f·™0Ô[6¹¦]s\-.¯M¯ÑVÙ«q­Çì¾^ïØ§QCˆ¸İş Ú.s‘Ç¼ò¶>¼Ùásµ€Èm^4ĞÖ8JÀŒ„Qº!¯•<½‹çV9ÔÚ½Û›¥¸2zg¤ùîÇ£Æ^ÂïtCúú
/YLë:4gKƒİDÙ<w­]_›Ö*€ø	¥Z{‹ËîuùÈ[p¯ÙI¹\„“²h]¤ƒTÓÌYÏ3ñwËËÛ@c¨+0Ğ>šÎ,İ€Z¨`Ú:a€60)<«Ïâõà^ÊEQ›Á	àËÓ$Ï­tU*q‰®¦B^Åï™§öAÁfáÔqC?E[Qz¦¡eğğ7wû?ûœ†x³ÕeRêË¥bóîé›ZøğyxfçÀÄ?ydó$¹'ZWŞIx]Ö]¯»Kö5Ø5JJ\¥Üz-"„øÜNì¬§Ò³ÃZ—&ş( ¿;=^Œ¡—>|¦À8NBşßo»·ş•#(qq”}%ÁÌ ¸f½Ä<I…ñ0™Y S—@Ü1)ü›¾Î/àÈCéhzq­[nı@É9Ø	ƒT¢r­ÜVƒë›4 .Ñÿ‹Z.Ğ_‚[¡G ÎC-äşÆM9ÅîZB¡7iËÏµœQ’CÕ.é{8Kş9LÅ Qzah#ÍzáPïäİŒ>€|¾¸
Qò0@,Ø„6X²ŸNâ¿Zwò 8øg‡ìC£8óÿ²¡·¨PŠé:¼~	zÏë:b«™/\UÌ}l¤Óÿñ7cš! ñ«%ÂowHª¡wñûÍöphƒ- „wĞ‚=Qk4iK.w–’=²¦²\|:ƒL_&Q¹ZŞ0“á h¿êıòÎã8qãbë…Ód÷ ÿJ§-SMcñ© èäëò]Ä«ÖĞMfñ‡]sà|ÂGC^,¥•İ„¢ZÈfÓØ‡œ!î·¹Meå5 BQnÊ#JÄ:º®bm„JÌŞA7:‰ñ ê¨´Ú•g%t®7½cmİL\Mi}¼ºOC)‰^ôì·ôåğ…	‡-mŸ"•Q×Ô¤&Ñà” ×´–¾…O/äo4œÈÕƒsçš¢×pçOhûÅ¬Ãµ¦x¶CÓ6•‰¶¸+ügf´2æ)ãMÖ“òGx
yóÉ¸1B´zÜÈ)³„&OTıWp¸úi-bÚPÑEĞ”ÛOºÍ#÷!î¯sëŸ¡…5*=sOÙ³,„sşO]¨ı•«Š‰)áHjbÌ
˜$ä0#ğv^,;€¿£.”ª@½‹×Òééâ“º…¿…K^Ä†]]mĞÑÚkã´Ñ¥µæ½¯çzelÄ,yÈ}ÆD^Ò·É÷á‡L§ô ­Ş+İE r5Lƒ…pÏ}—İ{øöÚ‹ä‘N£"LĞ*Hzmg®8#-xÀê6%%+/ŞòJ#Ğq”…^E
t”m™txğÖ×İW’ƒm{Øİ@ûÙ³†2˜àìš(˜©	õãeze`œ³qH\ƒ	o[Ù‡Ñ<4Gëî¢D¸–­‰l2ş4	ûgr‘ÿ
“Ø¦`.b^şpS¤»t‡?4uã´Ù­º#ÆM;ß÷Ôş¨³ËÈ§ãÆï2R8+#[øí>_;€ı	í>½‚D¯ı{²L]U_ódò¯¢Æ."è¡‚=%–
š,	¨ÙÉl-\jìt±X}1,K+—Å:ñ¬‰ğ`	‹eÁ—óz½ ş…Ş×ËÑ
¨}Š­¶¼÷d±Zú>Wô}E­€ùÀÉ
şïA4eê˜ZÏZ›‹Î=ö0ıà‹…_À•h.6æ<ÛŞ:;‡Œ=¬WJÌÍˆw Ôm jMF]ÉåĞ ”ŒT7JŞ‰ÍÕ–Vé€T-¯¯ÆuSDF¼“¿û…±›h÷Îˆ-õ‘E´ª Òt}*™EšCºÿ’5†Ô0I7é)§Ooµi–Ó§·Zö}mşòYµifk³éImf7t}ÂnL[İòGÎGíuiû•ÇJ÷f]“½–Àß	>â,™Š0WÙxzºü`8Üªãíf‡
h*-EÕ*§ĞXÌz+‰,ÓjÉf±Y	«ÍåeM*)/¬·Rjsu]Q®Ôe&´V‹¶¼'p¦‚,£rŞÀÕªĞ£ÛV}N4]V\R§Âµû­£<×FûM!¢ÕíôJõå-d~»éÜ$å{a¯µ‰ıÕ (§Iï"á¡ém<e7ø‰gsEş‹ğrŠêºã¸5YîúÒŠ7Ê¹“sM§šh4Ç˜b[µ[dßiŒdE@ØeE–}³{÷Í¾—İ…İe—eEÀDÈCEL¥iRµm’6I[gÒéÄ™LÎe™éA›?ÛÜÿïó½çûış>?TÌoD|nÆåæT¶OÎSE&y•Öjkœµ@í7E`ôJÃÔ>C3óy›ÛªkKÚXq«9ef,øöu3í’9kµ °¶Fd‚^ª=ísO	Å$âÓÊÖ£W¶ Ü¹µ+ıJ¯–&³Ål²zıˆ‹xQõ¨røxgæì¢rÚ$²•‚âú
‡ñ€À¡¨××ƒÚŠRtSñ¸»­4Õ‡ía¨AÍÔ-ß»ñ.˜ş×ïü<Ä—­˜ı%ßA;&]—’Âñ6c4™ÜXqš;ZPæ¯fÔF£NÚ³İç=¢} û©2³Ê`ÔZIâşÅ¿&¸TÉ…¤ÕbÓY…Â« fV–öuôŸa[jDy —Px‰üƒÖ?åQ…—k„‘¾†É[=ú0ù9ÎX×ZI'[–²ÿîk€4T»»Éï
uÈoœS
*Zå1BOMíÄTsc(ƒöT¹”P ’êHö:.û½“™RŞKßĞtˆ»
ù-sú•>ƒ‡SÎf±Z¬.¯Î•ğ7U±Ú°,šÉ[Cô»Öfõ`²ìhNÓ©/JÂôÊ‡g—/kGËù:”±‚Ïš§¿¼	gã³øZ‡7 "¤D¯>*!t´eás,ª›ÛDã^Æ«pÖj´†€Ó¯ıA´=ƒ_Â´ÑA~írĞ‹¢¿ãçñn€áÑÕ[NA«[ğğöåOÑ"€nF/à%”²¿%_ËÛˆV  -E?øøt™¿Ú[¸vú6|ˆ¢W~ÓW‘:A“Oë\òüø+ôßœ]wÿqg÷Ú¬‚“[HÓzÌg4«ûTwÑ’/>%‘öÆŸğ«lA·5·€ä^Er_6ÜÒUÆ&«âÿ]ñÓı†(m --6U…Ø²ˆ6uc~*­á£ß3~Ñµç”æì¹¥GòÊ¡H&G¦ÀÌ¹é¼^˜®':î¢«OuÔìF:ş§4zšğ'ÇOåşxóÉ²W¶™}W!ï¡?ï¸ñg€gÏàõ0gwdg¾_CT5DEj^…ãÿ¨øm?IdÔç‰¶IL²+~¢½Dµ|©T¢^ƒMâDïv!~îÎàá»ÌÍñödÀâÖ³FƒcJU±á*vÚ¯éÃj&1ät÷{ägğhÜL ¿zdxK^PL†K¼èï•è‡•ø!ír9œL³× ò³Ÿáí½»zN_ĞeÚ,§gû‹>ÊÜ†Ös.¬e¦ãlÕàìòÁeAİ÷W<¼Eû$V[§Eh½^>É >ÿÁéšñÂ+lqÏÑhN›pÃå“©)psğÚûÓïî†{úÒ&@¶¶_3<v@ØâÓBQ++*îİÆà¥Û6®ÆôKÑs¿a¿9u»zÈÎ;¶}ßŞûùpªÄ›’3J§¶;L®:’É`ˆ¶{ìn'p9.İÂ¹à~Uà°ÕÛ¬ÀJ•Ùßd…ˆãÓtË}9Bsšd\Òy2!Äå´Fj¬ ¼ìZ“¿(:ı&P‘—Ğä8Ã <ÚšÂ‹F!~väàĞ—àr°«…GIjlñyÌíC?Ì˜A•³¹tÆªŸö—2çmºrkÊ®Ë7µÇìÔwÜ¼ 3f†Z†|3“~K;wŒz[UV¨‚m¹·
h\3ì™ü~f~à>¥]NbEÑyƒğ‡©¡sFÓvëšÙâ°I“dšê]1¶â2VµÛ8§”É˜‘à6“nn^Hû¨ë‰£^¿İ€Vê˜Z*×ˆ„ÈúİSç’ìsk¨İu¥…†y~hö‡ºˆe*©©Q€Èï£-M/s-¦ lM«ì—FŞqÓï«¦f_öZÂ¿<¶ÕğZú‘s,I`!ÖaJ€Fƒ›àU>——+ò+G&bGp@Á^Ôùäol¥ğù{øt
å…–"#DË)´ ~"Éh›©5T‰¹ï”øåŒÊ`ÖJ†{ål·Âs&€[Åí8yæ’íavêºSÊVŒØ'?OĞıKz@ÙP¶ÏâĞT¼“Â¿ğe¡‰vüæı×HĞ^ê¶µ·2yyœµ'4Å Î®²ËIÛ®ËS§…éoÿw8%Hğ×Èö»œHÄ|Â°7b‹“óyµP\mÒÙ8»f‰·QM:YÂ‰c/qÊr 1¨êjàz¼K`0[,Æbq{­,~è›-MW'4í ÉèRBıYãí^£Ô[5²NoBÏ6.TÅÏ¢Õ¸e¥OKv:€Ó¨CVi‘–ÖŠÒ§.é|ğşw¼›:¢‘ÄYq‹­k ¥T¸>ŒÏ7şĞ'tJŸ”‡¥(«V6Ÿk«Ài@Fí°©¿ñKIWj\£Æm}UÃ¯Fí¿º¥:–Éÿ$H÷ÚcjPs5ÊZhv
¼Wc$t‘ª L—Çù­M¨®1J¸Òğ)7Õ³ø«%¨uùìqú? x¯ú5

endstream
endobj
608 0 obj
<</Subtype/Type1C/Filter/FlateDecode/Length 816>>stream
H‰lĞkHSağ]O`Z¢›íÌ÷@ ’Ó!R1Åšx/¥–#œ»°4¦n©‘¥³#…¶tŠ×fŠCœµ–eæ4‹F³‚ÅO††Ÿâ¾v9§¢O}øóÀó|ø?ü0ŸËÁ0Œ8™ššœu¸ĞP®Ó0©ŒVÄ(âÑ±ññìù˜?œëçùÅ|¤
àmğı @lİM”á«2á´ ôsÒZ­G€Fîƒ‡ƒ |¿u{=˜ÃÇ0ÁÈ´Ø˜X&ŠjÅÿÚ8n©ÃZ0ùŒs3pÇwÚ¡D,,lÛd;ñßm"%¡ş>v·O†e¢2Á7?zHp$<’˜«= ÍË©É&*‡½d†×øjIú´Û=êN×İ7=OÍ–Íd_n­§›èJU[bÀKô—JÎJËn™ú-`Àr»a„şHAñ<	–WÂ2ïq!®w"^T÷QE ½Åq‡È¨¸3ˆ‹$Ò×/¶™ Ô[Rìƒ\(^ëPå˜JlÁp}
L"““ŞŸXHx|`*!Ó¡"´Æzsiªª3¥MÖÆÖ:=¦rÏH'zGïŞCû,C(˜ƒöÂVÔü6%lºÈ«z~‡8@ş¯½Õº‡äÃÒÁâÓÒSfµZtê‚Út"=¥oRIZEOÜ¡ÏÍS´‡o»mÇ»:úG¤½W»®ØÀ›åF9E¥i•JÜ*bı=ŒâW9Üƒ„k‰^Fqn¾fXı0ì}Eú¼NVñ²ÛèF—¦§˜Î¥òÊNew·vĞ7éêQí¤ŸÔ÷²Š&‹˜-å´’Bâ”	VÂ^Ş[sA£y›İ+Œ€Åq›ä×¸©?Š-›L ’7¿Ó!³d‘É=(ˆDŒ"J$—ŞZXf?¿txˆ	g½ÙAUu²ŠTãµ:ğeÌÃ*Vjî ÍÊO£
1ŠˆFÍÉ)a…Eùª,Vñ‘`	‰´üjİ9ò\i«8 ~À(ŞVë#|ïú&—Å"whùLƒ†VQº¶*;^ÙUÏ*¶wuÚ€İ6pc˜~A½Ö.ıVü%À á{™

endstream
endobj
614 0 obj
<</Length 187>>stream
142 0 23 173 92 0 d1
q
69 0 0 173 23 0 cm
BI
/W 69
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰ìĞ¡À0CQ±®íÑ<JG04ÈÕÍõ,R7 ¬ÀBıˆ9Ø†­q®¡R€7.b8a„B 1#”@Â	I<	àïøN×h4;¸ ¨³¾
EI
Q

endstream
endobj
613 0 obj
<</Length 532>>stream
142 0 8 173 132 0 d1
q
124 0 0 173 8 0 cm
BI
/W 124
/H 173
/BPC 1
/IM true
/F /Fl
ID H‰Ì–½qÄ …W£€P%PŠJ¥Q
%($Ğ€XØã;)ğØ$Ì7ï½]$t9—L¦qÁkXb_x˜ Ä‚³±Ë_£3"ìL½ŒMl¡3:ºÎp9LÄVÈ£A$6Â`vhè‰AÚ· K€foBĞ'‹qV´Ù0ÅÙà|à>ƒñºïÚxäBÓs/mu.mõ¡ñÎØïÛQ™úzänŸñÉ{†q.U9õ6¶$S6tÎöºÁÛœcgË8JŞ_wyÀç>~‡ã„í>A¼ÔSŞ‡‡ìÉjÊNñ!ÿÌIqiÇÂ8NxUåp /9§èIöVÚs.ò¼ü"ÏËóŠA–SåXüz°¸UÅs2Ş¸^øv§ngö^Ùƒ´ow&ÙÕâ˜Wv åñ
Vi¨š äoÉQº8MGÛ½*ŞÉ4I¥¹Tqºw§ê•WG£"«íIµ~zÒìdO%¤Ü·ÉI¹¬Ò%%7}™|”ÅÖ8‹âw¯‘—vôıaqwÅ¬šÙ[¿¼áKÅ¹àû_ÎQÅ‹ğìÔ&||`†µ=šÙØ>±ûc†Î_ ¢DÆ\
EI
Q

endstream
endobj
597 0 obj
<</Length 5009>>stream
BT
/F5 1 Tf
9.5 0 0 9.5 50.981 655.994 Tm
0 0 0 1 k
/GS2 gs
0.001 Tc
[(190)-2523(Abstracts)]TJ
ET
1 g
/GS1 gs
1 i 
41.5 674.5 105 -26.5 re
f
BT
9.5 0 0 9.5 256.039 655.994 Tm
0 0 0 1 k
/GS2 gs
0.006 Tc
0 Tw
(Genetic Epidemiology 17:190\226229 \(1999\))Tj
-21.5851 -62.3145 TD
[(\251 1999 )12(W)15(iley-Liss, Inc.)]TJ
/F8 1 Tf
10.5 0 0 10.5 183.302 613.871 Tm
0.003 Tc
(ABSTRACTS FROM THE)Tj
/F10 1 Tf
16 0 0 16 134.83 594.709 Tm
-0.009 Tc
0.018 Tw
[(EIGHTH ANNU)34(AL MEETING)]TJ
4.9252 -1.2012 TD
-0.01 Tc
0.009 Tw
(OF THE)Tj
-4.7835 -1.2012 TD
-0.009 Tc
0.04 Tw
[(INTERNA)51(TIONAL GENETIC)]TJ
0.4961 -1.1976 TD
0.025 Tw
(EPIDEMIOLOGY SOCIETY)Tj
/F11 1 Tf
3.1429 -2.4024 TD
-0.005 Tc
(fffeee)Tj
/F8 1 Tf
12 0 0 12 182.962 465.109 Tm
0 Tc
0.002 Tw
[(ST)76(. LOUIS, MISSOURI)]TJ
-0.2646 -1.2 TD
-0.001 Tc
0 Tw
(SEPTEMBER 9\22610, 1999)Tj
/F13 1 Tf
-1.1811 -2.2016 TD
0.029 Tw
(With financial support from:)Tj
/F8 1 Tf
-0.1417 -1.2 TD
0 Tc
0.01 Tw
[(Integrated DNA)57( T)90(echnologies)]TJ
1.2756 -1.2 TD
0.001 Tc
0.004 Tw
(Division of Biostatistics,)Tj
-4.1575 -1.2 TD
0 Tc
0.005 Tw
[(W)93(ashington University School of Medicine)]TJ
/T14 1 Tf
14 0 0 14 50.981 306.992 Tm
0 Tw
(1)Tj
/F5 1 Tf
8 0 0 8 50.981 289.021 Tm
0.009 Tc
0.004 Tw
[(The )51(Additive Gamma Genetic Model For)9( Linkage)]TJ
0 -1.2543 TD
0.008 Tc
0.012 Tw
[(Analysis of )37(Age-of-Onset )9(V)85(ariation for)15( Complex)]TJ
0 -1.2472 TD
0.011 Tc
(Diseases.)Tj
/F14 1 Tf
T*
0.01 Tc
0.025 Tw
(Hongzhe Li)Tj
0 -1.2543 TD
0.003 Tw
(UC Davis School of Medicine, Davis, CA 95616)Tj
1.5024 -1.8709 TD
0.009 Tc
0.03 Tw
(Analysis of age of onset is a key factor in the link-)Tj
-1.5024 -1.2543 TD
0.008 Tc
0.046 Tw
[(age analysis of many complex diseases. A)-7(f)22(fected indi-)]TJ
0 -1.2472 TD
0.009 Tc
0.094 Tw
[(viduals with dif)9(ferent ages of onset may be the result)]TJ
0 -1.2543 TD
0.007 Tc
0 Tw
[(of dif)14(ferent genetic etiologies, and unaf)21(fected individu-)]TJ
0 -1.2472 TD
0.009 Tc
0.005 Tw
[(als may develop disease later)52(. Current methods in link-)]TJ
T*
0.004 Tc
0 Tw
[(age analysis are mainly concentrated on af)25(fected family)]TJ
0 -1.2543 TD
0.011 Tc
0.187 Tw
(members, and age of onset information is either ig-)Tj
0 -1.2472 TD
0.009 Tc
0.157 Tw
(nored or is taken into account by specifying age-de-)Tj
0 -1.2543 TD
0.048 Tw
[(pendent penetrances for liability classes. In this paper)30(,)]TJ
0 -1.2472 TD
0.103 Tw
(multiple markers are used to calculate the probability)Tj
T*
0.029 Tc
0.059 Tw
(distribution of the inheritance vector at the locus of)Tj
0 -1.2543 TD
0.128 Tw
(interest. Using this probability distribution, we de-)Tj
0 -1.2472 TD
0.188 Tw
(fine genetic frailties for each individuals within a)Tj
T*
0.153 Tw
[(nuclear family)57(, and conditioning on these frailties,)]TJ
0 -1.2543 TD
0.044 Tw
(we use the proportional hazards model to model the)Tj
0 -1.2472 TD
[(risk of developing disease. )-35(W)87(e)-1( define a hazard ratio)]TJ
25.5047 27.8716 TD
0.125 Tw
(statistic to measure familial aggregation, and show)Tj
0 -1.2472 TD
(that the test of linkage can be formulated as a test)Tj
0 -1.2543 TD
0.062 Tw
[(of zero variance of the additive gamma frailty)57(.)60( )-35(T)66(w)-3(o)]TJ
0 -1.2472 TD
0.154 Tw
(LOD score statistics are proposed for testing link-)Tj
T*
0.028 Tc
0 Tw
(age. Results from simulation study indicated that the)Tj
0 -1.2543 TD
0.032 Tc
0.188 Tw
(proposed methods can be more powerful than the)Tj
0 -1.2472 TD
0.029 Tc
0 Tw
(NPL score statistic of GENEHUNTER.)Tj
/T14 1 Tf
14 0 0 14 255.019 212.995 Tm
0 Tc
(2)Tj
/F5 1 Tf
8 0 0 8 255.019 197.008 Tm
0.01 Tc
[(In Sear)24(ch of Genes for)24( )19(T)75(ype 2 Diabetes in )24(W)53(est)]TJ
T*
0.009 Tc
(Africa: the Design and Results of the First Phase of)Tj
0 -1.2543 TD
0.002 Tw
[(the )66(Africa )52(America Diabetes Mellitus \(AADM\))]TJ
0 -1.2472 TD
0.01 Tc
0 Tw
[(Study: For)17( the )51(AADM Investigators.)]TJ
/F14 1 Tf
0 -1.2543 TD
0.009 Tc
0.007 Tw
(Presenter Charles Rotimi, PhD)Tj
0 -1.2472 TD
0.03 Tc
0.015 Tw
[(Howard University)65(, College of Medicine,)]TJ
T*
0.031 Tw
[(W)81(ashington, DC)]TJ
1.4953 -1.6299 TD
0.009 Tc
0.021 Tw
(The purpose of this study is to map type 2 diabetes)Tj
-1.4953 -1.2472 TD
0.005 Tc
0.094 Tw
[(susceptibility genes in )-74(W)]TJ
10.4882 0 TD
-0.022 Tc
(est )Tj
1.4386 0 TD
0.009 Tc
0.095 Tw
(African ancestral popula-)Tj
-11.9268 -1.2472 TD
-0.014 Tc
0.188 Tw
(tions of )Tj
3.685 0 TD
0.01 Tc
(African-Americans, through an international)Tj
-3.685 -1.2543 TD
0.007 Tc
0.049 Tw
[(collaboration between )-28(W)]TJ
10.2685 0 TD
-0.007 Tc
(est )Tj
1.3819 0 TD
0.01 Tc
(African and US investiga-)Tj
-11.6504 -1.2472 TD
-0.025 Tc
0.309 Tw
[(tors. A)-33(f)]TJ
3.2173 0 TD
0.009 Tc
0.164 Tw
[(fected sib-pairs along with unaf)16(fected spouse)]TJ
ET

endstream
endobj
615 0 obj
<</ModDate(D:20231027091417-07'00')/Creator(PageMaker 6.0)/CreationDate(D:19990715140625)/Producer(şÿPDFlib PLOP 2.0.0p6 \(SunOS\)/Acrobat Distiller 3.01 for Windows; modified using iText 4.2.0 by 1T3XT)/Subject(Genetic Epidemiology 1999.17:190-229)/WPS-PROCLEVEL(2)/WPS-JOURNALDOI(10.1002/\(ISSN\)1098-2272)/Author(Celia)/Title(Abstracts from the Eighth Annual Meeting of the International Genetic Epidemiology Society)/WPS-ARTICLEDOI(10.1002/\(SICI\)1098-2272\(1999\)17:3<190::AID-GEPI5>3.0.CO;2-8)>>
endobj
486 0 obj
<</Filter/FlateDecode/Type/ObjStm/Length 4660/First 632/N 70>>stream
xœí[[oÜ8²ş+zÜÅ ‘xI‹œÄö»“‰svA”¶b÷™¶ÛÛ—İÉ¿ßï+’’Znßr;ûp`”É&Yd±X,V)lQ6˜¢FÒTE£˜Âè€TVW8Õ ­gk¤¶p(«+UxÛ µEÓ¤¦P
?êÊÊ(…ŒCÆxdjd2(U×ÊÊ¹`ùİ(`5®BXMÀ ª.teÑ6…Vè¬Ö®Ğ¦F?UÖlİÚy`¡S-di_h_ƒƒ6„×&¦bb”GtŠn422$Ş4…ñ˜}šlE†8°ÀÔhì|a-éñ`N`?<ãXÓ¯C¡4IAÏÊ:Œ95Ò;PA³àsğm0ŒWc!4–†¼Uhœ®
­QâÑ™1ÈjÁê |Æ:4
õ¤»!º7ãla0hc1]WU†ÁD©Pš¦A®qe\e±XC¬V¼ª²ä‰ãòY9®¨œ@Üš«Ã•S†í€Z1šbÎˆœ ?G©qªbÜ4˜r˜¢ÒlW[Süå/åéçë®<¼š-ÏæWçå‹ù§Oİª»šuë÷µ.g Ê#ñşúWb GşC`ßH¥!å5—ƒùØğùòjÓ]mÖï!Ğ(„Ä*Icò!ıº=ïÊ7İz¹]aP`½^-go»Mñ¾|ıâ¨(O»?6Eyr‰fÏRú<¥'ÊÃ?6Ço7í¦âñ[-S“ñË#Â#
¸¶BàQ-KÄì©+¶ıõÕÇÿíflşëÜ`×Õ±5¯[0c#‹N´_º³yûlùÇ{NˆìöN\IdÕBô7".öş²½ìX^¾İ~Ümä)æ«õæùE»‚ŒGv²ç’%¤g-JBzGñ3î‹':€7¤ø—v³šcFO+îqNlÈ~è%CÔ{ê—JKşŞf|ùùÙæbıº¥Á>ÅM5w¡…\j€›Ja“¥ê0K¡C¾IyjÁjŸD
[P©£DÖßI"•l;Òr¯ œŠ7a˜J'”‹ûÒùİ‘ÔæVI…ï“TMû$Õ>ZRyÜíJ*OÂ{$µÚùû:™ÅgÍMÅYWIL-Oê$¦l¨ö‰i¢˜ª(¦uó£8OëJ„»EGŒÿAŠs‡ ½JtWëêÑâ¨&âè¾XÕqTSqÔ·(Îo&ˆ½
 xH÷ÒƒGGw­²Ò¤WRªÕ ¥y!v¤TE‹Ú¨UUõCx'fßí¢€åWb©î‘Yvá‡ÉlOÅˆÈ¯z´üjÿ~ZôùÕÍD~ëıêô[K1LzZœÙ"èî‹©z{´6j8ıÙ˜Aİ+ÈIßÆ3‚üCî §ÜÆß)»‚ªùa‚<&î‘‚¬od£÷rœ× ÈO$Y˜Bı8Q¶ÕT”­ÚeøhY–½XÓ¿}¶Ã-ö„›öå§tJİ¤¡XªMFWizŠ®m?Œ ólŠëS‹
*Ö¡)<{Å‚|Å.ÄòÌ¼a3ºl’Ö9ÖÃckzS5cãø‡<¾¿àß60ˆ`µãÈ(gé\ÕªfZyfä_`:°J3Î*ËŒü#
¥†LÛX6mzôTĞÍ?pÖÕÖæş¨‹ì1ÔÉø%mµõ
Ä¦Ò0NHÆKê*7â¤q0ùºîgE?8Æ¨í ‹êzĞEu›ØıØ8…ë46Ã u“»E…KƒæÓØ4éÇæ~lîöé;›¼ Õı^^Ğ^%b$¢G#qš›
E" Ğ‚ğ›«¦¿Ív´£y´vtíXEå‘z´rô7”£ÿ
åx›*¼ûÏïíèë”buS'VßR#6ÙÀîõß—+¾;t2n¿Ê5çóÖ§šófĞf>«<j3_ÚÌ»Aiù¬v¨´|)-?òQC5(ª FŠ*¤Áé:3(­Ğ«[VÔƒ¢
n¤¨B¯ó@Uƒ¢’]µ³+Ôh#<k×dNç—İúÉÉ¦]ÌgƒH›FßèÌßßÙÛÏ——‹¬f‚5lÌj_;~vøüùO±£Lk^tëÙj~½Y®$Íi6=qõ`W3ŠÏ¥~§È™3.“6ß 4VÑÀVöruÇü±44"5¦¯cûœ2öşàqĞVÚ[ßƒµZRÏĞ5¶½O!l¾=4†ÂYÆñÖC˜Bˆy
o+9Wë&âº„vÖñòÄ7FÊÙOÀ	*ıIx&ÒÆ¾{š hˆK§Øª7¨gÚÓÎyèjøòl#¸¨'?I+/vbŠ~±½4Æcº»¾_úÇU›‹D	•g^IÊÌOû’ÙŸ†7œ4Ql6†by¼PÒuENñrB2`_HËAö²?Y
@ÈËBPêvÈõX6B hİ‹—Oìƒ&âù#§$”k“;ğ!ÎŞ@CíYƒKÄ×>N$ÃCğ{ï™Q•ç«ö_]ÙÎ¶›®œÍW³íå§E÷G¹™/Îºò²­–WåÇU‡6gËM;›Á„)ÏæÀ_Ï×åŠıÍ`È,my±½:oWÛËE»İ”ËóåU÷{9k‰ÌE·^ÏyU~Ü.İf’üs»Ü Ç«óÅGè¬òÓb‰®céÙÇXÖ-ókzÖŸw«” vLöu·Ú\,·ëöê¬|?ßÎÒó¢û´)_î'`L‡4”Üj~~±éÉÊñ#V%´îê¬]_”İ¥$‘w›U{Ö]¶«ßËõ„ˆºì&cÿÖ³u}İÎ:FÊ‹Ï×İoBÓZÀŒRåå‰ádçË3®ğÎÒZS£ÓÌ|¢qNQmÃŒøS¹)åÇ?—ÏÛëŸ;eÏwÓ]şl9æ‹Îˆ†—?Ÿ"ÃQ-Úó5l¢ò×ÜKcÇ0„ô‰Ö´C¿u4øäÌÚ{Åä <éŠ'J•‘vt;>ítuëi·c†»“ƒ_~’CøéËîßOß,/Û«
vÙS˜X7¾xÿ7²<“é¼ïàÓp–¨œEQá78låÇ‡Q4Çs{¦ñ02‚ş0B,¶FCÁœça¤xpĞ³c 4PÙ¤º\_—Û—y9ÈR]c†vù0"Fãppñ&_ænã<Æ)ÛÜ =å=oÔ'óË4y"ô¥<û´Ph
úŸi»ğ/s—-š¦ÙéQ~×1Â`¥çU±èE¨å‰QÅö‚“Ôˆ™!ÎRä^^½)õ*½k0V†%¯š¹JÒGêÅ}7Ğ \‚Ì•„PE³\Å«êñaÈ6y5¦À‹‘ š#ÈóÌp¾pÚùÛëêÑ*ì½¯<¯üXn{ïn˜¨´jĞgÇĞÇPÇªÂ?k‘[rjføÌ±uå±s,aÆ	 ğ}Pˆ.°)ÿÁ…9vš š†¥ò¯bşyÅ_ø…ƒşÒøçñ+°¤’b=Ö°UÒ¯»ÊÕÜ£\ÇúBùD[šEp¨Bcvµé]n¬W«¬U«ÈÍ¿ÍÏÖïU´íå=	SãÏ981Š¹¬ËçË-ÃUyrúëéŸìSı´úó¨«:^Vãl¯bšºR)š£ê¼NQ};œ`1¸­Óm_¬ìb'u3
Éè:Ş:ªÓ¨:´
FÕiTR¯ê±óâèFÉè&†ö¡OÓ¨&j|JÓ¨6ÍÕÆ¹ÂÅJ©™†º2ºµ9N9I-iô‘åá–ÄÓâı—¼²’4†ƒä%TŒ·=rô°C©äy7B'ÏX—:H÷}TòšIPñ±SŒt)yĞt{Ô«<UVŞ-Å&ÑŸFÃê‡ºıÏ–‹³[œşÿKÜ4#›»+‡ÿıQº³ål»â
~¦~Ãò,ï®>24‰£¥o=[^N]®Î>u—ó«ùí{].–çóY»¸Zn’©_®ºóùZú¼ægİùªëÊëÅvÌíºÜü{¹ŞŠñ¿*7¨ëEáÙëôÂièÛƒœËv=Û.„XùÏm»³íâS!®V.¢¤ÄÑF‹{{ĞÏü@äòà°|‡?ŒÈ‡ùp„|ØcÄ6'±ÍÉ¨ÍIßæpsQ¾ŒÃ½ŠÍ_Åæ¯FÍ_¥=Öåv±™_/>—¯Ö
Â»ˆú.¢¾¡¾ëq~‹•§ËD¤[á …t­Ë6mØXİpÛ8lÛwÑ
ZìëÌ†."w¹!w=Ö<¶™Ç6óQ›yß¦®âpËØ|›/GÍ—©Au6ÿ×œ‘	Ûˆ¸ˆÛâ¶Çø+7Â„Ï¹øÃX?†ÇÅ$_·ğéjùDL—©SÆ÷©;N™¹Ã)›š½rä°8iF¥ºğ°èVŒ"ÂD÷ªÆ÷ e|ä:ôMÜõcJÜ«zDô±®zœf…gôÑyBëé¬Á}`ÑDF ƒaô1¹:>µmpJ˜&Œ6‘‘’ÒÃqç”‘ş™Œq2ø$ìX¹>•ğS­òi­ƒÓÂr†4ái¸Ğ´Àø›ù Áv-6¾“»?FòjØ;V| 	UÂêÄ‘«Èa¬ñøcà"df	áù+Z›œ-2¾†Ş‡=î!ÏNzŠ.`É3||ídç{˜®Ù˜E\§Ìª<…\fsÛöÓdÄ82:bµ¯àzí†utıháŒ ÊÃ ”™,S ]1š¾Û·ˆDeû¥ÙtsIÅaÜ[cW/‰Ã„‡µëÃ¨b™ÈùÈVPãHV“#YÁŞáXÛG­,½QÔ
¶:ºd Öx£ıÈÍšè¨½n•7fçjæö`Õş«™£WÏ^üt¼Ü}ş'Ëf¹\tgÏNŸ¼éÎ·‹vuS1ÖWŒ_tİaÑ¾úfÀoFŒáuI#Ï[(XÁ8Æ4A»¥*Ñ&n‚Œ¤ıC@Ãê'°†Wr~ÙP3ÖÁ[V'w}QybSpSÖVÀóá„×EÃHTƒM!‚h%õD
kCeÊkjÃ †Ò*¹–äDä¤à'ceå3+~_5ZPc¨Şë¨…ãÂÇVŠ@JÒ/lÏ—¥m$È¯c¿ñì›_ãğÂ(˜U$ÊÍ M%œ²NïGh|Ü›†\*^036Ø)ëa^Šyè!¨Ñ¹Aòb‰V%KÆä_4IZ<“.ZÒı‡”‘mùN,icö-mX‡…|4Â
ÀMÀ¬áşR(D F¢†Y“@Ü SŠpŞ¢Åàjsùo´,lÔ ür`q bĞ‹Ã.È2çúP$DÔœšjOÕ„Q­|[”ïÊ¿—¿”§åAù²ü­|^¾*._”¯£—S–Gå›qdËWÃİE·\zèş0%¬õöPÂÔ
¨nÜN¬ë>y‹Z;jYİª–÷zòôèÅËŸşK-»~ª+ôSúH7²øõÁ·ºÿ`°»[ÅƒŒæşå‹ eëT)al¨KP ^wŞ—WÊ°w!_6U.uéŸÃ¶$Ğ0İœcàW;@ñÌërlÉñpû ³¡`0¾–ÃGî´åË»øñ"§|Ü7À—‚¬?Íø*På;;p÷1ée¨“4ÔïjÿĞvLÅ/)´\x¥ån{
Ò'êr¿Ş>Ö&|/^ş·‚7ÃZï{ïåyÁèë17)¯9ŒDæEUš:Üq;"WØæ÷İG¸ôõÏƒî#*hh~ïÉWèØW»ú6ey×MDÒÌæã³îÊäªæëƒıMníö–?4xĞûÏÙÔ	Ñœ'Ä¯ÎÁÔKJ+ğ+ƒâØÉÓ%˜$|ÿ’	bÿ&Gã™ô\)¢ÃIÜh«Ç>Ä!c"9‡bûe¤;ƒô ‚˜g:ÜF‡Œ“^lh"^húò0êãŞàA=0+­©	T#Jš´
H&ÏK”±Á›}BĞ÷RïF
úèäèA&ÿAÑƒüm2S¾SšF’@ô‚‘eì\e¸5zdbg'àMŠL`ß¼2ï€Ñ¿=*Û²Zß¡µÓÚêÛB¾’~ùl¤İ¾ÂH]í>{LVív£}è…SŒNÜñÌôtÒ×Î[ÍŞ—ÜN¥Û³<Kü¾ÿ±ßk¹xë8ºtj¢ëjò½Ö×|Õ?î¿À¨$è™_;5ºÉ|õºøÔ.Ö]ê0ß6–?ŸB`>µÛÅ¦|{›ô›Õöíÿº¾ò
endstream
endobj
616 0 obj
<</Info 615 0 R/Filter/FlateDecode/Type/XRef/W[1 3 2]/Index[0 617]/ID [<6ba1a08c8c7b476953861dd0fd6af69f><cf72a3a9b7701359c7d7594bb70a6f96>]/Root 596 0 R/Length 1723/Size 617>>stream
xœ5×wX—Uğ÷¼[Aœ¸MQD@ÄŠ{ïr›€Š€¥¶M-3G) ˆ’#+ÛÃ²¥PÉ¥«z¬,µa64Ë¦ñırøçóœçåû»ç¾÷½÷b†qã†qgÃ4Œ†!FÈ%è/‡1[`ĞW0ö=Øà_ÜK†u·ÁP¶*‚[Â°08*F-öhØf;L¸F¦Ã¾y0¾1øl{°`‹ù°ÿ£pL8ôl6F·Ş»]ƒf44êÃÁU°WXİÙÕºRO(£áÄ±ôq8É¤á¤wàd›æÒ]p
ëš’OOÂ©íé*zNëG9òiWámèó”£DYubÊYMÜ“Ñû(kIîLÒoàŒXºrfRXK
kIe-©¬%•µ¤±–´9t'LoGùÒOÀ™¬næJz
f°–Ö’qfò]d>GƒY¬%‹µd7¤œçìá¬¦t1åûİƒ>L/ÃœÊ•Ã_™3rÆrÙg.ûÌeŸyì3}æÑ5,bÌ›ŠX.CiíO»±Å8†±I]êP[Œ|íöİÚ§'Æ“5®C}Hh]1¶:ÈÚÈw´y¢¶¯'Æ‰Ã:p>©Oƒh#Ú6ã8kü˜ëêğ0xôAí§±ˆs^ã`Ú„6§ÍhSoA3#ø¢ù¼…H|Æ­hKzmC[‹Ä• «V…ÄşMƒ4«­HÖACh;J;Ğö"AÈJÁz®1Iñ4ëf‘µ§5çlt¢|F#iG!RˆıDVã›•‚mšÛIäà·GÓ(K;Ó‘ªJdU>DÂò$Íê"r}ƒÆ]iíA»Ón"à+ßæÂ+µ3/fì|{qü5¿Ø“ö¡	´·˜Ñ˜I³S0ŒXÃ†ÃĞ@í¡¯˜Ùµë¤?íGÑt€˜‡•¾¦Õ|°˜¥ïj<”¡#èp:LÌ¢óÈ*Áşl®Æœ˜…£5k¤˜U³4MGÑqt,#æ¾Wµ·VÔ…»4ë1ÿŠÔx<½•N¢é1¯ã=š¿cÿ7¯v€×fhÖd±âÆi<•N¡ÓémtšX±xƒVTS¤íÅJİ®q2M¢©4…Î+§••ôœ~YÛ§‰U6Hã™4fÑLš!V)ÎA«shí……áğ±° ·ö-VUªÆ³é,šKçĞ±ö÷AVy+Xù4Ü}R³òÄºú‹Æsi>Gï ·‹uå^d]fîÏUÚ~¾ØQç4¾“k²æ[X@ï¡wÓ»ÄÄ¹l‡/…íñfíĞc°İ<íá^±3Fë~U³¢î§÷ÑEôºPì4œ¡vÊD8#K{X,ö†Ï4~.¡Ó¥ô!±KpÙ¥° g™½vf-ûÀH—ÓGè*º’®»;­]ù,Üó€¶TìjWõjú-¤tØ²öëØçík8ƒì«µ¿X$NLÆÅ´„®åœÔìëi)]'NtóêœÈB1
†'kÄÉ©ıf§et3İD7Š3»ƒ™'{“¾C³¶ˆSvAã­ô	ú4}Š>)Îz|#N1nNÉrm¿Mœã5~>KŸ¡Ï±¢â®ı.^¢/ÒÄ9ö*z;ŠoÇù¤\Û¼,®«ñ«ôú:}n×ÂçÜÀ­ÉœÎ¿ašµCÜø/4~“cèÂøú}›¾%n×}è¡;înÌO°K#Íİ)nÎbß¥»èô}ú¸Ùì!3ì¦_Ôö»Åİ4Pã½t­¤´\Ü2Ôî–şK°Ÿ»Å‡4kŸ¸g?Òø İÏZ„Ö<¯#ö÷sÜHİ3¸]»§'è÷eŠ4Rc›ÖÜL<êRG¼€5ÕY· úèÁ³+4Ë/!Qãº´­Gi€x=·"«û=0şm$^ş7 õicÚˆ6/ç ²òÆÃYØ7¼ÌD˜]ª¹MÄÛ\®qSL[Ğæ´™x›ğ]xëYEî«^ÉXº\s[Š÷SÆ­i+Ú–ŞDÛˆ÷ñÈú'©÷#n†ŞyÜy¼ÃGáçQğ;Ü½ƒõàq>ù~<±	[/í`ìŞ¡sğ3ÜX¼8+½S{àÙ,xrüô%ø%Ç1IÇÙNü˜ ÛÓz3¥ÄÅíG…Â6+`$Få7áóæøŞı¿ÂN10'…ßw~?«ÎoŠÿÎü8;ü¶ü«C>:†Hñ'Í×8Š&ˆ?u>‰¦qâçó×—åêó®´'íA{Ó´/§½ªs“5«ø‹ŞÒ¸LÑâ/ÅYã?Ô–UïÿßüÅOı4
endstream
endobj
startxref
568781
%%EOF
